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A growing body of evidence shows that presynaptic nerve terminals throughout the nervous system are 
vulnerable to a range of traumatic, toxic and disease-related neurodegenerative stimuli. The aim of this 
study was to further characterise this vulnerability by examining the response of mouse -motor nerve 
terminals at the neuromuscular junction (NMJ) to hypoxia-reperfusion injury. To address this aim, a 
novel model system was generated in which ex vivo skeletal muscle preparations could be maintained 
in an hypoxic environment, at an O2 concentration below in vivo normoxic values (<0.25% O2), for 2hr 
followed by 2hr reperfusion (2H-2R). Using this model system combined with quantitative assessment 
of immunohistological preparations as well as some ultrastructural observations, I present evidence to 
show that -motor nerve terminals are rapidly and selectively vulnerable to hypoxia-reperfusion injury 
with no apparent perturbations to postsynaptic endplates or muscle fibres.  I show that the severity of 
-motor nerve terminal pathology is age and muscle type/location dependent: in 8-12wk old mice, 
nerve terminals in fast-twitch lumbrical muscles are more vulnerable than predominantly slow-twitch 
transversus abdominis and triangularis sterni. In 5-6 week old mice however, there is an age 
dependent increase in vulnerability of -motor nerve terminals from the predominantly slow-twitch 
muscles while the fast-twitch lumbricals remained unaffected by age. The functional, morphological 
and ultrastructural pathology observed in -motor nerve terminals following 2H-2R is indicative of 
selective and ongoing nerve terminal disassembly but, occurs via a mechanism distinct from Wallerian 
degeneration, as the neuroprotective slow Wallerian degeneration (Wld
s
) gene did not protect nerve 
terminals from these pathological changes. I also provide provisional evidence to show that 1A/II 
muscle spindle afferents and -motor nerve terminals are more resistant to hypoxia-reperfusion injury 
compared with -motor nerve terminals. In addition to this, I also report preliminary finding that 
indicate that the oxygen storing protein, neuroglobin, maybe expressed at the mouse NMJ and report 
the difficulties of using mice that express yellow fluorescent protein (YFP) in their neurons for 
repeat/live imaging studies. Overall, these data show that the model of hypoxia-reperfusion injury 
developed in this study is robust and repeatable, that it induces rapid, quantitative changes in -motor 
nerve terminals and that it can be used to further examine the mechanisms regulating nerve terminal 
vulnerability in response to hypoxia-reperfusion injuries. These findings have clinical implications for 
the use of surgical tourniquets and in the aetiology of many neurodegenerative diseases and 
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1.1 General introduction 
 
“…one common brief fundamental law …: The nervous system consists of numerous 
nerve units (neurons), anatomically and genetically independent. Each nerve unit 
consists of three parts: the nerve cell, the nerve fiber and the fiber arborizations 
(terminal arborizations).” 
                                                            (Waldeyer 1891) 
          
The subject of neuroanatomy and pathology has a long history with documented evidence of its study 
extending as far back as the ancient Egyptians with the Edwin Smith Surgical Papyrus. Dating from c. 
3000-1700 BC, this papyrus describes the symptoms of 48 patients many of whom had head wounds. 
The unknown Egyptian author annotated his clinical findings and suggested treatments (only one of 
which included magic) with observations of the brain, skull, cerebrospinal fluid and meninges 
(Feldman and Goodrich 1999). Our modern understanding of neuroanatomy and pathology however, 
has its foundations in the 19
th
 century with the works of a number of eminent scientists, anatomists and 
clinicians, the most notable of which were Santiago Ramón y Cajal and Camillo Golgi (see  Shepherd 
1991) for a full historical review). During the 1880‟s Golgi discovered a technique that enabled 
neurons to be filled with silver chromate allowing for the first time the resolution required to explore 
the gross structural features of the nervous system that Golgi, Cajal and many others used to great 
effect.  By the end of the 19
th
 century, Wilhelm Waldeyer was able to combine the works and ideas of 
his peers with his skills of scientific interpretation and talent for terminology to produce the 
fundamental law of the nervous system translated above (Shepherd 1991).  It is now unequivocally 
accepted that neurons are the highly specialized cells that form the basic unit of the nervous system and 
that they mediate the transfer and integration of electrical and chemical information from one part of an 
organism to another. It is however, worth noting that the neuron wasn‟t conclusively confirmed to be 
anatomically independent until the electron microscope was developed
1
 and used in the 1950‟s to show 
that nerve terminals were truly separated from their targets cells (Palade and Palay 1954; De Robertis 
and Danielli 1959). This finally gave the fine structural details to add to Charles Sherrington‟s theory 
of the „synapse‟ in 1897 (Liddel 1952; Shepherd 1991). What many of these early scientists 
demonstrated is that clear and systematic study of neuronal structure gives important clues to neuronal 
function. The intrinsic relationship between structure and function can be demonstrated in pathological 
conditions where abnormal function i.e., the clinical manifestations, more often than not can be directly 
linked to some kind of structural change. As a result, observations of structural changes can provide an 
important starting point in determining and understanding pathological processes.  
 
                                                          
1 The first prototype of the electron microscope was built by Ernst Ruska in 1931 and for his continual development of field of 
electron optics and microscopy; he was awarded the Nobel Prize for Physics in 1986. For their work on the structure of nervous 
system Golgi & Cajal shared a Nobel Prizes in 1906 and for his work on the function of the nervous system Sherrington also 
received a Nobel Prize in 1932.  (Nobelprize.org) 
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With our improved understanding of neurons, Waldeyer‟s concept of a neuron being composed of at 
least three structural parts or compartments appears to be increasingly important, particularly in regards 
to neuropathology. We now know that as well as being structurally different, the cell body, axon and 
nerve terminal may also be considered compartmentalised by their functional roles, metabolic 
properties and their vulnerability to pathological stimuli.  Recent work in many traumatic, toxic and 
disease-related neurodegenerative conditions has highlighted the fact that nerve terminals appear to be 
highly vulnerable, with changes in their structure and function often appearing prior to changes in 
axons or cell bodies. The loss of nerve terminals undoubtedly causes a loss in neuronal connectivity 
and function, and therefore contributes to many of the punitive symptoms that characterise 
neuropathological conditions. One condition that affects up to 1 in 11,000 people in the UK is 
ischaemic paralysis following the routine use of surgical and non-surgical tourniquets (Kam 2007). 
This condition is characterised by long-term neurological and functional defects affecting -motor 
neurons and their command of skeletal muscle, but the exact cause of this injury is still poorly 
understood. There is some indication that -motor nerve terminals may be the principal site of 
tourniquet-induced paralysis and that hypoxia/ischaemia-reperfusion injury caused by tourniquets may 
be the principal stimulus. The potential involvement of -motor nerve terminals in ischaemic paralysis 
and their vulnerability to hypoxia/ischaemia-reperfusion injury however, has yet to be conclusively 
addressed.  This represents a serious gap in our knowledge and understanding of -motor neurons, 
their nerve terminals and the cause of ischaemic paralysis following the use of tourniquets.  
 
In the following chapter, I will review some of the evidence suggesting that -motor nerve terminals 
are vulnerable to hypoxia/ischaemia-reperfusion injury. This includes their high energetic demands, the 
known vulnerability of nerve terminals, in general, to a range of pathological stimuli and the known 
vulnerability of nerve terminals to hypoxia/ischaemia-reperfusion injuries in the central nervous system 
(CNS). Finally, I will review our current knowledge of peripheral nerve hypoxia/ischaemia-reperfusion 
injuries and why it is still unclear if -motor nerve terminals are vulnerable. I will however begin the 
discussion with a brief overview of why hypoxia (ischaemia) is a pathological stimulus and the basic 
structure and function of -motor neurons and their nerve terminals. The rest of this study documents 
the progress made into resolving the issue of vulnerability of -motor nerve terminals in response to 
hypoxia-reperfusion injury. 
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1.2 Oxygen & cellular respiration 
 
To determine if and how peripheral -motor nerve terminals are vulnerable to hypoxia-reperfusion 
injury it is important to understand why hypoxia is a pathological stimulus. The following section 
therefore takes a very brief look at aerobic respiration and the role of oxygen to provide a basis for 
understanding the consequences of hypoxia-reperfusion injury at -motor nerve terminals and to 
clearly introduce some important aspects of cellular metabolism that are referred to in later 
discussions.  More detailed information can be found in a range of standard texts, including Alberts et 
al. (1989), Zubay (1998), Hanes and Hooper (2000), Lodish et al. (2008) which have been used in 
general reference in the following section.  
1.2.1 Why is oxygen important?  
Oxygen (O2) is a colourless, odourless diatomic gas that makes up 21% of the atmosphere and is vital 
for aerobic respiration that sustains many forms of prokaryotic and eukaryotic life. Aerobic respiration 
is an exergonic process that liberates energy in the presence of O2 from ingested/stored „food‟. This 
liberated energy is used to drive the phosphorylation of adenine nucleotides to generate the universal 
energy carrying molecule, adenosine triphosphate (ATP). The energy released by dephosphorylation 
of ATP into adenosine diphosphate (ADP) and to a lesser extent adenosine monophosphate (AMP) 
supplies all the cells endergonic processes, i.e., those processes that require energy, which maintain 
cellular homeostasis, morphology, and those that carry out generic as well as cell-specific functions.  
1.2.2 Cellular respiration  
The chemical fuel that supplies the energy for ATP synthesis can come from lipids, proteins or 
carbohydrates/sugars derived from ingested food. With limited cellular fuel stores, neurons almost 
solely rely on glucose supplied from the blood stream (Zubay 1998) and for this reason, only glucose 
metabolism will be considered here. The whole process of aerobic respiration using glucose as the fuel 
source and dephosphorylation of ATP can be summarized as: 
C6H12O6 +  6O2 → 6CO2 + 6H2O  + ~30ATP
2
 
ATP +  H2O → ADP + HPO4  + H
+
 + „free energy‟ 
 
The process of liberating the energy stored in glucose to ATP begins with the breakdown of glucose (a 
6-carbon compound) to a pyruvate (a 3-carbon compound) via the process glycolysis which yields two 
molecules of ATP. Pyruvate is then further catabolised into carbon dioxide (CO2: a single carbon 
compound) in the Krebs‟ cycle (alternatively known as the citric acid cycle or the tricarboxylic acid 
cycle) that drives the phosphorylation of 1 molecule of ATP per turn of the cycle. Both glycolysis and 
                                                          
2 There is considerable debate over the exact yield of ATP during aerobic respiration with values ranging from 29.5 to 36 
molecules of ATP per glucose. I have elected for the conservative, whole number estimate of 30ATP‟s used by Zubay (1998).  
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the Krebs‟ cycle do not require oxygen i.e., they are anaerobic, and collectively yield four molecules 
of ATP. By harvesting electrons from glucose as it is catabolised to CO2 and donating them to O2, via 
the process of electron transport and oxidative phosphorylation that occurs in the mitochondria, a cell 
may increase this energy yield ~8 times.  
 
1.2.3 Mitochondria, electron transport and oxidative phosphorylation 
Mitochondria are large (1-10m) bean-shaped, double-membrane bound organelles and their inner 
membrane is convoluted into a number of finger-like projection (cristae) that gives mitochondria their 
highly characteristic morphology. Mitochondria play an important role in buffering intracellular Ca
2+
 
via a range of Ca
2+




 exchanger) located on the mitochondrial 
membranes and can therefore modulate intracellular processes via Ca
2+
 signalling. Mitochondria can 
also mediate programmed cell death or „apoptosis‟ by releasing cytochrome c (either by rupture or by 
the formation of pores) which activate caspases, a family of cysteine proteases that bring about the 
execution of cell death. The primary role of mitochondria however is electron transport and oxidative 
phosphorylation that supplies most of a cell‟s ATP. As glucose is broken down during glycolysis and 




 ions are harvested and bound to electron carriers. The 
electron carriers most commonly used by a cell during respiration are nicotinamide adenine 
Fig 1.1 Overview of the electron transport chain and oxidative phosphorylation. 
The four protein complexes (I, II, III and IV) and cytochrome c that constitute the 
electron transport chain are embedded in the inner-membrane of mitochondria. NADH 
and FADH2 carry electrons from the sites of glycolysis and the Krebs’ cycle to the 
electron transport chain where they are oxidised and release their electrons. As the 
electrons are passed down the chain they pump H
+
 into the inter-membrane space to 
form an electrochemical/concentration gradient. These H
+
 pass down their gradient via 
ATP synthase providing the energy required to drive the re-phosphorylation of ADP to 
ATP. The process is completed when the electrons are donated to O2 in the presence of 
H
+





) and flavin adenine dinucleotide (FAD), and as they gain electrons, they become 













 ↔ FADH2 
 
NADH generated by glycolysis in the cell cytosol and, NADH and FADH2 generated by the Krebs‟ 
cycle in mitochondria transport e
-
 to the electron transport chain imbedded into the inner-membrane of 




 ions (i.e., they become oxidized) and return to the 
sites of glycolysis and the Krebs‟ cycle to harvest more e
-
. The electron transport chain (see Fig1.1) is 
composed of four large protein complexes (I, II, III and IV) and cytochrome c that sequentially carry 
and exchange e
-
 to finally donate them to O2 in the presence of H
+
 to form H2O. The energy generated 
by the exchange of e
- 
down the chain powers H
+
 pumps and the movement of H
+
 into the inter-
membrane space to form a potential store of energy as an electrochemical/concentration gradient. As 
and when the cell requires, H
+
 ions are allowed to flow down their H
+
 electrochemical gradient, 
controlled by ATP synthase, to provide the energy to drive the phosphorylation of ADP to ATP. 
Collectively this process is known as oxidative phosphorylation and generates ~26 molecules of ATP 
per glucose, providing >86% of the total supply of ATP.     
 
1.2.4 Why does hypoxia kill cells?  
The average adult human will utilize ~60kg of ATP a day while a top marathon runner can expect to 
generated and consume a similar amount in a little over 2hr (Buono and Kolkhorst 2001). It would be 
almost impossible for humans or any organism to store the amount of ATP required to fuel daily 
activities and therefore they have to rely on the constant recycling of dephosphorylated ATP to fulfil 
their bioenergetic needs (Buono and Kolkhorst 2001). The most likely cause of insufficient ATP and a 
failure in cellular respiration is the inhibition of electron transport and oxidative phosphorylation due 
to the lack of oxygen. A lack of oxygen (hypoxia) can occur in a variety of different situations: 
environmental changes (e.g., at altitude), poor/intermittent gaseous exchange, or the result of 
reduced/impaired blood flow (ischaemia). The latter, ischaemia, is perhaps the best studied however, 
it is important to note that while many authors use the terms hypoxia and ischaemia interchangeably 
they represent related but distinct stimuli. Hypoxia refers to a lack of oxygen while ischaemia refers to 
a reduction/loss of the blood supply.  Ischaemia therefore, not only encompasses hypoxia but also 
hypoglycaemia and other co-stimuli related to a loss or stagnation of blood supply. It is however the 
hypoxic element of ischaemia that is believed to be the major pathological stimulus.  
 
In response to hypoxia/ischaemia cells are forced to reduce and adapt metabolic output as the supply 
of ATP becomes depleted. For a limited duration, cells may survive on already dissolved O2 and ATP 
generated via anaerobic pathways, however insufficient oxidation of NADH and FADH2 will also 
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eventually inhibit glycolysis and the Krebs‟ cycle. This can in part, be prevented by the conversation 
of pyruvate to lactate via lactate dehydrogenase.  
 
pyruvate + NADH + H
+




The production of lactate and other adaptive responses can generally only buffer transient 
hypoxic/ischaemic insults as they cannot make up for the >86% of ATP generated via electron 
transport and oxidative phosphorylation. As ATP levels fall further, there will be an increasing failure 
of all ATP-dependent process and loss of cellular homeostasis. In particular, leak currents in the 
plasma membrane will go unchecked and accumulated ions (and other substances) will dissipate down 
their concentration gradients which can quickly lead to irrecoverable cellular damage and death (Hand 
and Menze 2008). Once cell death has become an inevitable outcome, residual ATP levels become 
pivotal in determining the mechanism of cell death.  If the damage is severe and/or there is little or no 
available ATP, cell death will proceed by necrosis characterized by cellular swelling and lysis, 
mediated by Ca
2+
 proteolytic enzymes such as calpains.  Less severe damage and/or residual levels 
ATP may allow for activation of an active, regulated program of cell death i.e., apoptosis 
characterized by cell shrinkage without lysis, typically mediated by mitochondrial release of 
cytochrome c and subsequent activation of caspases (e.g., Ankarcrona et al. 1995; Eguchi et al. 1997; 
Leist et al. 1997; Northington et al. 2007; Hand and Menze 2008; Mattson et al. 2008).  
 
1.2.5 Summary 
ATP is the major source of energy for most cells and the energy released by de-phosphorylation of 
ATP is used to fuel a range of activities from basic homeostasis to specific cell functions. The major 
source of ATP is from electron transport and oxidative phosphorylation in the mitochondria; however, 
this process relies heavily on a constant supply of O2. If O2 becomes rate limiting (hypoxia) as 
commonly occurs due to a failure in the blood supply (ischaemia), ATP levels will quickly begin to 
fall causing a failure in all ATP-dependent process that can quickly lead to cell death. The remaining 
levels of ATP are then pivotal in determining the mechanism of cell death. 
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1.3. Structure and function of  -motor neurons 
 
-motor neurons have a specialized structure that allows them to carry out their specific role of 
controlling posture and commanding voluntary skeletal muscle movement (Fig1.2). In the following 
chapter, I review the basic structure of -motor neurons to demonstrate that each compartment has 
specific structural characteristics related to their function. I will also briefly describe the functional 
and structural characteristics of skeletal muscle, as it is important to consider that efficient control of 
movement and posture relies on both muscle and -motor neurons. Overall, this will provide the basis 
for understanding structural and functional response(s), especially of nerve terminals, to hypoxia-
reperfusion injury. Further details, and used in general reference for the following section, can be 
found, for example in Kuffler et al. (1984), Kandel and Schwartz 1985, Alberts et al.  1989,  Hall and 
Sanes (1993), Sanes and Lichtman (1999): Longstaff (2000) and Lodish et al. (2008). 
1.3.1 Cell Body & Dendrites 
The cell bodies of mammalian -motor neurons are situated in the ventral horn of the spinal cord. The 
cell body is the location of the neuron‟s nucleus and synthetic machinery for the generation of 
proteins, enzymes, signalling molecules and many other macromolecules vital for cell survival and 
function. The dendrites of the cell body are the primary receptive region of -motor neurons, 
receiving synaptic inputs from other neurons located within the CNS. The primary role of cell bodies 
is therefore to provide trophic support for the rest of the neuron and the coordination/initiation of 
electrical impulse to bring about muscle fibre contraction. In mammals, each motor neuron may 
command up to several thousand muscle fibres, where the motor neuron and the fibres that it 
innervates are collectively referred to as a „motor unit‟ (Kandel and Schwartz 1985; Longstaff et al. 
2000) 
1.3.2 Axons 
Inputs received onto the dendrites are conveyed by membrane depolarization (action potentials) via 
axons that track though the periphery to targeted skeletal muscle fibres. Axons typically bundle 
together to form „nerves‟ that exit the spinal cord through the ventral roots. The primary role of axons 
is the propagation of action potentials from the cell body to the nerve terminal. One of the most salient 
features of motor neurons is their overall length and the axon, as a general rule in vertebrates, can 
extend approximately half the overall length of the animal (e.g., over a metre in humans or 10 metres 
in a whale: Bunge 1986). Their structure is therefore highly dependent on the cytoskeleton that 
provides mechanical/structural support for the maintenance of overall morphology and transportation 
of macromolecules and organelles to and from nerve terminals and cell bodies (reviewed by Wuerker 
and Kirkpatrick 1972). Neurofilaments, composed of polymerised light (~68kDa), medium (~168kDa) 
and heavy filaments (~200kDa), are the most stable of the three cytoskeletal components with a half-
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life estimated to be 1-2 years and provide the most mechanical support (Petzold 2005). In direct 
contrast, microfilaments and microtubules are highly dynamic and undergo constant polymerisation 
and depolymerisation (treadmilling) of their constituent units, actin and tubulin respectively.  
Microfilaments and microtubules however can be stabilised with a variety of associated proteins and 
complexes so that they can provide the stability required for the transportation of macromolecules and 
organelles to and from nerve terminals and cell bodies (for reviews see e.g., Galbraith and Gallant 
2000; Dent and Gertler 2003; Dillon and Goda 2005).  To aid the speed and efficiency of action 
potential conduction along the length of the axon, Schwann cells wrap around and insulate axons in a 
myelin sheath and by leaving gaps of 1-2m of exposed axon („nodes of Ranvier‟), action potentials 









 exchangers, voltage-gated Na
+
 channels and others, that are responsible 
for polarisation and depolarization of the axon membrane are located. 
1.3.3 The neuromuscular junction (NMJ) 
First indentified as early as 1830s by Valentin and Emmert, and famously studied by numerous 
eminent scientists including Kühne, Ranvier and Cajal (Lu and Lichtman 2007), the neuromuscular 
junction (NMJ) is the specialised communication point between -motor neurons and muscle fibres.  
In the adult, each skeletal muscle fibre is innervated by only one collateral branch of an -motor 
neuron. The NMJ is composed of the presynaptic -motor nerve terminal, the postsynaptic endplate
3
 
located on the muscle fibre and terminal Schwann cells. For this reason, it is often referred to as being 
a „tripartite‟ synapse and is found in a depression in the central region of each muscle fibre. The 
primary role of the NMJ is the conversion of the electrical impulses/action potentials initiated at the 
cell body and conveyed by the axon into a chemical signal that can trigger the contraction of muscle 
fibres. 
 
-motor nerve terminals 
-motor nerve terminals are formed by a series of small closely packed varicosities or „boutons‟, 
approximately 1-5m in diameter linked by fine unmyelinated axons. Collectively, these boutons 
form the arborisation of the nerve terminal that in adult rodents typically ranges from ~20 to 50m in 
size.  Nerve terminals are loaded with up ~170,000 synaptic vesicles (Reid et al. 1999), ~40nm 
diameter organelles, that cluster towards and bind with synaptic contact points or active zones on 
regions of the presynaptic bouton membrane that directly oppose post-synaptic specialisations. Upon 
the arrival of an action potential and the influx of Ca
2+
 via voltage gated Ca
2+
  ion channels, vesicles 
bound to presynaptic active zones and that have been primed to response to Ca
2+
  undergo fusion-pore 
opening with the presynaptic membrane to release chemical neurotransmitters into the synaptic cleft. 
                                                          
3 In some of the early studies of NMJ morphology, Wilhelm Krause (1863) coined the termed “motorische endplatte” (muscle 
endplate) referring to the entire NMJ, both pre- and postsynaptic (Lu and Lichtman 2007). While the term endplate is still in 
use, in more recent times it has been increasingly used to refer to just the specialised postsynaptic structures on the muscle fibre.   




Fig 1.2 Organisation of -motor neurons and the neuromuscular junction. a) 
The cell bodies of -motor neurons are located in the spinal cord and project axons 
in the periphery to innervate skeletal muscle. b)  Neuromuscular junctions are the 
specialised communication point between -motor neuron and skeletal muscle. In 
the adult, each muscle fibre is innervated by one -motor neuron but each -motor 
neuron innervates several muscle fibres to form motor units. c) The nerve terminal 
of -motor neurons forms an arborisation on each muscle fibre. b) The nerve 
terminal arborisation is composed of series of boutons that synapse with skeletal 
muscle fibres. The presynaptic membrane of the nerve terminal boutons contains 
active zones that are the sites of synaptic vesicle release. Separated by the 
synaptic cleft and opposing the presynaptic membrane is the postsynaptic endplate 
of the muscle fibre that is highly folded with high densities of acetylcholine receptors 
(AChRs). Figure adapted from Hall and Sanes 1993. 
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his process of exocytosis is then followed by endocytosis, whereby empty vesicles are recycled and 
refilled with neurotransmitter chiefly acetylcholine (ACh) but also compounds including ATP.  The 
ACh released by nerve terminals traverses the ~50nm synaptic cleft that contains the synaptic basal 
lamina and separates the pre- and postsynaptic apparatus and binds to postsynaptic nicotinic 
acetylcholine receptors (AChRs). 
 To limit the duration of action, ACh is deactivated by acetylcholinesterase bound to the synaptic 
basal lamina into acetate and choline, the latter of which is transported back into the nerve terminal. 
Further metabolism by several enzymes, including choline acetyltransferase (CHAT: first identified 




Directly opposing the  motor nerve terminal is the postsynaptic specialisation or muscle fibre 
endplate. The endplate is composed of a highly folded membrane with AChRs densely packed on the 
top of crests directly opposing the presynaptic active zones and voltage gated Na
+
 channels located at 




 to trigger a 
localised depolarisation known as an endplate potential (EPP), that if above threshold activates 
voltage gated Na
+
 channels to depolarise the whole muscle fibre generating the muscle action 
potential (MAP). Spontaneous release of single vesicles from active zones trigger miniature endplate 
potentials (MEPP) that are not above threshold and do not trigger whole muscle fibre depolarisation. 
  
Schwann cells 
Once the axon starts to specialize into the nerve terminal, myelinating Schwann cells are replaced by 
up to four unmyelinating terminal Schwann cells that completely overlie the nerve terminal but do not 
intrude into the synaptic cleft (Palade and Palay 1954; Desaki and Uehara 1981). Schwann cells are 
electrically non-excitable so do not play a direct role in neurotransmission but they have an important 
role in the development, maintenance, plasticity and pathological responses of motor neurons and 
their nerve terminals.  
 
1.3.4 Muscle Fibres (and Muscle Spindles) 
Skeletal muscle is formed from the fusion of multiple myoblasts into multinucleated, elongated fibres 
that are ~10-100m in diameter and can extend the length of the muscle of which they form a part. A 
thin layer of connective tissue encases each muscle fibre (endomysium) and groups of muscle fibres 
(perimysium) to form a continuous network of connections with the thick outer layer of muscle 
(epimysium) and tendons to which muscles attach to the skeleton. Viewed under a light microscope, 
skeletal muscle fibres have a striated appearance due to the highly ordered array of cytoskeletal 
filaments that are responsible for their contractile properties. These filaments bundle together to form 
myofibrils and are composed of actin and polymerised myosin molecular motors or thin and thick 
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filaments respectively (Fig1.3&4). In response to muscle fibre depolarisation and release of Ca
2+
 from 
sarcoplasmic reticulum, the myosin heads of thick filaments bind to and slide actin filaments to 
shorten the muscle fibre and cause contraction. Also contained within most muscles are a group or 
groups of weak „intrafusal‟ muscle fibres that do not contribute to the force of contraction but provide 
sensory feedback concerning changes in the force and velocity of the muscle contraction/relaxation 
via specialised sensory neurons.  These fibres are encased in a thick, fluid filled “capsule” composed 
of alternating layers of collagen fibrils (which either encircle or run longitudinally) and layers of 
specialised “ capsular sheet cells” that is believed to form a mechanical and metabolically-active 
barrier to isolate and protect the specialised sensory endings located on the intrafusal muscle fibres 
(Barker 1974). IA/II nerve terminals located on the non-contractile equatorial regions of the intrafusal 
muscle fibres fire action potentials in response to the degree of muscle fibre stretch (i.e., they are 
mechanoreceptors rather than synapses). Located towards the contractile polar regions of the 
intrafusal fibres are small neuromuscular junctions that help to maintain sensory feedback by 
triggering intrafusal muscle fibre contraction to keep the equatorial regions of the fibres taut so that it 
can continue to respond to muscle stretch (Barker 1974; Longstaff 2000: Fig 1.4). Collectively these 
intrafusal muscle fibres and IA/II and  innervations are called the muscle spindle whose primary role 
is the coordination of antagonistic muscle contraction and proprioception, especially important in 
stabilising posture, coordinating gait and scaling responses to stimuli (e.g., van Deursen and Simoneau 
1999; Longstaff 2000; Muller et al. 2008). 
 
1.3.5 Summary 
-motor neurons, as well as all other neurons, can be thought of as being anatomically and functional 
compartmentalised. Cell bodies and dendrites located in the spinal cord are responsible for the 
initiation of action potentials that are propagated through the periphery by axons to elicit skeletal 
muscle contraction by chemical transduction at -motor nerve terminals located on the centre of 
muscle fibres. These anatomical and functional characteristics of -motor neurons, alongside those of 
skeletal muscle and the muscle spindle, collectively coordinate efficient control of voluntary 
movement and the maintenance of posture. As a result of these different anatomical and functional 
compartments of neurons, there may also be compartmentalisation of other properties such as 
bioenergetic properties and vulnerability to pathological stimuli.  
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Fig 1.3 (above): Overview of skeletal muscle structure at increasing magnification. 
(a) the whole muscle; (b) bundle of muscle fibres; (c) a single muscle fibre, composed 
of myofibrils, showing nuclei and striations; (d) a single myofibril, composed of 
myofilaments.  The regular arrangements of filaments across the whole muscle fibre 
accounts for the striated appearance of skeletal muscle when examined with a 
microscope and are responsible for bringing about contraction. Figure adapted from 
answers.com that was originally adapted from Jennett, S. (1989). Human physiology. 
Churchill Livingstone, Edinburgh.  
 
Fig 1.4 (below): Overview of filament arrangement in skeletal muscle. (a) when 
relaxed and (b) when shortened during contraction. Myofibrils are composed of a 
repeating unit or sarcomere shown below (also identified in Fig 1.3(d) above) composed 
of thin actin filaments and thick myosin filaments that appear as alternating light and 
dark bands. A sarcomere is defined as extending from one z-line to another which can 
be identified as a thin dark band (see Fig 1.3(d) above) and  the centre  of a sarcomere 
is identified by another thin dark band called the m-line. During muscle contraction, the 
myosin heads on the thick filaments form cross bridges with the actin filaments to cause 
the filaments to overlap to a greater degree, decreasing the distance between z-lines. 
As this occurs in all sarcomeres the whole skeletal muscle shortens or contracts. Figure 
and legend adapted www.answers.com/topic/skeletal-muscle. 
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Fig 1.5: Overview of the mammalian muscle spindle.  (a) Intrafusal fibres and 
spindles are encased in a capsule which is embedded in the muscle and surrounded 
by force generating extrafusal fibres. (b) There are two types of intrafusal fibres 
according to the arrangement of muscle fibre nuclei: bag and chain. IA afferent 
neurons form annulospiral endings surround the equatorial regions of the intrafusal 
fibres (primary endings). II afferent neurons can also form annulospiral endings in 
sub-equatorial regions of the chain fibres (secondary endings). -motor efferent 
neurons form either plate or trails of small -neuromuscular junctions at polar ends of 
the intrafusal fibres. These -neuromuscular junctions help ensure that the equatorial 
regions of the intrafusal muscle fibres remain taut and able to respond to the degree 
of stretch (Figure with minor adaptations Kuffler et al. 1984). 
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1.4 Bioenergetics & Metabolism: implications for -motor neurons 
Neurons and skeletal muscle have some of the highest workloads and metabolic rates of all tissues. 
For example, skeletal muscle may increase its demand for ATP >100 times per unit of time during 
exercise compared to when at rest (Kernell 2006), while the brain consumes approximately 20% of all 
inspired oxygen (reviewed by Rolfe and Brown 1997). Based on the previous chapter where I 
described the basic structure and function of -motor neurons and skeletal muscle, the following 
chapter discusses how different functional attributes appear to lead to metabolic compartmentalisation 
within neurons. I will go on to discuss how metabolic characteristics differ between different skeletal 
muscle fibre types and review some of the evidence that suggest a reciprocal relationship between -
motor neurons and skeletal muscle fibres.  
1.4.1 Bioenergetic and metabolic properties of neurons 
Neurons gain nearly all of their energy from the oxidative phosphorylation of ATP in mitochondria 
(Ames 2000) and depolarization induced increases in O2 consumption, glucose utilization and CO2 
production have been known for decades (Gerard 1930; Bak et al. 2006).  It has been estimated that 
only 25-35% of a neuron‟s total energy production is used to fuel generic house-keeping tasks while 
the remaining 65-75% of a neuron‟s energy expenditure is used for signalling processes (Attwell and 
Laughlin 2001; Du et al. 2008). Little is known about the energy demands of specific process but at 
nerve terminals for example, conversion of choline and acetyl-CoA to acetylcholine via CHAT is 
energy dependent (Nachmansohn and Machado 1943), filling of synaptic vesicles with 
neurotransmitter is dependent on H
+
-ATPase pumps (e.g., Stadler and Tsukita 1984; Haigh et al. 
1994) and two vesicular proteins important for endocytosis, Synaptic Vesicle 2 (SV2) protein and 
synapsin have been shown to have ATPase activity/ATP binding sites (Hosaka and Sudhof 1998; Yao 
and Bajjalieh 2008). The metabolic cost of vesicle docking, fusion pore opening and recycling has 
been calculated to require at least 400 molecules of ATP per released vesicle (Attwell and Laughlin 
2001). Using all the available information concerning the energy dependent process in the 
predominantly glutamatergic grey matter of the rodent brain, Attwell and Laughlin (2001) identify 
that neurotransmitter recycling, vesicle recycling and clearance of Ca
2+
 from nerve terminals accounts 
for ~7% of the total energy expenditure. The highest energy consuming process, accounting for the 
>90% remainder of Attwell and Laughlin signalling energy budget, is maintaining and re-establishing 





ATPase exchanger alone (Astrup et al. 1981; Erecinska and Silver 1989). While only 7% of 
the total energy used in neuronal signalling is utilized at the nerve terminal, when this is added to the 
regional cost of maintaining and re-establishing membrane potentials, the result is a high localized 
demand for ATP. Cytochrome oxidase activity and mitochondrial density at nerve terminals is second 
only to that found in the dendritic trees reflecting the high energy demands of these compartments, 
while axons, with the lowest overall energy requirements contain the lowest levels of mitochondria 
and cytochrome oxidase activity (Wong-Riley 1989; Hollenbeck and Saxton 2005). Further 
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compartmentalization of metabolism is reflected in the distribution of neuroglobin, a recently 
identified neuron-specific oxygen storing molecule related to myoglobin and haemoglobin (Burmester 
et al. 2000; Dewilde et al. 2001) which has also been shown to localize in cell bodies and dendrites 
with little present in axons, but unfortunately nerve terminals were not studied (Hundahl et al. 2008): 
see Chapter 5). It has also recently been shown that mitochondria with the highest potentials that drive 
the oxidative phosphorylation of ATP are transported towards nerve terminals while those with the 
lowest potentials are transported towards cell bodies where they are probably degraded (Miller and 
Sheetz 2004). This has added to the general opinion that there are also fundamental differences in 
synaptic mitochondria versus non-synaptic mitochondria and that these differences in turn differ 
between neurons from different brain regions e.g., cortex and hippocampus (e.g., Blokhuis and 
Veldstra 1970; Lai et al. 1977; Dagani et al. 1983; Leong et al. 1984; Dagani et al. 1988; Kiebish et 
al. 2008). More recent studies investigating the threshold activities of the mitochondrial complexes 
(see section 1.2.3 and Fig 1.1) have shown that to cause an abrupt decrease in oxidative 
phosphorylation and depletion of ATP, complexes I, III, and IV in non-synaptic mitochondrial and III 
and IV in synaptic mitochondria need to be inhibited by ~60-80%. Complex 1 in synaptic 
mitochondria however has a significantly lower threshold for inhibition at 25%, indicating that subtle 
changes in metabolism will cause a significant decrease in ATP production (John 1996; Davey et al. 
1998).  Synaptic mitochondria have also been shown to have reduced Ca
2+
 buffering capacity, which 
is probably related to the higher cyclophilin D content (Brown et al. 2006; Naga et al. 2007). This 
reduction in Ca
2+
 buffering capacity is suggested to be a consequence of accumulated oxidative 
damage and mitochondrial ageing. This may occur as they are transported to terminals and makes the 
formation of large mitochondrial pores more probable resulting in swelling and mitochondrial rupture 
(Brown et al. 2006).  Overall this evidence indicates that neurons conserve energy by determining 
oxidative capacity by functional attributes at the cellular level as well as at the local level (Wong-
Riley 1989) which is consistent with the idea that to improve efficiency and overcome poor 
cytoplasmic diffusion, sites of ATP generation must oppose sites of ATP consumption (Ames 2000; 
Hollenbeck and Saxton 2005). Unfortunately there are no comparable studies in -motor neurons in 
the peripheral system, however it is known that -motor nerve terminals also have a high density of 
mitochondria with more complex cristae compared to axons (Palade and Palay 1954; Vial 1958) and 
in the frog, mitochondria can occupy up to 38% of terminal bouton volume (Alnaes and Rahamimoff 
1975).  
 
1.4.2 Reciprocal properties of -motor neurons and muscle fibres 
As well as having different functional attributes determining metabolic demands at the local and 
cellular levels some of a neuron‟s function, structure and therefore metabolic properties may also be 
determined by their post-synaptic targets. In the case of -motor neurons these post-synaptic targets 
are skeletal muscle fibres, which are well known to vary their properties to match functional demands. 
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Some skeletal muscles are tonically activated requiring long-term contraction, such as postural 
muscle, while others are used for making more rapid, short term movements. Those muscle fibres 
belonging to the latter group are predominantly composed of fast-twitch muscle fibres (also referred to 
as type II), which contract and relax more rapidly compared to tonically activated slow-twitch muscles 
fibres (also referred to as type 1). The activation patterns of these two groups of muscle fibres are also 
reflected in their metabolic properties and fatigability. Slow-twitch muscle fibres rely predominantly 
on aerobic (oxidative) respiration, have more mitochondria and associated proteins/complexes, more 
myoglobin, larger capillary networks and are relativity fatigue resistant, which suits long term 
activation. Conversely, fast-twitch muscle fibres rely predominantly on anaerobic respiration and 
therefore have more enzymes relating to anaerobic pathways, fewer mitochondria, less myoglobin, 
smaller capillary networks but will quickly fatigue in response to activity and are therefore, more 
suited to quick bursts of activity (e.g., Ranvier 1874; Ogata and Mori 1964; Close 1972; Ogata and 
Yamasaki 1985; Rolfe and Brown 1997; Kernell 2006). It is important to note however that 
classification of muscle fibre type is highly complex with differing criteria and classification systems 
depending on molecular myosin isoforms, ATPases and a range of physiological parameters. 
Furthermore, fibre types are not easily separated into clear groups as they appear to exist on a 
continuum between fast and slow extremes (Kernell 2006) and it is for this reason and the purpose of 
this study muscles and their fibre types will be simply classified as either „fast‟ or „slow‟. 
 
The differences in fibre type properties between fast and slow muscles appear also to be reflected in 
some of the anatomical and functional properties of innervating -motor neurons. In comparison to -
motor neurons that innervate fast-twitch muscle, there is a tendency for -motor neurons innervating 
slow-twitch muscle fibre types to have smaller cell bodies and axons with corresponding slower 
conduction velocities than those innervating fast-twitch muscles that are used for rapid and more 
powerful motor activities (Campa and Engel 1971; Kernell 2006). Furthermore, -motor neurons 
innervating slow-twitch muscles also have reduced repetitive firing rate but also require smaller 
excitatory currents to induce muscle fibre contraction which is advantageous for continuing tonic 
activation of slow-twitch, postural muscles (Hennig and Lomo 1985; Wood and Slater 1995; 1997; 
Kernell 2006). There also appears to be a difference in NMJ morphology according to fibre type with 
NMJs on fast-twitch fibres being smaller but having larger numbers of AChRs and releasing more 
synaptic vesicles that enhances efficiency and contributes to the larger safety factor of 
neurotransmission (Sterz et al. 1983; Fahim et al. 1984; Wood and Slater 1997; 2001; Bewick et al. 
2004). Conversely, -motor nerve terminals from slow-twitch muscles have larger pools of synaptic 
vesicles facilitating long term neurotransmission required to maintain tonic/repetitive muscle 
contraction (Reid et al. 1999; Bewick et al. 2004). This apparent „reciprocal‟ relationship between 
fibre type and motor neurons, or covariance of functional and anatomical properties (Kernell 2006) 
has led to several studies to try and determine if neuronal oxidative capacity correlates with muscle 
fibre type. Comparison of succinate dehydrogenase (SDH, a key enzyme in the mitochondrial 
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respiratory chain see fig1.1) in -motor neuron cell bodies shows that there are differences in 
metabolic capacity across motor neurons and between motor neurons that innervate the same muscle. 
Motor neurons that have larger cell bodies and innervate fast-twitch anaerobic fibres are consistently 
found to have low levels of SDH, while those with small cell bodies innervating slow-twitch oxidative 
muscles tend to have higher SDH levels (Campa and Engel 1971; Donselaar et al. 1986; Ishihara et al. 
1988; Chalmers and Edgerton 1989; Chalmers et al. 1992; Ishihara et al. 1995; Nakano et al. 1997, 
(c.f. Roy et al. 2007)). This would suggest that larger motor neurons that innervate fast-twitch muscles 
rely less on energy supplied via mitochondria.  
 
1.4.3 Summary 
Neurons in general have high energy demands but there is evidence to suggest that there is distinct 
regionalization of bioenergetic needs, with nerve terminals requiring a large amount of ATP to supply 
their functional demands. This high bioenergetic need of nerve terminals is also combined with 
evidence that would indicate that the mitochondria located in nerve terminals are more susceptible to 
inhibition and pathological stimuli. Additionally, due to increased length of time in transit, increasing 
age and accumulation of oxidative damage, the mitochondria in nerve terminals of the longest 
neurons, such as -motor neurons, may be more susceptible.  Overall, this would indicate that the 
nerve terminal compartment of neurons and in particular, those of -motor neurons would be highly 
vulnerability to metabolic inhibition such as that occurring during an hypoxic/ischaemic insult. 
Further to this, it may be predicted that there is a difference in -motor nerve terminal vulnerability 
according to muscle fibre type. Different skeletal muscles fibre types and -motor neurons are 
recruited in a task-dependent manner and therefore share patterns of activity. Based on this and 
evidence that indicates -motor neurons co-vary many of their anatomical and functional parameter to 
match that of their innervated muscle fibre type, there may also be co-variance of metabolic 
parameters. Slow-twitch muscle fibres rely predominantly on aerobic respiration while fast-twitch 
muscle relies on more anaerobic respiratory pathways. This would suggest that according to muscle 
fibre subtype and therefore perhaps their innervating motor neurons, there may be significantly 
different responses to hypoxic/ischaemic insults. 
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1.5 Pathological responses of -motor neurons 
As a conservative estimate, but excluding psychiatric disorders such as depression, 6% of the UK 
population suffers from a neurological disorder at least once in their lifetime (MacDonald et al. 2000). 
The morbidity and socio-economic burden of these neurological conditions, such as stroke, diabetic 
neuropathies, compressive neuropathies, congenital diseases and major injury, which all appear within 
the top 10 of the most common conditions in the UK (MacDonald et al. 2000), has driven a significant 
amount of research in their neuropathogenesis and the mechanisms of neuronal death. This has 
revealed that there appears to be specific cellular mechanisms relating to the loss of cell bodies and 
dendrites, axons, and in particular, nerve terminals. In the following section, I will discuss some of the 
evidence that highlights the compartmentalisation of pathological response in -motor neurons with a 
particular focus on -motor nerve terminals to demonstrate that nerve terminals are a highly 
vulnerable compartment. 
 
1.5.1 Wallerian degeneration 
Structural characteristics 
Due to their length, the peripheral axons of -motor neurons are highly susceptible to mechanical 
trauma such as transection (axotomy) or crush injuries. This coupled with their experimental 
accessibility means that the pathological response of -motor neurons to such injuries is historically 
well established.  One of the first to study the effects of axotomy was Augustus Waller who, in 1850, 
published a study describing the loss of sensory reflexes and motor control of the frog tongue after 
glossopharyngeal and hypoglossal axotomy (Waller 1850). Waller documented the progressive 
fragmentation and eventual removal of debris from the nerves distal to the site of injury (distal nerve 
stump), a process now known to occur in a range of species including humans (Chaudhry and 
Cornblath 1992) and referred to as „Wallerian degeneration‟.  The principal event of Wallerian 
degeneration is functional failure due to loss of connectivity but the distal nerve stump can continue to 
conduct axon potentials and release synaptic vesicles in rodents for up to 6-10hr in vivo or 20hr ex 
vivo at 25
o
C following axotomy (Miledi and Slater 1968; 1970; Winlow and Usherwood 1976; Tsao et 
al. 1994; Tsao et al. 1999; Gillingwater and Ribchester 2001). Following this lag phase, there is a loss 
of action potential propagation at 12-24hr in vivo (Miledi and Slater 1968; 1970) or >24hr at 25
o
C  ex 
vivo (Tsao et al. 1999) and degenerative events are observed at the -motor nerve terminal. At rodent 
-motor nerve terminals this includes progressive disruption and lysis of mitochondria, activation of 
Schwann cells with processes encroaching into the synaptic cleft, aggregation and loss of synaptic 
vesicles, loss of neurofilaments, vacuoles and disruption of the presynaptic membrane (Birks et al. 
1960; Miledi and Slater 1968; 1970; Winlow and Usherwood 1975; 1976; Gillingwater and 
Ribchester 2001). Signs of axonal degeneration swiftly follow, with microtubule depolymerisation 
and neurofilament degradation respectively proceeded by the retraction of the myelin sheath from the 
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nodes of Ranvier and the cytoplasm becoming electron dense. Both axons and nerve terminals become 
fragmented into small „ellipsoid‟ membrane-bound chambers that undergo myelomonocytic invasion 
and engulfment by Schwann cells to be cleared away over a period of a few weeks (Vial 1958; Birks 
et al. 1960; Schlaepfer and Hasler 1979; Glass and Griffin 1991; Gillingwater and Ribchester 2001; 
Zhai et al. 2003; Beirowski et al. 2005).  These degenerative events in axons and nerve terminals tend 
to be matched with apoptotic death of cell bodies in young/neonatal animals up to ~2wks of age (e.g., 
Adalbert et al. 2006). In adults however, there is some retraction of the dendrites that may be 
permanent (Sumner and Watson 1971; Brännström et al. 1992) but the cell body normally survives 
and may eventually re-innervate its skeletal muscle target (Waller 1852; Kashihara et al. 1987; 
Johnson and Duberley 1998; Gillingwater and Ribchester 2001; Tiraihi and Rezaie 2004).  
Postsynaptic endplates, AChRs and muscle fibres are largely unaffected by Wallerian degeneration in 
the short term, where for at least 3 weeks following axotomy no structural changes in the endplate are 
apparent but depolarisation of muscle fibres can be observed 3hr after axotomy (Birks et al. 1960; 
Miledi and Slater 1968; Bray et al. 1976). Following a few days to weeks there is increasing muscle 
fibre atrophy (Miledi and Slater 1968; Schmalbruch et al. 1991a), peri-junctional AChRs increase and 
there is increased turnover of AChRs at the endplate (Szabo et al. 2003; Kernell 2006).  
 
Mechanism of Wallerian degeneration: The Wld
s
 mutation  
The mechanism(s) underlying Wallerian degeneration are still unclear. Despite its highly ordered 
execution, Wallerian degeneration does not appear to be linked with apoptosis as studies have ruled 
out caspases-3 activation, the primary apoptotic mediator in neurons (Finn et al. 2000) or involvement 
of other pro-apoptotic factors such as Bcl-2 (Sagot et al. 1995)  Bax and Bak (Whitmore et al. 2003). 
Wallerian degeneration can however be inhibited in cultured dorsal root ganglia by decreasing Ca
2+
 
concentration and with calpain inhibitors (Glass et al. 1994; George et al. 1995; Wang et al. 2000). 
The serendipitous discovery by Lunn et al (1989) that Wallerian degeneration can be inhibited in the 
CNS and PNS for up to 3 weeks and that impulse conduction and transmitter release can be 
maintained for >3 days by the autosomal dominant mutation known as the Wallerian degeneration 
slow gene („Wld
s
‟), has forced some significant conceptual changes regarding Wallerian degeneration 
and mechanisms of neuronal death (Lunn et al. 1989; Perry et al. 1990; Tsao et al. 1994; Ribchester et 
al. 1995; Adalbert et al. 2005). This tandem triplication mutation causes an additional open-reading-
frame on mouse chromosome 4 and transcribes a novel 85kd in-frame fusion protein consisting of 
nicotinamide mononucleotide adenylyltransferase (Nmnat1: a NAD
+
 synthesising enzyme), a unique 
„Wld
s
 -18‟ linking sequence, and the last 70 N-terminal amino acids of Ube4b, a ubiquitination 
enzyme responsible for regulated protein degradation (Lyon et al. 1993; Coleman et al. 1998; Conforti 
et al. 2000; Mack et al. 2001; Gillingwater et al. 2002; Adalbert et al. 2005). How this mutation 
confers protection against Wallerian degeneration is still unknown, especially as the transcribed Wld
s
 
protein is thought to remain exclusively in the cell body (Gillingwater and Ribchester 2001; Mack et 
al. 2001; Fang et al. 2005, although this has recently been disputed with evidence of a 
cytoplasmic/mitochondrial distribution of the Wld
s
 protein by Beirowski et al. 2009). It does appear 
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that both Nmnat1 and Ube4b are required to prevent axonal degeneration (Coleman 2005; Conforti et 
al. 2007b; Watanabe et al. 2007 (c.f. Sasaki et al. 2009a)) and synergy between the proteins ability to 
modulate NAD
+
 synthesis and the ubiquitin-proteasome system have been suggested as possible 
mechanisms of inhibition (Mack et al. 2001; Raffaelli et al. 2002; Zhai et al. 2003; Araki et al. 2004; 
Coleman and Ribchester 2004; Adalbert et al. 2005; Wang et al. 2005; Laser et al. 2006; Sasaki et al. 
2006; Conforti et al. 2007b).  Alternatively, more recent work indicates that the Wld
s
 protein may alter 
cell cycle status (Wishart et al. 2008) and gene transcription relating to cell stress responses 
(Gillingwater et al. 2006b; Laser et al. 2006; Wishart et al. 2007), axonal transport proteins (Simonin 
et al. 2007) as well as transcription/distribution of other gene products (Gillingwater et al. 2006b; 
Laser et al. 2006). What the Wld
s
 mutation shows however is that Wallerian degeneration is unlikely 
to be a passive process but rather a genetically regulated intrinsic program of axonal and nerve 
terminal loss that, at the molecular level, is distinctive from apoptosis (Gillingwater and Ribchester 
2001; Raff et al. 2002; Coleman 2005; Low and Cheng 2005; Luo and O'Leary 2005; Wishart et al. 
2006; Saxena and Caroni 2007). This is most clearly suggested by studies that show that the rate of 
Wallerian degeneration can be modulated by a transgene in a „dose‟ dependent manner (Mack et al. 
2001) and that Wld
s
 mediated neuroprotection can be completely lost in „wasted‟ mice lacking a key 
protein synthesising/elongation factor (eEF1A2: Murray et al. 2008b), that shows Wallerian 
degeneration relies on transcriptional processes. 
 
Wallerian degeneration in pathological processes  
As well as providing protection against mechanical trauma the Wld
s
 mutation has been shown to 
inhibit degeneration caused by: disruption of microtubules (Luduena et al. 1986; Wang et al. 2000; 
Wang et al. 2001), progressive motor neuropathy (Ferri et al. 2003; Simonin et al. 2007), a genetic 
dysmyelination disorders (Samsam et al. 2003), axonal dystrophy (Mi et al. 2005), autoimmune 
encephalomyelitis (a multiple sclerosis model :Kaneko et al. 2006), traumatic brain injury 
(Gillingwater et al. 2006a), glaucoma (Howell et al. 2007; Beirowski et al. 2008), Parkinson‟s 
diseases (Sajadi et al. 2004; Hasbani and O'Malley 2006), removal of nerve growth factor (NGF: 
Deckwerth and Johnson 1994) and CNS ischaemia-reperfusion injuries (Gillingwater et al. 2004). 
This would clearly suggest that the mechanisms that govern Wallerian degeneration in response to 
axotomy are important in mediating the loss of axons and nerve terminals in response to many 
neurodegenerative and toxic stimuli, and are linked by some shared cellular processes (Raff et al. 
2002; Ferri et al. 2003; Coleman 2005; Luo and O'Leary 2005; Saxena and Caroni 2007). The Wld
s
 
mutation has also helped to reveal that there is a second morphologically and mechanistically distinct 
process of nerve terminal loss: withdrawal (Parson et al. 1997; Gillingwater and Ribchester 2001; 
Gillingwater et al. 2002; Raff et al. 2002; Gillingwater et al. 2003; Parson et al. 2004; Luo and 









 mutation protects -motor axons and nerve terminals against axotomy-induced 
Wallerian degeneration, nerve terminal structure and function are only transiently protected for 3-
7days post axotomy (Tsao et al. 1994; Ribchester et al. 1995; Gillingwater et al. 2002; Gillingwater et 
al. 2003; Parson et al. 2004). Following this delay, nerve terminals undergo a process of 
asynchronous, distal to proximal retraction/„withdrawal‟ of their arborisation into the distal axon 
(Gillingwater and Ribchester 2001; Gillingwater et al. 2003; Parson et al. 2004). While there is some 
clustering of synaptic vesicles, neurofilaments and invasion of terminal Schwann cells, as in Wallerian 
degeneration, during withdrawal there is minimal disruption to the internal organization of nerve 
terminal boutons including little or no perturbations to mitochondria or fragmentation of axons or 
changes to the postsynaptic endplate (Gillingwater and Ribchester 2001; Gillingwater et al. 2003; 
Parson et al. 2004). Rather, nerve terminals are progressively and systematically retracted in a distal to 
proximal fashion into the pre-terminal axon that forms a bulbous retraction club until the nerve 
terminal has vacated its postsynaptic endplate.  This process of withdrawal can be executed within 
4hrs (Bettini et al. 2007) but is more typically seen over a period of days to weeks (e.g. Yin et al. 
2004). 
 
Mechanism of withdrawal 
Like Wallerian degeneration the mechanisms that underlie the withdrawal of nerve terminals, 
particularly in adults, are still unknown (Bettini et al. 2007). The remarkably similar morphology 
between withdrawal and developmental synapse elimination suggests, at least in part, a shared 
mechanism (Bernstein and Lichtman 1999; Gillingwater et al. 2002; Raff et al. 2002; Gillingwater 
and Ribchester 2003; Parson et al. 2004), although upstream regulation appears to be different as the 
Wld
s
 mutation fails to alter developmental synapse elimination (Parson et al. 1997; Hoopfer et al. 
2006). During developmental synapse elimination in -motor neurons (Bixby 1981; Riley 1981; 
Keller-Peck et al. 2001; Walsh and Lichtman 2003, but compare Rosenthal and Taraskevich 1977) 
and post-injury re-innervation (Brown et al. 1976; Costanzo et al. 2000) muscle fibres that are poly-
innervated, slowly adopt (over ~2 week period) the mature pattern of mono innervations, i.e., one 
motor neuron collateral innervating each muscle fibre, by removing exuberant innervation. As nerve 
terminals from different motor neuron collaterals compete for sole innervation the amount of endplate, 
which they occupy and alter their synaptic strength by expanding and contracting their arborisations 
(Colman et al. 1997; Herrera and Zeng 2003). The „losing‟ nerve terminal is completely withdrawn 
into a retraction club and into the distal axon (Riley 1981).  It has been suggested that the mechanisms 
that govern synapse elimination may be retained but modified or reactivated in adult peripheral nerve 
terminals as part of the repertoire of gross/ ongoing structural plasticity (Caroni 1997b). Small 
postsynaptic junction folds have been identified in rodents with no opposing presynaptic apparatus, 
also known as synaptic guttering, and is highly suggestive of recent structural reorganisation (e.g., 
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Cardasis and Padykula 1981; Wernig et al. 1984; Wernig and Herrera 1986; Wigston 1989; 1990). 
This evidence of adult structural plasticity and the process of developmental synapse elimination in 
wild-type nerve terminals indicates that withdrawal of Wld
s 
nerve terminals is not a mechanism unique 
to the mutation. The cellular processes that govern withdrawal, especially in developmental, appear to 
be under the control of the actin cytoskeleton and myosin molecular motors (Wylie and Chantler 
2003). Similar control is suggested in adults (Billuart et al. 2001; Luo and O'Leary 2005; Vega-
Riveroll et al. 2005; Saxena and Caroni 2007) and indicates that withdrawal is an active process (c.f. 
(Bernstein and Lichtman 1999). Interestingly, it has been shown (in adult Drosophila) that the cellular 
pathway that governs retraction is inhibited under normal physiological condition and that to initiate 
retraction the mechanism must be de-repressed (Billuart et al. 2001). Similar results have been found 
in rats (Lamprecht et al. 2002), and helps support the hypothesis that developmental processes and 
machinery for retraction are retained but modified in adults and are poised to act rapidly in response to 
stimuli (Luo and O'Leary 2005; Saxena and Caroni 2007).  
 
Withdrawal in pathological processes  
There are now increasing numbers of reports of nerve terminal withdrawal in response to pathological 
stimuli (Gillingwater et al. 2002; Gillingwater and Ribchester 2003). For example, in genetic 
dysmyelination disorders (Yin et al. 2004), progressive withdrawal of nerve terminals in mice over-
expressing myelin specific Protein-0 caused >90% of nerve terminals to be partially or fully 
withdrawn by postnatal day 90. This preceded evidence of axonal degeneration that ultimately led to 
fatality by 6 months. Exogenous application of high affinity agonists to ATP-sensitive-P2X7-
purinoceptors known to be involved in neurodegeneration (Le Feuvre et al. 2002) has also been shown 
to cause progressive nerve terminal withdrawal akin to Wld
s
 withdrawal in de-nucleated preparations 
(Bettini et al. 2007). Much like Wallerian degeneration, this latter study shows that withdrawal can 
occur in the absence of cell bodies and therefore must be a mechanism that is under local control 
(Bettini et al. 2007). Withdrawal of nerve terminals has also been described in wasted mice (Murray et 
al. 2008b), following postsynaptic protein synthesis inhibition (McCann et al. 2007), postsynaptic 
blockade (Balice-Gordon and Lichtman 1994), application of neuregulin (a glial growth factor: 
Trachtenberg and Thompson 1997) and muscle fibre damage (Rich and Lichtman 1989; Bernstein and 
Lichtman 1999). It is however, the type of pathological stimuli that triggers withdrawal that has 
caused some disagreement as to whether withdrawal is an active or more passive process. These 
studies appear to show that withdrawal maybe triggered by loss/changes in trophic support supplied 
by neuronal protein synthesis (Murray et al. 2008b), cell bodies in Wld
s
 mice (Tsao et al. 1994; 
Ribchester et al. 1995; Gillingwater et al. 2002; Gillingwater et al. 2003; Parson et al. 2004), 
Schwann cells (Trachtenberg and Thompson 1997; Yin et al. 2004)  or postsynaptic muscle fibres 
(Rich and Lichtman 1989; Balice-Gordon and Lichtman 1994; Bernstein and Lichtman 1999; McCann 
et al. 2007), and competition for trophic support is thought to be a key in mediating developmental 
synapse elimination (e.g., Bernstein and Lichtman 1999; Sanes and Lichtman 1999). This has led to 
the suggestion that withdrawal is the result of atrophy of nerve terminals due to loss of trophic support 
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(Bernstein and Lichtman 1999) indicating that it is a more passive process than perhaps the one 
mediated by the actin cytoskeleton suggested above. Nevertheless, what these studies primarily reveal 
is that there are at least two distinctive mechanisms of nerve terminal loss: withdrawal and Wallerian 
degeneration, and that they appear to be activated differentially depending on the type of stimulus.  
 
1.5.3 Evidence of a third type of -motor nerve terminal loss: necrosis 
Although not as extensively studied, there is some evidence to suggest that very specific local insults 
to nerve terminals can cause a third type of nerve terminal loss: necrosis, that is characterised by the 
rapid breakdown of the presynaptic membrane.  Following application of -latrotoxin (LTX: black 
widow spider venom) or auto-ganglioside/complement attack (an experimental model of Miller-Fisher 
syndrome) that both selectively form large pores in the presynaptic membrane (Clark et al. 1970; 
Okamoto et al. 1971; Duchen et al. 1981; O'Hanlon et al. 2001; O'Hanlon et al. 2003; Ushkaryov et 
al. 2004), there is massive synaptic vesicle release, muscle contractures and functional block within 
about 15-60min. This is followed by bouton swelling, almost complete loss of synaptic vesicles, the 
cytoplasm becoming electron-lucent, breakdown of the cytoskeleton and presynaptic membrane, 
invasion of Schwann cell process and engulfment of the terminal boutons over the next 1-2hr. Both 
LTX and auto-ganglioside/complement attack are at least in part mediated by Ca
2+
 and proteolytic 
calpain activation (O'Hanlon et al. 2003). -bungarotoxin
4
 also causes similar changes to -motor 
nerve terminals as LTX and auto-ganglioside/complement attack. Following application of -
bungarotoxin there is rapid release of synaptic vesicles 0.5-3.5hr followed by irreversible functional 
block, loss of synaptic vesicles and their release machinery (synaptophysin, SNAP and syntaxin), 
swelling and lysis of mitochondria, and loss of neurofilaments over 3-12hr in vivo (Abe et al. 1976; 
Dixon and Harris 1999; Prasarnpun et al. 2004; Prasarnpun et al. 2005).  This -motor nerve terminal 
pathology appears to cause progressive retrograde fragmentation into pre-terminal axons and 
intramuscular nerve over the next 12hr. There is also breakdown of the presynaptic membrane and 
invasion of Schwann cell process and engulfment but unlike LTX and auto-ganglioside/complement, 
boutons become shrunken and cytoplasm becomes electron-dense. The mechanism of action of -
bungarotoxin is still unknown (Dixon and Harris 1999) and probably involves multiple molecular 
mechanisms including phospholipid hydrolysis, massive Ca
2+ 
entry and a direct action on 




                                                          
4 -bungarotoxin is a specific pre-synaptic neurotoxin and has a very different action from - bungarotoxin that has a post-
synaptic action by binding to AChRs (that latter has been used extensively in the current study). Both however, form part of the 
lethal venom of the Bungarus genus of snakes that are widespread over southeast Asia. The toxins were originally identified by 
C. Chang and colleagues during the 1960-70‟s in the Taiwanese banded krait (B. multicinctus: Chang 1999)  
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1.5.4 Compartmentalisation & Nerve terminal vulnerability 
As discussed earlier, Wallerian degeneration of axons and nerve terminals, and apoptosis of cell 
bodies are not mechanistically linked. Since the discovery of the Wld
s
 mutation and with further study, 
it has become apparent that there are distinct degenerative mechanisms relating to each neuronal 
compartment (Gillingwater and Ribchester 2001; Gillingwater et al. 2002; Raff et al. 2002; Coleman 
2005; Wishart et al. 2006; Conforti et al. 2007a). In cultured superior cervical ganglion removal of 
NGF in wild-type neurons normally results in apoptosis of cell bodies and degeneration of axons but if 
the Wld
s
 protein is present, removal of NGF results in loss of only the cell bodies while axons survive 
(Deckwerth and Johnson 1994). Similarly, the Wld
s
 mutation does not prevent the death of cell bodies 
in young rats following axotomy (Adalbert et al. 2006) or the loss of cell bodies in experimental 
models of glaucoma (Beirowski et al. 2008) and alternatively, protecting cell bodies from apoptosis 
by over-expression of Bcl-2 protein does not confer protection to axons (Sagot et al. 1995; Burne et 
al. 1996). This evidence collectively suggests that there is compartmentalisation of degenerative 
mechanisms and that they may be activated independently by different stimuli (Gillingwater and 
Ribchester 2001; Raff et al. 2002; Gillingwater and Ribchester 2003; Wishart et al. 2006): apoptosis 
in cell bodies, Wallerian degeneration in axons, and at least two mechanisms in nerve terminals: 
Wallerian degeneration and withdrawal. This concept of compartmentalisation is particularly 
important when studying neuropathogenesis (Gillingwater and Ribchester 2001; 2003; Coleman 2005; 
Wishart et al. 2006).  To help prevent the manifestation of punitive symptoms it is vital to determine 
where pathology begins (i.e., in which compartment) and then direct therapeutic strategies to that 
compartment to prevent loss of connectivity, the ultimate cause of the clinical and punitive symptoms 
(Wishart et al. 2006; Conforti et al. 2007a; Kariya et al. 2009). Examination of the early events of 
neuropathological conditions has provided overwhelming evidence that indicates nerve terminals are 
the principal site of structural and functional loss (see Table 1) and include  many of the most 
prevalent conditions affecting the modern world. Further compelling evidence for 
compartmentalisation and vulnerability of nerve terminal is provided by studies into amyotrophic 
lateral sclerosis (ALS). ALS is „dying back‟ neuropathy that progresses in a distal to proximal manner 
with nerve terminal loss identified as a principal event, and in familiar models of ALS this is caused 
by mutations in the superoxide dismutase 1 (mSOD1) gene (e.g., Fischer et al  2004 and Wishart et al  
2006, see Table 1). When axons are protected by the Wld
s
 mutation in mice expressing mSOD1 there 
is little or no improvement in animals survival, loss of nerve terminals or the disease‟s punitive effects 
(Vande Velde et al. 2004; Fischer et al. 2005). Similarly, protection of -motor neuron cell bodies in 
mSOD1 mice with glial derived neurotrophic factor does not prevent loss of -motor nerve terminals 
or improve the symptoms of the disease (Suzuki et al. 2007). Similar results have been documented in 
mouse models of spinal muscular atrophy where the Wld
s
 mutation failed to prevent nerve terminal 
loss and the diseases punitive affects (Kariya et al. 2009), in hereditary spastic paraplegia (Edgar 
2004) that has also been identified as a „dying back‟ neuropathy (Ferreirinha et al. 2004) and 
following disruption of CNS nerve terminals with botulinum C neurotoxin that also triggers 
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withdrawal (Berliocchi et al. 2005). This clearly indicates that nerve terminals are highly vulnerable 
and highlights the need to identify the correct neuronal compartment and cellular mechanism for 
effective neuroprotection.   
 
1.5.5 Summary 
 In summary, I have reviewed some of the evidence that indicates neurons have compartmentalised 
responses to different pathological stimuli and that overall, nerve terminals are highly vulnerable with 
functional and structural loss triggered by a range of toxic, traumatic and neurodegenerative disease 
stimuli. This is particularly evident in -motor nerve terminals, where following axotomy the first 
morphological signs of Wallerian degeneration are identified in -motor nerve terminals, and even 
when axotomy induced Wallerian degeneration is inhibited by the Wld
s
 mutation, nerve terminals are 
still only transiently protected for a few days before being lost by withdrawal. Based on this general 
concept of nerve terminal vulnerability, it would not be surprising if -motor nerve terminals were 
also vulnerable to hypoxia. The precedence for this can be observed in the CNS in response to 




Table 1: Traumatic, toxic and neurodegenerative disease stimuli identified with nerve terminal loss as principal event 
and/or causing ‘dying back’ neuropathies. 
Disruption of microtubule network (Vincristine 
neuropathies) 
Hsu and Lentz 1972; Wang et al. 2000; Wang et al. 2001 
gracile axonal dystrophy Miura et al. 1993; Mi et al. 2005 
spinal muscular atrophy Cifuentes-Diaz et al. 2002; Murray et al. 2008a; Kariya et al. 2009 
Mechanical Trauma/Axotomy 
Birks et al. 1960; Miledi and Slater 1968; 1970; DeSantis and 
Norman 1979 
Charcot-Marie-Tooth Disease  &  Demyelination Samsam et al. 2003; Yin et al. 2004 
Bachtrachotoxin Hudson et al. 1984 
Guillane-Barre syndromes (including Miller-Fisher 
syndrome) 
Roberts et al. 1994; O'Hanlon et al. 2001; Spaans et al. 2003; 
Goodfellow et al. 2005 
Focal postsynaptic blockade Balice-Gordon and Lichtman 1994 
beta-bungarotoxin 
Abe et al. 1976; Dixon and Harris 1999; Prasarnpun et al. 2004; 
Prasarnpun et al. 2005 
P2X7-receptor activation Bettini et al. 2007 
Myasthenia gravis Rich et al. 1994 
Dynein/dynactin molecular motor disruption LaMonte et al. 2002; Hafezparast et al. 2003; Laird et al. 2008 
Muscle fibre trauma Rich and Lichtman 1989; Bernstein and Lichtman 1999 
Alcoholic neuropathy Casey and Le Quesne 1972 
deletion of translation factor eEF1A2 (Wasted mice) Newbery et al. 2005; Murray et al. 2008b 
Organophosphate toxicity Prineas 1969b; Glazer et al. 1978; Kawabuchi et al. 1991 
Motor neuron disease  Schmalbruch et al. 1991b; Frey et al. 2000; Ferri et al. 2003 
Latrotoxin Clark et al. 1970; O'Hanlon et al. 2003 
Zinc pyrithione toxicity Sahenk and Mendell 1979 
Vacor (rodenticide) toxicity Watson and Griffin 1987 
dithiobiuret toxicity Kemplay 1984; Sahenk 1990 
Intoxication by the fruit of the tullidora shrub  Munoz-Martinez et al. 1983 
Botulinum toxin Pastor et al. 1997; Berliocchi et al. 2005 
Critical illness polyneuropathy Schwarz et al. 1997 
Inhibition of post-synaptic protein synthesis McCann et al. 2007 
Diabetic neuropathy 
Fahim et al. 2000; Dobretsov et al. 2007; Ramji et al. 2007; 
Muller et al. 2008 
Temporary limb immobilisation & space flight Mohamed 1989; Riley et al. 1990; D'Amelio and Daunton 1992 
Palytoxin Amir et al. 1997 
Paralysis induced by upper spinal injury Burns et al. 2007a 
Chronic corticosterone treatment Mohamed 1995 
Normal ageing (cognitive, motor & sensory decline) 
Swash and Fox 1972; Cupp and Uemura 1980; Fahim and Robbins 
1982; Larsson and Ansved 1995; Tanaka et al. 1996; Peters et 
al. 1998 
Hereditary spastic paraplegia Ferreirinha et al. 2004 
acrylamide poisoning 
 
Fullerton and Barnes 1966; Fullerton 1969; Prineas 1969a; 
LoPachin et al. 2002 
Traumatic brain injury Erb and Povlishock 1991; Gillingwater et al. 2006a 
Use of methamphetamine (aka „crystal meth‟ or 
speed)  
Cadet et al. 2003 
Huntington's disease 
Graveland et al. 1985; DiProspero et al. 2004; Ribchester et al. 
2004; Milnerwood et al. 2006 
amyotrophic lateral sclerosis (ALS) & mSOD1 
Sasaki and Iwata 1996; 1999; Frey et al. 2000; Fischer et al. 2004; 
Schaefer et al. 2005; Zang da et al. 2005 
Prion disease & spongiform encephalopathies 
Kitamoto et al. 1992; Clinton et al. 1993; Niewiadomska et al. 
2002; Cunningham et al. 2003 
Human immunodeficiency virus  (HIV)-associated 
dementia 
Kim et al. 2008 
Thrombin injection Herrera et al. 2008 
Vitamin E deficiency  Southam et al. 1991 
Deficiency in dietary protein intake (kwashiorkor) Oldfors 1981; Oldfors and Persson 1982 
Succinate dehydrogenase inhibition Sonsalla et al. 1997 
Alzheimer‟s Disease Davies et al. 1987; Terry et al. 1991; Coleman et al. 2004 
Cathepsin D deficiency Partanen et al. 2008 
Ischaemia-reperfusion injury (CNS) 
Williams and Grossman 1970; Rothman 1983; Ishimaru et al. 
2001; Jourdain et al. 2002; Kovalenko et al. 2006 
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1.6 The vulnerability of CNS nerve terminals to hypoxia & 
ischaemia-reperfusion injury 
 
Studies into hypoxia/ischaemic injuries, „stroke‟ or „cerebral vascular accident‟ has a long history with 
Hippocrates (460-370 BC) being one of the first to describe the sudden onset and paralysis caused by 
„apoplexy‟ or transient ischaemia (Thompson 1996). It is now known that even a brief 
hypoxic/ischaemia insult in the CNS will cause significant loss of neurons leading to either death of 
the patient or long-term brain damage and disability. Perhaps because ischaemic brain injury is one of 
the leading causes of disability and mortality worldwide (Dewar et al. 1999; White et al. 2000), it is 
also one of the most extensively studied. In the following section, I will briefly discuss some of the 
mechanisms of neuronal cell death in response to ischaemic/hypoxic insults as a basis for 
demonstrating the vulnerability of CNS nerve terminals and for understanding potential events at 
peripheral -motor nerve terminals.   
 
1.6.1 Ischaemia-reperfusion injuries trigger a complex maelstrom of 
pathological stimuli 
Ischaemia refers to the reduction or loss of the blood supply and it is generally agreed that the major 
pathological stimulus brought about by ischaemia is the lack of oxygen (hypoxia) that inhibits 
oxidative phosphorylation causing ATP depletion (Dewar et al. 1999; Lipton 1999; Ames 2000; 
White et al. 2000; Bickler and Donohoe 2002). Unlike skeletal muscle or the liver, neurons do not 
store significant amounts of chemical fuel stores to supplement ATP supply when either O2 or glucose 
is lacking, making them highly vulnerable to hypoxic/ischaemic insults (Zubay 1998; Ames 2000; 
Attwell and Laughlin 2001). Precipitous falls in ATP levels are observed within minutes of the onset 
of in vivo ischaemia and in vitro hypoxia and this triggers ionic gradient breakdown leading to a rise 
in extracellular K
+
 and intracellular Na
+
 followed by a rise in intracellular Ca
2+ 
(e.g., Silver 1977; 
Lipton 1999; Ames 2000). The mechanism of this ionic gradient breakdown is still unclear and many 




ATPase pump to which so much of the neuron‟s 
energy supplies are devoted, but while this seem likely, it has yet to be conclusively shown (Lipton 
1999). The rise in intracellular Ca
2+
 has been attributed to disruption of Ca
2+
 stores and in particular 




exchanger in response to elevated Na
+
 and opening of 
voltage dependent Ca
2+
 channels (Lobner and Lipton 1993; Zhang and Lipton 1999; Jeffs et al. 2007). 
This ionic gradient breakdown triggers release of neurotransmitters, in particular glutamate from 
nerve terminals to activate post-synaptic NMDA
5
 receptors, exacerbating Ca
2+
 entry and triggering 
excitotoxicity (Olney 1969; Rothman 1983; Benveniste et al. 1984; Rothman 1984; Choi 1988; 
                                                          
5 NMDA:N-methyl-d-aspartate,  
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Lobner and Lipton 1993; Zhang and Lipton 1999). Excitotoxicity and many of these 
hypoxic/ischaemic events may trigger necrotic cell death, as the elevated Ca
2+
 can be sufficient to 
trigger proteolytic calpains (Siesjo 1988), while progressive inhibition of electron transport, 
mitochondrial swelling and/or activation of mitochondrial pore opening due to ionic imbalance may 
activate apoptotic cell death via the release of cytochrome c from the mitochondria (e.g., Lipton 1999; 
White et al. 2000). Ischaemia is however associated with a range of potentiality pathological stimuli, 
not just hypoxia, that may also contribute to injury. For example, ischaemia causes significant 
intracellular and extracellular acidification (Silver 1977; Kass and Lipton 1982; Fujiwara et al. 1992) 
that if prevented, by maintaining pH with an alkaline buffer, can reduce the area of cell death 
following in vivo ischaemia in the cat by ~40%  (Nagao et al. 1996). The underlying cause of this 





 transporters in response to elevated levels of Na
+
, increasing dephosphorylation of ATP that 
releases H
+
 ions and/or disruption of the bicarbonate buffering system coupled to increasing CO2 
levels have been suggested (Lipton 1999; Cerretelli and Samaja 2003; Obara et al. 2008). Ischaemia 
also causes a fall in glucose levels, maintenance of which is vital for continuing respiration via 
glycolysis that may be able to help support ATP levels but is also associated with lactate production 
and increasing acidification (Ridge 1972; Lipton 1999; Cerretelli and Samaja 2003; Malthankar-
Phatak et al. 2008). There is also accumulation of other metabolic by-products such as free fatty acids 
and hypoxanthine, the latter from the breakdown of adenosine nucleotides (Gardiner et al. 1981; 
Zhang 1995; Abramov et al. 2007). Reoxygenation or reperfusion, while vital for tissue survival, may 
also cause cellular damage and is the reason why ischaemia/hypoxia insults are normally referred to as 
hypoxia/ischaemia-reperfusion injuries. They are typically associated with systemic inflammation and 
the formation of reactive oxygen species (ROS) which can uncontrollably react with and damage 
cellular structures and cause inactivation of receptors, enzymes and increased leakiness of cell 
membranes (Halliwell 2006). With returning oxygen levels ROS may be produced (Chan 1996) 
directly from damaged mitochondrial electron transport chains (Piantadosi and Zhang 1996; Nicholls 
and Budd 2000) and by clearance of accumulated metabolic by-products such as hypoxanthine by 
xanthine oxidase (Abramov et al. 2007) as well as fatty acids (Chan and Fishman 1980; White et al. 
2000) and reactions with Fe
2+
 delocalized from intracellular stores (Komara et al. 1986). Infiltration 
and up-regulation of leukocytes, cytokines and other inflammatory mediators such as nitric oxide 
synthase and cyclooxygenase, while an important injury response, may also contribute to damage by 
triggering ROS formation and other damaging stimuli (Nogawa et al. 1997; Samdani et al. 1997; 
Fukuyama et al. 1998; Lipton 1999; Costa et al. 2006; Doyle et al. 2008; Froyland et al. 2008). 
Reperfusion is also the stage where most cell death occurs (delayed cell death), when neurons that 
appear to survive the initial ischaemic insult die hours to weeks later due to propagation and 
accumulation of cell damage (e.g. Nakano et al. 1990; Lipton 1999). For example, Kovalenko et al. 
(2006) observed no signs of cell death in rat hippocampal neurons up to 2hr after a 15min ischaemic 
insult induced by clamping of the carotid artery, however by 7 days, 64% of neurons were undergoing 
necrosis and a further 16% showed some degenerative changes.  
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1.6.2 The role of nerve terminals in ischaemia-reperfusion injuries 
Overall, ischaemia-reperfusion injuries cause a maelstrom of biochemical and cellular events that we 
are only just beginning to understand, but it is becoming increasingly clear that the events at nerve 
terminals have a key role in many of these pathological responses. The best characterized of these 
events is the release of glutamate from nerve terminals to trigger excitotoxicity. This was 
demonstrated in the early 1980‟s when primary cultures of rat hippocampal neurons maintained in an 
hypoxic environment (95% N2: 5% CO2) become swollen and vacuolated within a few hours and died 
by 14hr. Blocking transmitter release (Rothman 1983) or inhibiting the post-synaptic action of 
glutamate Rothman (1984) attenuated neuronal cell death and provided the first clear evidence that 
hypoxia was capable of causing neuronal cell death via action at nerve terminals. We also know that 
as well as initiating excitotoxic events in neighbouring neurons, functional and structural changes to 
nerve terminals are one of the first pathological events to occur in the parent neuron. Rats subject to 1 
hour of middle cerebral artery occlusion, a relatively mild ischaemic insult that causes delayed cell 
death, followed by 1-3hr reperfusion have been shown to partially recover to propagate action 
potentials but display no postsynaptic potentials, suggesting long term functional failure of nerve 
terminals Bolay et al.  (2002). Further investigation by Bolay et al. (2002) showed that 
phosphorylation of
 
synapsin-l, involved in mobilisation of synaptic vesicles towards active zones, was 
significantly decreased. Others have also shown similar selective loss of critical vesicular proteins 
during reperfusion following mild ischaemic insult including SNAP-25, synaptophysin and mint1 
prior to whole cell death (Nishimura et al. 2000; Ishimaru et al. 2001).  Kovalenko et al, (2006) also 
noted no degenerative changes to cell bodies prior to 24hr after 15min ischaemic insult in rat 
hippocampus but observed widening of the synaptic cleft, decreases in the number of synaptic vesicles 
while those that remained were clustered away from the membrane after 2hr reperfusion. These 
structural changes at nerve terminals were followed by whole cell death after 3-7days of reperfusion 
and only those neurons (~20%) that presented with no alterations in nerve terminal ultrastructural 
appeared to survive beyond 7 days. Similar results have been obtained by others, showing progressive 
loss of rat hippocampal synaptic vesicles beginning within 10min of ischemia (von Lubitz and Diemer 
1983). In cat cerebro-cortical synapse rendered ischaemic by chronic hypotension, electrodes 
confirmed rapid depolarisation within 5min and ultrastructural studies showed clumping and 
retraction of synaptic vesicles from the presynaptic membrane, increased frequency of nerve terminal 
profiles with no vesicles and all in advance of other structural changes (Williams and Grossman 
1970). Others have also demonstrated selective degenerative changes in cultured rodent hippocampal 
slices subjected to environmental hypoxia and glucose deprivation (the accepted in vitro model of 
ischaemia: Jourdain et al. 2002; Jung et al. 2004; Kovalenko et al. 2006) but as is typical of these 
cultured model systems, it required a longer period of ischaemia compared to in vivo models to induce 
pathological changes (Lipton 1999; Kovalenko et al. 2006).  Collectively, this has led to the 
suggestion that signalling events at nerve terminals and/or nerve terminal loss propagates back 
towards the cell body to instigate cell death (Martone et al. 1999; Nishimura et al. 2000; Ishimaru et 
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al. 2001; Bolay et al. 2002; Jourdain et al. 2002). What the pathological stimulus is or stimuli are that 
are responsible for loss of nerve terminals are unknown, however direct inhibition of nerve terminal 
metabolism alone has been shown to cause retrograde neuronal death. Microinjection of malonate, a 
SDH inhibitor, into rat striatum where dopaminergic neurons project, caused loss of their cell bodies 
in the substantia nigra 7 days later, which clearly indicates that inhibition of electron transport can 
cause loss of nerve terminals and retrograde cell death (Sonsalla et al. 1997; Zeevalk et al. 1997).  
 
1.6.3 Summary 
I have previously discussed that neurons appear to be highly compartmentalised in terms of anatomy, 
function, metabolism, and vulnerably to pathological stimuli and put forward the hypothesis that -
motor nerve terminals are probably highly vulnerable to hypoxic/ischaemic insults. Here I have 
discussed some of evidence that shows a precedence for nerve terminal vulnerability to 
hypoxic/ischaemic-reperfusion injuries in the CNS. By utilising a range of different in vivo and ex 
vivo model systems, the complex events of hypoxia/ischaemia-reperfusion injuries in the CNS appears 
to be largely initiated by metabolic failure at nerve terminals. Due to lack of ATP, progressive 
depolarisation causes excitotoxic cell death in neighbouring neurons while in the parent neuron, other 
functional and structural changes to nerve terminals appears to lead to cell death. Despite our 
increasing understanding of the events that lead to loss of nerve terminals and neuronal death in the 
CNS following hypoxia/ischaemia-reperfusion injuries, and the precedent this sets, very little is 
known about the response of -motor neurons and their nerve terminals in the PNS.  
 
 44 
1.7 Are -motor nerve terminals vulnerable to hypoxia-reperfusion 
injury? 
 
In the following section, I will discuss that while there is some evidence to indicate that -motor 
nerve terminals of the PNS are highly vulnerable to hypoxia/ischaemia-reperfusion injuries, most of 
these studies are inconclusive. Due the fact that the PNS can be extremely susceptible to such injuries, 
especially as the result of application of surgical and non-surgical tourniquets, establishing that the 
vulnerability of -motor nerve terminals to hypoxia/ischaemia-reperfusion injuries is of significant 
importance and worthy of further study.    
 
1.7.1 The susceptibility of the PNS to hypoxia/ischaemia-reperfusion injuries 
When some of the metabolic properties of neurons from the CNS and PNS are compared, it appears 
that the PNS has a greater metabolic safety factor than the CNS, suggesting an increased resistance to 
hypoxia/ischaemia. Peripheral nerves have been estimated to have 10% of the brain‟s oxygen 
requirements, but similar ATP levels (Stewart et al. 1965; Low et al. 1985; Zollman et al. 1991) and 
they also appear better able to supplement their energy requirements via anaerobic pathways (Campa 
and Engel 1971; Low et al. 1985; Mohler et al. 1999). The PNS however, is not invulnerable to 
hypoxic/ischaemic insults and it is perhaps their susceptibility to hypoxia/ischaemia that drives the 
requirement for a high metabolic safety factor. Unlike the CNS, blood flow to peripheral nerves is not 
auto-regulated and reductions in blood pressure result in reductions in neuronal blood supply (Smith et 
al. 1977; Low and Tuck 1984). Consistent with the idea of -motor neurons being compartmentalised, 
this lack of auto-regulation makes peripheral axons and nerve terminals highly susceptible to 
reductions in oxygen supply compared to cell bodies located in the spinal cord. Reduced oxygen 
delivery in the extremities can therefore be expected in cold environments when blood flow is reduced 
to maintain core temperature, intermittent blood flow in resting muscle (Shibata et al. 2005), quick 
rest-to-work transitions and lateral forces produced during muscle contraction may all cause 
temporary ischaemia and deficits in oxygen supply (Kernell 2006; Clanton 2007). Poor gaseous 
exchange in the lungs during chronic obstructive pulmonary disease, ageing, and low oxygen 
environments may also produce decreases in systemic oxygen levels. Cardiovascular diseases, 
haematological disorders that affect the oxygen binding/release capacity of haemoglobin, thromboses 
and traumatic injury are also other clinical conditions that may cause a significant reduction in blood 
supply and oxygen delivery to peripheral tissues. In particular, the routine use of surgical and non-
surgical tourniquets to control bleeding, blood flow, blood pressure and for the regional administration 
of drug therapies will render entire limbs ischaemic for hours at a time (McEwen 1981; Idstrom et al. 
1990; Pedowitz et al. 1992; Kam et al. 2001; Kam 2007; Murphy and O'Connor 2007). It is such acute 
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ischaemia-reperfusion injures caused by the application of tourniquets that are of most interest and 
form the focus of the following discussion and study.   
 
1.7.2 Long-term neurological damage caused by tourniquets 
Tourniquets have a long history, with the first recorded use in the second century AD by the Roman 
surgeon Heliodorus, with the French surgeon Jean Louis Petit giving the name „tourniquet‟ („tourner‟ 
meaning „to turn’) in 1718 to his screw device that could stem blood flow (Leonardo 1943; Rorabeck 
1980; Murphy and O'Connor 2007). This was followed over a century later by the von Esmarch‟s 
elastic bandage in 1873 and the development of the pneumatic tourniquet by Harvey Cushing c.1904  
upon which all modern, computer controlled, tourniquets are based (Rorabeck 1980; McGraw and 
McEwen 1987; Murphy and O'Connor 2007). Tourniquets are a vital part of everyday clinical practice 
but are well known to cause potentially severe injuries with von Esmarch being one of the first to 
caution the use of his own „Esmarch‟ bandages in 1873: 
 
“…we must not ignore the possibility that the firm strapping of a limb for any 
considerable length of time may be followed by dangerous derangements of the 
circulation and innervation such as thrombosis, inflammation, paralysis, etc.” 
                                     (Von Esmarch 1873, quote taken from Rorabeck 1980) 
 
Occluding the blood supply to an entire limb or multiple limbs (by either tourniquets or vascular 
occlusion) over a long time frame is a massive undertaking (Rorabeck 1980) that can lead to 
amputations and even in the clinical setting, death (Chervu et al. 1989; Carden and Granger 2000; 
Kam et al. 2001). Much like ischaemia in the CNS, ischaemia in peripheral limbs will also cause 





and oedema with the sheer mass of tissues probably exaggerating these changes. When blood flow is 
restored (which may be delayed due to vascular collapse: Ames et al. 1968; Gustafsson et al. 1999) 




, ROS generation especially from xanthine oxidase, and systemic 
acidosis that can all perpetuate local tissue damage but also trigger compartment syndrome, systemic 
inflammatory response, shock, and multiple organ dysfunction (Silver 1977; Rorabeck 1980; McGraw 
and McEwen 1987; Idstrom et al. 1990; Pedowitz et al. 1992; Nagamatsu et al. 1996; Gustafsson et 
al. 1999; He et al. 1999; Mitsui et al. 1999a; Carden and Granger 2000; Kam et al. 2001; Matsumoto 
et al. 2005; Bagdatoglu et al. 2006; Kam 2007; Bagdatoglu et al. 2008). Tourniquets are most clearly 
associated with skeletal muscle damage and necrosis both underneath and distal to the tourniquet. 
Numerous authors have reported perturbations and loss of muscle fibre striations, whole muscle fibres 
becoming wavy, vacuolised, swollen or atrophied with disrupted cell membranes leading to necrotic 
muscle fibre death following as little as 2hr of ischaemia (Scully et al. 1961; Stenger et al. 1962; 
Haljamae and Enger 1975; Makitie and Teravainen 1977a; Patterson and Klenerman 1979; Mars and 
Gregory 1991; Pedowitz et al. 1992; Awerbuck et al. 1994; Ohara et al. 1996; Woitaske and McCarter 
1998; Mohler et al. 1999; Kawamura et al. 2006). For this reason the upper limit of applied time for 
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surgical tourniquets has generally been agreed to be 1.5-2hr (e.g. McElvenny 1945; Kessler 1966; 
Rorabeck 1980; Pedowitz et al. 1992; Kalla et al. 2003; Younger et al. 2005; Malanjum and Fischer 
2006; AORN 2007; Kam 2007), although some have suggested that skeletal muscle may survive total 
ischaemia for as long as 4hr (Gustafsson et al. 1999). In spite of this ~2hr upper limit, there are 
numerous reports of paralysis and long term motor deficits following peripheral limb ischaemia. In 
human surgical patients the most common complications following tourniquet use are neurological 
and range from mild functional loss through to complete limb paralysis and permanent functional 
deficits (e.g., Bernard Roth 1931; Eckhoff 1931; McElvenny 1945; Rudge 1974; Saunders et al. 1979; 
Rorabeck 1980; McGraw and McEwen 1987; Kalla et al. 2003; Kam 2007; Murphy and O'Connor 
2007). This has been estimated to affect >60% of surgical patients (Saunders et al. 1979), or  up to 
1:11,000 and 1:250,000 of the UK population following the use of surgical tourniquets on the upper 
and lower limbs respectively (Kam 2007) but under-reporting may mean that the incidence of 
ischaemic tourniquet paralysis is much higher (Kam et al. 2001). Similar long term functional and 
behavioural deficits (e.g. reduced grip, toe spreading, self-mutilation etc) have been observed in 
animal models following as little as 2hr ischaemia which tend to worsen over time/during reperfusion 
(e.g., Fowler et al. 1972; Makitie and Teravainen 1977a; b; Nitz et al. 1986; Zollman et al. 1991; 
Pedowitz et al. 1992; Iida et al. 2003; Wang et al. 2008).  For example, after 4hr arterial occlusion in 
adult rats or 3hr of tourniquet-induced ischaemia in adult baboons, the ability to elicit muscle action 
potentials was still significantly reduced and movement of limbs impaired after 42 and 180 days 
reperfusion respectively (Fowler et al. 1972; Iida et al. 2003). This would suggest that PNS is highly 
vulnerable to ischaemia-reperfusion injuries and results in punitive and long-term neuropathies. With 
an estimated ~1million procedures utilising surgical and non-surgical tourniquets annually in the USA 
(McEwen 1981), and the average orthopaedic surgeon applying ~200 tourniquets per annum 
(Middleton and Varian 1974), a clear understanding of what is causing these long term injuries is of 
significant clinical importance.  
  
1.7.3 Effects of hypoxia/ischaemia-reperfusion injuries on peripheral nerves. 
One of the first reports of peripheral ischaemic neuropathy was made by Thomas (1909), who 
reviewed numerous case reports of his predecessors, peers, and his own patients regarding „ischaemic 
paralysis‟.  He concluded that in ~60% of patients that had splints, bandages and plaster casts applied 
to their limbs, paralysis could be directly attributable to nerve damage and that this is most likely the 
result of disturbances in the circulation. We now know that when a peripheral nerve is rendered 
ischaemic either by arterial occlusion or by application of tourniquets, there is a failure to transmit 
action potentials or „conduction block‟ within ~35mins (Gerard 1930; Maruhashi and Wright 1967; 
Low et al. 1985; Zollman et al. 1991). During vascular occlusion in rats, a reduction in caudal nerve 
action potential amplitude was seen after 10min and complete conduction block with in 35mins which 
coincided with a 50% decrease in ATP levels by 10mins that dropped to less than 10% after 60mins 
(Low et al. 1985).  Both the axonal conduction block and metabolic changes can be reversed within 
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3hr reperfusion following mild ischaemic insults (Low et al. 1985; Zollman et al. 1991).  This clearly 
indicates metabolic failure in response to ischaemia and is likely to underlie membrane depolarisation 
(Maruhashi and Wright 1967; Low et al. 1985), in keeping with the high energetic demands of 
maintaining and re-establishing polarised membranes (see section 1.4.1). More severe ischaemia 
causes structural changes to sciatic/tibial nerves underlying and distal to tourniquets with minor 
axonal swelling and degenerative changes after 3hr ischaemia alone, followed by clear signs of 
lesions, degeneration and demyelination following reperfusion (e.g. Fowler et al. 1972; Makitie and 
Teravainen 1977b; Nukada and McMorran 1994). In vascular occlusion studies similar finding have 
been noted, where minor degenerative changes and swelling have been noted after 3hr (Iida et al. 
2003; Kawamura et al. 2006) with obvious signs of degeneration after 7 days reperfusion (Nukada and 
McMorran 1994; Iida et al. 2003; Kawamura et al. 2006). These studies have led to the suggestion 
that reperfusion is a major factor in causing neuronal injury (Nukada and McMorran 1994; Iida et al. 
2003), with significant inflammatory response including infiltration of inflammatory cells and 
cytokines (Mitsui et al. 1999c; Kawamura et al. 2006), nitric oxide (Qi et al. 2001) and ROS 
especially from xanthine oxidase leading to oxidative damage of proteins (Nagamatsu et al. 1996; He 
et al. 1999; Mitsui et al. 1999a). Overall, this is consistent with some of the biochemical and 
mechanistic events known to occur in CNS hypoxia/ischaemia-reperfusion injuries but unlike the 
CNS, the potential involvement of nerve terminals in such injuries has been neglected or overlooked. 
This is a critical issue to resolve as by not clearly examining possible structural and functional events 
at -motor nerve terminals may have led to incorrectly identifying the primary target of 
hypoxia/ischaemia-reperfusion injuries as being skeletal muscle whose tolerance to 
hypoxia/ischaemia-reperfusion injuries determines the applied time of tourniquets. 
 
1.7.4 Are -motor nerve terminals vulnerable to ischaemia-reperfusion 
injuries? 
In his 1909 paper describing ischaemic paralysis, Thomas also discusses the work of the German 
clinician, Chvostek, who published a case report in 1892 (Chvostek 1892) describing a patient who 
presented with flaccid paralysis in his right leg and was found at autopsy to have an embolism in his 
popliteal artery. Chvostek apparently argued that the paralysis in the first instance was due to damage 
of the nerve endings but Thomas (1909) largely rejected this view, saying the affects of “terminal 
muscle branches” was of secondary consequence to muscle atrophy and degeneration in response to 
ischaemia. This viewpoint still dominates even in modern clinical practice and in experimental 
models. It is typical practice for neuromuscular function to be assessed by measuring muscle action 
potentials (MAP) generated by stimulating the distal nerve (Iida et al. 2003). While this method may 
give an indication of overall functional deficits, it is inappropriate for distinguishing neurological 
deficits from that of skeletal muscle and may have led to widespread misinterpretation of data 
(Eastlack et al. 2004).  For example, Zollman et al (1991) have shown that 30mins reperfusion after 
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1hr arterial occlusion is sufficient to restore nerve action potential propagation measured between two 
electrodes on the rat sciatic/tibial nerve. MAP measured in the muscles of the foot upon stimulation of 
sciatic/tibial nerve at the ankle however, remained less than 34% of control values 1 week after 
reperfusion and if ischaemia was increased to 3hr, values are less than 30% of control values after 
1month reperfusion. On the basis of this experimental evidence, Zollman et al (1991) and others using 
similar techniques (e.g., Fish et al. 1989; Pedowitz et al. 1992; Ohara et al. 1996; Mohler et al. 1999) 
have largely concluded that the primary site of ischaemia-reperfusion injury is skeletal muscle but 
their results could equally reflect transmission failure at the NMJ rather than in axons or skeletal 
muscle. A recent study has shown clear functional evidence that deficits occur in the nerve before the 
muscle (Hatzipantelis et al. 2001).  Ischaemia induced by arterial occlusion in rats produced a rapid 
and progressive decrease in muscle fibre contractile properties and at 50-80min there was complete 
failure to elicit muscle fibre contraction via stimulation of the nerve. This reduction in contractile 
force was almost completely reversed when muscles were stimulated directly, independently of the 
nerve supply. This study is supported by other studies in the rabbit following vascular occlusion for 1-
3hr (Chervu et al. 1989) and has also been shown  24hr after tourniquet ischaemia in rats (Eastlack et 
al. 2004: c.f discussion below ,section 1.7.5). These studies clearly identify that ischaemia-reperfusion 
injury affects nerve more severely than skeletal muscle and that the principal site of injury is at the 
NMJ and most likely at -motor nerve terminals (Eastlack et al. 2004). In the former of these studies, 
Hatzipantelis et al (2001) go on to show that after 50-80min ischaemia induced by arterial occlusion 
and cessation of neuromuscular transmission, significant degenerative changes could be observed in 
-motor nerve terminals. Makitie & Teravainen (1977b) have also shown swelling of mitochondria 
and some minor degenerative changes in rat -motor nerve terminals but these changes were not 
always independent of minor postsynaptic or skeletal muscle pathology. Similar findings were found 
following transection of the vascular supply (carefully avoiding the nerve supply) in rat soleus 
muscles where some muscle fibre pathology was observed alongside both IA/II, - (the nervous 
supply of the muscle spindle) and -motor nerve terminals pathology, with the latter undergoing 
Wallerian-like degeneration (Diwan and Milburn 1986). Building on the functional studies described 
above that show the nerve is affected prior to skeletal muscle these studies suggest that -motor nerve 
terminals may not only be vulnerable to hypoxia/ischaemia-reperfusion injuries but may also be the 
principal site of injury. The most conclusive study that indicates that -motor nerve terminal may be 
principal site of injury in ischaemia-reperfusion injuries is that of Tombol et al (2002). These authors 
have shown progressive degeneration of rat  motor nerve terminals after 2hr tourniquet ischaemia 
followed by 2hr-5weeks reperfusion without any signs of ultrastructural changes to postsynaptic 
endplates or skeletal muscle fibres. The degenerative changes peaked between 24hr and 1week of 
reperfusion, with complete loss of synaptic vesicles, mitochondrial disruption, vacuolization and 
evidence to indicate activation of Schwann cells affecting 43% and 97% of nerve terminals 
innervating slow-twitch and fast-twitch muscles respectively. Signs of recovery were observed after a 
week but were not complete by the end of the experiment at 4 weeks with 26% and 37% of nerve 
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terminals from slow-twitch and fast-muscle muscles respectively still showing signs of pathological 
ultrastructure. In the most recent study, and the only study at light microscopy level, David et al 
(2007) have shown significant fragmentation and loss of -motor nerve terminals from mSOD1 mice 
(see section 1.5.4) that express endogenous yellow fluorescent protein (YFP: see Chapter 4) in their 
neurons following 30min tourniquet ischemia and 6hr reperfusion. They also indicate that nerve 
terminals from wild-type animals that served as controls, are significantly less vulnerable than those 
from mSOD1 mice but their nerve terminals may also be lost following 30-60mins tourniquet 
application with reperfusion lasting somewhere between 6 and 24hrs (not specified). Important muscle 
fibre type differences were also highlighted, with -motor nerve terminals from fast-twitch muscles 
being more vulnerable than those from slow-twitch muscles, consistent with the findings of Tombol et 
al (2002).   
 
1.7.5 But why are these studies inconclusive and why are further studies 
needed? 
Collectively, these studies do give some indication that - nerve terminals are vulnerable to ischaemia 
reperfusion injury but are far from conclusive at demonstrating -motor nerve terminal vulnerability, 
especially those that utilise experimental tourniquets (Makitie and Teravainen 1977a; Tombol et al. 
2002; David et al. 2007). Tourniquets, by their very nature, cause significant compression to 
underlying tissues including peripheral nerves. In the clinical setting, tourniquets are applied with 
extreme care often by specially trained medical staff, with significant attention paid to tourniquet 
design, pressure, patients‟ resting blood pressure, local anatomy and limb diameter, and limbs are 
generally exsanguinated before application. This is done to ensure blood supply is reduced to clear the 
surgical field but not completely occluded to prevent oedema and to reduce necrosis, crush injuries, 
mechanical trauma and lesions to underlying muscle and nerves (e.g. Eckhoff 1931; McElvenny 1945; 
Fowler et al. 1972; Ochoa et al. 1972; Saunders et al. 1979; McEwen 1981; Nitz et al. 1986; McGraw 
and McEwen 1987; Pedowitz et al. 1992; Ohara et al. 1996; Kam et al. 2001; AORN 2007; Murphy 
and O'Connor 2007). This is because it is believed that the neurological complications following the 
use of tourniquets is caused primarily by mechanical stress and/or as a result of the physical lesion of 
nerves underlying tourniquets, particularly if tourniquets are applied incorrectly and over-pressurized 
(e.g., Eckhoff 1931; McElvenny 1945; Fowler et al. 1972; Ochoa et al. 1972; Rydevik and Nordborg 
1980; Ohara et al. 1996; Kam et al. 2001; Kalla et al. 2003). While this does not rule out ischaemia-
reperfusion injury at -motor nerve terminals distal to the tourniquets, as discussed in section 1.5.1, 
crush injuries, lesions/ axotomy cause Wallerian degeneration of axons and nerve terminals with the 
first morphological signs in vivo being in -motor nerve terminal within 12hr. Complete loss of distal 
region of -motor neurons below the site of injury as a result of Wallerian degeneration probably 
accounts for many of the long-term neurological injuries seen in human patients. In experimental 
animal models of ischaemia-reperfusion injuries, tourniquets are not applied with the same care as 
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they are applied clinically. In particular, the two most recent studies describing structural -motor 
nerve terminal pathology in response to ischaemia-reperfusion injuries (Tombol et al. 2002; David et 
al. 2007), have utilized elastic rubber bands wound around the hind limbs of rodents, a method that 
will significantly increase the risk of mechanical trauma to underlying nerves. This makes the 
degenerative changes identified in -motor nerve terminals by Makitie and Teravainen 1977a, 
Tombol et al. 2002, David et al. 2007, and many of the other studies examining the effects of 
tourniquets, difficult to interpret. The data presented by David et al (2007) does not conclusively show 
the loss of wild-type nerve terminals prior to 12hr in response to tourniquet ischaemia-reperfusion, 
i.e., before any structural changes caused by potential Wallerian degeneration induced by mechanical 
trauma to nerve. They do show that -nerve terminals from mSOD1 are lost prior to the effects of 
Wallerian degeneration, but these nerve terminals are already known to be in a vulnerable, diseased 
state (see section 1.5.4).  Of the studies that have shown structural pathology at -motor nerve 
terminal following the use of tourniquets, only the study by Tombol et al (2002) show some selective 
degenerative changes in - nerve terminals before 12hr and prior to any potential influence of lesion 
induced Wallerian degeneration. The remaining studies utilise vascular occlusion/transection to 
induced ischaemia and therefore avoid the influence of lesion induced Wallerian degeneration but of 
these studies only one, Hatzipantelis et al. 2001, shows pathology at -motor nerve terminals without 
any changes to muscle fibres. The remainder of studies therefore cannot rule out  the possibility that 
structural changes observed in -motor nerve terminals is not caused by postsynaptic/skeletal muscle 
pathology that is known to also cause loss of -motor nerve terminals (Rich and Lichtman 1989; 
Bernstein and Lichtman 1999; McCann et al. 2007). Overall there has yet to be a study that 
conclusively demonstrates the functional and/or structural vulnerability of -motor nerve terminals to 
ischaemia-reperfusion injury and therefore, assess their potential contribution to the neurological 
impairments seen following the application of tourniquets.  
 
Further evidence for the potential involvement of -motor neurons and their nerve terminals comes 
from a few isolated reports that ex vivo -motor neurons are functionally vulnerable to hypoxia. By 
maintaining ex vivo rodent diaphragm muscles in hypoxic salines sparged
6
 with N2 gas, studies have 
shown similar functional findings as the in vivo studies discussed above. Failure to elicit muscle fibre 
contraction via the phrenic nerve after 12-45mins hypoxia could be reversed with ~15min of 
reoxygenation (reperfusion) with O2 gas or upon direct stimulation of the diaphragm (Krnjevic and 
Miledi 1959; Hubbard and Loyning 1966; Bazzy 1994; Zhu et al. 2006). Before the onset of 
neurotransmission failure, several authors have also observed massive increase in MEPP frequency 
(Hubbard and Loyning 1966; Nishimura 1986; Bukharaeva et al. 2005) followed by progressive 
decrease in EPPs and loss of contractile ability upon stimulation of the phenic nerve (Hubbard and 
Loyning 1966). These studies therefore clearly indicate that in response to hypoxia there is a rapid 
increase in spontaneous vesicle release followed by progressive loss of the ability to evoke vesicle 
                                                          
6 Sparge meaning to introduce air or gas into a liquid (dictionary.reference.com) 
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release or conduction block. The mechanism(s) governing this response are still unknown but one 
study in rats has shown similar increases in MEPP frequency following metabolic inhibition with 
sodium azide (Anwyl and Ling 1983). Rabbit sciatic nerves removed and placed into mineral oil 
bubbled with N2 gas show decreases in ATP and glucose within the first 2mins of hypoxia with levels 
becoming almost undetectable by 30-60min. This coincides with increases in lactate and AMP, which 
overall is consistent with inhibition of aerobic respiration, up-regulation of anaerobic respiration and 
metabolic fatigue (Stewart et al. 1965). These studies parallel the metabolic and functional effects of 
CNS hypoxic/ischaemic-reperfusion injuries where metabolic inhibition causes depolarisation of 
neurons that triggers massive vesicle release followed by conduction block. These functional events at 
nerve terminals are known to coincide rapidly with structural pathology that can led to death of 
neighbouring neurons but also retrograde death of the parent neuron. What is still unclear in the PNS 
however is if -motor nerve terminals are also structurally vulnerable to ischaemia/hypoxia-
reperfusion injuries?   
 
1.7.6 Summary and the present study 
Functional and structural changes at nerve terminal have been identified to occur as principal events in 
a wide range of toxic, traumatic and degenerative neuropathologies where loss of synaptic 
connectivity leads to the manifestation of punitive symptoms (see Table 1 and section 1.5). The 
routine use of surgical and non-surgical tourniquets on peripheral limbs is also known to cause long-
term neuropathies, but it is still unclear if pathology at -motor nerve terminals because of 
hypoxia/ischaemia-reperfusion injuries are causing or contributing to the punitive complications of 
tourniquet use. A precedence for nerve terminal vulnerability has been already been set in CNS 
hypoxia/ischaemia-reperfusion injuries where functional and structural events at CNS nerve terminals 
are pivotal in mediating injury that leads to cell death, permanent disability and morbidity. The 
underlying reason(s) for this pivotal role is the susceptibility of nerve terminals to metabolic inhibition 
caused by the hypoxic element of ischaemia-reperfusion injury (e.g. Rothman 1983; Rothman 1984; 
Dewar et al. 1999; Lipton 1999; Ames 2000; White et al. 2000; Bickler and Donohoe 2002: see 
section 1.6) and to the fact that nerve terminals, in general, are known to have high energy demands 
(e.g. Wong-Riley 1989; Attwell and Laughlin 2001; Miller and Sheetz 2004; Hollenbeck and Saxton 
2005), see section 1.4.1). This high energy demand combined with evidence indicating that the 
mitochondria contained within nerve terminals are more susceptible to inhibition, Ca
2+
 overloading 
and rupture than those in other neuronal compartments (John 1996; Davey et al. 1998; Brown et al. 
2006; Naga et al. 2007) and may led to the observed vulnerability of nerve terminals in a range of 
neuropathies, not just hypoxia/ischaemia-reperfusion injuries (Davey et al. 1998). In combination with 
other studies that indicate functional and structural changes, this gives good reason to believe that -
motor nerve terminals may also be vulnerable to hypoxia/ischaemia-reperfusion injuries. What can 
also be learnt from the CNS is that it is vitally important to have a range of different experimental 
model systems to investigate these injuries. Combinations of in vivo, ex vivo and in vitro experimental 
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models have been used not only to identify individual stimuli that contribute to hypoxia/ischaemia-
reperfusion injuries, characterized by highly complex biochemical and cellular events, but also the 
underlying mechanisms by which they are governed. While a truly successful therapeutic strategy has 
yet to be developed to tackle CNS ischaemia-reperfusion injuries in human patients (Dewar et al. 
1999; White et al. 2000; Brouns and De Deyn 2009), this method has provided a number of novel 
targets to direct therapeutic strategies against in the future (Dewar et al. 1999; Mehta et al.  2007; 
Brouns and De Deyn 2009).  In the PNS, current studies are dominated by in vivo experimental model 
systems, either vascular occlusion or tourniquet application, which make identification of the major 
pathological stimuli caused by ischaemia-reperfusion injuries very difficult and further hinder 
identification of underlying mechanisms and the development of future preventative or therapeutic 
strategies. The major pathological stimuli that have been identified in other models systems, both in 




It is therefore my aim to determine the structural vulnerability of ex vivo adult mouse -motor nerve 










Hypoxia-reperfusion injury causes rapid and selective disassembly 




Previous ex vivo studies of hypoxia-reperfusion injury have shown reversible functional changes at -
motor nerve terminals (Krnjevic and Miledi 1959; Hubbard and Loyning 1966; Anwyl and Ling 1983; 
Nishimura 1986; Bazzy 1994; Zhu et al. 2006) but have not been used to show any structural changes 
that would indicate longer-term pathology. One possible reason for this may be the difficulty in 
generating physiologically relevant hypoxic environments in ex vivo model systems. There is no data 
on the normal in vivo O2 levels (normoxia) at -motor nerve terminals but the extracellular normoxic 
levels in the interstitial space of rodent skeletal muscle has been estimated to be between ~1 and 4% 
(Gorczynski and Duling 1978; Honig and Gayeski 1993; Shibata et al. 2001; Eu et al. 2003; 
Matsumoto et al. 2005), falling to as low as ~0.5% during muscle contractions (Gorczynski and 
Duling 1978; Klitzman et al. 1983; Eu et al. 2003). This low normoxic O2 level is thought to be a 
mechanism that helps ensure O2 supply from arterioles /capillaries to skeletal muscle by creating a 
steep O2 gradient (Clanton 2007).  It has been shown that the contraction force of mouse skeletal 
muscles is significantly improved when perfused with salines containing 1% O2 compared to those 
with higher O2 levels, indicating that this is a more physiological relevant O2 level (Eu et al. 2003). -
motor nerve terminals are spatially related to the capillary network, for example, 12m distant in the 
hamster cremaster muscle (Pierzga and Segal 1994) but do not appear to have overlying vasculature 
that would indicate they are not subject to significantly higher O2 levels than skeletal muscles. 
Furthermore, it seems likely that -motor nerve terminals may employ a similar adaptive mechanism 
in keeping low O2 levels to help ensure O2 supply as occurs in skeletal muscle. This low normoxic 
value (0.5-4%) in muscle fibres and their nerve terminals is an important issue that needs to be 
addressed in the experimental design of any ex vivo model systems that utilises environmental hypoxia 
rather than chemical inhibition of aerobic respiration, the former being a more physiological relevant 
stimulus. There is a general difficulty in reducing O2 levels in physiological salines to below 0.8% due 
to atmospheric O2 exchange and having to displace already dissolved O2 (Clanton 2007). This value of 
0.8% is well within the working range of skeletal muscle (0.5-4%) and presumably -motor nerve 
terminals. Those studies that have shown function changes to -motor nerve terminals in response to 
environmental hypoxia have recorded O2 values ranging from 6-8% at or near the muscle surface 
(Bukharaeva et al. 2005; Zhu et al. 2006) while others have recorded an intramuscular value of 0-
2.6% (Bazzy 1994). This would indicate that in these experiments the level of O2 might have varied 
from hypoxic to normoxic, and possibly even hyperoxic levels, with this degree of variance possibly 
further exacerbated across the depth of the muscle.  As O2 delivery relies on diffusion rather than 
supply from the vasculature, the muscle fibres/-motor nerve terminals located in the deeper regions 
are likely to be subject to much lower levels of O2 (Eu et al. 2003; Zhu et al. 2006), particularly in the 
dense diaphragm muscle that these studies utilised. Overall, these studies and the model systems that 
they utilise may not be generating a truly hypoxic, physiologically relevant stimulus, with difficulty in 
interpretation of results further compounded by considerable degree of variability. By selecting small, 
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less dense skeletal muscles, reducing O2 levels as low as possible and taking into consideration 
dissolved O2 and atmospheric O2 exchange it should be possible to reduce potential O2 gradients 
within skeletal muscle/-motor nerve terminals, reduce variability and create more physiologically 
relevant O2 levels in the ex vivo model system used in this study. In particular, if extracellular O2 
levels can be reduced below in vivo values of normoxia (0.5-4%) and near to in vivo values of hypoxia 
recorded in ischaemic limbs of surgical patients, 0.25% (Gustafsson et al. 1999; Matsumoto et al. 
2005), it would be possible to create a more relevant hypoxic stimulus which, regardless of muscle 
fibre location (either superficial or in the central/deeper regions), would render the entire preparation 
hypoxic.  
 
In previous studies, the Parson et al group have utilised ex vivo mouse lumbrical muscles found in the 
sole of the hind foot (see methods for details) which can be maintained under experimental conditions 
and used to examine structural response of -motor nerve terminals using indirect fluorescence 
immunohistochemistry (Moores et al. 2005; Bettini et al. 2007). This neuromuscular preparation has 
been previously characterised, can be maintained in physiological saline (i.e., Krebs‟ solution) where 
variables may be controlled/monitored (e.g. O2, pH and glucose) and the muscles are small allowing 
for better penetration of antibodies and O2. This neuromuscular preparation also provides an 
interesting paradigm of the effects of lower limb tourniquet application and is composed of 
predominantly fast-twitch fibres (Betz et al. 1990; Murray et al. 2008a) that are more vulnerable to 
tourniquet induced ischaemia-reperfusion injury (Tombol et al. 2002; David et al. 2007).  By 
necessity, in these preparations axotomy of the nerve supply occurs and over time (~12hr: see section 
1.5.1) this will cause structural and functional loss of -motor nerve terminals due to Wallerian 
degeneration. To prevent the complication of axotomy-induced -motor nerve terminal 
pathology/loss, lumbrical muscles can be dissected with long distal nerve stumps extending up to the 
lower sciatic/upper tibial nerve (>2.5cm) to provide an additional 1-2hr per cm increase in the lag 
phase of Wallerian degeneration (Miledi and Slater 1970; Ribchester et al. 1995) where little change 
occurs in the distal axon and nerve terminal (Miledi and Slater 1968; 1970; Winlow and Usherwood 
1976; Tsao et al. 1999; Gillingwater and Ribchester 2001). Wallerian degeneration is also temperature 
dependent, with a temperature of <25
o
C slowing the progression of Wallerian degeneration in isolated 
sciatic nerve from 2 to 7 days (Tsao et al. 1999). These measures have been previously shown to 
prevent functional and structural signs of Wallerian degeneration in the same neuromuscular 
perpetrations for at least 4hr (Bettini et al. 2007) and very similar preparations consisting of the flexor 
digitorum brevis for at least 6hr (Parson et al. 2004: see fig 2.1). With this in mind, I have elected that 
experimental time should not exceed 4hr with additional time to spare to complete dissection and pre-
fixation processing. It is generally agreed that the upper limit for tourniquet application in human 
patients is 2hr (McElvenny 1945; Kessler 1966; Rorabeck 1980; Pedowitz et al. 1992; Kalla et al. 
2003; Younger et al. 2005; Malanjum and Fischer 2006; AORN 2007; Kam 2007). As 
reoxygenation/reperfusion is key to recovery but also important in the injury process (e.g., Fowler et 
al. 1972; Makitie and Teravainen 1977b; a; Nitz et al. 1986; Zollman et al. 1991; Pedowitz et al. 
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1992; Iida et al. 2003; Wang et al. 2008), I have elected to use an experimental procedure consisting 
of 2hr hypoxia followed by 2hr reperfusion (reoxygenation):  With this protocol any observed 
response(s) of -motor nerve terminals can be largely attributed to hypoxia-reperfusion injury, rather 
than axotomy induced Wallerian degeneration.  This is also the time frame shown by Tombol et al. 
(2002) to induce selective degenerative events in -motor nerve terminals in vivo following tourniquet 
induced ischaemia-reperfusion injury.  
 
Throughout the course of this study, I have used the term “reperfusion” to refer to the stage where O2 
is returned to the experiment. Use of either of the terms reoxygenation or reperfusion to refer to this 
stage can potentially be considered erroneous or confusing. “Reoxygenation” does not preclude in the 
first instance to the fact that glucose is present throughout the course of the experiment and that once 
the Krebs‟ solution is reoxygenated contains all that is necessary for short to medium-term survival of 
neuromuscular preparation. Future studies (considered here but due to time restraints not carried out) 
may wish to investigate the potential role glucose has in both stages and would therefore need to be 
clearly distinguished from experiments that only examined the presence/absence of O2 as the key 
variable. Alternatively, in vivo reperfusion injury involves as many complex co-stimuli as those of 
ischaemia (see section 1.6.1 and sections 1.7) which are not directly studied here (further discussed 
below in sections 2.4.2 and 2.4.3) hence use of the term “reperfusion” here may be considered 
erroneous. The important aspect of reperfusion injury however, is the ability of cells to reinstate 
metabolic activity (where both reinstatement and failure to do so contribute to most of the 
pathological stimuli of reperfusion injury) upon return of the blood supply. From a reductionist point 
of view (which was one of the aims of this study) it may be considered that the presence of glucose 
and O2 are the two key aspects of reperfusion injury and it is for this reason why I have elected to used 
the term “reperfusion”, rather the term “reoxygenation” in this study.  
 
In the following chapter, I describe the use of a novel experimental model system to show rapid and 
selective -motor nerve terminal pathology in response to 2hr hypoxia, 2hr reperfusion. The resulting 
-motor nerve terminal pathology is indicative of on-going nerve terminals disassembly with 
evidence to indicate that multiple mechanisms of -motor nerve terminal loss may be active.  
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2.2 Methods 
2.2.1 Animals and skeletal muscle dissection 
Tissue was obtained from female 8-12 week old C57Bl/6 mice (Harlan-Olac, UK). Only female mice 
were used to avoid possible gender differences that have been highlighted in ischaemic brain injury 
(Alkayed et al. 1998; Bramlett 2005) and female mice are smaller (Gall and Kyle 1968) with less fatty 
tissue deposits (Parson et al: unpublished observations) that helps improve antibody penetration, 
quality of immunohistochemistry and O2 diffusion.  Mice were culled by a rising CO2 concentration or 
cervical dislocation in accordance with the Animal (Scientific Procedures) Act 1986 (no difference 
was noted in the experimental data with these two culling methods). Tissues were dissected under a 
Zeiss binocular microscope in silicone-lined (Sylgard 184: Dow Corning, Germany) petri dishes. The 
tissues were maintained in Krebs‟ solution (144 mM Na
+
, 5 mM K
+
, 2 mM Ca
2+
 , 1 mM Mg
2+
 , 131.2 
mM Cl
-
, 23.8 mM HCO
3-
 , 0.4 mM H2PO4
2-
 , 5 mM D-glucose, 5.5mM HEPES
7
: pH 7.2-7.4) sparged, 
via a sintered glass bubbler, with 95%:5% O2:CO2 gas.  Extreme care was taken in all instances to 
ensure that each preparation was free of dissection damage and with as much of the overlying tissues 
removed as was practically possible. In this study, -motor nerve terminals were studied from 4 deep 
lumbrical muscles, which are composed of predominantly fast-twitch fibre types (Betz et al. 1990; 
Murray et al. 2008a). These four small muscles (~2.5mm in length, ~1mm in diameter) are found in 
the second layer of the plantar aspect of the foot. They are numbered 1 to 4 according to their 
anatomical location from the hallux (big toe: see fig 2.1) and are involved in flexing distal and 
proximal phalanges of the lateral four digits. The hind limbs of the mice were amputated at the level 
of the thigh, skinned and pinned out in petri dishes. The sciatic/tibial nerve protruding from the thigh 
was carefully released from the surrounding tissues and tendons as it tracked through the lower hind 
limb until it reached the level of the calcaneus (heel bone). The plantaris and flexor digitorum brevis 
longus tendon was then severed at the attachment point on the calcaneus, avoiding the sciatic/tibial 
nerve stump sandwiched between the two tendons as it continues into the sole of the foot. The 4 deep 
lumbrical muscles attached to the plantaris tendon were dissected free from the foot and midway up 
the digits along with the overlying flexor digitorum brevis muscles and flexor digitorum brevis longus 
tendon. The flexor digitorum brevis muscle and flexor digitorum brevis longus tendon remained in 
place until after experimentation and fixation to ensure the nerve supply to the lumbrical muscles was 
not damaged. To ensure that lumbrical muscle preparations from the left and right hind foot could be 
identified and that each of the four lumbrical muscles could be correctly assigned a number, a small 
suture was tied in the plantaris tendon of the right hind leg. As a long nerve stump, >2.5cm in length, 
is particularly vulnerable to dissection damage, especially around the heel bone/ankle joint I verified 
their integrity before use in experiments by stimulating the nerve stump with a suction electrode 
(custom made) connected to an isolated stimulation and trigger unit (Model DS2A, Digitimer Ltd, 
                                                          
7 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid: Sigma 
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Hertfordshire, UK). Where tested, all muscles produced a strong twitch response with a 0.2ms pulse at 
0.5V or below. From time of death to the start of the experiment typically took no more than 1hr. To 
help with visualisation of motor nerve terminals from lumbrical muscles and after processing for 
immunohistochemistry was complete, each of the four lumbrical muscles was isolated from the 
plantaris, had overlying connective tissues removed and were mounted onto their lateral surface.  
 
2.2.2 Hypoxia-reperfusion model system  
250ml HEPES buffered Krebs‟ solution was vigorously bubbled with 95%:5% N2:CO2 via a sintered 
glass bubbler for a minimum of 1.5hr in a 250ml conical flask prior to the start of experimentation. 
The long setup period was required to ensure maximum displacement of already dissolved O2 and the 
use of a conical flask created a high N2, low O2 micro-environment coupled with a small surface to 
reduce atmospheric oxygen exchange (see Fig 2.2). Muscles dissected from the right-hand side, with 
their respective nerve stumps, were subject to 2hr of hypoxia followed by 2hr reperfusion in 95%:5% 
O2:CO2 sparged Krebs‟ solution. Muscles from the left-hand side of the same animals were 
maintained as experimental control specimens in 95%:5% O2:CO2 sparged Krebs‟ solution also in a 
Fig 2.1: The plantar aspect of the human foot showing the lumbrical muscles that, 
except for relative proportions, are very similar to that of the mouse. The pseudo-colour 
tissues of the first and second layer of the sole of foot shown in (A) was removed from 
the rest of the foot at the beginning of the experiment but with the sciatic/tibial distal 
nerve stump extending up to level of the mid-thigh. Following 2H-2R or control 
procedures and fixation, the first layer of the sole of the foot was removed (flexor 
digitorum longus tendon, flexor digitorum brevis muscle and distal nerve stump) to fully 
expose the 4 deep lumbrical muscles attached to the plantaris tendon (B). This was to 
ensure that the nerve supply to the deep lumbrical muscles, which is sandwiched 
between flexor digitorum longus and plantaris tendons, was not damaged prior to the 
start of the experiment. Careful note of the position of the hallux (‘big toe’) was taken so 
the each of the deep lumbrical could be assigned its correct anatomical number (1-4). 
Image adapted from the bartleby.com edition of Gray’s Anatomy of the Human Body.  
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conical flask for the duration of the experiment (4hr). All muscles were left free floating with 
sufficient flux so as not to become stagnant but to remain below the surface during the course of the 
experiment.  
Oxygen: The system was monitored with a Clark-type (Clark et al. 1953) micro-oxygen electrode 
(MLT1120, AD Instruments, UK/ MI-730 Microelectrodes Inc, USA). The electrode, composed of a 
platinum cathode and a silver/silver chloride anode, is enclosed in a housing chamber filled with 
electrolyte solution. The tip of the housing chamber (3mm) is covered with a Teflon membrane that 
allows passage of O2 into the supplied electrolyte solution. When the platinum cathode is held at 0.8V, 
the following redox reaction occurs to produce a current proportional to the concentration of the O2 
diffusing across the membrane. 
Anode: 4Ag + 4Cl
- → 4AgCl + 4e- 





 → 2H2O 
 
The O2 electrode was connected to an analogue adapter unit (MLT1122) and 8/30 Powerlab bridging 
amp (ML870: both AD Instruments, UK) with data recorded on an Apple Mac G3 computer and 
MacLab/Chart 4 software (AD Instruments, UK). Prior to the start of each experiment, the electrolyte 
solution was replaced and the electrode underwent two-point calibration in ~40ml of distilled water 
placed on a magnetic stirring platform. Both solutions were left to equilibrate for at least 10mins, one 
with ambient air that was later used to calibrate the electrode to 21% O2. The other solution was 
rendered anoxic (0% O2) with the addition of sodium sulphite (~2g) before being left to equilibrate 
and the addition of a further ~2g of sodium sulphite at the point of calibration. During the course of 
the experiment, the electrode was placed well below surface level and away from the line of bubbles 
produced by sparging. O2 levels were recorded every 10s over a 10V range, with the signal filtered for 
mains noise.  
Temperature: Temperature was monitored via a thermistor probe (2mm tip) and a temperature 
controller unit (BSC-T3 and TC-202A respectively, Harvard Apparatus, Hertfordshire, UK). The 
controller unit was connected to the Powerlab bridging amp and Mac computer as above and set to 
record temperature continuously with a scaling factor of 100mV per 
o
C as indicated by manufactures 
instructions and confirmed via the temperature controller‟s display.  
pH: pH was monitored visually using an analogue volt meter (Corning Eel model 7 pH meter) with a 
combination pH electrode (Thermo Russell) that was calibrated to pH7 at the start of each experiment. 
pH was maintained in the Krebs‟ solution by using biocarbonate/CO2 and HEPES buffer 
 
2.2.3 Fluorescent Immunohistochemistry  
At the end of the experiment, post-synaptic acetylcholine receptors were labelled by incubation in 
tetramethylrhodamine
 
isothiocyanate-conjugated -bungarotoxin (BTX) for 7mins (2.5µg/ml in 
oxygenated Krebs‟ solution: Invitrogen) prior to fixation in absolute methanol (MeOH) at -20
o
C for 
15mins. Tissues were washed in phosphate buffered saline (PBS, Sigma) and immersed in a blocking 
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solution (0.1% TX-100, 0.2% IgG/protease free bovine serum albumin (Jackson ImmunoResearch, 
Stratech, Newmarket, UK), 0.1% sodium azide in PBS) for a minimum of 1.5hr. This was followed by 
at least 16hr incubation on a rocking platform with monoclonal anti-neurofilament (NF) 165kDa 
primary antibodies (1:250: Developmental Studies Hybridoma Bank, Iowa, USA) diluted in blocking 
solution at 4
o
C. This was followed by 3x10min washes in PBS and a subsequent 1hr incubation in 
Cyanine2 (Cy2) donkey anti-mouse secondary antibodies (1:500; Jackson ImmunoResearch) diluted 
in blocking solution. Following 3x20min wash in PBS, the above process was repeated but with anti-
synaptic vesicle protein 2 (SV2) primary antibodies (1:250: Developmental Studies Hybridoma Bank). 
Following the final wash for 2x10min and 2x15min in PBS muscles were mounted on to glass slides 
in 4% n-propylgallate in glycerol and stored in the dark at 4
o
C.  
Alternatively and as indicated in the text, tissues were directly fixed by immersion in freshly made 
PLP
8
 fixative (4% liquid formaldehyde (Electron Microscopy Sciences, PA 19440, USA), 1.8% 
lysine, 0.2% sodium-m-periodate: McLean and Nakane 1974) for 30mins before washing for a 
minimum of 3x10min in PBS containing 0.5% TX-100. After incubation in blocking solution for 1hr, 
the above sequential staining protocol was used but with the following combinations of primary 
antibodies: rabbit anti- -tubulin III (1:100: Abcam), goat anti-Choline Acetyltransferase (1:100: 
Calibochem) and SV2 (as above).  These antibodies were visualised with appropriate Cy2 or Cyanine 
3 (Cy3) secondary anti-rabbit, goat, or mouse antibodies (1:500; Jackson ImmunoResearch) 
respectively. Muscles were then washed 2x10min and incubated in alexa647-conjugated -
bungarotoxin at 5 µg/ml in PBS for 30min. Following a final wash in PBS muscles were mounted and 
stored as above. 
 
2.2.4 Electron Microscopy 
At the end of some experiments, lumbrical muscles were fixed in a 2.5% Glutaraldehyde/4% 
formaldehyde solution in 0.1M phosphate buffer for 6hr. The 2
nd
 lumbrical muscle was isolated and 
washed 3x10mins in 0.1M phosphate buffer (PB). Muscles were then post-fixed in 1% osmium 
tetroxide (in 0.1% phosphate buffer) for 45mins, followed by 3x10min wash in PB and dehydration 
through an ascending series of ethanol solutions (30-100% ethanol). Following immersion in 
propylene oxide for 2x10mins, muscles were embedded in Durcupan resin and left to set for 24-48hr 
at 60
0
C. 70-90nm sections were cut on an ultramicrotome, floated onto Formvar-coated grids (Agar 
Scientific, UK) and impregnated with heavy metal stains (uranyl acetate and lead citrate) in a LKB 
„Ultrostainer‟. Sections were viewed on a Philips CM12 transmission electron microscope and 
negatives were scanned on to PC using an Epson (Long Beach, CA) 4870 photo flatbed scanner 
                                                          
8 PLP is the acronym for this fixative developed by McLean and Nakane (1974) standing for Paraformaldehyde-Lysine- 
Periodate. It is a common mistake that formaldehyde is often referred to paraformaldehyde: the latter refers to the solidified 
polymerised form (para meaning polymer) while the former refers to the liquid monomeric form. To avoid confusion I will use 
the PLP acronym used by developing authors (and many others) throughout the course of this study.  
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equipped with transparency adaptor at 800dpi. Minor adjustments for brightness and contrast were 
made with Abode Photoshop CS2 software. 
2.2.5 Image Capture, Quantification and Statistical analysis  
All fluorescent immunohistochemical preparations were examined to ensure quality of 
immunohistochemistry. Preparations were then quantified on an epifluorescence upright microscope 
(Zeiss Standard 10) fitted with a FITC/TRITC filter set and 50W mercury vapour light source.  
Fluorescence images were captured using x25, 0.6NA or x50, 0.8NA water immersion objectives 
(Zeiss) via a monochrome Cohu 4910 CCD camera (Vista Vision, Steventon, UK) and frames 
averaged (2-100 frames) using Scion Image capture software (Alrad, UK) running on an Apple 
Macintosh Quadra 650 microcomputer. Image capture was also carried out on BioRad Radiance 2000 
laser scanning confocal microscope (x40, 0.8NA oil-immersion objective) using Lasersharp 2000 
software on PC to project composite images of serial optical sections. All images had minor 
adjustments for brightness and contrast and were coloured and reconstructed as required using Abode 
Photoshop CS2 software on PC. 
All quantification of NF/SV2 labelled muscles was carried out at x25 magnification. Muscles were 
assessed to ensure that there was no significant muscle fibre death beyond one or two dead muscle 
fibres seen at the edge of the muscle preparation (assumed to be the result of minor dissection 
damage). The postsynaptic endplates were then quantified from top right to bottom left through the 
depth of the muscle, with every attempt made to ensure the whole population was counted. There were 
however, the following exclusions: endplates that were right angles to the plane of view, obscured 
from the plane of view (e.g. by intramuscular nerve or debris) or belonged to a muscle fibre that 
lacked striations or had significant autofluorescence. The -motor nerve terminals opposing each 
endplate were assessed and categorised as follows: 
 
Full: NF/SV2 immunoreactivity fully opposed postsynaptic BTX staining of the endplate.  
 
Partial: NF/SV2 immunoreactivity did not fully oppose postsynaptic BTX staining of the 
endplate. To account for normal ongoing synaptic re-organisation (synaptic 
guttering) endplates were only classified as being partially occupied when NF/SV2 
immunoreactivity was absent from a region that corresponded to approximately two 
or more synaptic boutons.  
 
Vacant: No clearly distinguishable NF/SV2 immunoreactivity could be detected opposing the 
muscle endplate. 
 
All numerical data was collated using Microsoft Excel 2003 on PC. The percentage of full, partial and 
vacant endplates were calculated per lumbrical and then pooled.  All values are percentage mean  
standard error of the mean (SEM), where N= the number of animals, n=the number of muscles with 
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total number of endplates counted enclosed in brackets. Statistical testing was carried using GraphPad 
Prism 4 software. Multiple testing was carried out using a Kruskal-Wallis test, the non-parametric 
equivalent of an ANOVA (Dytham 2003), followed by a Dunn‟s post-hoc test to identify which group 
of pairs were statistically different.  Those pairs identified as being statistically different underwent 
further testing with a pairwise Mann-Whitney U-Test, a more powerful and less conservative test, and 
resulting P-valves reported. Only selecting pairs already identified as being significant in the Kruskal-
Wallis /Dunn test avoided having to reduce the critical threshold of P to below 0.05 to compensate for 




2.3.1 Characterisation of the experimental system designed to model hypoxia-
reperfusion injury. 
To successfully determine the vulnerability of -motor nerve terminals to hypoxia-reperfusion injury 
it was important to generate a model system in which ex vivo neuromuscular preparations could be 
monitored and maintained in a constant, physiologically relevant hypoxic environment. In vivo, the 
normoxic working range of rodent skeletal muscle has been estimated to be 0.5-4% (Gorczynski and 
Duling 1978; Klitzman et al. 1983; Honig and Gayeski 1993; Shibata et al. 2001; Eu et al. 2003; 
Matsumoto et al. 2005) but due to atmospheric O2 exchange and already dissolved O2, there is 
considerable difficulty in reducing O2 to below 0.8%, (Clanton 2007). To help overcome this 
difficulty, preparations were maintained in a conical flask with 250ml of HEPES buffered Krebs‟ 
solution. By using the conical flask and vigorously sparging with 95%:5% N2:CO2 gas, it was aimed 
to reduce the surface area to volume ratio, increase the displacement of already dissolved O2 and 
create a low O2 micro-environment at surface level to reduce atmospheric oxygen exchange (Fig 
2.2A). Monitoring this system with a calibrated O2 electrode showed that O2 levels typically fell 
below 0.5% within 15-30mins after sparging commenced (Fig 2.2B) but O2 levels could continue to 
fall for a further 45mins (1.25hr from the start) until a steady state level was reached at between 0.1% 
and 0.25%. This steady state level of <0.25% is in agreement with previously reported O2 values in 
vivo following tourniquet-induced ischaemia (Gustafsson et al. 1999; Matsumoto et al. 2005). Due to 
this delay in producing a steady-state O2 level, all subsequent experiments were allowed to equilibrate 
for a minimum of 1.5hr before being used to induce hypoxia in ex vivo nerve/muscle preparations, 
thereby improving the consistency of the hypoxic environment.  Following the set-up (1.5hr) and 
hypoxic (2hr) phases of the experiment, a 2hr phase of reperfusion was carried out by introducing 
95%:5% O2:CO2 gas that, within minutes, produced a dissolved oxygen concentration in the region of 
54-59%.  Control experiments were maintained for 4hr in a conical flask with 250ml of HEPES 
buffered Krebs‟ solution sparged with 95%:5% O2:CO2. Monitoring the system with a pH electrode 
showed that no significant changes in pH occurred during the course of the experiments. Temperature 
was also monitored to show that this remained relatively consistent within the same experiment and 
between experiments (22 - 24.5
o
C). 
2.3.2 Neuromuscular preparations and control morphology 
To assess potential -motor nerve terminal pathology following 2hr hypoxia - 2hr reperfusion (2H-
2R) a fluorescent immunohistochemical staining protocol targeted at synaptic vesicle 2 protein (SV2) 
and neurofilament 168kDa (NF) was modified from those previously established by Parson et al. 
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Fig 2.2 Hypoxia-reperfusion model system. (A): Schematic representation of the 
hypoxia-reperfusion model system with key principals/ assumptions indicated. 
Monitoring of the system took place by positioning oxygen, temperature and pH probes 
well below surface level and away from the direct line of the bubbles (not shown). (B): 
Example recording from the model system indicated in (A) showing O2 concentration 
(red line) during the system set-up phase and the experimental phases of hypoxia and 
reperfusion. In the set-up phase, 250ml of Krebs’ solution is sparged with 95:5% N2:CO2 
gas and O2 concentration is seen to reach below the lowest reported threshold for 
skeletal muscle normoxia, i.e., less than 0.5%, within 30mins. In the recording shown, 
hypoxic conditions begin after 19mins (-1.2hr). The O2 concentration however, could 
continue to fall for a further 1hr until it reached a consistent, steady state. In all 
experiments where recordings took place, steady O2 state was below 0.25% and in this 
example recording reached the mean value of  0.23% after 1hr 14min (-16mins).  To 
ensure that oxygen levels remained as consistent as possible, all hypoxia-reperfusion 
experiments began after the Krebs’ solution was sparged with  95:5% N2:CO2  for 1.5hr 
(system set-up phase). After the set-up phase, skeletal muscle preparations were added 
to the Krebs’ solution to begin the hypoxic phase which lasted for 2hr. This was followed 
by 2hr reperfusion using 95:5% O2:CO2 gas. In the recording above, O2 concentration 
exceeded 0.5% within 2mins and was maximal by 5mins (54%) which were typical 
values for all experiments. After reperfusion, preparations where removed and 
processed for immunofluorescent staining.  Temperature was monitored throughout and 
was maintained at 23-24
0
C (blue line). pH was also monitored throughout experiments 
and maintained between 7.2-7.4 (not shown). Control muscles were maintained in 
250ml Krebs’ solution sparged only with 95:5% O2:CO2 gas for the full 4hrs duration. 





(2004) and Bettini et al. (2007). This included changing the fixative from formaldehyde to MeOH
9
, 
use of IgG/ protease free bovine serum albumin (that can help in the reducing non-specific binding of 
antibodies (Jackson ImmunoResearch/Stratech product information)), sequential application of 
antibodies and increasing the length of time tissues were in the blocking and primary antibody 
incubation stages (factors influencing antibody binding and immunohistochemistry (and in particular 
fixation) are further discussed in Chapter 5,section 5.4.1 and 5.4.2). The result of these changes 
produced NF/SV2 immunoreactivity that was robust and intense across the length and depth of 
individual lumbrical muscles (Fig 2.3) and provided the consistency required to establish the 
parameters for control morphology (see Fig 2.7 for quantification of control morphology) and 
identification of pathological morphology. By comparing presynaptic NF/SV2 immunoreactivity with 
that of post-synaptic acetylcholine receptors (endplates) identified with -bungarotoxin (BTX) 
showed that under control conditions, NF/SV2 immunoreactivity completely and fully opposed that of 
the BTX in >95% of cases. A small population of endplates were seen to have no NF/SV2 
immunoreactivity in a small part of their overlying nerve terminal and in most cases appeared to 
correspond with approximately one nerve terminal bouton. This is thought to represent on-going 
synaptic plasticity at nerve terminals and has been previously been termed „synaptic guttering‟ 
(Cardasis and Padykula 1981; Wernig and Herrera 1986; Wigston 1989).  Due to this, -motor nerve 
terminals were classified as having a normal, „full‟ morphology as long as NF/SV2 was absent from 
no more than one terminal bouton. Rarely (<~2%), endplates were identified with no NF/SV2 
immunoreactivity in two or more boutons and were therefore categorised as having a „partial‟ -motor 
nerve terminal morphology.  Occasionally, some endplates in control muscles (<~2%) were also 
identified with no opposing NF/SV2 immunoreactivity and categorised as „vacant‟.  Like synaptic 
guttering, this is probably the result of on-going synaptic plasticity and/or the result of a naturally 
occurring injury (examples of partial and vacant -motor nerve terminal morphologies in control 
preparations can be seen in Chapter 3, Fig 3.6 and Fig 3.10 respectively) 
 
2.3.3 Post-synaptic endplate and muscle fibre morphology is maintained 
following hypoxia-reperfusion injury 
The effects of 2hr hypoxia followed by 2hr reperfusion (2H-2R) on the morphology of pre- and post-
synaptic components of the mouse neuromuscular junction in the 4 deep lumbrical muscles from the 
right hind leg (N=7, n=28(4974)) were compared with those muscles from the left hind leg kept under 
control conditions (N=7, n=28(5090)).  2H-2R did not cause any identifiable changes to the 
integrity/morphology of post-synaptic endplates or muscle fibres compared with control preparations 
                                                          
9 The anti-NF 165KDa antibody has been used with formaldehyde fixation for a number of years by the Parson et al. group 
providing intense and robust staining. It was noted independently by the Parson et al.  and Gillingwater et al.  groups (personal 
communication from Dr. Simon Parson and Dr. Tom Gillingwater, University of Edinburgh) that, despite no change to 
processing protocols, there had been a progressive loss of immunoreactivity with several different batches/lots of this antibody. 
This surprising (the antibody is both monoclonal and from a hydridoma cell line) loss of immunoreactivity with established 




Fig 2.3: Reconstruction of a lumbrical muscle kept under control conditions. 
Reconstructed confocal projections of a mouse lumbrical muscle (8-12wks) showing 
there is no significant -motor nerve terminal pathology after being maintained in control 
conditions (4hr in 95%:5% O2:CO2 sparged Krebs’ solution). Presynaptic neurofilament 
165kDa (NF) and synaptic vesicle 2 protein (SV2) immunoreactivity (visualised with Cy-2 
secondary antibodies: GREEN) can be seen to fully oppose post-synaptic endplates 
labelled with TRITC-conjugated BTX (RED). The main branches of the intramuscular 
nerve (*) can be seen to send a complex network of collateral branches through the 
length and depth of the muscle. These collateral branches end in nerve terminal 
arborisations and oppose post-synaptic endplates located on individual muscle fibres. -
neuromuscular junctions are present (arrow: see chapter 3), although no IA/II nerve 
endings can be identified. Immunoreactivity in general, appears robust and relatively 




Fig 2.4: Reconstruction of a lumbrical muscle following 2hr hypoxia-2hr 
reperfusion (2H-2R).Reconstructed confocal projections of a mouse lumbrical muscle 
(8-12wks) showing widespread loss of presynaptic neurofilament 165kDa and synaptic 
vesicle 2 protein (NF/SV2) immunoreactivity (visualised with Cy-2 secondary antibodies: 
GREEN) leaving most post-synaptic endplates labelled with TRITC-conjugated BTX 
(RED) appearing vacant. The main intramuscular nerve (*) can still be identified but the 
complex network of axon collaterals is reduced and often discontinuous. Some 
endplates however, still remain with some opposing NF/SV2 immunoreactivity in their 
presynaptic -motor nerve terminals and pre-terminal axons (e.g., arrowheads). -motor 
nerve terminals and IA/II sensory endings can still be identified (arrows: see section 




Fig 2.5: Selective pathology in -motor nerve terminals following hypoxia-
reperfusion injury. In control conditions (A) confocal projections demonstrate the 
characteristic ‘pretzel-like’ morphology of postsynaptic endplates (visualised with BTX: 
RED) which are fully opposed by an overlying nerve terminal arborisation, identifiable by 
NF/SV2 immunoreactivity (GREEN). Axons can also be clearly traced back into the 
nearest collateral branch and phase-contrast micrographs (C) show uniform muscle 
fibres with clear striations. Following 2H-2R, confocal projections (B) show that 
postsynaptic endplates appear unchanged but a large proportion of endplates have lost 
all opposing NF/SV2 immunoreactivity in their presynaptic nerve terminals and pre-
terminal axons. Muscle fibres (D) appear unaffected by 2H-2R with a uniform structure 





Fig 2.6: A small population of -motor nerve terminals show Wallerian-like and 
withdrawal-like mechanisms of disassembly. Endplates that are only partially 
occupied or in the intermediate stage of breakdown can provide morphological insights 
into the mechanisms of -motor nerve terminal pathology following hypoxia-reperfusion 
injury. (A) Confocal micrographs showing immunohistochemically labelled 
neuromuscular junctions in lumbrical muscles following 2H-2R treatment. One endplate 
(RED) remained fully occupied (bottom left) with 'full’ overlying NF/SV2 immunoreactivity 
(GREEN). A neighbouring endplate (upper middle; less than 50µm away) had no 
residual NF/SV2 immunoreactivity (vacant). A third endplate (upper right) was partially 
occupied by overlying NF/SV2 immunoreactivity. However, note how the presynaptic 
staining is fragmented in both the motor nerve terminal and pre-terminal axon. This 
would be synonymous with nerve terminal loss by a Wallerian degeneration-like 
process. (B) Micrograph showing another example of a partially occupied endplate 
(arrowhead) which remains entirely connected to its incoming pre-terminal axon (i.e. no 
fragmentation). The endplate has lost approximately 25% of it overlying nerve terminal 
while the remainder appears normal. This type of partial loss is indicative of nerve 
terminal loss by an asynchronous, withdrawal-like process. (C) Micrograph showing 
another example of a partially-occupied endplate with complete loss of NF/SV2 
immunoreactivity in one part of the nerve terminal, much like the asynchronous, 
withdrawal-like process observed in (C) . This was also accompanied by the presence 
of isolated nerve terminal fragments (arrowhead) like that seen in (A) which is opposed 
by the endplate. Note however, that the pre-terminal axon presents with weak NF/SV2 
immunoreactivity, compared to the fragmented or normal immunoreactivity seen in (A) 
and (B) respectively. Scale bar 10m. 
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Fig 2.7 Quantification of -motor nerve terminal response to hypoxia-
reperfusion injury compared with those maintained in control conditions. (A), 
Bar chart (%meanSE) showing the categorical quantification of -motor nerve 
terminal status (i.e., fully occupied, partially occupied or vacant) that oppose post-
synaptic endplates from hypoxia-reperfusion treated (2H-2R: black bars) and control 
(white bars) lumbrical muscles. Results were statistically analyzed (see methods) to 
show that there was a highly significant increase in both vacant and partial 
morphologies and a concurrent decrease in full nerve terminal morphologies following 
2H-2R injury compared with controls. (B), Scatter plot (%mean indicated by line) 
showing intra-lumbrical differences in the number of endplates identified with no 
NF/SV2 immunoreactivity, i.e., vacant, following 2H-2R injury. Statistical analysis 
showed there is no significant difference between the 4 lumbricals however, it is clear 
that the 4
th
 lumbrical has a highly variable response to 2H-2R. (C): Scatter plot 
(%mean indicated by line) showing intra-lumbrical differences in the number of 
endplates identified with partial nerve terminal morphology following 2H-2R injury. 
There is no statistical difference in the number of partially occupied endplates 
between lumbricals. Interestingly the highly variable number of vacant endplates 
identified in the 4
th
 lumbrical shown in (B), is not reflected in the number of partially 
occupied endplates (note the different x-axis scale).  
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(Fig 2.5). The latter was determined by the presence of regular striations (using phase-contrast 
microscopy) and by no noticeable increase in the levels of autofluorescence that would indicate loss of 
fibre integrity. No changes to the post-synaptic endplates and muscle fibres are in agreement with 
previous in vivo studies examining the effects of tourniquet induced ischaemia-reperfusion injury 
(Tombol et al. 2002).  
 
2.3.4 Significant loss of -motor nerve terminal morphology following hypoxia-
reperfusion injury. 
2H-2R caused 82.5 4.2% of endplates to appear with no opposing NF/SV2 immunoreactivity in their 
motor nerve terminal arborisations and pre-terminal axons (Fig 2.7). The remaining endplates either 
appeared to show „full‟ (16.1 4.0%) or „partial‟ (1.4 0.3%) innervation by some nerve terminal 
boutons. While distal pre-terminal axons were not present, larger branches of the intramuscular nerve 
could always be identified (Fig 2.4).  This dramatic and highly significant loss of nerve terminal 
morphology was in stark contrast to -motor nerve terminals from control lumbrical muscles where 
99.3 0.2% of endplates were fully occupied and only a small number of endplates appeared vacant 
0.6%0.2% or partially 0.20.06% occupied.  
 
2.3.5 -motor nerve terminal undergo rapid disassembly in response to hypoxia-
reperfusion injury with characteristics of both withdrawal and Wallerian 
degeneration –like processes.  
Partially innervated endplates were very rarely observed in control preparations but formed a small 
(1.4 0.3%) but significant subpopulation in response to 2H-2R (see Fig 2.6-2.7).  This offered an 
ideal opportunity to examine nerve terminals at „intermediate‟ stages of breakdown and may provide 
possible insights into the pathways responsible for loss of -motor nerve terminal morphology.  
Examination of this subpopulation of neuromuscular junctions revealed an apparently heterogeneous 
set of morphological responses. Some partially occupied endplates had lost part of their overlying 
nerve terminal in an asynchronous manner while their remaining nerve terminal and incoming pre-
terminal axon remained intact. This is indicative of a withdrawal or retraction-like process of nerve 
terminal loss (Fig 2.6(B); Gillingwater et al. 2002; Gillingwater and Ribchester 2003; Walsh and 
Lichtman 2003; Parson et al. 2004; Bettini et al. 2007). Other partially occupied endplates had 
fragments of remaining nerve terminals that were disconnected from each other and/or their pre-
terminal axon (Fig 2.6(A&C). These fragments were identified by intense NF/SV2 immunoreactivity 
and care was taken to ensure that they corresponded with endplate staining to help rule against the 
possibility of these fragments being non-specific binding artefacts.  Fragmentation of axons and nerve 
terminals is indicative of a classic Wallerian degeneration-like process of nerve terminal loss (Waller 
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1850; Miledi and Slater 1970; Winlow and Usherwood 1975; Gillingwater and Ribchester 2001; 
Gillingwater et al. 2002; Gillingwater et al. 2003). Other -motor nerve terminals showed aspects of 
both mechanisms within the same arborisation (Fig2.6C). With evidence of withdrawal and Wallerian 
degeneration-like process present, it appears unlikely that rapid and significant loss of NF/SV2 
immunoreactivity in -motor nerve terminals following hypoxia-reperfusion injury occurs by a single 
mechanism. Furthermore, the overall small population of endplates observed to be partially occupied 





 deep lumbrical muscle shows a highly variable response to 
hypoxia-reperfusion injury. 
It was noted during data collection that there may be differences in -motor nerve terminal responses 
to 2H-2R injury between the four lumbrical muscles (Fig2.7B&C).  Data presented above was 
reanalysed to show the response of -motor nerve terminals according to the anatomical 
location/number (Fig 2.1). This revealed that there was a difference, but not statistically significant, in 
the mean number of vacant endplates in the 4
th







 lumbricals (collective mean range 89.3% to 91.7%). The 4
th
 lumbrical muscle also showed 
a very high degree of variance in the number of vacant endplates, ranging from 6.6% to 97% 
compared to the collective variance of the 1
st
, 2nd and 3
rd
 lumbrical muscle of 73.6% to 100% (see Fig 
2.7B and the appendix of data tables). Further analysis shows that this variance in the number of 
vacant endplates in the 4
th
 lumbrical was not reflected in the number of partially innervated endplates, 
which represent ongoing nerve terminal disassembly (Fig 2.7C). This collectively suggests that while 
the 4
th
 lumbrical has no statistical difference in overall response to hypoxia reperfusion injury, the 4
th
 
lumbrical muscle has a greater range of resistance/vulnerability but the cellular processes that govern 
the loss of -motor nerve terminal morphology remain unchanged. The reason(s) for this difference 
remains unclear. 
 
2.3.7 Perturbations to -motor nerve terminal microtubule network and cytosol 
following hypoxia-reperfusion injury  
The above data clearly shows significant loss of the neurofilament immunoreactivity in -motor nerve 
terminals from lumbrical muscles following injury. To investigate further the affect of 2H-2R on the 
cytoskeletal architecture of -motor nerve terminals, antibodies directed against the microtubule 
network, neuron specific -tubulin III (tubulin), were used following 2H-2R and compared to that of 
controls. In control preparations tubulin immunoreactivity was intense, without any breaks, in axons 
and the central regions of the -motor nerve terminal arborisation, with staining becoming slightly 
less intense towards the edges of the arborisation (N=2, n=6: Fig 2.8). Following 2H-2R, tubulin 
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immunoreactivity became disorganised and obviously fragmented in both axons and -motor nerve 
terminals (N=2, n=6). Unlike NF/SV2 immunoreactivity where >82% of -motor nerve terminal 
appeared vacant, most endplates did appear with some overlying -tubulin III immunoreactivity but 
this could sometimes be „ghostly‟ in appearance. This would clearly suggest that 2H-2R triggers 
significant disruption to microtubule network as well as loss of neurofilaments and synaptic vesicles 
but not complete, gross structural loss of -motor nerve terminals. This indicates that there are 
specific spatiotemporal events occurring in response to 2H-2R where neurofilaments and synaptic 
vesicles are lost prior to microtubules.  This is further supported by evidence from -motor nerve 
terminals triple-labelled with SV2, BTX and anti-choline acetyltransferase (Fig2.9). Choline 
acetyltransferase (CHAT) has a predominantly cytoplasmic pattern of expression (Smith and Carroll 
1980; Pahud et al. 1998) and its immunoreactivity is routinely used to identify cholinergic neurons in 
the CNS but has rarely been used to identify -motor nerve terminals in the periphery. In control 
conditions CHAT can be seen to intensely stain axons and to co-localise with SV2 at -motor nerve 
terminals and to fully oppose BTX/endplate staining (Fig2.9A: N=3, n=12). Following 2H-2R (Fig 
2.9B: N=3, n=12), SV2 staining is lost from most -motor nerve terminals as above whereas CHAT 
immunoreactivity largely remains but, on occasion could appear to be fragmented. As CHAT is 
predominantly cytoplasmic, these findings indicate that while there is loss of neurofilaments, synaptic 
vesicle proteins and disruption to the microtubule network, the gross structure of -motor nerve 
terminals is not lost in response to 2H-2R. In summary, this would suggest that -motor nerve 
terminals do not undergo a gross structural loss in response to 2H-2R but are in the process of 
disassembly with a distinct set of spatiotemporal morphological events.  
 
2.3.8 Selective ultrastructural pathology to nerve terminals in response to 
hypoxia-reperfusion injury 
To help understand some of the morphological events observed above, preliminary ultrastructural 
analysis was carried out on the 2
nd
 deep lumbrical (n=1), as this lumbrical muscle showed the most 
constant response to 2H-2R (see Fig 2.7B&C). Following 2H-2R (Fig 2.11), muscle fibres appeared 
healthy with distinctive and regular striations, and the postsynaptic apparatus appeared as in control 
conditions (Fig2.10). -motor nerve terminal boutons however were dominated by large vacuoles and 
disruption of mitochondria. Many axon profiles appeared normal but some also appeared to be 
undergoing some degenerative events with the cytoplasm becoming very electro-dense. While much 
further analysis is needed, these preliminary ultrastructural results appear to confirm that -motor 
nerve terminals are highly and selective vulnerable to 2H-2R with no observable changes to 
postsynaptic endplates or muscle fibres. They also support the finding that while -motor nerve 
terminals remain grossly intact following 2H-2R, there are distinct pathological events affecting the 




Fig 2.8: Disruption of the microtubule network following hypoxia-reperfusion 
injury. Confocal projections show neuron specific -tubulin III visualised with Cy2 
secondary antibodies (GREEN) and post-synaptic endplates visualised with TRITC-
conjugated BTX (RED). In control condition (A), with boxed area magnified in (C), 
strong tubulin immunoreactivity can be seen in both axons and in the central regions of 
the -motor nerve terminal arborisation. Slightly less intense tubulin immunoreactivity 
can be seen to fill the outer regions of the terminal arborisation, but this fully opposes 
postsynaptic endplates. Following 2H-2R (B), with boxed area magnified in (D), tubulin 
immunoreactivity in axons and -motor nerve terminals can still be identified but is 
highly fragmented with some regions only just identifiable by low intensity, ‘ghostly’,  


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig 2.10: Ultrastructure of the 2
nd
 lumbrical muscle kept under control conditions. 
In (A), two -motor nerve terminal boutons (NT) can be observed opposing some 
postsynaptic folds (Ps-F) separated by the synaptic cleft (arrow). Numerous 
mitochondria (m) can also be observed with cristae and synaptic vesicles (sv) can be 
easily identified, ~40nm in size. While the central nerve terminals bouton does appear 
slightly depleted of vesicles, the nerve terminal bouton in the left of image shows large 
numbers of vesicles that are clustering towards the membrane. A large muscle fibre 
nucleus (MN) can also be observed. In (B), a small branch of a small intra-muscular 
nerve can be identified by numerous axon (Ax) profiles enclosed in a myelin sheath (ms: 
note how the axo-plasm appears quite electro-lucent). The striations of muscle fibre 
(MF) are clearly visible with identifiable sarcomeres (arrow), m-lines and z-lines.  
Numerous mitochondria (m) can be observed to be scattered throughout axon profiles 




2.11: Selective ultrastructural changes to -motor nerve terminals and axons from 
the 2nd lumbrical muscle following hypoxia-reperfusion injury. In (A) several nerve 
terminal bouton (NT) can be observed with two boutons appearing with large vacuoles 
(V).  In general, boutons appear very electro-dense and while synaptic vesicles (sv) can 
be identified, they appear irregular and possibly interspersed with small vacuoles 
especially in the central bouton. The muscle fibre nucleus (MN) can be identified as well 
as postsynaptic folds (Ps-F) which appear normal and as in controls. Numerous 
examples of mitochondria (m) can be seen and in (B), many appear disrupted (*) while 
those in the adjacent muscle fibre (MF) appear normal with clear cristae. A clear 
Schwann cell process (Sch) can be observed overlying the terminal bouton. In (C), an 
electro-dense axon profile (Ax) surrounded by the myelin sheath (ms) can be observed 
while others appeared normal and as in controls. Muscle fibres appeared unaffected by 
2H-2R with regular striations (C) and in (D), a sarcomere (arrow) can be seen with 





Here I describe a novel ex vivo model of hypoxia-reperfusion injury and show that adult mouse -
motor nerve terminals of the lumbrical muscle are highly and selectively vulnerable to 2hr hypoxia 
followed by 2hr reperfusion (2H-2R). The model system used to generate hypoxia successfully 
produced an O2 concentration below reported values of skeletal muscle normoxia, i.e., <0.5%, and 
showed rapid and significant loss of morphology in >82% of -motor nerve terminals. A complex set 
of spatiotemporal events is indicated by heterogeneous morphological responses and by the range of 
partially innervated nerve terminals which show features that have previously been identified as being 
indicative of Wallerian-like degeneration (Waller 1850; Miledi and Slater 1970; Winlow and 
Usherwood 1975; Gillingwater and Ribchester 2001; Gillingwater et al. 2002; Gillingwater et al. 2003 
and sections 1.5.1) and withdrawal-like processes of nerve terminal loss (Gillingwater et al. 2002; 
Gillingwater and Ribchester 2003; Walsh and Lichtman 2003; Parson et al. 2004; Bettini et al. 2007: 
see also below and sections 1.5.2).  Ultrastructural analysis of the 2
nd
 deep lumbrical following 2H-2R 
also revealed pathology indicative of selective -motor nerve terminal pathology without 
perturbations to skeletal muscle fibres or postsynaptic apparatus. This demonstrates that despite the 
belief that peripheral nerves have a greater metabolic safety factor and are better able to supplement 
their energy requirements via anaerobic pathways than CNS neurons (Stewart et al. 1965; Campa and 
Engel 1971; Low et al. 1985; Zollman et al. 1991; Mohler et al. 1999), hypoxia-reperfusion injury is a 
major pathological stimulus at -motor nerve terminals.  
  
2.4.1 hypoxia-reperfusion causes rapid and selective structural pathology to -
motor nerve terminals 
Nerve terminals are known to be highly vulnerable to a range of pathological stimuli (e.g., Raff et al. 
2002; Wishart et al. 2006; Conforti et al. 2007a) but there has yet to be a conclusive study that 
demonstrates the structural vulnerability of -motor nerve terminals to hypoxia/ischaemia-reperfusion 
injuries. Previous studies have identified that -motor nerve terminals may be vulnerable following in 
vivo ischaemia-reperfusion injuries but have failed to clearly distinguish the cause of this from 
tourniquet induced ischaemia-reperfusion injury, tourniquet induced mechanical trauma or that of 
muscle damage (Makitie and Teravainen 1977a; Diwan and Milburn 1986; Tombol et al. 2002; 
Eastlack et al. 2004; David et al. 2007). Other studies have shown that ex vivo -motor nerve 
terminals are functionally vulnerable to hypoxia-reperfusion injury, but the observed changes were 
rapidly reversible with no reports of structural pathology (Krnjevic and Miledi 1959; Hubbard and 
Loyning 1966; Anwyl and Ling 1983; Nishimura 1986; Bazzy 1994; Zhu et al. 2006). In the present 
study, I have shown distinct and selective structural pathology at ex vivo -motor nerve terminals 
following 2H-2R. It has previously been shown that muscle fibre trauma (Rich and Lichtman 1989; 
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Bernstein and Lichtman 1999) and disruption to postsynaptic endplates (Balice-Gordon and Lichtman 
1994; Rich et al. 1994; McCann et al. 2007) can all cause loss of -motor nerve terminals.  In all 
these studies however, -motor nerve terminal pathology develops over a number of days even in 
vivo. In the present study, -motor nerve terminals developed significant pathology within 4hr with no 
evidence of structural damage to postsynaptic endplate or muscle fibres. This is in direct contrast to 
several studies examining the effects of ischaemia/ischaemia-reperfusion injuries induced by 
tourniquet or arterial occlusion that have shown -motor nerve terminal pathology alongside muscle 
fibre (Makitie and Teravainen 1977a; Diwan and Milburn 1986) and endplate (Hatzipantelis et al. 
2001) pathology. These results are however in line with those found by Tombol et al (2002) that have 
shown selective ultrastructural changes, including vacuolisation, synaptic vesicle depletion and loss of 
-motor nerve terminal profiles in response 2hr tourniquet followed by ≥2hr-reperfusion injury. What 
is not clear from the results presented here is whether distal axon pathology is a result of a retrograde 
spread of -motor nerve terminal pathology or if axonal pathology is induced by hypoxia-reperfusion 
injury independently of events at terminals. Axons have been shown to be vulnerable in in vivo 
models of ischaemia-reperfusion injuries (Nukada et al. 1996; Iida et al. 2003; Kawamura et al. 2006) 
but functional analysis by others has collectively shown that axonal conduction (Fish et al. 1989; 
Zollman et al. 1991; Pedowitz et al. 1992; Ohara et al. 1996; Mohler et al. 1999) and skeletal muscle 
(Krnjevic and Miledi 1959; Hubbard and Loyning 1966; Chervu et al. 1989; Bazzy 1994; 
Hatzipantelis et al. 2001; Zhu et al. 2006) recover, which indicates the primary site of injury to be at 
the NMJ. The preservation of NF/SV2 immunoreactivity in the large intramuscular nerve branches 
(Fig 2.4) but loss of -motor nerve terminal NF/SV2 immunoreactivity in response to 2H-2R 
presented here would certainly indicate a distal to proximal progression.  This collectively suggests 
that pathology begins in -motor nerve terminals but further studies are needed to confirm this. 
Additional experiments that include functional analysis may be beneficial in resolving this issue and 
could be used to determine if 2H-2R also causes functional deficits in the muscle fibres and endplates. 
While the results obtained here indicate that muscle fibres and postsynaptic endplate were not 
structurally vulnerable to 2H-2R, functional changes to either cannot be ruled out, as this was not 
studied. 
 
2.4.2 Pathology is primarily caused by changes in O2 levels 
I have demonstrated that structural pathology occurs as the result of O2 level being less than 0.25%, 
which replicates the O2 levels that have previously been reported to occur during in vivo ischaemia 
(Gustafsson et al. 1999; Matsumoto et al. 2005). This is in contrast to previous ex vivo studies of 
hypoxia-reperfusion injury where O2 levels at the muscle surface or just below have been recorded as 
being between 6% and 8% (Bukharaeva et al. 2005; Zhu et al. 2006) while others have recorded  
intramuscular values of 0% to 2.6% (Bazzy 1994). As the normoxic working range of skeletal muscle, 
and probably -motor nerve terminals, has been estimated to be between 0.5% and 4% (Gorczynski 
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and Duling 1978; Klitzman et al. 1983; Honig and Gayeski 1993; Shibata et al. 2001; Eu et al. 2003; 
Matsumoto et al. 2005), some of these studies may not have been modelling an hypoxic environment. 
While it can be expected that muscle fibres and their nerve terminals located in the central, deeper 
regions are subject to much lower levels of O2 due to the reliance on diffusion (Eu et al. 2003; Zhu et 
al. 2006), the result presented here show that even those muscle fibres and -motor nerve terminals 
located on the surface of the muscle are subject to hypoxic conditions. In contrast to previous in vivo 
studies that cannot distinguish between the range of potentially pathological co-stimuli caused by 
ischaemia-reperfusions injuries, I show that the -motor nerve terminal pathology was almost solely 
attributable to changes in O2. Acidosis, known to occur in O2 limiting conditions (Cerretelli and 
Samaja 2003) contributes significantly to CNS hypoxia/ischaemia-reperfusion injuries (Kass and 
Lipton 1982; Fujiwara et al. 1992; Nagao et al. 1996) and in the periphery (Silver 1977; Kam et al. 
2001) was prevented in the current study.  Significant changes in CO2 levels, also known to occur 
during ischaemic injuries (Rorabeck 1980; Kam et al. 2001; Kam 2007) can also contribute to 
acidification are also unlikely in the model system presented here as levels were maintained at 5%. A 
gross systemic inflammatory response occurs in CNS (Nogawa et al. 1997; Samdani et al. 1997; 
Fukuyama et al. 1998; Lipton 1999; Costa et al. 2006; Doyle et al. 2008; Froyland et al. 2008) and in 
peripheral ischaemia-reperfusion injuries (Carden and Granger 2000; Kam 2007; Bagdatoglu et al. 
2008) is also unlikely to have significantly contributed to the pathology described here due to the 
reduced nature of neuromuscular preparations and the rapidity of the response. The relatively large 
volume of perfusate (250ml) containing glucose should have also prevented hypoglycaemia as well 
reducing the build up of potentially toxic extracellular metabolites and extracellular ionic changes that 
have all been identified to occur during in vivo ischaemia-reperfusion injuries (e.g., Rorabeck 1980; 
Idstrom et al. 1990; Pedowitz et al. 1992; Nagamatsu et al. 1996; Kam et al. 2001). I also demonstrate 
that -motor nerve terminal pathology induced by 2H-2R was probably independent of 
axotomy/lesion induced Wallerian degeneration. -motor nerve terminals were protected from 
Wallerian degeneration by long distal nerve stumps (>2.5cm) that provide 1-2hr protection per cm 
(Miledi and Slater 1970; Ribchester et al. 1995) and by low temperatures (22-24.5
o
C) which delay 
Wallerian degeneration by up to 4 times at 25
o
C (Tsao et al. 1999). Furthermore, total experimental 
time did not exceed 5.5hr (~1hr to complete dissection + 4hr hypoxia-reperfusion injury + time to 
complete BTX staining and fixation), and the first signs of Wallerian degeneration in vivo begin at 
around 12hr (Miledi and Slater 1968; 1970; Winlow and Usherwood 1976; Tsao et al. 1999; 
Gillingwater and Ribchester 2001). While some possible contribution of Wallerian degeneration 
resulting from axotomy cannot be entirely ruled out, others have used similar neuromuscular 
preparations over >4-6hr and shown axotomy independent changes at -motor nerve terminals 
(Parson et al. 2004; Bettini et al. 2007). This contrasts with many in vivo studies of ischaemia 
reperfusion injury that have utilised tourniquets (Fowler et al. 1972; Makitie and Teravainen 1977b; 
Nukada and McMorran 1994; Eastlack et al. 2004) and include using elastic rubber bands wound 
round the hind limbs (Tombol et al. 2002; David et al. 2007) that have significant risk of causing 
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lesions to underlying nerves. There is some difficulty distinguishing the cause of -motor nerve 
terminal pathology indentified in some of these in vivo studies from ischaemia-reperfusion injury and 
axotomy/lesion induced Wallerian degeneration especially when experimental procedure was in 
excess of 12hr. This study therefore demonstrates that hypoxia-reperfusion injury is a significant 
pathological stimulus at -motor nerve terminals and can induce rapid structural pathology. 
2.4.3 Which aspects of changing O2 levels are causing -motor nerve terminal 
pathology?  
What is unclear from the model presented here is what aspects of the hypoxic or the reperfusion stages 
are contributing to -motor nerve terminal pathology. Hypoxia inhibits oxidative phosphorylation 
causing ATP depletion that leads to a failure to meet the bioenergetic demands required to maintain 
cellular homeostasis, morphology, and to carry out generic as well as cell-specific functions. ATP 
depletion/bioenergetic rundown have been shown to occur as a result of hypoxic/ischaemic injury in 
peripheral nerve bundles (Stewart et al. 1965; Low et al. 1984; Zollman et al. 1991) and are well 
characterised in CNS injuries (Dewar et al. 1999; Lipton 1999; Ames 2000; White et al. 2000; Bickler 
and Donohoe 2002). As nerve terminals are known to have high energetic demands (Wong-Riley 
1989; Miller and Sheetz 2004; Hollenbeck and Saxton 2005) but the mitochondria contained within 
them appear to be more susceptible to inhibition and rupture (John 1996; Davey et al. 1998; Brown et 
al. 2006; Naga et al. 2007), overall it seems likely that ATP depletion as a result of hypoxia is the 
major pathological stimulus in the results presented here.  This is further supported by observations of 
disruption of mitochondrial ultrastructure in response to 2H-2R (Fig2.11B), but further studies are 
needed to show if this results in ATP depletion. What the consequences of this ATP depletion are and 
how that leads to the observed pathological response in -motor nerve terminals is unknown and 











 ionic gradients which are critical in mediating CNS ischaemic injuries 
(e.g., depolarisation and excitotoxicity: e.g., Lipton 1999). While extracellular ionic changes were 
probably prevented by the large volume of perfusate in this study, intracellular changes are still likely 
to have occurred, including increases in Ca
2+
 (possibly, but not only from disrupted mitochondria), 
Na
+
 and acidosis. Furthermore, extracellular changes cannot be ruled out in poorly diffused 
microdomains, such as synaptic cleft. Carrying out experiments in the presence of glucose may also 
have contributed to acidification, as any continuing respiration via anaerobic glycolysis would be 
associated with lactate production and increasing acidification (Ridge 1972; Lipton 1999; Cerretelli 
and Samaja 2003; Malthankar-Phatak et al. 2008). Reoxygenation/reperfusion injury is also known to 
contribute significantly to pathology in both the CNS and peripheral nerves. Reperfusion allows for 
minor cellular insults caused during the hypoxic/ischaemic phase to develop and manifest into late-
stage pathology, and in both the CNS (Nakano et al. 1990; Lipton 1999; Kovalenko et al. 2006) and 
peripheral nerve bundles (Nukada et al. 1996; Iida et al. 2003; Kawamura et al. 2006) the full extent 
of pathology is not seen until days or even weeks after the initial ischaemic insult. On the other hand, 
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reperfusion is also associated with its own pathological stimuli. Once blood flow or O2 levels are fully 
restored, the return of O2 is known to trigger significant formation of ROS due to clearance of toxic 
metabolites (e.g., adenine nucleotide  breakdown products via xanthine oxidase: Nagamatsu et al. 
1996; He et al. 1999; Mitsui et al. 1999c), activation of inflammatory mediators (Mitsui et al. 1999a; 
Qi et al. 2001; Kawamura et al. 2006), but also damage to or disequilibrium of the mitochondrial 
respiratory chain (Piantadosi and Zhang 1996; Nicholls and Budd 2000). Although not directly shown 
but discussed above, extracellular ionic changes, build-up of potential toxic metabolite and systemic 
inflammation have been largely (but not entirely) ruled out in this model system. Re-oxygenation was 
however carried out at ~50% O2 (presumably reflecting the O2 saturation point for Krebs‟ solution 
sparged with 95% O2 gas), well above in vivo level of normoxia, possibly increasing the risk of ROS 
formation.  This would overall indicate that the reperfusion stage of the model presented here is a 
weak paradigm of pathological stimuli associated with in vivo reperfusion injuries. There is however, 
the general difficulty in all studies examining ischaemia/hypoxia-reperfusion injuries: how do you 
distinguish between pathology that was caused by the hypoxic/ischaemic injury but has taken time to 
develop/become identifiable, from the pathology caused by the reperfusion injury? Nevertheless, 
using the model system developed here, others have recently provided preliminary evidence to show 
that a significant amount of pathology can be caused by hypoxia alone, with 23% and 44% of 
postsynaptic endplates from lumbrical muscles appearing vacant following 1.5hr and 2hr hypoxia 
respectively (preliminary observations made during undergraduate BSc research project/dissertation 
undertaken by Miss Marie Parsons (2008) at the University of Edinburgh under the supervision  
Simon Parson). Overall, this study does demonstrate that changes in O2 tension during hypoxia-
reperfusion injury is a major pathological stimulus at -motor nerve terminals however, more studies 
are needed to understand further the cellular and biochemical events that mediate this injury. These 
studies should include assessment of the biogenetic changes following hypoxia-reperfusion injury, as 
well as intra and extra-cellular ionic changes. The robust nature of the model system described here 
will be of benefit in such studies as many external variables can be controlled and it will also allow for 
systematic pharmacological investigations that would help in our understanding the underlying 
mechanisms of hypoxia-reperfusion injury. 
 
2.4.4 -motor nerve terminal pathology is indicative of on-going disassembly 
Synaptic vesicles, neurofilaments and microtubules are vitally important features of -motor nerve 
terminals and the loss or disruption of immunoreactivity in response to 2H-2R indicates significant 
impairment to the mechanical stability, transport and function of -motor nerve terminals. The 
degradation and loss of neurofilaments, microtubules and synaptic vesicles in -motor nerve terminals 
and axons are known to occur in response to other neurodegenerative processes including axotomy-
induced Wallerian degeneration and in peripheral neuropathies (e.g., Miledi and Slater 1970; Miura et 
al. 1993; Gillingwater et al. 2002; Ferri et al. 2003; Gillingwater and Ribchester 2003; Zhai et al. 
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2003; Parson et al. 2004; Pun et al. 2006; Wishart et al. 2006; Bettini et al. 2007; Murray et al. 
2008a). These studies have shown that progressive loss of neurofilament and/or synaptic vesicle 
protein immunoreactivity is not only a good correlate of nerve terminals loss but also a good indicator 
of the mechanism of loss, either Wallerian degeneration or withdrawal (e.g., Gillingwater et al. 2002; 
Gillingwater and Ribchester 2003; Parson et al. 2004; Bettini et al. 2007). But, the results presented 
here indicate that the gross structure of -motor nerve terminals is not lost following 2H-2R as -
motor nerve terminal profiles could be still identified with antibodies raised against tubulin, 
cytoplasmic CHAT and observed at the ultrastructural level, although some pathological changes were 
noted. Loss of neurofilaments but not microtubules has however been shown to occur during ongoing 
Wallerian degeneration in primary cultures of rat sympathetic superior ganglia (Zhai et al. 2003). 
These authors have shown that 4-8hr following axotomy, microtubules become 
depolymerised/disorganised (LoPachin et al. 2002; LoPachin et al. 2003) and this is followed by 
degradation of neurofilaments but, microtubule degradation and loss of immunoreactivity did not 
occur until >16hr post-axotomy. It is possible that a similar set of spatiotemporal events are also 
occurring in response to 2H-2R, and that while numerous authors have shown -motor nerve terminal 
loss with antibodies raises against NF/SV2 or similar (e.g. Trachtenberg and Thompson 1997; Dixon 
and Harris 1999; van der Putten et al. 2000; Gillingwater et al. 2002; Parson et al. 2004; Prasarnpun et 
al. 2004; Yin et al. 2004; Bettini et al. 2007; Murray et al. 2008a) this may not always completely 
coincide with complete gross structural loss. The results presented here most likely reflect a process of 
-motor nerve terminal and distal axon disassembly that may eventually led to gross structural loss 
where it could be expected to see loss of tubulin and cytoplasmic CHAT immunoreactivity as 
disassembly progresses to loss. In future studies, it would be particularly important to determine when 
-motor nerve terminals pathology first develops and if, and when, pathology advances into gross 
structural loss. In addition, combinations of a broader spectrum of immunohistochemical markers 
labelling a range of different membranous, cytoskeletal and vesicular proteins, alongside a complete 
ultrastructural analysis as well as the functional analysis already suggested would be beneficial in 
developing our understanding of the pathological events of hypoxia-reperfusion injury.  
 
2.4.5 Does hypoxia-reperfusion cause multiple mechanisms of -motor nerve 
terminal disassembly? 
A review of the literature clearly provides evidence of at least two structurally and mechanistically 
distinct processes of nerve terminal loss/disassembly: the synchronous fragmentation of Wallerian 
degeneration and asynchronous retraction of withdrawal (Bernstein and Lichtman 1999; Gillingwater 
and Ribchester 2001; Raff et al. 2002; Gillingwater and Ribchester 2003; Low and Cheng 2005; Luo 
and O'Leary 2005; Saxena and Caroni 2007; Murray et al. 2008b). In the results presented here there 
was a small (1.4%) but significant population of -motor nerve terminals with NF/SV2 staining 
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characteristics of both Wallerian degeneration and withdrawal to suggest multiple mechanisms of 
nerve terminal loss are triggered in response to 2H-2R.  
 
Is there evidence to suggest that Wallerian degeneration and/or withdrawal could be triggered in 
response to hypoxia/ischaemia-reperfusion injuries? 
Wallerian degeneration appears to be a global means of axonal and nerve terminal loss, triggered by a 
diverse range of stimuli (Raff et al. 2002; Ferri et al. 2003; Coleman 2005; Luo and O'Leary 2005; 
Saxena and Caroni 2007) such as; disruption of microtubules (Luduena et al. 1986; Wang et al. 2000; 
Wang et al. 2001), progressive motor neuropathy (Ferri et al. 2003; Simonin et al. 2007), genetic 
dysmyelination disorder (Samsam et al. 2003), axonal dystrophy (Mi et al. 2005), autoimmune 
encephalomyelitis (Kaneko et al. 2006), traumatic brain injury (Gillingwater et al. 2006a), glaucoma 
(Howell et al. 2007; Beirowski et al. 2008), Parkinson‟s diseases (Sajadi et al. 2004; Hasbani and 
O'Malley 2006), removal of NGF (Deckwerth and Johnson 1994). The Wld
s
 mutation has also been 
shown to convey some neuroprotection in CNS ischaemia-reperfusion injuries, demonstrating that 
Wallerian degeneration plays an important role in these types of injuries (Gillingwater et al. 2004) and 
therefore may be triggered in -motor nerve terminals in response to 2H-2R. Degeneration of -motor 
nerve terminals following in vivo ischaemia via Wallerian-like pathways has also been previously 
suggested (Diwan and Milburn 1986). Further support for activation of Wallerian degeneration 
pathways is provided by studies that show the decreasing levels of bioenergetic molecules, including 
ATP, appear critical in mediating this mechanism (Coleman 2005). Following injury and during the 
lag phase prior to the onset of Wallerian degeneration, there is a progressive fall in levels of ATP and 
NAD
+
 (Stewart et al. 1965; Ikegami and Koike 2003; Wang et al. 2005). If the levels of bioenergetic 
molecules, including ATP, are maintained by application of NAD
+
, in neurons over expressing 
Nmant1 (a NAD
+
 biosynthetic enzyme) or the Wld
s
 mutation that has Nmant1 as part of its protein 
product, Wallerian degeneration is inhibited (Mack et al. 2001; Ikegami and Koike 2003; Araki et al. 
2004; Wang et al. 2005; Kaneko et al. 2006; Sasaki et al. 2006; Sasaki et al. 2009b; Yahata et al. 
2009). This indicates that a fall in ATP is vital for initiating Wallerian degeneration and therefore, 
decreasing ATP levels as a consequence of hypoxia-reperfusion would be consistent with activation of 
Wallerian degeneration.  
 
Withdrawal appears to be triggered by local stimuli and in particular, by loss of/changes in trophic 
support (e.g., Balice-Gordon and Lichtman 1994; Trachtenberg and Thompson 1997; Bernstein and 
Lichtman 1999) and if it is under the active control of actin cytoskeleton as has been suggested, may 
be a highly dynamic and reversible process (Billuart et al. 2001; Luo and O'Leary 2005; Vega-
Riveroll et al. 2005; Saxena and Caroni 2007).  In line with the view that withdrawal or “atrophy” of 
nerve terminals is triggered by loss of/changes in trophic support (Bernstein and Lichtman 1999), 
depletion of ATP (that is vital for all cell processes) could conceivably cause atrophy/withdrawal of 
-motor nerve terminals in response to 2H-2R. There is a possibility that ATP depletion causes a loss 
of other trophic support/signalling processes provided by the motor neuron itself (i.e., cell body), 
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muscle fibres or Schwann cells due to inhibition of axonal transport and protein synthesis. 
Considering the rapid disassembly of -motor nerve terminals observed here, it seem unlikely that 
there was sufficient time for trophic support/signals to have become depleted and to then trigger -
motor nerve terminal disassembly, as all previous studies demonstrate this type of trophic deprivation 
takes a number of days (Rich and Lichtman 1989; Balice-Gordon and Lichtman 1994; Trachtenberg 
and Thompson 1997; Bernstein and Lichtman 1999; McCann et al. 2007; Murray et al. 2008b). 
Alternatively, if withdrawal is an active withdrawal mechanism mediated by the actin cytoskeleton 
(Billuart et al. 2001; Luo and O'Leary 2005; Vega-Riveroll et al. 2005; Saxena and Caroni 2007) that 
is repressed under normal physiological conditions (Billuart et al. 2001; Lamprecht et al. 2002), ATP 
depletion may cause a failure in repression of the retraction mechanism. In a recent study that 
demonstrated rapid (>4hr) withdrawal of adult mouse -motor nerve in response P2X7 –receptor 
activation, the authors also proposed a mechanism that may be important in mediating ischaemic injuries 
(Bettini et al. 2007). P2X7 –receptors are ligand-gated non-selective cation channels (Surprenant et al. 
1996; Chessell et al. 1998) that are known to be expressed at nerve terminals (Deuchars et al. 2001; Moores 
et al. 2005; Anderson and Nedergaard 2006), and have been linked with downstream modifications to the 
actin cytoskeleton (Kim et al. 2001; Pubill et al. 2001; Omatsu-Kanbe et al. 2004; Pfeiffer et al. 2004). 
These receptors are thought to primarily have a patho-physiological role as they are only opened by high 
concentrations of their endogenous ligand, ATP (North and Surprenant 2000; North 2002; Burnstock 2006). 
At nerve terminals, extracellular accumulation of ATP can occur in response to vesicle release  (Silinsky 
1975) as, independent of its bioenergetic role, ATP is a co-transmitter (Abbracchio et al. 2008) and in -
motor nerve terminals it is stored alongside ACh in an estimated ATP:ACh ratio of between 1:1 to 1:10 
(Volknandt and Zimmermann 1986; Smith 1991). It is known that excitotoxicity is a major pathological 
stimulus in CNS hypoxia/ischaemia-reperfusions injuries (Rothman 1983; Rothman 1984; Lipton 1999; 
White et al. 2000) and significant increases in vesicle release have previously been shown at -motor nerve 
terminals in response to hypoxia (Krnjevic and Miledi 1959; Hubbard and Loyning 1966; Anwyl and 
Ling 1983; Nishimura 1986; Bazzy 1994; Zhu et al. 2006). It is possible that during hypoxia/ischaemia-
reperfusion injuries such as those observed here, accumulation of ATP at the synaptic cleft because of rapid 
vesicle release may cause P2X7-receptor activation leading to rapid withdrawal of -motor nerve terminals, 
possibly mediated by the actin cytoskeleton, like that described by Bettini et al (2007). In support of this, 
the ionic gradient breakdown seen during hypoxic/ischaemic insults would facilitate activation of P2X7-
receptor opening (Colomar and Amedee 2001; North 2002; Moores et al. 2005) and P2X7-receptors have 
previously been identified to be involved in mediating cell death in neurodegenerative/pathological 
conditions (Le Feuvre et al. 2002; Yiangou et al. 2006; Matute et al. 2007) and in CNS hypoxia/ischaemia-
reperfusion injuries (Le Feuvre et al. 2003; Cavaliere et al. 2004).  
 
Could necrotic mechanisms play a role in observed responses of  -motor nerve terminals? 
There is however, the possibility that despite the morphological appearances, neither Wallerian 
degeneration nor withdrawal processes are responsible for -motor nerve terminal disassembly in 
response to hypoxia-reperfusion injury. The structural events observed in response to LTX and auto-
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ganglioside/complement attack causes very rapid (<3hr) necrotic pathology to -motor nerve 
terminals that includes breakdown of the cytoskeleton, loss of synaptic vesicles, and, swelling and 
lysis of nerve terminal boutons (Clark et al. 1970; Okamoto et al. 1971; O'Hanlon et al. 2001; 
O'Hanlon et al. 2003). While the pathology observed in -motor nerve terminals in response to 2H-2R 
does not appear to be as extensive as those described in response to these specific necrotic stimuli, the 
rapid changes to synaptic vesicles and the cytoskeleton is perhaps consistent with some of these 
necrotic features. Furthermore, necrotic mechanisms of cell death are known to occur in acute 
hypoxia/ ischaemia reperfusion injuries (Lipton 1999; White et al. 2000). It is possible, that due to the 
relatively large size of -motor terminals, spatiotemporal activation of singular mechanism, possibly 
necrotic, gave the morphological appearance of both Wallerian degeneration and withdrawal. This is 
perhaps supported by a recent structural analysis of the response of -motor nerve terminals to -
bungarotoxin (Prasarnpun et al. 2005). -bungarotoxin is a necrotic stimulus (Dixon and Harris 1999; 
Prasarnpun et al. 2004; Prasarnpun et al. 2005) and shares many similarities with LTX auto-
ganglioside/complement attack in that it is a very specific, rapid insult that has Ca
2+
 mediated 
component and causes lysis of presynaptic membranes (Abe et al. 1976; Dixon and Harris 1999; 
Prasarnpun et al. 2004; Prasarnpun et al. 2005; Rigoni et al. 2008). Prior to this however there is loss 
of synaptic vesicles and their release machinery (synaptophysin, SNAP and syntaxin), swelling and 
lysis of mitochondria, and loss of neurofilaments over 3-12hr in vivo (Abe et al. 1976; Dixon and 
Harris 1999; Prasarnpun et al. 2004; Prasarnpun et al. 2005). Prasarnpun et al (2005) noted that some 
-motor nerve terminals showed an overall gross morphology that was necrotic, others with obvious 
signs of fragmentation (Wallerian-like), while others appeared to be withdrawing, very much like the 
results presented here. This does suggest that perhaps necrosis may also have a role to play in the 
observed response of -motor nerve terminals described here and that necrotic stimuli can give the 
impression of multiple mechanisms of -motor nerve terminal disassembly. Prasarnpun et al (2005) 
however believe their results reflect activation of multiple mechanisms of nerve terminal disassembly 
which is probably due to the multiple molecular mechanisms of -bungarotoxin toxicity which 
appears to involve phospholipid hydrolysis, massive Ca
2+ 
entry and, a direct action on mitochondria 
and opening of their pores (Prasarnpun et al. 2004; Rigoni et al. 2008).  
 
Are transitions between different mechanisms of nerve terminal disassembly responsible for the 
range of morphologies observed? 
There is increasing awareness that the mode of cell death and therefore, perhaps the mode of nerve 
terminal disassembly is heavily dependent on the availability of ATP (e.g., Ankarcrona et al. 1995; 
Eguchi et al. 1997; Leist et al. 1997; Fujikawa 2000; Nicotera et al. 2000; Northington et al. 2007). 
During and following hypoxic/ischaemic insults ATP levels become increasingly depleted due to 
increasing levels of cellular damage. Once cellular damage has reached levels sufficient to activate a 
cell death program, continuing ATP depletion may prevent a cell from completing an active ATP 
dependent program of cell death and force a more passive form of cell death, resulting in different 
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morphological phenotypes of cell death with intermediate forms (Fujikawa 2000). There is some 
debate as to whether this change reflects a switch between multiple independent pathways of cell 
death (Portera-Cailliau et al. 1997; Northington et al. 2007) or rather a morphological and mechanistic 
continuum between necrotic and apoptotic extremes (Yakovlev and Faden 2004). This possibility of 
changing mechanisms may help to explain the appearance of multiple morphological phenotypes of -
motor nerve terminal loss following hypoxia-reperfusion injury.  -motor nerve terminals may be 
progressing through withdrawal, Wallerian and possibly necrotic mechanisms of disassembly caused 
by subtle differences in pathological stimuli and/or changing levels of ATP. This possibility of 
mechanistic transitions may also be supported by the observations of single -motor nerve terminals 
with characteristics of both withdrawal and Wallerian degeneration (Fig 2.6(C)). Other studies 
examining -motor nerve terminals during developmental synapse elimination and in response to 
pathological insults in adults have also noted similar results, with nerve terminals undergoing a 
process of withdrawal but with some fragmentation and isolation of boutons, and in some cases 
observations of degenerative ultrastructure (Rich and Lichtman 1989; Trachtenberg and Thompson 
1997; van der Putten et al. 2000; Gillingwater et al. 2003; Bishop et al. 2004; Yin et al. 2004; 
Newbery et al. 2005; Bettini et al. 2007; Ey et al. 2007).  Some have suggested this duplicity reflects 
incomplete execution of the withdrawal mechanism with fragments of nerve terminals/axons getting 
„left behind‟ during retraction (Gillingwater and Ribchester 2003) but others have suggested that it 
may be that shedding of fragments represents a separate mechanism of removing excess neuronal 
debris (Bishop et al. 2004).  
 
Section Summary 
From the morphological result presented here, there was evidence to suggest that the two most highly 
characteristic mechanisms of nerve terminal disassembly, Wallerian degeneration and withdrawal, 
were triggered in response to hypoxia-reperfusion injury. It must be noted however, the preliminary 
results from the ultrastructural analysis showed domination of -motor nerve terminal profiles that 
had significant perturbations to the internal organisation (i.e. vacuoles and mitochondria) whereas 
withdrawal, at the ultrastructural level, is characterised by minimal internal reorganisation 
(Gillingwater and Ribchester 2001; O'Hanlon et al. 2001; Gillingwater et al. 2002; Parson et al. 2004; 
Ushkaryov et al. 2004; Bettini et al. 2007). From the discussion above however, this preliminary 
evidence of degenerative ultrastructure may not negate the possibility of the activation of a withdrawal 
mechanism. A full, and perhaps quantitative, ultrastructural analysis of the response of -motor nerve 
terminals would be beneficial in helping to understand the pathological processes of hypoxia-
reperfusion injury and may give further insight as to the mechanisms that govern nerve terminal 
disassembly. Collectively, the evidence supports the possibility that multiple mechanisms of -motor 
nerve terminal disassembly could be activated in hypoxia-reperfusion injuries.  Multiple mechanisms of 
cell death characterise CNS ischaemia-reperfusion injuries and neurodegeneration caused by 
glutamate excitotoxicity where different mechanisms of cell death can be observed between, and 
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within the same population of neurons (Ankarcrona et al. 1995; Eguchi et al. 1997; Leist et al. 1997; 
Northington et al. 2007; Hand and Menze 2008).  The reasons underlying the activation of multiple 
mechanisms is still not understood but as hypoxia/ischaemia-reperfusion injuries involve so many 
complex co-stimuli, activation of multiple cellular pathways leading to cell death is perhaps not 
surprising. The range of possible pathological stimuli following hypoxia-reperfusion injury at -motor 
nerve terminals in the present study has purposely been reduced but will still most likely include ATP 
depletion, dissipation of ionic gradients including Ca
2+
, direct mitochondrial damage and ROS 
formation. These stimuli acting independently and/or synergistically may affect each -motor 
terminal differently to cause activation of different mechanisms of nerve terminal disassembly.  
Further work on the molecular mechanisms of -motor nerve terminal disassembly is required as our 
understanding of the cellular processes that govern them are still poor. Given the range of 
morphologies observed in response to hypoxia-reperfusion injury described here, this model system 
may provide an opportunity to investigate some of these mechanisms. The rapid response, control of 
pathological stimuli and the ability to apply a range of pharmacological agents as well as to use 
genetically altered tissues provides the opportunity to study systematically the mechanism(s) of 
hypoxia-reperfusion injury. This may in turn provide further insights into -motor disassembly in 
response to both hypoxia-reperfusion injury but also other pathological stimuli. Of particular interest 
would be an investigation into the ability of the Wld
s
 mutation to covey neuroprotection to -motor 
nerve terminals following hypoxia-reperfusion injury.   
 
2.4.6 Summary 
I have demonstrated for the first time that -motor nerve terminals of the adult mouse are structurally 
vulnerable to hypoxia-reperfusion injury. With a novel experimental model system, I have shown that 
the rapid and selective disassembly of -motor nerve terminals occurs in response to O2 levels similar 
to those occurring during in vivo ischaemia. I highlight that further studies are needed to fully 
characterize this model system and to understand the cellular/molecular consequences of hypoxia-
reperfusion, which is more than likely a consequence of ATP depletion. While the experimental model 
system developed here is not without its caveats, it may provide a valuable tool in further studies of -
motor terminal pathology in response to hypoxia/ischaemia-reperfusion injuries but may also provide 










-motor nerve terminal pathology following hypoxia-reperfusion 
injury is age and fibre type-dependent but is not mitigated by the 
neuroprotective Wld
s




In Chapter 2, I showed that -motor nerve terminals from predominantly fast-twitch adult lumbrical 
muscles are highly and selectively vulnerable to hypoxia-reperfusion injury. Fast-twitch muscle fibres 
rely on predominantly anaerobic respiration for rapid bursts of activity and it is known that in many 
respects, there is a relationship between the properties of muscle fibre sub-types and innervating -
motor neurons (see 1.4.2). For this reason it seems possible that -motor nerve terminals, like their 
fast-twitch muscle fibres may also have increased provisions for sustaining ATP supply in anaerobic 
conditions and may also be more resistant to hypoxia/ischaemia-reperfusion injury.  In previous 
studies however, Tombol et al (2002) and David et al (2007) have shown that -nerve terminals from 
fast-twitch muscles are more vulnerable to tourniquet induced ischaemia-reperfusion injury than those 
from slow-twitch muscles, while others have shown a mixed response of skeletal muscle fibres 
(Chervu et al. 1989; Mars and Gregory 1991; Pedowitz et al. 1992; Awerbuck et al. 1994; Idstrom et 
al. 1990; Woitaske and McCarter 1998; Chan et al. 2004). The novel ex vivo model system developed 
in Chapter 2 provides the opportunity to explore possible muscle fibre type differences in -motor 
nerve terminal response to hypoxia-reperfusion injury. Transversus abdominis (TA) and triangularis 
sterni (TS) are relatively large but very planar muscles, both composed of predominantly slow-twitch 
muscle fibre types (e.g., Iscoe 1998; Hodges 1999; Murray et al. 2008a). Consistent with the 
experimental design criteria discussed in Chapter 2, they can be dissected with >1cm intercostal nerve 
stumps and as they are thin planar muscles, maximum diffusion of O2 across their muscle fibres will 
occur (Barclay 2005). Also following on from the results described in Chapter 2 where some -motor 
nerve terminals were observed to fragment in response in 2H-2R to indicate the involvement of 
Wallerian degeneration, I will investigate the ability of the naturally occurring Wld
s
 mutation to confer 
protection to -motor nerve terminals. The Wld
s
 mutation inhibits axotomy induced Wallerian 
degeneration, preserving the structure and function of -motor nerve terminals for >3 days in vivo and 
in culture (Tsao et al. 1994; Ribchester et al. 1995; Gillingwater et al. 2002; Gillingwater et al. 2003; 
Parson et al. 2004). The Wld
s
 mutation has also been shown to convey neuroprotection in response to 
a range of pathological stimuli including CNS ischaemic-reperfusion injuries (Gillingwater et al. 
2004). The ability of the Wld
s
 to modify the response of -motor nerve terminals may provide 
valuable mechanistic insights into hypoxia-reperfusion injury.  
In the following chapter, I report further morphological evidence of the vulnerability of -motor nerve 
terminals to hypoxia-reperfusion injury and show significant intermuscle variability in the 
pathological response that is both age and fibre type dependent. I demonstrate that -motor nerve 
terminal disassembly in response to hypoxia-reperfusion injury is unlikely to occur by classic 
Wallerian degeneration, as the Wld
s
 mutation did not convey any significant neuroprotection. I also 
provide preliminary evidence to show that structural pathology of -motor nerve terminals is preceded 
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by functional failure to release/recycle synaptic vesicles and that the nerve terminals of the muscle 





3.2.1 Animals & skeletal muscle dissection 
Neuromuscular preparations were obtained from female 5-6 and 8-12 week old C57Bl/6 or 5-6 week 
old C57Bl/6 -Wld
s
 mice as indicated (all obtained from Harlan-Olac, UK) and were maintained as 
described previously in Chapter 2. In addition to the four deep lumbrical muscles (see Chapter 2 for 
full details), TA and TS muscles were also dissected. These planar muscles are found on the inner 
surface of the abdominal and thoracic wall respectively. The TS muscles attach to either side of the 
posterior surface of the sternum and extend to just beyond the costal cartilage of the lower 4/5 true 
ribs. They are respiratory muscles involved in the depression of the ribs and are supplied by 1 or 2 
branches of the intercostal nerves. The TA arises either side of the vertebral column from the 
thoracolumbar fascia and ends on a strong connective sheet of tissue (linea alba/aponeurosis) at the 
midline of the anterior abdominal wall. TA is innervated by multiple branches of the lower intercostal 
nerves and is a postural muscle involved in compressive support and stabilisation of the abdomen. The 
TA and TS are almost continuous with each other as they interface behind the lower ribs (costal 
margin) and it is for this reason that they are always dissected together. These muscles were exposed 
after death by first taking the entire abdominal wall from just below the clavicle to below the iliac 
crests of the hips and extending to either side of the spine and pinned out in a large silicon-lined petri 
dish with oxygenated Krebs‟ solution. On the posterior surface, both TA and TS are covered in a thick 
layer of connective tissue (peritoneum and costal pleura respectively) but are otherwise in direct 
contact with Krebs‟ solution. On the anterior surface, TS is covered by the intercostal muscles and 
ribs, which cannot be removed without the risk of damage to the underlying TS. The overlying 
pectoral muscles were however removed along with most of the rectus abdominis and external 
oblique muscles that overly the TA muscles. This leaves a window of exposed TA muscle fibres on 
the anterior surface around the abdominal midline just below the sternum. Those fibres located 
laterally and inferior to this window are covered by the thin planar internal oblique muscle, which 
cannot be removed until after dissection.  The whole preparation was then split at the midline, along 
the linae alba/aponeurosis and the sternum, to create two hemi-TS/TA preparations with distal nerve 
stumps of ~1cm and ~1.5 respectively. From time of death to the start of experimentation, dissection 
of all muscles took no more than 1hr. At the end of the experimental process and after fixation, the TA 
window and TS were removed from surrounding tissues with fat deposits, and as much of the 
connective tissues/membrane removed as possible. These preparations were then mounted on to glass 





3.2.2 Hypoxia-reperfusion model system and fluorescent immunohistochemistry 
The hypoxia-reperfusion model system and fluorescent immunohistochemical protocol is described in 
detail in Chapter 2. In summary, neuromuscular preparations were maintained in 250ml of HEPES 
buffered Krebs‟ solution in a conical flask. Preparations from the right-hand side were subjected to 
2hr hypoxia induced with 95%:5% N2:CO2 following by 2hr reperfusion induced with 95%:5% 
O2:CO2. Preparations from the left-hand side acted as controls, and were maintained for 4hr in 250ml 
of HEPES buffered Krebs‟ solution in a conical flask sparged with 95%:5% O2:CO2. Following 
experimentation, postsynaptic endplates were labelled with TRITC-conjugated -bungarotoxin (BTX) 
and the preparations were fixed in MeOH for 15min at -20
o
C. They then underwent fluorescence 
immunohistochemical processing using antibodies raised against neurofilament (NF) 165kDa and 
synaptic vesicle 2 (SV2) protein, visualised with Cy-3 secondary antibodies.  
 
3.2.3 Functional Studies 
 In order to assess the functional state of motor nerve terminals after 2H-2R, TA/TS muscle 
preparations were exposed to the fixable analogue of the styryl dye FM1-43 (FM1-43FX, 1mg/ml: 
Molecular Probes) for 15mins in high K
+
 Krebs‟ solution (102 mM Na
+
, 50 mM K
+
, 2 mM Ca
2+
 , 2 
mM Mg
2+
 , 132 mM Cl
-
, 23.8 mM HCO
3-
 , 0.4 mM H2PO4
2-
 , 5 mM D-glucose, 5.5mM HEPES: pH 
7.2-7.4) sparged with 95%: 5% O2:CO2) to induce depolarisation. FM1-43FX that was not 
incorporated into synaptic vesicle membranes and then internalised into -motor nerve terminals 
during depolarisation was washed off by a brief rinse in fresh Krebs‟ solution. TA and TS muscles 
then underwent fixation in 4% formaldehyde in PBS for 30mins, followed by a 3x10min wash in PBS. 
Postsynaptic endplates were labelled by incubation in alexa647-conjugated -bungarotoxin (BTX, 
5µg/ml in PBS: Invitrogen) for 30mins. Muscles were then washed for 2x10min and 2x15min in PBS 
prior to mounting on glass slides and stored as described in Chapter 2. 
 
3.2.4 Image Capture, Quantification and Statistical analysis  
Image capture, quantification and statistical analysis of -motor nerve terminals and their endplates 
was carried out as previously described in Chapter 2. The pattern of muscle spindle innervation, IA/II 
nerve terminals and -neuromuscular junctions, of the lumbrical muscles was also assessed following 
2H-2R and compared with controls. IA/II nerve terminals and -neuromuscular junctions were 
examined and quantified on a „yes/no‟ basis. „Yes‟ scores were given separately to IA/II nerve 
terminals and -neuromuscular junctions that appeared to be morphological normal while „no‟ scores 
were given separately to IA/II nerve terminal endings and -neuromuscular junctions when they could 
not be identified. There was no occasion where either IA/II nerve terminal endings or -
neuromuscular junctions were present („yes‟) but had obvious signs of pathology. Data for each 
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lumbrical muscle was then pooled and the % of muscles with at least one observable IA/II nerve 










































Fig 3.1 Anatomy of the abdominal/thoracic wall showing transversus abdominis 
(TA) and triangularis sterni (TS) muscles. (A&B) is a representation of surface (A) 
and deep (B) anatomy of the anterior abdominal wall based on the human. The 
pectoral, rectus abdominis and external oblique muscles (A) were removed to reveal a 
window of the transversus abdominis muscle (B) that is mostly overlaid by the internal 
oblique muscle that cannot be safely removed until after fixation. (C) shows the internal 
aspect of the human thoracic wall with the triangularis sterni muscle pseudo-coloured. 
As this muscle is overlaid by the ribs and the intercostal muscles it cannot be fully 
exposed on the anterior surface until after fixation. Both TA and TS muscles are 
innervated by the intercostal nerves that exit the spinal cord and track along the lower 
aspects of the ribs. For the 2H-2R protocol, preparations where split up the abdominal 
midline, i.e., along the connective tissue of the linea alba/ aponeurosis and up the 
centre of the sternum to produce two TA/TS muscle preparations.  Following the 2H-2R 
and fixation, the TA window was removed (that always corresponded to the area of 
muscle innervated by the first 3/4 branches of its intercostal nerve supply) and TS was 
dissected free of its overlying tissue. Image (C) adapted from the bartleby.com edition of 





3.3.1  -motor nerve terminals from slow-twitch muscles, TA and TS, are slower 
to respond/more resistant to hypoxia-reperfusion injury than fast-twitch 
lumbrical muscles.  
The effects of 2hr hypoxia followed by 2hr reperfusion (2H-2R) on the morphology of pre- and post-
synaptic components of the mouse neuromuscular junction in the TA and TS muscles, aged 8-12wks, 
from the right-hand side of the abdominal and thoracic wall respectively were compared with those 
muscles from the left hand side kept under control conditions.  2H-2R did not cause any identifiable 
changes to the integrity/morphology of post-synaptic endplates or muscle fibres compared with 
control preparations in either TA (Fig 3.2) or TS (Fig 3.3) muscles. Both TA and TS muscles showed 
a noticeable loss of NF/SV2 immunoreactivity in response to 2H-2R, with 58.911.4% and 27.77.8% 
of endplates appearing vacant in TA (N=4, n=4 (1753)) and TS (N=4, n=4 (1765)) muscles 
respectively. This contrasted with control values where 100% and 99.80.2% of nerve terminals fully 
opposed their postsynaptic endplates in TA (N=3, n=3 (2123)) and TS (N=4, n=4 (2069)) muscles (Fig 
3.4). Intermuscle comparison showed that the difference between the percentage of vacant endplates 
from TA and TS muscles was not significant (Fig 3.4C). When data from TA and TS was statistically 
compared to that of 4 deep lumbricals (see Chapter 2 for details), the decreased number of vacant 
endplates in TA muscle compared to that of the lumbrical muscles was also not statistically different. 
The difference between the number of vacant endplates in TS and lumbrical muscle however was 
statistically significant (P=0.0034). This would indicate that TS and to a lesser extent TA, both 
predominantly composed of slow-twitch fibres, are either more resistant or slower to respond to 
hypoxia-reperfusion injury than predominantly fast-twitch lumbrical muscle.  
 
In line with results obtained from lumbrical muscles, there was a small population of endplates in TA 
and TS muscles that were observed to be only partially opposed by presynaptic NF/SV2 
immunoreactivity in response to 2H-2R (4.80.8% and 3.31.2% of TA and TS nerve terminals 
respectively) which were only rarely observed in control preparations (0% and 0.10.1% in TA and 
TS respectively: Fig3.4A&B).  These partial -motor nerve terminals also had a similar range of 
morphological characteristics as previously described in lumbrical muscles, where some -motor 
nerve terminals appeared to be undergoing Wallerian-like fragmentation while others appeared to be 
withdrawal-like processes of disassembly (Fig3.2&3, E&F). It was noted that there was an increased 
frequency of partially occupied endplates with 4.80.8% and 3.31.2% of TA and TS nerve terminals 
respectively observed with a partial morphology compared to 1.40.3% observed in lumbrical 
muscles (Fig3.4D). Intermuscular comparison showed that the percentage of partially occupied 
endplates in TA was significantly (P=0.0048) more than that in lumbrical muscles. TS also showed an 
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increase in the number of partially occupied endplates but this did not reach significance. This would 
suggest that -motor nerve terminals from TA muscles and to a lesser extent TS muscles are slower to 
undergo disassembly than lumbrical muscles following hypoxia-reperfusion injury.  This is most 
likely due to the generally larger and more complex morphology -motor nerve terminal arborisation 
in slow-twitch muscles observed here and described by others (Wood and Slater 1997; Bewick et al. 
2004). 
 
3.3.2 Reduced vesicle release/recycling in -motor nerve terminals from TA and 
TS following hypoxia-reperfusion injury 
The immunohistochemical data collected here and in Chapter 2 suggests disruption of proteins related 
to synaptic vesicles, (i.e., SV2) and would therefore indicate disturbance of synaptic vesicle 
release/recycling. As TA and TS are thin, planar muscles they are highly suited to functional studies 
with the vital dye FM1-43FX as larger thicker muscles, like the lumbricals, can suffer from poor 
penetration of the dye. FM1-43FX can be used to assess synaptic release/recycling as the lipophilic 
tail regions of the dye become weakly embedded into the exposed membranes of vesicles as they bind 
with the presynaptic membrane. The dye then becomes internalised into nerve terminals during 
endocytosis while non-internalised dye can then be washed off (Betz et al. 1992; Rizzoli et al. 2003; 
Adalbert et al. 2005). Rather than electrically stimulating the nerve stump, depolarisation was 
produced with a high (50nM) K
+
 stimulus to avoid the potential complications of axonal conduction 
block caused by 2H-2R. Neurons typically have a resting membrane potential ranging from 
approximately -65mV to -90mV, which arises largely due to the tendency of K
+
 to leak out the cell 





exchanger that generates a high concentration of K
+
 and a low concentration of Na
+
 in the cytosol (see 
e.g., Kandel and Schwartz 1985; Longstaff 2000; Lodish et al.  2008). Neurons need to be depolarised 
to 40-70mV to trigger exocytosis (Kandel and Schwartz 1985) and during an action potential 
depolarisation this is achieved by the inward flow of Na
+
 via voltage gated ion channels (see e.g., 
Kandel and Schwartz 1985; Longstaff 2000; Lodish et al.  2008).  Application of 50mM K
+
 stimulus 
however acts simply to reduce the K
+
 concentration gradient across the cell membrane and thereby 
causing the resting membrane potential to be approximately 40mV (i.e., depolarised: Katz 1966). By 
depolarising with high K
+
, exocytosis (and therefore endocytosis (Zefirov et al  2006)) is maintained 
by a constant influx of Ca
2+
  (via voltage gated Ca
2+
) adjacent to the active zones in the nerve 
terminals.  
-motor nerve terminals were depolarised in TA (n=2) and TS (n=2) muscles following 2H-2R by 
transferring them into a high K
+
 Krebs‟ solution to load synaptic terminals with the dye (Adalbert et 
al. 2005: Fig 3.5). No nerve terminals from 2H-2R treated muscles with clear FM1-43FX fluorescence 
were identified. By contrast, in control preparations nearly all terminals examined showed clear FM1-
43FX fluorescence. This suggests that 2H-2R treated terminals have a significantly reduced ability to 
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release/recycle synaptic vesicles. Compared with the immunohistochemical data where TA and TS 
showed 57.911.4% and 27.77.8% loss of NF/SV2 immunoreactivity following 2H-2R, this data 
suggests that functional disruption may occur prior to the morphological signs of disassembly.  
 
3.3.3 Age dependent increase in the vulnerability of -motor nerve terminals 
from TA and TS muscles to hypoxia-reperfusion injury. 
 I wished to determine whether the Wld
s
 mutation could protect -motor nerve terminals from 2H-2R, 
but  Wld
s
 mediated neuroprotection is age-dependent, with electrophysiological signs of weakening 
beginning at 10wks of age (Derek Thompson, University of Edinburgh, personal communication) and 
protection being lost by 16wks of age (Gillingwater et al. 2002). To fully assess the ability of the Wld
s
 
mutation to convey protection against 2H-2R, it was necessary to use juvenile animals (elected age, 5-
6wks) but prior to this, it was important to determine if similar responses to 2H-2R occurred in wild-
type juvenile animals. Using lumbrical, TA and TS muscles, I examined -motor nerve terminal 
pathology following 2H-2R in tissue from juvenile mice aged 5-6wks. In line with previous results 
2H-2R did not cause any major perturbations to postsynaptic endplate or muscle fibre 
morphology/integrity in lumbrical (Fig 3.6), TA (Fig 3.7) or TS (Fig 3.8) muscles. In response to 2H-
2R, 84.84.2% of postsynaptic endplates in lumbrical muscles aged 5-6wks had no opposing NF/SV2 
immunoreactivity (N=4, n=16 (3697) which was significantly different (P<0.0001) from only 
1.10.8% of vacant endplates observed in control preparations (N=4, n=16 (3493): Fig 3.9A). As 
observed in lumbrical muscles aged 8-12wks (Fig 2.7B), the 4
th
 deep lumbrical from 5-6wk old mice 
showed a decreased response to 2H-2R (Fig 3.9D), which was significant (P=0.029) when compared 
to the percentage of vacant endplates found in the 2
nd
 deep lumbrical muscle. This would again 
indicate subtle intra-lumbrical differences in the response to 2H-2R however, the actual significance 
of this should be treated with caution due to the high degree of observed variance in both 5-6wk and 
8-12wk old 4
th
 lumbrical muscles and the lower number of repeat experiments from 5-6wk old 
animals. The numbers of partial -motor nerve terminals was also similar in 5-6wk old (2.20.6%) 
lumbrical muscles, and again showed signs of fragmented and withdrawing morphologies 
(Fig3.6E&F). Overall, there was no significant difference in the response of lumbrical muscles from 
mice aged 5-6wks compared to mice aged 8-12wks (Fig 3.9E) to 2H-2R. This contrasts with the 
response of TA and TS muscles from animals aged 5-6wks which showed a significantly (P=0.0286) 
increased response to 2H-2R compared with TA and TS muscles from animals aged 8-12wks (Fig 
3.9E). In TA and TS muscles aged 5-6wks, 99.40.2% (N=4, n=4 (2104):Fig 3.9B) and 97.3 1.4% 
(N=4, n=4 (2220):Fig 3.9C) of endplates appeared with no opposing NF/SV2 immunoreactivity which 
directly contrasts with control muscles where 0% (N=3, n=3 (1381)) and 0.3 0.3% (N=3, n=3 (1912)) 
of endplates appeared vacant in TA and TS respectively. Only a very small population of -motor 
nerve terminals could be observed with either a partial (TA: 0.40.1%, TS: 1.3 0.7%) or full (TA: 
0.2 0.2%, TS: 1.4 0.8%) morphology following 2H-2R. The slightly larger number of partial 
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Fig 3.2 2H-2R causes selective -motor nerve terminal disassembly in TA muscles 
(8-12wks). Reconstructed confocal projections of part of a mouse TA muscle aged 8-
12wks after being maintained in control conditions (A) and following 2H-2R (B). While 
postsynaptic endplates (visualised with BTX: RED) appear unchanged, there is 
widespread loss of presynaptic NF/SV2 immunoreactivity (GREEN) following 2H-2R. 2H-
2R does not appear to affect muscle fibres as phase-contrast micrographs show uniform 
muscle fibres with clear striations in both control (C) and 2H-2R treated TA muscles (D).  
Confocal projections of a small population of endplates following 2H-2R appear partially 
occupied by presynaptic NF/SV2 immunoreactivity (E&F). In (E) there is asynchronous 
loss of NF/SV2 at one endplate (arrow) which is indicative of a withdrawal-like 
mechanism. In contrast (F) shows an endplate (arrow) with fragmented NF/SV2 





Fig 3.3 2H-2R causes selective -motor nerve terminal disassembly in TS 
muscles (8-12wks). Reconstructed confocal projections of part of a mouse TS 
muscle aged 8-12wks after being maintained in control conditions (A) and following 
2H-2R (B). While postsynaptic endplates (visualised with BTX: RED) appear 
unchanged, there is widespread loss of presynaptic NF/SV2 immunoreactivity 
(GREEN) following 2H-2R. 2H-2R does not appear to affect muscle fibres as phase-
contrast micrographs show uniform muscle fibres with clear striations in both control 
(C) and 2H-2R treated TS muscles (D).  Confocal projections of a small population of 
endplates following 2H-2R appear partially occupied by presynaptic NF/SV2 
immunoreactivity (E&F). In (E) there is asynchronous loss of NF/SV2 at one endplate 
(arrow) which is indicative of a withdrawal-like mechanism. In contrast (F) shows an 
endplate (arrow) with fragmented NF/SV2 immunoreactivity that is more consistent 
with a Wallerian-like mechanism. Scale bars: 50m 
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Fig 3.4 Quantification of -motor nerve terminal response to hypoxia-reperfusion 
injury shows there are significant inter-muscle differences in 8-12wk mice that 
may be related to fibre type. Bar charts (%meanSE) showing the categorical 
quantification of -motor nerve terminal status (i.e., fully-occupied, partially-occupied or 
vacant) that oppose postsynaptic endplates from TA (A) and TS (B) muscles where 2H-
2R treated muscles (black bars) can be compared to controls (white bars). In (C), a 
scatter plot (%mean indicated by line) showing inter-muscle differences in the number of 
endplates identified with no NF/SV2 immunoreactivity, i.e., vacant, following 2H-2R 
injury (data from all 4 deep of lumbrical (lum) muscles from chapter 2). Statistical 
analysis showed there is no significant difference between TA and TS muscles that are 
both composed of predominantly slow type fibres but in comparison with lumbrical 
muscles, composed of predominantly fast type fibres, there was a significant difference 
between the %number of vacant endplates observed in the lumbrical muscles and the 
TS muscle. In (D), a scatter plot shows some inter-muscle differences in the percentage 
of endplates observed with a partial nerve terminal morphology. Statistical analysis 
showed there is a significant difference between the %number of partial endplates 




Fig 3.5 Loss of synaptic vesicle release/recycling following 2H-2R. In control 
conditions (A), confocal projections show postsynaptic endplates (visualised with BTX: 
BLUE) of TS muscles are opposed by clear presynaptic FM1-43FX (GREEN) that has 
become incorporated into synaptic vesicles as they are released/recycled following 
depolarisation with high K
+
. Following 2H-2R (B), there is no clear  presynaptic FM1-
43FX staining opposing endplates suggesting a failure in synaptic vesicle 
release/recycling following depolarisation with high K
+




Fig 3.6 2H-2R causes selective -motor nerve terminal disassembly in lumbrical 
muscles from mice aged 5-6wks. Reconstructed confocal projections of part of a 
mouse lumbrical muscle aged 5-6wks after being maintained in control conditions (A) 
and following 2H-2R (B). In controls (A) most postsynaptic endplates (visualised with 
BTX: RED) are fully opposed by presynaptic NF/SV2 immunoreactivity (GREEN) 
however a small cluster of endplates (e.g., arrow) can be observed to have no opposing 
NF/SV2  immunoreactivity. This is most likely the result of naturally occurring patho-
physiological processes. Following 2H-2R, postsynaptic endplates appear unchanged 
but there is widespread loss of presynaptic NF/SV2 immunoreactivity. 2H-2R does not 
appear to affect muscle fibres as phase-contrast micrographs show uniform muscle 
fibres with clear striations in both control (C) and 2H-2R treated lumbrical muscles (D).  
Confocal projections of a small population of endplates following 2H-2R appear partially 
occupied by presynaptic NF/SV2 immunoreactivity (E&F). In (E) there is asynchronous 
loss of NF/SV2 at one endplate (arrow) which is indicative of a withdrawal-like 
mechanism. In contrast (F) shows an endplate (arrow) with fragmented NF/SV2 





Fig 3.7 2H-2R causes selective -motor nerve terminal disassembly in TA muscles 
from mice aged 5-6wks. Reconstructed confocal projections of part of a mouse TA 
muscle aged 5-6wks after being maintained in control conditions (A) and following 2H-
2R (B). While postsynaptic endplates (visualised with BTX: RED) appear unchanged, 
there is widespread loss of presynaptic NF/SV2 immunoreactivity (GREEN) following 
2H-2R. 2H-2R does not appear to affect muscle fibres as phase-contrast micrographs 
show uniform muscle fibres with clear striations in both control (C) and 2H-2R treated 
TA muscles (D).  In contrast to other muscles there were almost no occurrences of 
endplates partially occupied by presynaptic NF/SV2 immunoreactivity (see Fig 2.9B). 




Fig 3.8 2H-2R causes selective -motor nerve terminal disassembly in TS 
muscles from mice aged 5-6wks. Reconstructed confocal projections of part of a 
mouse TS muscle aged 5-6wks after being maintained in control conditions (A) and 
following 2H-2R (B). While postsynaptic endplates (visualised with BTX: RED) 
appear unchanged, there is widespread loss of presynaptic NF/SV2 
immunoreactivity (GREEN) following 2H-2R. 2H-2R does not appear to affect 
muscle fibres as phase-contrast micrographs show uniform muscle fibres with clear 
striations in both control (C) and 2H-2R treated TS muscles (D).  Confocal 
projections of a small population of endplates following 2H-2R appear partially 
occupied by presynaptic NF/SV2 immunoreactivity (E&F). In (E) there is 
asynchronous loss of NF/SV2 at one endplate (arrow) which is indicative of a 
withdrawal-like mechanism. In contrast (F) shows an endplate (arrow) with 
fragmented NF/SV2 immunoreactivity that is more consistent with a Wallerian-like 




Fig 3.9 Quantification of -motor nerve terminal response to hypoxia-
reperfusion injury shows there are significant age related differences between 
muscles. Bar charts (%meanSE) showing the categorical quantification of -motor 
nerve terminal status (i.e., fully-occupied, partially-occupied or vacant) that oppose 
postsynaptic endplates in lumbrical (A), TA (B), and TS (C) muscles from mice aged 
5-6wks, where 2H-2R treated muscles (black bars) can be compared to controls 
(white bars). In (D), a scatter plot (%mean indicated by line) showing inter-muscle 
differences in the number of endplates identified with no NF/SV2 immunoreactivity, 
i.e., vacant, following 2H-2R injury). Similar to the results described in Chapter 2 in 8-
12wk old mice, there were some intra-lumbrical differences in 5-6wk old mice, with the 
4
th
 lumbrical (Lum) showing a decreased response that was statistically significant 
when compared to the 2
nd
 lumbrical muscle. In contrast to the results obtained in 8-
12wk old animals, in 5-6wk old animals there were no statistically significant 
differences in the percentage of vacant endplates in response 2H-2R between 
lumbrical, TA and TS muscles. In (E) a bar chart compares the percentage of vacant 
endplates from all three muscles following 2H-2R in animals aged 5-6wks (black bars) 
and 8-12wks (white bars). In both TA and TS muscles there is statistically significant 
increase in the percentage of vacant endplates in 5-6wk old animals compared to 8-
12wk old animals. The percentage of vacant endplates in the 4 lumbrical muscles 
appears unchanged in the two age groups.     
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morphologies in TS muscle showed a similar range of morphologies as described previously with 
aspects of fragmentation and withdrawal. Overall, these results show age and muscle type-dependent 
changes in -motor nerve terminal vulnerability to hypoxia-reperfusion injury, with fast-twitch 
lumbrical muscles being unaffected by age but slow-twitch muscles, TA and TS, being more 




 mutation does not convey protection to -motor nerve terminals 
against hypoxia-reperfusion injury 
Next, I investigated if mice carrying the Wld
s
 mutation could protect -motor nerve terminals from 
hypoxia-reperfusion injury. The fragmented partial morphologies observed in response to 2H-2R in 
previous experiments implicated Wallerian-like degenerative pathways and the Wld
s
 mutation 
significantly delays Wallerian degeneration in the CNS and PNS (Lunn et al. 1989; Ribchester et al. 
1995; Gillingwater et al. 2003; Gillingwater et al. 2006a; Gillingwater et al. 2006b; Wishart et al. 
2007) and has been shown to be protective in ischaemia-reperfusion injuries in the CNS (Gillingwater 
et al. 2004). Compared to wild type animals of 5-6wks of age described above, the Wld
s
 mutation 
conveyed no significant (Fig 3.13E) neuroprotective effect on -motor nerve terminals in lumbrical 
(Fig 3.10), TA (Fig 3.11) or TS (Fig 3.12) muscles against 2H-2R.  For Wld
s
 lumbrical muscles values 
for vacant endplates with no apparent NF/SV2  immunoreactivity were: 82.42.9.3% (N=6, n=24 
(5468):Fig 3.13A), TA 98.10.7% (N=5, n=5 (2568): Fig 3.13B) TS 96.61.2% (N=5, n=5 2290): 
Fig3.13C). This contrasts with control preparations from Wld
s
 mice where only 0.5 0.1% and 1.0 
0.4% of endplates were observed to have either a partial or vacant morphology in lumbrical muscles 
(N=3, n=12 (2718)) contrasting with no partial or vacant endplates observed in control Wld
s
 TA (N=3: 
n=3 (1934)) or TS (N=3: n=3 (1894)) muscles.  In line with previous experiments, there were subtle 
but non-significant intra-lumbrical differences (Fig 3.13D) in percentages and variance of vacant 
endplates. Curiously, this affected the 1
st
 deep lumbrical muscles as well as the 4
th
 deep lumbrical 
muscles described previously. There were also no major differences in the percentage of partially 
occupied endplates in Wld
s
 mice in response to 2H-2R (values: Lumbrical 1.5 0.3%, TA 1.2 0.3 and 
TS 1.8 0.6%) and a similar range of fragmenting and withdrawing morphologies were observed (Figs 
3.10-12). In summary, the failure of Wld
s
 mutation to protect -motor nerve terminals against 2H-2R 
injury or alter the apparent mechanism(s) of -motor nerve terminal disassembly suggests that nerve 






3.3.5 -motor and IA/II sensory nerve terminals may be more resistant to 
hypoxia-reperfusion injury.  
During the course of experiments on lumbrical muscle described here and in Chapter 2, it was noted 
that muscle spindles (between 1 and 2 per muscle) often appeared to be preserved following 2H-2R in 
8-12wks (Fig 3.14) 5-6wks (Fig 3.15) and 5-6wk Wld
s
 lumbrical muscles (Fig 3.16). The muscle 
spindle is the name used to collectively describes the specialised sensory IA/II afferent and motor -
efferent innervations, (as well as the capsule that surrounds them and the intrafusal muscle fibres) that 
provide sensory feedback to aid proprioception and antagonise/co-ordinate skeletal muscle 
contraction.  Identified here with NF/SV2 immunoreactivity, sensory IA/II afferent nerve terminals 
typically form evenly spaced and regular spiral or half-ring annulospiral endings that are even in 
diameter around the equatorial/ subequatorial regions of the intrafusal fibres as described by 
(Sherrington 1893; Boyd 1962; Barker 1974: Figs3.14-16). Alternatively and much less common 
(Barker and Ip 1960), rather than observing evenly spaced spirals some endings appeared to be 
composed of scattered varicosities which would be consistent with II secondary „flower spray‟ 
endings originally described by (Ruffini 1898:Fig 3.16B). The motor innervations are found 
towards the polar regions of the intrafusal muscle fibres and terminate in small -neuromuscular 
junctions that form either singular/small groups of varicosities at the distal regions of their muscle 
fibres or form numerous „trails‟ of varicosities extending away from the IA/II endings.  Unlike IA/II 
endings, these - nerve terminals are apposed by small endplates that have postsynaptic AChRs that 
can be identified by BTX. The relative intensity of BTX staining could be highly variable with the 
appearance of these endplates ranging from intense bright plaques to unidentifiable against 
background fluorescence. This high degree of variability in both the IA/II endings and the -
neuromuscular junctions has been previously reported and in many cases represent differences in the 
innervation patterns between the bag and chain intrafusal muscle fibres that make-up the muscle 
spindle (e.g. Sherrington 1893; Ruffini 1898; Boyd 1962; Barker et al. 1970; Barker 1974; Boyd and 
Gladden 1985). For the purposes of this study however, innervation was simply characterised as either 
being IA/II endings or -neuromuscular junctions.  Overall, analysis of the possible response and 
extent of response(s) of both IA/II endings and -neuromuscular junctions to 2H-2R was hindered by 
difficulties in identifying these nerve terminals and determining pathology. The thick collagen-
containing capsule that surrounds the muscle spindle can inhibit penetration of antibodies (Dow et al. 
1980) creating difficulties in determining if lack of immunoreactivity was due to hypoxia-reperfusion 
injury. The lack of  postsynaptic BTX opposing IA/II endings and the variable BTX staining apposing 
-motor nerve terminals also made identification of possible „partial‟ as well as „vacant‟ nerve 
terminal morphologies very difficult. It must however be noted that on no occasion during the course 
of this study was any obvious pathology noted in IA/II or - nerve endings (e.g. 
breaks/fragmentation/swellings/atrophy of NF/SV2 immunoreactivity) either following 2H-2R or in 
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controls. Rather, IA/II and -neuromuscular junctions either had completely normal morphology or 
were absent. To try and determine if 2H-2R was affecting muscle spindle innervation, the percentage 
of muscles observed to have IA/II endings and -neuromuscular junctions (each assessed 
independently) following 2H-2R was compared to controls (Fig3.17).  In response to 2H-2R, a large 
decrease in the number of IA/II endings was observed in 5-6wk old animals, where only 56% of 
lumbrical muscles (N=4, n=16) could be observed to have IA/II endings followed 2H-2R compared to 
100% of muscles from 5-6wk old controls (N=4, n=16).  In 8-12wk old animals and 5-6wk old Wld
s
 
animals, 75% (N=7, n=28) and 78% (N=7, n=28) of muscles had IA/II nerve terminal ending 
respectively and 86% and 93% of muscles had  -neuromuscular junctions respectively. When these 
values are compared to control values however this is unlikely to reflect any major response to 2H-2R: 
in 8-12wk old animals and 5-6wk old Wld
s
 animals, 67% (N=6, n=24) and 79% (N=7, n=28) of 
muscles had IA/II nerve terminal ending respectively and 100% and 89% of muscles had  -
neuromuscular junctions respectively. The less than maximal presence of IA/II endings and  -
neuromuscular junction in control 8-12wk and 5-6wk Wld
s
 animals most likely reflects poor 
penetration of NF/SV2 antibodies into the capsule and the difficulty in identifying these terminals and 
therefore, the results obtained from 5-6wk old animals needs to be treated with caution. When these  
figures are compared to the number of -motor nerve terminals retaining a full morphology following 
2H-2R  (between 13% and 16.1% from all
 
lumbrical muscles) however, this data would indicate that 
IA/II ending and -nerve terminals that innervate intrafusal muscle fibres maybe more resistant to 
hypoxia-reperfusion injury than -motor nerve terminals that innervate extrafusal muscle fibres. This 
would support the general finding of selective vulnerability/resistance of nerve terminals to hypoxia-
reperfusion injury and indicates that vulnerability may not only determined by age and muscle type 
differences but also neuron/nerve terminal type. This however remains a preliminary finding as 
overall, the results obtained here are difficult to interpret due to the staining caveats and do not lend 
themselves to any sure conclusions regarding the extent to which IA/II ending and -nerve terminals 
may be vulnerable to hypoxia-reperfusion injury or the ability of the Wld
s
 to convey protection. 
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Fig 3.10 2H-2R causes selective -motor nerve terminal disassembly in lumbrical 
muscles from Wld
s
 mice aged 5-6wks. Reconstructed confocal projections of parts of 
Wld
s
 mouse lumbrical muscles aged 5-6wks after being maintained in control conditions 
(A) and following 2H-2R (B). In controls (A) most postsynaptic endplates (visualised 
with BTX: RED) are fully opposed by presynaptic NF/SV2 immunoreactivity (GREEN) 
however an endplate (arrow) can be observed to have no opposing NF/SV2  
immunoreactivity in part of its arborisation, i.e., the endplate is partially occupied. This is 
most likely the result of naturally occurring path-physiological processes. Following 2H-
2R, postsynaptic endplates appear unchanged but there is widespread loss of 
presynaptic NF/SV2 immunoreactivity. 2H-2R does not appear to affect muscle fibres as 
phase-contrast micrographs show uniform muscle fibres with clear striations in both 
control (C) and 2H-2R treated Wld
s
 lumbrical muscles (D).  Confocal projections of a 
small population of endplates following 2H-2R appear partially occupied by presynaptic 
NF/SV2 immunoreactivity (E&F). In (E) there is asynchronous loss of NF/SV2 at one 
endplate (arrow) which is indicative of a withdrawal-like mechanism. In contrast (F) 
shows an endplate (arrow) with fragmented NF/SV2 immunoreactivity that is more 




Fig 3.11 2H-2R causes selective -motor nerve terminal disassembly in TA 
muscles from Wld
s
 mice aged 5-6wks. Reconstructed confocal projections of parts 
of Wld
s
 mouse TA muscles aged 5-6wks after being maintained in control conditions 
(A) or following 2H-2R (B). While postsynaptic endplates (visualised with BTX: RED) 
appear unchanged, there is widespread loss of presynaptic NF/SV2 immunoreactivity 
(GREEN) following 2H-2R. 2H-2R does not appear to affect muscle fibres as phase-
contrast micrographs show uniform muscle fibres with clear striations in both control 
(C) and 2H-2R treated Wld
s
 TA muscles (D).  Confocal projections of a small 
population of endplates following 2H-2R appear partially occupied by presynaptic 
NF/SV2 immunoreactivity (E&F). In (E) there is asynchronous loss of NF/SV2 at one 
endplate (arrow) which is indicative of a withdrawal-like mechanism. In contrast (F) 
shows an endplate (arrow) with fragmented NF/SV2 immunoreactivity that is more 




Fig 3.12 2H-2R causes selective -motor nerve terminal disassembly in TS 
muscles from Wld
s
 mice aged 5-6wks. Reconstructed confocal projections of parts 
of Wlds mouse TS muscles aged 5-6wks after being maintained in control conditions 
(A) or following 2H-2R (B). While postsynaptic endplates (visualised with BTX: RED) 
appear unchanged, there is widespread loss of presynaptic NF/SV2 immunoreactivity 
(GREEN) following 2H-2R. 2H-2R does not appear to affect muscle fibres as phase-
contrast micrographs show uniform muscle fibres with clear striations in both control 
(C) and 2H-2R treated Wld
s
 TS muscles (D).  Confocal projections of a small 
population of endplates following 2H-2R appear partially occupied by presynaptic 
NF/SV2 immunoreactivity (E&F). In (E) there is asynchronous loss of NF/SV2 at one 
endplate (arrow) which is indicative of a withdrawal-like mechanism. In contrast (F) 
shows an endplate (arrow) with fragmented NF/SV2 immunoreactivity that is more 




Fig 3.13 Quantification of -motor nerve terminal response to hypoxia-reperfusion 
injury shows that the Wld
s
 mutation does not convey any neuroprotection. Bar 
charts (%meanSE) showing the categorical quantification of -motor nerve terminal 
status (i.e., fully-occupied, partially-occupied or vacant) that oppose postsynaptic 
endplates in lumbrical (A), TA (B), and TS (C) muscles from Wld
s
 mice aged 5-6wks, 
where 2H-2R treated muscles (black bars) can be compared to controls (white bars). In 
(D), a scatter plot (%mean indicated by line) showing inter-muscle differences in the 
number of endplates identified with no NF/SV2 immunoreactivity, i.e., vacant, following 
2H-2R injury). Similar to the results described in 8-12wk old mice, and 5-6wk old mice, 
there were some intra-lumbrical differences in 5-6wk old Wld
s
 mice, but this was not 
statistically significant. There were also no statically significant inter-muscle differences 
in 5-6wk old Wld
s
 mice. In (E) a bar chart compares the percentage of vacant endplates 
from all three muscles following 2H-2R in animals aged 5-6wks carrying the Wld
s
 
mutation (black bars) and age matched wild type animals (white bars: i.e., data from 5-
6wk old animals described above). Statistical analysis shows there was no significant 
difference between the percentage of vacant endplates following hypoxia-reperfusion 
injury in wild-type animals and those carrying the Wld
s




Fig 3.14 the morphology of nerve terminals of the muscle spindle does not appear 
to be affected by 2H-2R in 8-12wk old mice. Reconstructed confocal projections of 
complete muscle spindles from a lumbrical muscle after being maintained in control 
conditions (A) and following 2H-2R (B). In both control and in 2H-2R treated lumbricals, 
sensory IA/II afferent nerve terminals can be seen to form evenly spaced and regular 
spiral or half-ring annulospiral endings, indentified in the low-half of (A) and (B) by 
presynaptic NF/SV2 immunoreactivity (GREEN).  - motor nerve terminals form trails of 
varicosities extending away from the IA/II endings (upper-half of (A) and (B)) and are 
opposed by small postsynaptic plaques that are visualised with variable intensities of 
BTX staining (RED: arrowheads). This directly compares with -motor nerve terminals 
(arrow) from controls (A) that can be seen to form relatively large and complex 
arborisations and are opposed by clear postsynaptic staining of the postsynaptic 
endplate.  While there is no obvious sign of pathology in IA/II afferent or -motor nerve 
terminals following 2H-2R (B), there are clear examples of vacant morphologies of -




Fig 3.15 The morphology of nerve terminals of the muscle spindle does not 
appear to be affected by 2H-2R in 5-6wk old mice. Reconstructed confocal 
projections of complete muscle spindles from a lumbrical muscle after being 
maintained in control conditions (A) and following 2H-2R (B). In both control and in 
2H-2R treated lumbricals, sensory IA/II afferent and  - motor nerve terminals can be 
clearly indentified by presynaptic NF/SV2 immunoreactivity (GREEN) with no apparent 
signs of pathology. The postsynaptic plaques of the  - motor nerve terminals 
(arrowheads) and -motor nerve terminals are visualised with BTX (RED:). In direct 
contrast to sensory IA/II afferent and  - motor nerve terminals, following 2H-2R (B) 
there are clear examples of vacant and partial (arrow) morphologies of -motor nerve 




Fig 3.16 The morphology of nerve terminals of the muscle spindle does not 
appear to be affected by 2H-2R in 5-6wk old Wld
s
 mice. Reconstructed confocal 
projections of complete muscle spindles from a Wld
s
 lumbrical muscle after being 
maintained in control conditions (A) and following 2H-2R (B). The postsynaptic plaques 
of the - motor nerve terminals (arrowheads) and -motor nerve terminals are visualised 
with BTX (RED). In contrast to formation of spiral or half-ring annulospiral endings of 
sensory IA/II afferent that can be observed in (A) by presynaptic NF/SV2 
immunoreactivity (GREEN), in (B) the IA/II afferent nerve terminal appears composed of 
closely scattered varicosities that is know as a ‘flower spray’. Despite this less common 
form of IA/II afferent nerve terminals, there is again no obvious signs of pathology to 
either IA/II afferent or -motor nerve terminals following 2H-2R. In contrast, following 2H-
2R (B) there are clear examples of vacant morphologies of -motor nerve terminals, 




Fig 3.17 Quantification of the presence of IA/II afferent and - motor nerve 
terminals following hypoxia-reperfusion injury Bar chart showing the percentage 
of lumbrical muscles from 8-12wk, 5-6wk old mice and 5-6wk Wld
s
 mice where IA/II 
afferents and/or -motor nerve terminals could be indentified without any signs of 
pathology after being maintained in control condition (white bars) and following 2H-2R 
(black bars).  Even in control conditions, IA/II afferents and/or -motor nerve terminals 
could not always be observed which is most likely due to the poor penetration of 
antibodies. Without good control data, the observed presence of IA/II afferents and/or 
-motor nerve terminals following 2H-2R is difficult to assess. For example, in 5-6wk 
old animals the presence of IA/II afferents nerve terminals is seen to decrease 
following 2H-2R compared to age-matched controls however, in 8-12wk old animals 
the reverse occurs. This data on its own therefore provides little information on the 
vulnerability of IA/II afferents or -motor nerve terminals to hypoxia-reperfusion injury, 
or the ability of Wld
s





Using the novel hypoxia-reperfusion model described in Chapter 2, I present further evidence in 
support of the finding that -motor nerve terminals are highly and selectively vulnerable to hypoxia-
reperfusion injuries. In this Chapter I have presented morphological evidence that shows -motor 
nerve terminals from TA and TS muscles undergo disassembly following 2hr hypoxia-2hr reperfusion 
and that functional disruption of synaptic vesicle release/recycling probably precedes loss of 
morphology. I have identified important age dependent, inter-muscular differences affecting the 
severity of -motor nerve terminal pathology between lumbrical, TA and TS muscles. I have also 
provided some preliminary evidence suggesting that hypoxia-reperfusion is highly selective for -
motor nerve terminals with -motor nerve terminals and IA/II sensory endings, which innervate the 
intrafusal muscle fibres of the muscle spindle, being more resistant. Finally, I have shown that the 
rapid loss of -motor nerve terminals following hypoxia-reperfusion injury occurs via mechanisms 
distinct from classic Wallerian degeneration pathways, as the Wld
s
 mutation failed to protect -motor 
nerve terminals.  
 
3.4.1 Hypoxia-reperfusion causes functional impairment followed by selective 
morphological signs of on-going -motor nerve terminal disassembly.  
Following on from the results presented in Chapter 2 where I showed that 82.5% of -motor nerve 
terminals from lumbrical muscles had lost their NF/SV2 immunoreactivity following 2H-2R, I have 
now also shown significant loss of NF/SV2 immunoreactivity from 57.9% and 27.7% of -motor 
nerve terminals and distal axons from TA and TS muscles respectively following 2H-2R. Consistent 
with results obtained from lumbrical muscles, I observed a small population of terminals, 4.8% and 
3.2% in TA and TS muscles respectively, showing evidence of on-going disassembly via both 
Wallerian-like degeneration and withdrawal-like processes. In addition to this morphological 
evidence, I have shown additional data that indicates that loss of morphology in -motor nerve 
terminals from TA and TS muscles is preceded by functional loss of synaptic vesicle 
release/recycling. This is indicated by the 37% and 69% of -motor nerve terminal that still retain full  
NF/SV2 immunoreactivity in TA and TS muscles respectively but complete failure of the vital dye 
FM1-43FX to label -motor nerve terminals from either muscle following 2H-2R. Functional changes 
to presynaptic -motor neurons following hypoxia have previously been shown with a massive 
increase in spontaneous vesicle release (MEPP frequency: Hubbard and Loyning 1966; Anwyl and 
Ling 1983; Nishimura 1986; Bukharaeva et al. 2005) followed by progressive decreases in evoked 
vesicle release (EPP) leading to complete failure to elicit skeletal muscles contraction by stimulating 
nerve stumps (Krnjevic and Miledi 1959; Hubbard and Loyning 1966; Bazzy 1994; Zhu et al. 2006). 
Functional loss is known to occur in CNS ischaemic injuries both in vivo and in vitro and appears to 
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coincide with conduction block, a reduction in the number of synaptic vesicles and followed by loss of 
key synaptic proteins critical for synaptic vesicle mobilisation, release and recycling that later leads to 
whole cell death (von Lubitz and Diemer 1983; Lipton 1999; Nishimura et al. 2000; White et al. 2000; 
Ishimaru et al. 2001; Bolay et al. 2002; Jourdain et al. 2002; Jung et al. 2004; Kovalenko et al. 2006). 
Similar temporal changes in function and morphology (where functional changes precede changes to 
gross morphology) are also known to occur in other neurodegenerative disease processes including 
axotomy induced Wallerian degeneration and in several peripheral neuropathies (e.g., Miledi and 
Slater 1968; 1970; Miura et al. 1993; Frey et al. 2000; LoPachin et al. 2002; Ferri et al. 2003; 
Gillingwater and Ribchester 2003; LoPachin et al. 2003; Pun et al. 2006; Wishart et al. 2006; Murray 
et al. 2008a; Murray et al. 2008b). It is possible that the loss of synaptic function described here, is 
related in part to the loss of SV2 protein immunoreactivity. The role of SV2 is still unknown but it has 
a structure characteristic of a trans-membrane transporter, possibly transporting Ca
2+
 ions, and appears 
to be involved in priming docked vesicles for release (Xu and Bajjalieh 2001; Sudhof 2004). 
Interestingly, two ATP binding sites have just been identified on the SV2 protein that appear to modify 
SV2 activity, suggesting a direct link between cellular energy levels and vesicle release (Yao and 
Bajjalieh 2008).  From the data presented here however, functional loss did not completely coincide 
with loss of synaptic vesicle proteins (SV2) which suggests that either SV2 function is lost prior to its 
loss of immunoreactivity and/or loss of function is due to the loss of other critical mediators of 
synaptic vesicle release/recycling. This will need to be the subject of further study. This data is 
however consistent with the general conclusion from Chapter 2 that hypoxia-reperfusion triggers 
selective -motor nerve terminal disassembly and further indicates that there is a complex set of both 
functional and structural spatiotemporal events leading to -motor nerve terminal pathology.  Further 
experiments are required to accurately define these spatiotemporal characteristics, particularly as 
assessment of -motor nerve terminal function with the vital dye FM1-43 is known to be a relativity 
insensitive means of determining functional impairment (Rogozhin et al. 2008). It would be of key 
importance to determine when functional impairment begins and if, and when, this is followed by 
complete functional loss and how this correlates with structural changes. It would also be of interest to 
investigate if there is an increase in vesicle release prior to functional block as indicated in previous 
studies (Krnjevic and Miledi 1959; Hubbard and Loyning 1966; Anwyl and Ling 1983; Nishimura 
1986; Bazzy 1994; Bukharaeva et al. 2005; Zhu et al. 2006). Further studies combining more detailed 
structural analysis (both morphological and ultrastructural) with more sensitive functional analysis 
using electrophysiology would help in pinpointing the exact course of cellular events. Such studies 





Is -motor nerve terminal disassembly in response to hypoxia-reperfusion 
independent of Wallerian Degeneration? 
The serendipitous discovery of the spontaneous Wallerian degeneration slow („Wld
s
‟) mutation in the 
late 1980‟s (Lunn et al. 1989) has since been shown to delay axotomy induced Wallerian-
degeneration of axons and -motor nerve terminals by at least 3days in vivo (Tsao et al. 1994; 
Ribchester et al. 1995; Gillingwater et al. 2002; Gillingwater et al. 2003; Parson et al. 2004). The 
Wld
s
 mutation has also been used to convey neuroprotection and demonstrate the importance of 
Wallerian degeneration in a range of CNS and PNS neuropathies including; disruption of 
microtubules (vincristine neuropathy: (Luduena et al. 1986; Wang et al. 2000; Wang et al. 2001), 
progressive motor neuropathy (Ferri et al. 2003; Simonin et al. 2007), genetic dysmyelination disorder 
(Samsam et al. 2003), axonal dystrophy (Mi et al. 2005), autoimmune encephalomyelitis (a multiple 
sclerosis model :(Kaneko et al. 2006), traumatic brain injury (Gillingwater et al. 2006a), glaucoma 
(Howell et al. 2007; Beirowski et al. 2008) and Parkinson‟s diseases (Sajadi et al. 2004; Hasbani and 
O'Malley 2006). Despite observations of Wallerian-like morphology in -motor nerve terminals 
following 2H-2R and previous studies identifying Wallerian-like morphology of -motor nerve 
terminals following in vivo ischaemia (Diwan and Milburn 1986), the Wld
s
 mutation did not provide 
any overall protection to -motor nerve terminals in the model system presented here. This would 
suggest that despite some morphological similarities with Wallerian-degeneration, the mechanism(s) 
that govern nerve terminal disassembly following hypoxia-reperfusion are independent of pathways 
that govern Wallerian degeneration. Further to the discussion in Chapter 2 (section 2.4.2) the finding 
that the Wld
s
 mutation does not convey protection demonstrates that the observed -motor nerve 
terminals pathology is very unlikely to involve a contribution from axotomy/mechanical trauma of the 
distal nerve that occurred during dissection. These results would also suggest that there are important 
differences between the response of -motor nerve terminals and neurons in CNS where it has been 
shown that the Wld
s
 mutation caused up to a ~30% reduction in ischaemic pathology 72hr after brief 
cerebral ischaemic insult (Gillingwater et al. 2004). This difference between the CNS and -motor 
neurons may however be due to the slightly different pathological stimuli to which each was 
subjected. In this study, ex vivo -motor nerve terminals were subjected to a very acute, rapid 
hypoxic-reperfusion stimulus while Gillingwater et al. 2004 showed Wld
s
 mediated protection against 
chronic, delayed neuronal death 72hr after a 17min ischaemic insult in vivo. Ischaemia-reperfusions 
injuries in vivo encompass a whole range of potentially pathological stimuli including hypoxia, 
hypoglycaemia, acidosis and ionic gradient breakdown, inflammation, excitotoxicity, elevated CO2, 
toxic metabolite build-up and ROS (see Chapter 2 and/or section 1.6.1). The model system developed 
here specifically aimed to reduce as many of these co-stimuli associated with in vivo ischaemia-
reperfusion injuries as possible to examine only the acute effects of changing O2 tension. It is possible 
that the different pathological stimuli between the model system used here and that used by 
Gillingwater et al (2004), may have altered the effectiveness of the Wld
s
 mutation to confer protection.  
If -motor nerve terminal disassembly following hypoxia-reperfusion injury is not governed by 
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Wallerian-degeneration pathways, then what mechanism(s) do mediate nerve terminal disassembly? 
As discussed in Chapter 2, observations of on-going -nerve terminal disassembly (partial 
morphologies) indicated that both Wallerian degeneration and withdrawal may have been the 
consequence of spatiotemporal activation of a singular unknown/recognized mechanism (possibly 
necrotic), which due to the relatively large size of -motor nerve terminals gave the morphological 
appearance of multiple mechanisms. It is possible that such a mechanism is therefore not modulated 
by the Wld
s
 mutation. Again, as discussed in Chapter 2, activation of multiple mechanisms of cell 
death characterises CNS ischaemia-reperfusion injuries and may also change during the progression of 
pathology.  White et al, (2000) suggest that because hypoxia/ischaemia-reperfusion injuries involve so 
many complex co-stimuli this results in multiple mechanisms of cell death but, because of this, 
inhibition or manipulation of a singular mechanism to ameliorate hypoxia/ischaemia reperfusion 
injuries are unlikely to be successful. Rather, once cellular damage reaches a threshold where cell 
death is inevitable (or in this case nerve terminal disassembly) an inhibited mechanism will be by-
passed and cell death will continue down another route. While invariably this should cause a change 
in morphological phenotype of cell death (Portera-Cailliau et al. 1997; Ferrari et al. 1999; Fujikawa 
2000; Northington et al. 2007), without thorough examination of a range of morphological markers 
the changes in morphology that indicate a change in mechanism may be relativity subtle, particularly 
if cell death types really do exist on a morphological and mechanistic continuum (Fujikawa 2000; 
Yakovlev and Faden 2004). In this study, morphological observations of -motor nerve terminals 
were based on NF/SV2 immunoreactivity and while no obvious differences in the extent and range of 
partial morphologies were noted between wild-type animals and Wld
s
 animals, this protocol may not 
have picked up other subtle changes in morphology than would indicate the Wld
s
 mutation modulated 
rather than prevented -motor nerve terminal response. There is also the distinct possibility that the 
neuroprotective effect of the Wld
s
 mutation was ineffective against the 2H-2R stimulus.  How the Wld
s
 
mutation confers axonal and synaptic protection is still unknown but one of the active protein products 
produced by Wld
s
 mutation is Nmnat1, an important enzyme in the synthesis and regeneration of 
NAD
+
(Conforti et al. 2000; Mack et al. 2001; Raffaelli et al. 2002; Adalbert et al. 2005; Sasaki et al. 
2006). NAD
+
 is a vital metabolic substrate that acts as an electron acceptor/donator to fuel aerobic 
respiration (see Fig 1.1) whose levels can be modulated by Nmnat1 (Raffaelli et al. 2002). Although 
the full Wld
s
 protein product appears to be necessary to convey neuroprotection (Mack et al. 2001; 
Gillingwater et al. 2002; Adalbert et al. 2005; Conforti et al. 2007b) the Nmnat1 portion alone, as 
well as exogenous application of NAD
+
 can convey some protection to neurons (Mack et al. 2001; 
Ikegami and Koike 2003; Araki et al. 2004; Wang et al. 2005; Kaneko et al. 2006; Sasaki et al. 2006; 
Sasaki et al. 2009a; Sasaki et al. 2009b; Yahata et al. 2009). Further to this, recent proteomic analysis 
has shown that of the 16 major changes in protein expression identified in Wld
s
 mice, 8 of these 
proteins are directly linked to or located in the mitochondria (Wishart et al. 2007). This would suggest 
that the Wld
s
 mutation confers its neuroprotective effect, at least in part, via modifications to 
mitochondria and bioenergetic pathways (Mack et al. 2001; Ikegami and Koike 2003; Araki et al. 
2004; Kaneko et al. 2006; Sasaki et al. 2006; Wishart et al. 2007; Yahata et al. 2009).  It seems 
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possible that in response to a pathological insult aimed directly at metabolic pathways and 
mitochondria, such as hypoxia/ischaemia, that the Wld
s
 neuroprotective mechanism may be ineffective 
or by-passed. This possibility that Wld
s
 mediated neuroprotection is linked but upstream of direct 
mitochondrial impairment has been previously suggested (Coleman 2005) based on the failure of the 
Wld
s
 mutation to prevent degeneration of cultured superior cervical ganglia following uncoupling of 
the mitochondrial respiratory chain with a cyanide derivative (Ikegami and Koike 2003). It is 
interesting to note that in many of the studies that describe a failure of the Wld
s
 mutation to convey 
neuroprotection, the pathological stimuli have direct links to respiratory pathways and mitochondria. 
This includes the familiar model of ALS caused by mSOD1, a powerful ROS scavenging enzyme 
(Vande Velde et al. 2004; Fischer et al. 2005) and in hereditary spastic paraplegia (Edgar 2004) where 
the disease has been linked to the mitochondrial protein, paraplegin, and impaired oxidative 
phosphorylation (Beal 2000; Ferreirinha et al. 2004). The Wld
s
 mutation has also failed to convey 
neuroprotection in response to other stimuli not linked to respiratory pathways and mitochondria: 
spinal muscular atrophy (Kariya et al. 2009) caused by lowered protein products of the survival motor 
neuron gene which have been suggested to alter mRNA transport and gene splicing (Burghes and 
Beattie 2009) and following application of botulinum C neurotoxin (Berliocchi et al. 2005). Overall, 
the failure of the Wld
s
 mutation to protect -motor nerve terminals from hypoxia-reperfusion may not 
necessarily mean that Wallerian degeneration pathways are not activated.  This study demonstrates the 
difficulty in attempting to determine the mechanisms of nerve terminal disassembly by morphological 
analysis alone, particularly as different morphological mechanisms have yet to be linked to a clear 
underlying biochemical mechanism, a problem that has also been highlighted in CNS ischaemic 
injuries (Lipton 1999; Fujikawa 2000; Hand and Menze 2008). Further studies investigating the 
mechanism(s) responsible for disassembling motor nerve terminals following hypoxia-reperfusion 
injury, as well as nerve terminals loss in response to other pathological stimuli are therefore required. 
Further investigation are also needs to address how the Wld
s
 mutation confers its neuroprotective 
effect.  
 
3.4.3 Age and muscle type/location difference in the -motor nerve terminal 
response to hypoxia-reperfusion injury 
When the affect of 2H-2R on predominantly slow-fibre type muscles (TA and TS: e.g., Iscoe 1998; 
Hodges 1999; Murray et al. 2008a) was compared with that of the predominantly fast-fibre type 
muscles (lumbricals: e.g., Betz et al. 1990; Murray et al. 2008a), I identified significant differences in 
the extent of pathology with the -motor nerve terminals from lumbrical muscles being more 
vulnerable than those from TA or TS muscles. This indicates that different populations of -motor 
nerve terminals are selectively vulnerable/resistant to hypoxia- reperfusion injury. Differences in the 
selective vulnerability/resistance between and within populations of neurons is a key feature of CNS 
ischaemia-reperfusion injuries where, for example, neurons in region CA1 in the hippocampus are 
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more vulnerable than CA2 and 3 in rats and gerbils (e.g., Nakano et al. 1990; Ordy et al. 1993; Lipton 
1999; Gillingwater et al. 2004). The mechanisms that govern this selective vulnerability in CNS 
hypoxia/ischaemia-reperfusion injuries are poorly understood, but are probably due to the large 
number of complex variables that can influence hypoxia/ischaemia tolerance. For example, Lipton 
(1991) identified at least 21 different factors that have been shown to be, at least in part, responsible 
for the selective vulnerability of CA1 hippocampal neurons.  The results presented here indicate that 
the selective vulnerability/resistance of -motor nerve terminals in response to hypoxia-reperfusion 
injury is influenced by factors relating to muscle-fibre subtype.  When the metabolic properties of 
muscle fibres are considered however, the increased vulnerability of -motor nerve terminals 
innervating predominantly fast-twitch muscles is intriguing. Fast-twitch fibres rely on predominantly 
anaerobic, oxygen independent pathways for the supply of ATP for rapid but short-term contraction, 
while slow-twitch muscles predominantly rely on oxygen dependent, aerobic pathways for slow but 
tonic contraction (Ranvier 1874; Ogata and Mori 1964; Ogata and Yamasaki 1985; Rolfe and Brown 
1997; Kernell 2006). These different patterns of activity between muscle fibres will also be shared by 
their innervating -motor neurons and others have already highlighted that there is a reciprocal 
relationship between the anatomical and functional parameters of -motor neurons and skeletal 
muscle fibre subtypes (Wood and Slater 1997; Bewick et al. 2004; Kernell 2006: see section 1.4.2). 
Very little work has been carried out to address the possibility that -motor neurons and skeletal 
muscle fibres also share a reciprocal metabolic relationship but a decreased reliance on aerobic 
pathways is suggested by the lower levels of SDH in -motor neurons innervating fast-twitch muscles 
(Campa and Engel 1971; Donselaar et al. 1986; Ishihara et al. 1988; Chalmers and Edgerton 1989; 
Chalmers et al. 1992; Ishihara et al. 1995; Nakano et al. 1997). Overall this would suggest that fast-
twitch muscles and therefore, possibly their -motor neurons have increased anaerobic provisions for 
sustaining ATP supply and be more resistant to hypoxic/ischaemic insults. This has been found to be 
the case in some studies concerning the vulnerability of skeletal muscle fibres to ischaemia-
reperfusion injuries in vivo where fast-fibre type skeletal muscles are more resistant (Chervu et al. 
1989; Mars and Gregory 1991; Pedowitz et al. 1992; Awerbuck et al. 1994; Chan et al. 2004) but, 
conversely others have found that slow-twitch muscles are more resistant (Idstrom et al. 1990; 
Woitaske and McCarter 1998).  The results presented here from 8-12wk old animals and in previous 
studies following application of tourniquets in rats (Tombol et al. 2002) and mice (David et al. 2007) 
indicate that -motor nerve terminals from predominantly fast-twitch muscles are the most vulnerable. 
This would overall suggest that despite the increased provisions for O2 independent supply of ATP in 
fast-twitch muscles and the possibly that this also applies to their innervating -motor neurons, there 
are other factors determining their vulnerability. The selective vulnerability of -motor nerve 
terminals from fast-twitch muscles is consistent with findings from amyotrophic lateral sclerosis 
(Kawamura et al. ; Frey et al. 2000; Pun et al. 2006), poliomyelitis (Hodes 1949; Hodes et al. 1949) 
and during the normal ageing process (Hashizume et al. 1988).  The reasons underling this selective 
vulnerability have been suggested to be the consequence of the larger size and the formation of larger 
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motor units by -motor neurons that innervate fast-twitch muscles (Campa and Engel 1971; Kernell 
2006) which overall increases stress and lowers tolerance to pathological stimuli (Kernell 2006). In 
spinal muscular atrophy however, -motor nerve terminals innervating slow-twitch muscles have 
been shown to be more vulnerable (Murray et al. 2008a). This would indicate that rather than 
differences based purely on muscle fibre type, selective vulnerability/resistance may also vary 
depending on the pathological stimulus (Murray et al. 2008a). Further to this, other studies have also 
identified differences in motor neuron properties and pathological responses between and within 
affected muscles that show correlation with speed at which developmental synaptogenesis/maturation 
took place, the ability of terminal Schwann cells to express the chemorepellent Semaphorin 3A, the 
capacity of -motor nerve terminals to sprout, as well as anatomical positioning/topographic mapping 
of innervating -motor neurons (Duchen 1970; Laskowski and Sanes 1987; Miura et al. 1993; Frey et 
al. 2000; Pun et al. 2002; Santos and Caroni 2003; Schaefer et al. 2005; De Winter et al. 2006; Burns 
et al. 2007a; Murray et al. 2008a). A further possibility is that the muscle type differences described 
here in response to hypoxia-reperfusion injury may relate to their anatomical position within the body 
and length of the motor neurons that innervate each of these muscles. It is thought that mitochondria, 
the principal target of hypoxic injuries, undergo ageing and accumulation of oxidative damage as they 
are transported to nerve terminals. This process reduces their Ca
2+
 buffering capacity and increases the 
risk of mitochondrial rupture that leads to increases in cell death stimuli and may be, in part, 
responsible for the general vulnerability of nerve terminals in a range of pathological conditions 
(Davey et al. 1998; Brown et al. 2006; Naga et al. 2007). This would imply a hierarchy of 
pathological vulnerability, with nerve terminals of the longest neurons being more vulnerable (Davey 
et al. 1998) to hypoxic/ischaemic insults than those of shorter neurons. This is seen in the results 
represented here, where at 8-12wks of age, the lumbrical muscles with the longest -motor neurons 
were observed to be the most vulnerable to 2H-2R, while TS muscles that had the shortest -motor 
neurons were the least vulnerable to 2H-2R.  TA muscles occupied the middle ground in terms of 
overall motor neuron length and extent of -motor nerve terminal pathology. This would help explain 
the observed differences between the extent of -motor nerve pathology in TA and TS muscle (58.9% 
and 27.7% loss of NF/SV2 in TA and TS muscles respectively) as they are both composed of 
predominantly slow-twitch muscle fibres. It must be pointed out however that the difference between 
the mean number of vacant endplates from slow-twitch TA muscles was found not to statistically 
different from either that of the lumbrical muscles or the TS muscles. This is probably due to a 
combination of factors including the lower n number (of both TA and TS muscles compared to 
lumbricals) but also the low power and conservative nature of the statistical testing that would have 
increased the chance of producing a false-negative P value (Dytham 2003). In combination with the 
high degree of variability in the observed responses of both TA and TS muscles, overall makes the 
true nature of the differences between TA and TS muscle, and the difference between those muscles 
and the lumbrical muscles difficult to accurately determine. The more variable response of the TA and 
TS muscles, as well as the observed variability in the 4
th
 deep lumbrical noted here and in Chapter 2, 
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may however further suggest that there are additional (and perhaps more important) factors like those 
already discussed above governing the vulnerability of -motor nerve terminals to hypoxic/ischaemic 
injury than fibre type alone. These results may also be a reflection of the over simplified classification 
of muscle fibre subtype used in this study (i.e., either fast- or slow-twitch) as there are numerous 
intermediate fibre subtypes, depending on classification method, between these two fast- and slow-
twitch extremes (Close 1972; Kernell 2006). While both TA and TS are composed of predominantly 
slow-muscle fibres (Iscoe 1998; Hodges 1999; Murray et al. 2008a), it is possible that there are subtle 
differences in the mix of muscle fibre sub-types between these muscles that perhaps, in part, caused 
the observed differences in response. There may be also factors that are more related to other, more 
discreet functional parameters: TA is a postural muscle while TS is a respiratory muscle that will each 
have unique patterns of activity that perhaps results in some distinctive properties between these 
muscles, with further differences observed between them and the fast-twitch lumbrical muscles used 
for flexing the digits (Wood and Slater 1997; Iscoe 1998; Polla et al. 2004) that may affect relative 
vulnerabilities.  Overall, the factors that influence -motor nerve terminal vulnerability/resistance to 
pathological stimuli are still almost entirely unknown and it may be that generalizations on the extent 
of vulnerability based on a single variable, such as fibre type, are an oversimplification. As well as 
relative vulnerabilities based on the type of pathological stimulus, rates of development  and fibre type 
(Murray et al. 2008a), other variables including, anatomical location, functional attributes, genetic 
differences, metabolic properties, level of maturity as well as environmental factors may all contribute 
to produce unique and dynamic subpopulations of motor neurons between and within different 
skeletal muscles that differ greatly in their responses to different pathological stimuli. Identification of 
some of these variables that contribute to selective vulnerability/resistances is important not only to 
identify the most vulnerable subpopulations of neurons in neuropathological conditions but also to 
identify novel therapeutic strategies than can improve their resistance. The hypoxia-reperfusion model 
system developed here provides an opportunity to study some of these variables. Further studies using 
a greater range of muscle where -motor nerve terminals pathology can be directly correlated with 
fibre-type should be used to confirm/disprove the finding of fibre-type differences that are indicated 
here. The model system presented provides an ideal opportunity to investigate other variables as the 
results shown here indicate a distinct age-dependent component to the fibre-types difference. The 
surprising and unexplainable finding that in juvenile mice aged 5-6wks there was no apparent muscle 
type differences suggests that there are rapid and fundamental changes in -motor nerve terminals 
between 5-6wks and 8-12wks of age that led to the observed increased resistance to hypoxia-
reperfusion injury in TA and TS muscle in adult mice. Such dramatic differences could perhaps be 
expected if a comparison had been carried out between adult mice and those in the first few post-natal 
weeks for example, but at 5-6wks of age these animals would have already adopted most, in not all, of 
their adult behavioural patterns including sexual maturity. It has also been noted that children and 
young adults tend to be more resistant to tourniquet induced ischaemia-reperfusion injuries (Bruner 
1951), contrasting to the results presented here where the TA and TS muscles in juvenile mice were 
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more vulnerable.  If the data from 8-12wk old animals reflects adult patterns of -motor nerve 
terminal vulnerability, it is curious to note that the lumbrical muscles appear to adopt their mature 
pattern of vulnerability before 5-6wks while the respiratory/postural TS/TA muscles do not until 8-
12wks. The very narrow time frame of these observed changes provides an ideal starting point to 
investigate the factor or factors acting synergistically that influence the vulnerability/resistance to 
hypoxia-reperfusion injury. Further studies that examine the extent of pathology with age (e.g., early 
postnatal versus >12mth) may also highlight other significant age-related differences and their critical 
time points following hypoxia-reperfusion injuries. Such studies may later also provide insights into 
the factors that govern selective vulnerability seen in response to hypoxia-reperfusion injury and also 
other pathological stimuli.  
 
 3.4.4 Preliminary evidence suggests that muscle spindles may be more resistant 
to hypoxia-reperfusion injury  
In support of the general finding of selective vulnerability of -motor nerve terminals, I also report 
preliminary evidence that may indicate -motor nerve terminals and IA/II sensory endings innervating 
intrafusal muscle fibres (collectively, the muscle spindle) of the lumbrical muscles may be more 
resistant to hypoxia-reperfusion injury. This is based on the preliminary finding that the observed 
frequency of IA/II sensory endings and -neuromuscular junctions that still appeared with normal 
morphology (determined by NF/SV2 immunoreactivity) following 2H-2R was >56% compared to 
<16% of -motor nerve terminals from lumbrical muscles. Furthermore, on no occasion (either in 
controls or following 2H-2R) were IA/II sensory endings and -neuromuscular junctions observed to 
have any obvious signs of pathology. Due to difficulty in interpreting the reliability of the negative 
data from study (where IA/II sensory endings and -neuromuscular junctions could not be observed, 
most probably due to immunohistochemical protocol staining caveats) this does however remain a 
preliminary finding and highlights the need for this to be the subject of further study. Differences 
between the relative vulnerabilities/resistance of -, -, and IA/II nerve terminals have however been 
reported following axotomy (Sherrington 1893; Tower 1932; Boyd 1962; Barker and Ip 1966; Barker 
et al. 1970; Taylor et al. 2005), latrotoxin (Queiroz and Duchen 1982), normal ageing (Swash and Fox 
1972) in the gracile axonal dystrophy mutant mouse (Takagi et al. 1996) and in their responses to 
local anaesthetics, low Na
+
 concentrations and hypothermia (Matthews 1964). Some authors have 
reported loss of sensory action potentials after vascular occlusion in the hind limbs of the rat 
(Kawamura et al. 2006) and loss of proprioception, paraesthesia („pins and needles‟) touch and 
vibration sensation have been noted in human surgical patients where tourniquets have been used 
(Eckhoff 1931; Moldaver 1954). The few studies that have examined the pathological response of 
muscle spindles to hypoxia/ischaemia-reperfusion injuries do indicate that the nerve terminals of the 
muscle spindle are vulnerable and that there are differences in the selective vulnerabilities/resistance 
of -, -, and IA/II nerve terminals. Ischaemia induced by aortic compression in the rabbit did not 
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affect IA/II sensory endings but triggered -nerve terminals to degenerate (Cipollone 1898 as 
described by Matthews 1964). In a more recent study,  -motor never terminals withdrew from their 
postsynaptic endplates following transection of the vascular supply to rat soleus muscles, while IA/II 
sensory endings and -motor nerve terminals underwent Wallerian-like degeneration. However, 
temporal analysis between these differences response was not documented (Diwan and Milburn 
1986). In this study, while I could not show any conclusive pathological response in IA/II sensory and 
-motor nerve terminals, the preliminary evidence may indicate that the sensory and motor nerve 
terminals of the muscle spindle may be more resistant than those of -motor nerve terminals 
following 2H-2R. The reasons underlying this possible selective resistance could be a reflection of 
some of those factors relating to selectively vulnerability already discussed above. A further unique 
property of muscles spindles that may affect their relative vulnerability/resistance to pathological 
stimuli is the capsule that surrounds the muscle spindle (see section 1.4.3). This capsule will create a 
unique microenvironment surrounding IA/II sensory and most -motor nerve terminals that may help 
buffer against some external stimuli (Barker 1974) and perhaps precondition these nerve terminals 
against hypoxic injury. Overall, further studies are needed to address the relative resistance of IA/II 
sensory and  motor nerve terminals to hypoxia-reperfusion injury to confirm/disprove the 
preliminary results presented here. These studies should investigate if IA/II and -motor nerve 
terminals are vulnerable to more intense and/or chronic hypoxia/ischaemic-reperfusions injuries as 
other studies indicate that they are not invulnerable to ischaemia (Cipollone 1898; Diwan and Milburn 
1986). These studies will need to address the problem of the generally poor immunohistochemical 
staining of muscles spindles that hindered analysis of any potential pathological response(s) here. This 
will probably be best achieved with quantitative electron microscopy, where responses of IA, II, and 
-nerve terminals can be assessed without the complication of poor penetration of antibodies and the 
lack of postsynaptic staining needed for comparative analysis. Once such a protocol is in place, the 
hypoxia-reperfusion model system here provides the opportunity to complete a temporal analysis of 
the possible responses of sensory and motor nerve terminals of the muscle spindle where other studies 
have indicated different vulnerabilities following in vivo ischaemia (Cipollone 1898; Diwan and 
Milburn 1986), alongside that of -motor nerve terminals. Such studies may also help to provide 
valuable insights into the factors that govern selective vulnerability/resistance between, as well as 
within, groups of neurons.  
 
3.4.5 Summary 
I have provided further evidence to show that hypoxia-reperfusion injury triggers rapid and selective 
disassembly of -motor nerve terminals that includes functional failure. The extent of pathology 
appears linked to age and fibre type but why different -motor nerve terminals from different skeletal 
muscle fibres show selective vulnerability/resistance to hypoxia-reperfusion injury (and other 
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pathological stimuli are still unknown) but is likely to involve a number of complex variables.  I have 
also shown that the neuroprotective Wld
s
 mutation fails to protect -motor nerve terminals against 
hypoxia-reperfusion injury. This may suggest that despite some morphological evidence, the 
molecular pathways of Wallerian degeneration are not involved in hypoxia-reperfusion injury. 
Alternatively, it may also suggest that the mechanism of Wld
s
 mediated neuroprotection is upstream of 
direct inhibition of aerobic respiration or that the neuroprotective mechanism of Wld
s
 was bypassed. 
Collectively, this may indicate that the molecular pathways of Wallerian degeneration may still have a 
role to play in -motor nerve terminal disassembly in response to hypoxia-reperfusion injury.  Further 
work is required to understand the underlying causes of selective vulnerability/resistance, the 
mechanisms of -motor nerve terminal disassembly and how these different mechanisms relate to 
each other (i.e., are they completely independent or do they exist on a mechanistic continuum?), and 
how the Wld
s
 mutation confers protection. The model system described here may provide an ideal tool 









Chapter 4  
 
A pilot study examining the response of  -motor nerve terminals to 




In the mid 1990‟s it was discovered that the gene for green fluorescent protein (GFP) from the 
bioluminescent jellyfish Aequorea victoria (first characterised by Shimomura et al. 1962) could be 
successfully expressed in other species and that the chromophore could autofluoresce upon excitation 
with blue light to produce a fluorescent signal without apparent toxicity (Chalfie et al. 1994; Inouye 
and Tsuji 1994b). More recent advances in molecular genetics have shown that endogenously 
expressed GFP (27kDa: Heim et al. 1994) and related colour-shift mutants (XFPs) can be used in a 
range of cells including whole animals to specifically identify chosen macromolecules, sub-cellular 
compartments or tissues (Cubitt et al. 1995; Tsien 1998; Niell and Smith 2004; Misgeld and 
Kerschensteiner 2006). On the genetic background of the C57Bl/6 mice, Feng et al (2000) generated 
several strains of transgenic mice that selectively express enhanced yellow fluorescence protein (YFP) 
under the neuron specific regulatory elements of the Thy1.2 immunoglobulin gene (Caroni 1997a; 
Lichtman and Sanes 2003). These transgenic mice express YFP in the cytoplasm (Misgeld and 
Kerschensteiner 2006; Walsh and Quigley 2008) of the majority of their neurons, including -motor 
neurons and can be visualised using a standard epifluorescence microscope fitted with FITC filter sets. 
YFP also has suitable emission spectra to be utilised with red light emitting fluorophores such as 
TRITC for dual labelling and is still excitable after formaldehyde fixation (Chalfie et al. 1994; Feng et 
al. 2000). These desirable characteristic have meant that these mice and related genetic strains are 
now in routine laboratory use, in many cases replacing more time consuming and irksome 
histochemical methods that have been traditionally used to examine neuron morphology (Bridge et al. 
2009).  One particular advantage of these transgenic mice is the ability to examine neuron morphology 
over time in vivo or in ex vivo explants to provide valuable information on dynamic responses that 
otherwise would be impossible to obtain by studying static images (Feng et al. 2000; Lichtman and 
Fraser 2001; Lichtman and Sanes 2003; Niell and Smith 2004; Misgeld and Kerschensteiner 2006). 
The potential for live-imaging techniques to give unprecedented spatiotemporal data is exemplified by 
results obtained by repeated imaging of dorsal root ganglia (DRG) by Kerschensteiner et al, (2005). 
Within minutes of axotomy, symmetrical axonal swelling was rapidly following by localised 
retraction (200 to 300m) and fragmentation of the proximal and distal DRG nerve stumps. This 
„acute axonal degeneration‟ occurred within 5min and accounted for 90% of all axonal loss over a 4hr 
period. These previously unknown events following axotomy preceded a static phase lasting 6-24hr in 
the proximal nerve stump and ~30hr in the distal nerve stump before the onset of regenerative and 
degenerative (classic Wallerian) processes respectively. Similar imaging studies during developmental 
synapse elimination of -motor nerve terminals also provided novel results, describing the shedding 
of membrane bound fragments or „axosomes‟ from withdrawing -motor nerve terminals that were 
engulfed by Schwann cells  (Bishop et al. 2004). A study examining the effects of dendritic spine 
morphology during and following ischaemia-reperfusion injuries have shown that during mild 
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ischaemia spines remain stable but 10-30mins after the onset of severe ischaemia spines become 
swollen and lost. During reperfusion some spines can recover within 60mins but most will later 
degenerate by 24hr (Zhang et al. 2005). These transgenic XFP lines of mice have also been used to 
examine tourniquet induced ischaemia-reperfusion injury at -motor nerve terminals (David et al. 
2007) but this study did not explore the possibility of using these mice to examine the responses of -
motor nerve terminals in real time by repeated imaging. To provide further details of the potentially 
dynamic, spatiotemporal responses of -motor nerve terminals to these types of injuries, the following 
chapter describes the results obtained in a pilot study looking at the response of mouse -motor nerve 




Adult (8-14wk old) Thy-1/16-YFP C57Bl/6 mice (YFP mice) were obtained from Jackson 
Laboratories, USA (genetic strain created by Feng et al. 2000) and maintained at the University of 
Leeds. TA muscles were dissected as described in Chapter 3 but after preparation was split up the 
midline, the two hemi-preparations were trimmed to leave 2x ~2.5cm
2 
pieces of tissue with the 
window of intact TA muscle fibres in the centre (see Fig 4.1 and Fig3.1 for details).  The better of the 
two preparations, determined by muscle fibre integrity, density of residual overlying tissue and fat 
deposits was selected for live imaging. N= number of animals, n = number of muscles.  
 
4.2.2 Tissue processing and live imaging system  
TA muscles preparations had their postsynaptic endplates visualised with TRITC conjugated -
bungarotoxin (BTX) for 10mins (5µg/ml in Kerbs‟ solution: Invitrogen) that directly labels AChRs 
followed by a brief rinse with fresh HEPES buffered Krebs‟ solution (see Chapter 2 for details). TA 
muscle preparations were then pinned out under tension in 3ml petri dishes lined with Sylgard and 
mounted into a microperfusion chamber (Harvard Instruments: see Fig 4.1) loaded on to the stage of 
the upright epifluorescence microscope (Zeiss Standard 10) in a darkened room to reduce light 
exposure. The microscope was fitted with FITC/TRITC filter sets, a 50W mercury vapour light 
Fig 4.1 Schematic overview of the live imaging set-up. TA muscles from adult 
YFP transgenic mice were dissected free from surrounding tissues and trimmed to 
a size corresponding to the blue-boxed area (LEFT). These preparations were 
then placed in an organ bath/superperfusion chamber mounted onto the stage of 
an upright epifluorescence microscope (RIGHT).  
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source, x50 Zeiss water immersion lens (0.8 NA) with the addition of a neutral density filter (No 6) to 
reduced illumination intensity by 94%. Images of the nerve terminals and postsynaptic endplates were 
captured over time using a monochrome Cohu 4910 CCD camera (Vista Vision, Steventon, UK) using 
Scion Image capture software (Maryland, USA) running on an Apple Macintosh Quadra 650 
microcomputer. Each image was averaged, typically between 50-100 frames with a total light 
exposure time of 3-5s per image. In all instances the postsynaptic endplate was only imaged at the 
beginning and end of the experiment, while the nerve terminal was imaged at indicated intervals and 
the light path completely blocked in-between each exposure to help reduce overall light exposure. The 
TA muscle preparations were maintained by superperfusion performed by gravity flow of Krebs‟ 
solution into the base of the chamber and vacuum aspiration at the top of the chamber to create a flow 
across the preparation. Chamber volume was maintained at ~2ml (flow rate 1.6ml per min, total saline 
exchange every to 2-3min) and temperature was maintained at 22-25°C. In control experiments, TA 
preparations were superperfused with Krebs‟ solution sparged with 95%:5% O2:CO2 gas or 
pressurised air. In hypoxic experiments the Krebs‟ solution was sparged with 100% N2 gas. In a subset 
of experiments, TA preparation were maintained in ~1ml static volume of Krebs‟ solution with -
latrotoxin (LTX: Alomone labs, UK) at a final dilution of 1nM (the upper limit of the suggested 
working concentration from the supplied data sheet). In a different set of experiments, lumbrical, TA 
and TS muscles (see Chapters 2 and 3 for details) were fixed with 4% formaldehyde in PBS for 30min 
immediately after dissection and incubation in BTX (i.e., no live imaging was carried out). After 
3x15min wash in PBS muscles were mounted onto slides as described previously.  
 
4.2.3 Image processing 
Images were aligned in Scion Image for Windows (release 4) and reconstructed in Abode Photoshop 
CS2 with each image adjusted for brightness, contrast and coloured as required. Each of the live 
imaging sequences was animated in Abode ImageReady CS2 and converted to a high resolution 
QuickTime Movies that can be seen using RealNetworks, Inc free version of RealPlayer for Mac and 
PC (www.real.com). These movies are supplied on enclosed DVD.   
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4.3 Results 
4.3.1 Characteristics of -nerve terminals and axons from YFP mice  
As the colony of YFP-mice maintained at the University of Leeds was newly established, initial 
observations examined the expression of YFP in nerve terminals from fixed lumbrical, TA and TS 
muscles (i.e., without live imaging). This showed that YFP was expressed in all the -motor neurons 
and nerve terminals supplying these three muscle groups and when postsynaptic AChRs were labelled 
with BTX, YFP could be seen to fully oppose BTX staining as shown previously (Feng et al. 2000). 
There was also a low level incidence of synaptic guttering, where small regions of postsynaptic BTX 
could be observed with no opposing presynaptic YFP (Fig 4.2A).  This is generally accepted as being 
the result of ongoing synaptic reorganisation (Cardasis and Padykula 1981; Wernig et al. 1984; 
Wernig and Herrera 1986; Lichtman et al. 1987; Wigston 1989; 1990) and appears to correspond to 
no more than 1 or 2 synaptic boutons, affecting less than an estimated 1% of the total population of 
nerve terminals.  The pre-terminal axons in these transgenic YFP mice however, were nearly always 
observed to be highly distended or extremely thinned, vacuolated and with evidence of a 
heterogeneous distribution of YFP (Fig4.2B). The severity of these features appeared greater in 
lumbrical muscles, becoming less severe in axons located in the intramuscular nerve and axons in TA 
and TS muscle (Fig 4.2C). On occasion -motor nerve terminals in the lumbrical muscles were 
observed to have sprouts (Fig4.2D), a feature that I have never observed in wild-type animals or very 
rarely by others (Wernig et al. 1984; Wernig and Herrera 1986; Lichtman et al. 1987: Parson et al 
group, unpublished observations (c.f Barker and Ip 1966)). Although not formally assessed, these 
animals showed no signs of behavioural/functional impairment compared to their wild-type relatives 
and bred well until 5 months of age when they were culled.  
 
4.3.2 Live imaging of Nerve Terminals under control conditions 
A live imaging system was developed (see methods) in which the nerve terminals of ex vivo TA could 
be observed over time and that could be used to examine -motor nerve terminal responses to 
hypoxia. As these preparations have minimal distal nerve stumps (<0.3cm), live imaging was limited 
to 3hr.  Overall, the success rate of this system was low, primarily due to the requirement of nerve 
terminals to be and remain in the plane of view for 3hrs. Even minor drifts or changes in muscle fibre 
tension (in some cases possibly due to spontaneous minor muscle fibre contractures) could cause 
changes in -motor nerve terminal orientation so they were no longer focused on a single plane of 
view and/or to have shifted away from the plane of view.  
In control conditions, nerve terminals were imaged every 15min over a period of 3hr to show that 
overall, the gross morphology of the nerve terminals, endplate and muscle fibre remained stable when 
perfused with Krebs‟ solution sparged with 95%:5% O2:CO2 (N=3, n=3) or pressurised air (N=3, 
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Fig 4.2 -motor nerve terminals and axons from YFP transgenic mice have a 
basal level of pathology. While most -motor nerve terminals visualised by 
endogenously expressed YFP (GREEN in merged images) fully oppose their 
postsynaptic endplates visualised with BTX (RED in merged images), there was 
evidence of synaptic gutting like that seen in (A: arrow) from a lumbrical muscle. The 
level of synaptic gutting was similar to that observed to occur in wild-type animals and 
is generally thought to present on-going re-organisation. Pre-terminal axons in YFP 
mice were observed to be highly distended and/or thinned with a heterogeneous 
distribution of YFP and vacuoles. This affected lumbrical muscles (B) more than TA 
(C) or TS muscles, and was less apparent in the larger intramuscular nerve branches 
(C). Although rare, -motor nerve terminals from these mice were also occasionally 
observed to have sprouts extending away from the terminal arborisation, either with 
(D: from lumbrical muscles) or without opposing BTX staining. A, B, and D are 
micrographs, C is a confocal projection (see Chapter 2 for details). Scale bars A&B 




Fig 4.3 -motor nerve terminals repeatedly imaged in control conditions did not 
typically show any changes in morphology. TA muscles from YFP transgenic mice 
were maintained in a superperfusion chamber mounted onto the stage of a microscope. 
In control conditions using HEPES buffered Krebs’ solution that was sparged with 
95%:5% O2:CO2 or pressurised air (shown), -motor nerve terminals (YFP, GREEN in 
merged images) were imaged every 15min for 3hr and compared to their postsynaptic 
endplates (visualised with BTX: RED in merged images) that were only imaged at the 
beginning and the end of the experiment. Comparison of presynaptic YFP and 
postsynaptic endplate morphology at the beginning (A) and the end of the experiment 
(B) shows no apparent changes in morphology. Serial reconstruction of images of the 
terminal (a-m) with time shown in hr:min in the lower left of each image also show no 




Fig 4.4 Minor changes in morphology could be observed in repeatedly imaged 
-motor nerve terminals in control conditions. Presynaptic YFP (GREEN in 
merged images) and postsynaptic endplates (visualised with BTX: RED in merged 
images) is compared at the beginning of the experiment (A) and after 3hr (B) where 
the -motor nerve terminal had been imaged every 15mins (a-m) while being 
superperfused with HEPES Krebs’ solution sparged with pressurised air.  -motor 
nerve terminal morphology remained unchanged until between 2hr 45min and 3hr 
where there was a sprout-like projection (l&m: arrow). There was no apparent change 
in postsynaptic endplate morphology and the sprout-like projection was not opposed 
by BTX staining. Note that the sprout-like projection comes from a region of the nerve 
terminal arborisation that appears with intense YFP fluorescence. Time in the lower 
left of images hr:min, scale bar 10m.  
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n=3:Fig 4.3). The reason why air instead of 95%:5% O2:CO2 was used in some experiments was 
because there were increasing concerns that the high O2 concentration may be causing ROS formation 
as part of the mechanism of phototoxicity (see below and discussion). In general, however no 
difference was noted between those preparations sparged with air or those with 95%:5% O2:CO2.   
Close examination of the serial reconstructions over time however, did demonstrate that minor 
alterations in morphology of the nerve terminal could occur even in control experiments (Fig 4.4). In 
one control experiment sparged with air, an outgrowth, „sprout-like‟ projection can be seen to develop 
at 2hr45min. In another control experiment that was sparged with 95%:5% O2:CO2, no change in 
morphology occurred but there were changes in the distribution of YFP, with regions appear more or 
less bright. In this case it was difficult to determine if this reflected real changes in YFP or if it was an 
artefact related to minor changes in -motor nerve terminal orientation and/or focal plane.   
 
4.3.3 Live imaging of Nerve Terminals under hypoxic conditions 
To investigate the response of nerve terminals from TA muscles to hypoxia, the Krebs‟ solution 
perfusing the TA muscles was replaced with a solution that had been sparged with 100% N2 gas (N=3, 
n=3:Fig 4.5). No significant changes were observed in the postsynaptic endplates or muscle fibres 
over the 3hr experiment. In -motor nerve terminals, serial reconstructions showed a range of small 
but rapid and dynamic morphological events prior to the sudden loss of YFP intensity that included 
swelling and rapidly appearing/disappearing sprouts and small fragments that were typified by events 
shown in Fig 4.5. In this - nerve terminal, these small morphological events could be observed 
within 15mins until 2hr 30min where there was a sudden loss of YFP intensity between 2hr 30min and 
2hr 45min with the nerve terminal appearing almost un-identifiable against background 
autofluorescence. When this nerve terminal (and those in other similar experiments) was imaged at the 
end of experiment without the neutral density filter (i.e., incident light level was returned to 100% 
rather than 6% used during the live imaging process), the nerve terminal appeared to still be largely 
present but with a highly punctate, ghostly morphology.  At the end of the experiment, examination of 
-motor nerve terminals that had not been in the field of illumination appeared normal, with no 
apparent perturbations in morphology. Very similar results were also obtained from -motor nerve 
terminals that were superperfused with Krebs‟ solution that had previously been sparged with 
95%:5% O2:CO2 gas but where sparging had been stopped at the onset of imaging (N=2, n=2). These 
results clearly show that nerve terminals can have a highly dynamic and rapid response to pathological 
insults but indicate that hypoxia and live imaging protocol of YFP filled neurons were probably acting 




4.3.4 Live imaging of nerve terminals following application of -latrotoxin 
(LTX) 
To try and help understand the morphological events observed in nerve terminals described above, 
nerve terminals were imaged in the 1ml static volume of oxygenated Krebs‟ solution containing 1nM 
of -latrotoxin (LTX). LTX is a neurotoxin selective for nerve terminals and is known to cause rapid 
synaptic vesicle release, swelling and lysis of motor nerve terminals (Clark et al. 1970; Okamoto et al. 
1971; Duchen et al. 1981; O'Hanlon et al. 2003; Ushkaryov et al. 2004). All but one of the attempts to 
live image the response of nerve terminals to LTX in TA muscles was unsuccessful due to significant 
muscle fibre contractures. In one experiment, (Fig 4.6) contractures were suitably inhibited to allow 
for continuous live imaging by increasing the incubation time of TA muscles preparation in FITC 
conjugated BTX to 30min. BTX is highly selective, irreversible ligand at postsynaptic AChRs and can 
causes neuromuscular blockade by preventing muscle fibre depolarisation in response to synaptic 
vesicle release (Chang 1999). Imaged every 5min (0hr20min time point was missed), the -motor 
nerve terminal incubated in LTX remained unchanged for 40min, following which there was rapid 
loss of several nerve terminal boutons by 45mins. Other regions of the arborisation were lost between 
1hr 10mins and 1hr 15mins leaving behind ghostly and punctate YFP fluorescence, like that observed 
affecting the whole -motor nerve terminal during hypoxia. Several swellings also appeared at 1hr 
and 1hr 25min like those observed during the hypoxia experiment, however these swelling remained 
largely unchanged until the end of the LTX imaging at 1hr 30min. Observations of the morphology in 
-motor nerve terminal that had not been repeatedly imaged at the end of the experiment also showed 
some pathological changes, i.e., loss of part or all of overlying terminal as determined by YFP. This 
suggests that there are some similarities between the response of -motor nerve terminals to LTX and 
hypoxia when they are repeatedly imaged.  
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Fig 4.5 Rapid and dynamic changes in morphology could be observed in 
repeatedly imaged -motor nerve terminals in hypoxic conditions. Presynaptic 
YFP (GREEN in merged images) and postsynaptic endplates (visualised with BTX: 
RED in merged images) is compared at the beginning of the experiment (A) and after 
3hr (B) where the -motor nerve terminal had been imaged every 15mins (a-m) while 
being superperfused with HEPES Krebs’ solution sparged with N2 gas. Changes in -
motor nerve terminal morphology could be observed within 15min (b) with a sprout-
like event (arrow) that appeared to swell by 30min (c) and to have disappeared by 
45min (d) but surrounded by small fragments (white arrowheads). The region of the 
terminal arborisation from which the sprout-like projection arose appeared with 
average intensity YFP but following the loss the sprout-like projection, this region 
becomes very YFP intense and possibly swollen that is still visible by 2hr: 30min 
(arrows).  Also beginning within 15min after the onset of hypoxia and imaging, a range 
of changes are observed in the region marked by the asterisk. Already quite YFP 
intense at the beginning of the experiment, this region begins to swell for 30min but in 
(d: 45min) this region becomes obscured even though the rest of the nerve terminal 
remains in relatively clear focus. This perhaps represents release of YFP from the 
nerve terminal. In the next image (e:1hr:0min) this region and the YFP-intense 
swelling is visible but the swelling appears reduced (compare c and e). This swelling 
then appears to fragment by 1hr:15min (f) and the fragments appear to move away 
from nerve terminal or disappear over the next 45min (images g-k). Various other 
fragmentation and swelling events are indicated by blue arrowheads. At 2hr:30min (k) 
the -motor nerve terminal still appears with good YFP intensity but by 2hr:45min (l) 
there is dramatic and synchronous loss of YFP from the entire arborisation leaving a 
‘ghostly’ shadow of the nerve terminal by 3hr:0min (m). By removing the neutral 
density filter and returning incident light levels to 100% (n) the -motor nerve terminal 
is again visible and appears to fully oppose its postsynaptic endplate (B) but YFP 
fluorescence has become highly punctate (m&B).  Time in the lower left of images 




Fig 4.6 Observations of the changes in -motor nerve terminal morphology in 
response to LTX shows some similarities to that observed during hypoxia. 
Presynaptic YFP (GREEN in merged images) and postsynaptic endplates (visualised 
with BTX: RED in merged images) is compared at the beginning of the experiment (A) 
and after 1hr30 (B) where the -motor nerve terminal had been imaged every 5mins 
(a-o) while being maintained in a static volume of oxygenated HEPES Krebs’ solution 
with 1nM of -latrotoxin (LTX). In the presence of LTX there was no observable 
change in -motor nerve terminal morphology for the first 35min (images from 5-
20min have been omitted) but there were some weak muscle fibre contractures 
(compare overall morphology in c with previous images). Between 40min (e) and 
45min (f) there is complete loss of YFP from a small region corresponding to one or 
two synaptic boutons (arrow). No further changes were noted until 1hr (i) after on the 
onset of imaging and application of LTX, where a small region of the nerve terminal 
appears to swell (arrow). This swelling, that is similar to some of the events observed 
during the hypoxia experiments, remains relatively unchanged until the end of the 
experiment at 1hr:30min (o). Between 1hr:10min (l) and 1hr:15min there is loss of 
another, larger region of the nerve terminal arborisation, leaving behind a ghostly 
punctate shadow (arrow), again similar to some of the events observed during the 
hypoxia experiments. Loss of this region leaves another region (corresponding to one 
or two synaptic boutons) apparently isolated from the rest of the arborisation (asterisk) 
which remains unchanged for the duration of the experiment. Another swelling 
appears at 1hr:20min (m: upper most arrow) and appears to increase in size until 
1hr:30min (o). Time in the lower left of images hr:min, scale bar 10m 
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4.4 Discussion  
The results presented here show that -motor nerve terminals from transgenic mice that express 
endogenous YFP in their neurons can undergo a very rapid and dynamic response to pathological 
stimuli. These results however raise concerns about the consequences of expressing fluorescent 
proteins within neurons and also the ability to monitor their responses to hypoxia in real time.  
 
4.4.1 Axonal and -motor nerve terminal pathology induced by YFP 
YFP is a colour-shift mutant of GFP created by substitution of Thr
203
 with aromatic amino acids that 
results in a subtle change in emission spectra and its yellowish appearance (Tsien 1998). Due to the 
fact that GFP and its colour-shift mutant relatives (XFPs) are based on a naturally occurring protein, 
they are generally considered to be innocuous and have been successfully expressed in a whole range 
of cell types to identify cells, sub-cellular compartments and macromolecules (Cubitt et al. 1995; 
Tsien 1998). Examination of tissue from YFP-mice that had not undergone live imaging showed that 
the axons of these mice were highly distended and vacuolated with regions of extreme thinning and 
very heterogeneous distribution of YFP. There was also a low-level incidence of -motor nerve 
terminal pathology with outgrowth or sprouting events that are relatively rarely seen in control, wild-
type animals (Wernig et al. 1984; Wernig and Herrera 1986; Lichtman et al. 1987 (c.f., Barker and Ip 
1966
10
)). Similar axonal pathology including localised axonal swelling and thinning but not as severe 
at that described here, could also be observed in the same YFP strain of mice but a different colony of 
mice maintained at the University of Edinburgh (personal observations and Gillingwater et al  group, 
unpublished observations). In reviewing the original publication that described this strain of 
transgenic mouse, there was some evidence of unusual axonal swelling in their micrographs (Feng et 
al. 2000). The underlying cause of this is unclear however, the creators of these mice did comment on 
the high variability of Thy1.2-YFP gene insertions site and copy number. It would seem the most 
likely explanation for these differences would be that the two colonies of YFP-mice may have 
differing expression levels of YFP due to differing genetic backgrounds (the colony maintained at 
Edinburgh University is known to have been out-crossed and therefore may have lower YFP 
expression levels: Derek Thompson, personal communication). High levels of YFP protein are known 
to cause dimerisation leading to oligomerisations (Cubitt et al. 1995; Shaner et al. 2005) and excess 
levels of YFP-protein aggregates may account for distension and swelling of axons observed here. 
                                                          
10 In this study the authors found a high degree of sprouting from three species than on average effected a total of ~25% of -
motor nerve terminals.  Most of these sprouting events were of the nodal and pre terminal varieties but the observed frequency 
of terminal sprouts like that observed and discussed here (referred to as ultraterminal by Barker and Ip(1966)) was low.  None 
were observed in muscles from the cat or the rabbit, and only 3 instances out of the 37 groups of -motor nerve terminals were 
observed in the rat. This frequency is still higher than that described by others (Wernig et al. 1984; Wernig and Herrera 1986; 
Lichtman et al. 1987) but the rat was the species least studied by Barker and Ip (1966) and there is no clear indication of 
numbers (or clear age) of rats used in their study. It may therefore be possible that this higher frequency of ultraterminal 
sprouting found in rats in this study was due to naturally occurring low-frequency pathological responses and/or perhaps due to 
using young animals where the dynamic morphological events of the process of developmental synapse elimination have yet to 
be fully completed. This in combination with a potentially low number of repeats may perhaps resulted in a higher percentage 
of ultraterminal sprouts.    
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The reason(s) for the apparent difference in these pathological features between axons located in the 
intramuscular nerve and pre-terminal axons of -motor nerve terminals innervating TA and TS (less 
affected) and those from pre-terminal axons and from the lumbrical muscles (more affected) is 
unknown. It is also unknown and highly surprising that despite the pathological appearance of axon 
and nerve terminals that behaviour and breeding, in these YFP-mice was no different from their wild-
type litter mates/counterparts. These observations of pathology in YFP-transgenic mice are consistent 
with a recent report of pathology in CNS neurons from the related YFP-H mouse strain that only 
express YFP in a random subset of neurons (Bridge et al. 2009). These authors report a significant 
increase in number of swellings or spheroids in the gracile tract, gracile nucleus and dorsal root 
ganglia in YFP-H mice that was independent of the effects of ageing. They show that up to 16 months 
of age no behavioural changes could be observed despite increasing frequency of axonal swelling. 
They also note that number of swellings increases in mice homozygous for YFP compared to 
heterozygous animals to indicate that increased expression of YFP is the cause of pathology.  
Swelling, with or without vacuolisation is a common feature of CNS ageing process (Yoshikawa et al. 
1985) but is also related to pathological and neurodegenerative disease stimuli including Alzheimer‟s 
disease and other tau-pathies (Lewis et al. 2000; Brendza et al. 2003; Tsai et al. 2004), Parkinson‟s 
disease (Galvin et al. 1999), stroke (Dewar et al. 1999; Lipton 1999), ALS (Tu et al. 1996), 
Creutzfeldt–Jakob disease (Liberski and Budka 1999), hereditary spastic paraplegia (Ferreirinha et al. 
2004), Niemann-Pick disease (Elleder et al. 1985; Bu et al. 2002), multiple sclerosis (Ferguson et al. 
1997), gracile axonal dystrophy and others (Mi et al. 2005). In general, axonal swelling is very rare in 
the PNS but in the CNS, it is thought to cause disruption of axonal transport and precede axonal 
degeneration (Mi et al. 2005). There are also increasing numbers of reports of deleterious 
consequences of XFP in other systems. There have been several reports of the difficulty in generating 
stable XFP cell lines, with cells undergoing cytotoxic apoptosis 48hr to 96hr after transvection 
(Lamhonwah and Tein 1999; Liu et al. 1999; Shaner et al. 2005). XPF expressed in myoblasts caused 
a 5-fold increase in cytokine production (Mak et al. 2007) and impairment of contractile function due 
to XFP interaction with myosin (Agbulut et al. 2007). This is the likely cause of impaired left 
ventricular ejection rates in rats (Agbulut et al. 2006) and may be responsible for an independent 
report of GFP induced cardiomyopathy (Huang et al. 2000). XFPs have also been shown to reduce 
mouse embryonic viability in an expression level dependant manner (Devgan et al. 2004), alter 
ubiquitination pathways that are involved in protein degradation in vitro and in vivo (Baens et al. 
2006), sensitise neuroblastoma cell lines to cytotoxic and chemotherapeutic agents (Goto et al. 2003), 
and to be neurotoxic to dopaminergic neurons (Klein et al. 2006). Co-expression of XFP with - 
galactosidase, that alone is not neurotoxic, caused developmental abnormalities with apoptosis of 
mouse forebrain neurons and death by 4 week of age (Krestel et al. 2004). When XFP was co-
expressed with members of Bcl-2 family, mitochondria become aggregated and later triggered 
apoptosis (Aokage et al. 2004) while XFP fused to DNA has been shown to cause production of anti-
DNA antibodies (Moens et al. 2002). It is unclear how and why XFPs have these effects but XFP 
aggregation has been suggested (Shaner et al. 2005) as well as the formation of ROS (Greenbaum et 
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al. 2000; Goto et al. 2003) with further indications that XFPs produce H2O2 (a ROS) as part of their 
fluorescent mechanism and probably in a 1:1 ratio (Heim et al. 1994; Inouye and Tsuji 1994a; Tsien 
1998). Production of ROS, particularly in highly expressing tissue may easily overwhelm endogenous 
protective mechanisms to cause irrecoverable damage to macromolecular structures, enzymes, cell 
membranes and to possibly trigger cell death (Halliwell 2006). In the results present here, while there 
was evidence of synaptic guttering that would indicate loss of terminal boutons, this was at a level 
consistent with wild-type controls. I did not observe any evidence of degenerating axons or nerve 
terminals that parallels the finding from the CNS of YFP-H mice (Bridge et al. 2009). The low levels 
of sprouting events observed at the nerve terminal may however indicate that there are some 
functional deficits as sprouting is known to be caused by partial denervation (Lichtman et al. 1987; 
Tam and Gordon 2003) and conduction block such as that produced by botulinum toxin (Botox: 
Duchen and Strich 1968; Duchen 1970; de Paiva et al. 1999; Meunier et al. 2002; Rogozhin et al. 
2008) or cholinesterase inhibition (Kawabuchi et al. 1991). Overall, these results suggest that while 
expression of YFP in -motor neurons is not toxic, it is certainly not innocuous and maybe increasing 
basal stress levels due to overly high YFP expression, aggregation and/or ROS formation. This 
therefore raises concerns about subjecting YFP neurons to additional pathological insults, particularly 
those types of stimuli linked with ROS formation such as hypoxia.  It may also raise concerns about 
novel findings in studies that utilise these mice. For example prior to the current study, the only recent 
light level study examining the effects of tourniquet induced ischaemia-reperfusion injury that 
specifically looked at -motor nerve terminals utilised YFP and mSOD1/YFP transgenic mice (David 
et al. 2007). With increasing numbers of the negative effects of YFP and without similar experiments 
carried out in wild-type animals, it is difficult to determine any potential contribution that XFPs may 
have made to results.  
 
4.4.2 The responses of -motor nerve terminals in real time: Patho- 
physiological or the ‘observer effect’. 
Since the generation of the YFP transgenic lines of mice, there have been numerous live/repeat 
imaging studies. This has included imaging of dendritic spines of pyramidal neurons over hours, days 
and months during development (Grutzendler et al. 2002) sensory deprivation (Trachtenberg et al. 
2002) and during/following ischaemic injury (Zhang et al. 2005). There have also been studies into 
the process of axotomy (Kerschensteiner et al. 2005) and developmental synapse elimination at the 
NMJ (Bishop et al. 2004), again over a time frame of minutes to months. There is however a certain 
degree of uncertainty in the results presented in all these studies due to the observer principal: are the 
observed changes truly physiological or are they the result of the act of looking (Lichtman and Fraser 
2001)? This observer principal is particularly important in live/repeat imaging studies due to the 
inherent risk of inducing phototoxicity. For fluorophores, such as YFP, to fluoresce they must first 
absorb light energy (photons) to cause electronic excitation. In returning to their natural/ground 
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electronic state, fluorophores spontaneously emit photons but at a lower energy level (or longer 
wavelength) than which they originally absorbed and this is detected as the fluorescent signal. This 
„fluorescence‟ mechanism however does not always occur: alternatively, excited fluorophores may 
return to ground state by donating their energy to other molecules, such as O2, in a process known as 
„quenching‟. This results in radicalisation (e.g., ROS formation) that causes damage to 
macromolecules, enzymes and cell membranes that may alter or cause dynamic responses and 
possibly lead to cell death, a process that is collectively referred to as phototoxicity. It is therefore 
imperative to reduce the light exposure as much as possible but some degree of phototoxicity is 
always going to occur in response to live/repeat imaging (Lichtman and Sanes 2003). In the 
preliminary results presented here and despite attempts to reduce light exposure as much as possible, it 
seems very unlikely that the response of -motor nerve terminals to hypoxia was truly patho-
physiological. This is primarily because -motor nerve terminals that were not repeatedly imaged and 
away from the field of light did not have any observable pathology in response to hypoxia. As 
discussed above, the mice used in this study already exhibit a basal level of pathology and potentially 
express YFP at very high levels that would increase the risk of inducing phototoxicity. In line with 
previous reports of YFP induced toxicity and sensitising cell lines to other stimuli (see above), the 
most likely explanation for the results presented here is that hypoxia and the live imaging protocol 
acted as co-stimuli to cause the observed pathology in -motor nerve terminals. The results presented 
here also contrast with the results obtained in wild-type TA muscles from animals of a similar age 
subjected to the 2H-2R protocol described in Chapters 2 and 3, where ~58% of endplates had no 
opposing NF/SV2 immunoreactivity. The lack of pathology in terminals that had not been repeatedly 
imaged described here suggests that the level of hypoxia induced during the live imaging protocol was 
perhaps not as severe as that induced by the 2H-2R model system.  This adds further evidence to 
indicate that the -motor nerve terminals being repeatedly imaged were not responding to hypoxia 
alone. Phototoxicity is also probably responsible for the observation of a sprout-like event in control 
preparations. Numerous studies have addressed the issue of -motor nerve terminal stability over time 
and have reached the conclusion that they are remarkably stable once synapse elimination is complete 
and until at least 18months of age (Lichtman et al. 1987; Balice-Gordon and Lichtman 1990; Sanes 
and Lichtman 1999; Lichtman and Sanes 2003).  Even the study that described the highest frequency 
of changes in gross morphology suggests that in mouse soleus each -motor nerve terminal may only 
undergo the loss or addition of one terminal branch every 10days (Wernig et al. 1984). It therefore 
seems unlikely that -motor nerve terminal sprout event observed within 15min in control conditions 
reflects physiological dynamism/plasticity. The live imaging system presented here is very similar to a 
very recently published protocol by Kerschensteiner et al. (2008) but these authors utilised TS 
muscles (rather than TA muscles: see Chapter 3) from a range of XFP expressing transgenic mice. 
They show that -motor nerve terminals can be repeatedly imaged over several hours to examine, for 
example, developmental synapse elimination. They state that superperfusion rates of 1ml per min 
(total chamber volume of >3.5ml) with Neurobasal A medium (preferred) or normal saline solutions 
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are suitable for these types of experiments. They do however imply that phototoxicity is a significant 
risk and utilise a computer controlled shutter system and neutral density filters (number unspecified), 
further advocating the use of intensified or electron multiplying CCD cameras to reduce overall light 
exposure.  It is possible that by using improved microscope technology (i.e., computerised shutter 
controls and more sensitive camera systems) that overall light exposure was reduced enough to 
prevent significant amounts of phototoxicity than appears to have occurred in the present study. 
Nevertheless, this protocol developed by Kerschensteiner et al . (2008) has yet to be used to 
live/repeatedly image -motor nerve terminal responses to pathological stimuli where perhaps it is 
more likely that the negative effects of live imaging/phototoxicity will be observed. Overall, the 
results presented here indicate that a certain amount of caution is required in interpreting the results of 
live imaging studies from XPF transgenic animals, especially in transgenic lines that appear to express 
very high levels of fluorescent protein such as those described here.  
 
4.4.3 Live imaging reveals very rapid and potentially dynamic responses may 
occur in -motor nerve terminals following a pathological insult.  
Despite the fact that the results presented here are most likely due to some degree of phototoxicity and 
hypoxia, they do demonstrate that -motor nerve terminals may respond very rapidly to pathological 
stimuli. Changes in morphology were observed to occur within 15min after the onset of live imaging 
and hypoxia but there are some difficulties in attempting to define what these events mean in regards 
to morphology.  For example, do the sprout-like events observed in controls (Fig 4.4) and during 
hypoxia (Fig 4.5) represent sprouts like those known to occur following partial denervation and 
conduction block that are capable of innervating vacant endplates (Duchen and Strich 1968; Duchen 
1970; Lichtman et al. 1987; de Paiva et al. 1999; Tam and Gordon 2003; Rogozhin et al. 2008), and 
reported to grow at 1.4m per hr (Huang and Keynes 1983)? Alternatively, do these sprout-like events 
represent deformation/blebbing of presynaptic membrane? The swelling/fragmentation event marked 
by the asterisk in Fig 4.5: does this represent lysis of the -motor nerve membrane and release of 
YFP, where the isolated „fragments‟ related to trapped YFP deposits in and around the NMJ?  
Alternatively, are these „fragments‟ membrane bound? These fragments may not be dissimilar to the 
axosomes described by Bishop et al . (2004) in their repeat/live imagining study, where axosomes 
were released from retreating -motor nerve terminals during developmental synapse elimination and 
were later engulfed by Schwann cells. At the end of the hypoxia experiments, -motor nerve terminals 
appeared with much reduced levels of YFP and composed of YFP puncta. Was this caused by a 
generalised release of YFP due to lysis/disruption of the presynaptic membrane? If so, where does the 
YFP go, especially considering that -motor nerve terminals are surrounded by terminal Schwann 
cells, basal lamina and muscle fibres? Alternatively, was YFP and the general gross morphology of 
the -motor nerve terminals still present but the YFP was no longer able to fluoresce, perhaps due to 
proteolytic breakdown?  To try and address some of these possibilities, I attempted to image the 
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response of -motor nerve terminal to LTX that is known to specifically cause large pore formation in 
presynaptic membranes, rapid swelling, lysis and necrosis of -motor nerve terminals (Clark et al. 
1970; Clark et al. 1972; O'Hanlon et al. 2003; Ushkaryov et al. 2004). Despite numerous attempts, 
experiments with LTX were generally unsuccessful due to the difficulty in keeping -motor nerve 
terminals in the plane of view because of muscle fibre contractures. In the one successful experiment, 
YFP appeared to be lost in an asynchronous manner with some evidence of swelling but there was no 
fragmentation or obvious YFP release events. Due to some similarities between the responses of -
motor nerve terminals to LTX and hypoxia, this suggests that perhaps the results found in the hypoxic 
experiments were overall, necrotic. Nevertheless, the results observed during the LTX experiment 
need to treated with extreme caution due to the lack of repeats, lack of superperfusion and the 
likelihood that there was also a significant contribution from phototoxicity, especially as they were 
imaged every 5min.  Overall these results suggest that -motor nerve terminals may respond in a 
highly dynamic manner to pathological stimuli but what exactly the observed events mean, as well as 
the cellular/molecular mechanism underlying them, are still unclear.   
 
4.4.4 Summary 
The probable contribution of phototoxicity and the general difficulty in interpreting results in the 
live/repeat imaging experiments on top of a basal level of pathology in the YFP transgenic animals 
used in this pilot study was the reason why this line of investigation was abandoned. With improved 
technology (e.g., computer controlled shutters systems and more sensitive light collection) it may be 
possible that future studies can be carried out to provide important information on the dynamic and 
spatiotemporal responses of -motor nerve terminals by repeated/live imaging. There will however 
remain the constant problem of fully distinguishing true physiological or patho-physiological 
responses from that induced, even in part, by phototoxicity. It therefore seems prudent to suggest, 
especially based on the preliminary results presented here, that any novel findings from YFP 
transgenic mice and live/repeat imaging studies should be treated with some degree of caution and 
wherever possible, backed-up with studies in wild-type animals. This study also highlights potential 
problems with using YFP/XFP transgenic mice to replace traditional immunohistochemical methods 
in fixed tissues to observe neuron morphology as YFP does not appear to be totally innocuous and 
expression levels may vary considerably between mice and between colonies.  The result presented 
here suggested that careful colony management of these mice maybe needed to prevent overtly high 
expression levels or that other transgenic lines need to be developed where XFP expression in 
known/controlled, with known gene insertion sites, to help prevent future potential for unknown and 















Neuroglobin (NGB) is a recently identified member of the mammalian globin family, which, like its 
distant relative‟s haemoglobin, myoglobin and cytoglobin, can bind, store, and release oxygen 
(Burmester et al. 2000; Dewilde et al. 2001). NGB is highly expressed in mammalian neurons 
(Burmester et al. 2000; Mammen et al. 2002; Wystub et al. 2003; Laufs et al. 2004) and has O2 
binding/release kinetics that suggests that it will only release O2 when demand is high (Dewilde et al. 
2001). This indicates that NGB may play a specific role in maintaining neuronal O2 homeostasis by 
acting as a buffer against transient hypoxic/ischaemic insults. NGB over-expression can confer 
protection to cultured cells and neurons in vivo against hypoxic/ischaemic insults and oxidative stress 
(Sun et al. 2001; Sun et al. 2003; Fordel et al. 2006; Fordel et al. 2007a; Fordel et al. 2007b; Li et al. 
2007; Jin et al. 2008; Li et al. 2008), and during prolonged hypoxic insults, NGB mRNA/protein has 
been shown to be significantly up-regulated and to remain elevated for over 50hr after an hypoxic 
insult (Fordel et al. 2007a). This would suggest that changes in NGB expression levels may also be an 
important long term adaptive response to reduced oxygen levels and there is some, although 
conflicting, correlation between NGB expression levels in vivo with neuronal populations known to be 
vulnerable to oxidative stress and other neurodegenerative stimuli (Burmester et al. 2000; Moens and 
Dewilde 2000; Wystub et al. 2003; Sun et al. 2005). NGB expression levels have recently been 
demonstrated to compartmentalise into cell bodies and dendrites, with only very low expression in 
axons (Hundahl et al. 2008). Unfortunately, axonal nerve terminals were not studied but this indicates 
that NGB is localised to regions of neurons that are known to have the highest metabolic demands 
(Wong-Riley 1989; Attwell and Laughlin 2001; Hollenbeck and Saxton 2005) to suggest that it may 
also be significantly expressed at nerve terminals.  
-motor nerve terminals of the neuromuscular junction (NMJ) are likely to have equally high-energy 
demands as nerve terminals in the CNS but unlike the CNS, may be regularly subjected to 
hypoxic/ischaemic insults.  Decreases in blood supply to peripheral limbs that occur as part of the 
body‟s thermoregulatory processes to maintain core temperatures, delays in capillary bed expansion 
during rapid rest-to-work transitions, intermittent blood supply at rest and lateral forces produced 
during strong muscle contractions may all cause temporary hypoxia/ischaemia (Shibata et al. 2005; 
Kernell 2006; Clanton 2007). Despite being regularly subjected to these types of insults, almost 
nothing is known about the metabolic and oxidative buffering abilities of -motor nerve terminals. As 
NGB is known to be expressed in numerous locations in the spinal cord including the cell bodies of -
motor neurons (Stefan Reuss of Johannes Gutenberg University, personal communication: Mammen 
et al. 2002; Reuss et al. 2002; Wystub et al. 2003; Fordel et al. 2004; Hundahl et al. 2008), I report 
the preliminary findings from a study examining the presence of NGB at the mouse NMJ.   
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5.2 Methods 
5.2.1 Animals and skeletal muscle dissection 
Triangularis sterni (TS) muscles from 8-12wk female C57Bl/6 mice were dissected in silicone-lined 
petri dish and maintained in HEPES buffered Krebs‟ solution as previously described in Chapter 3 
(section 3.2.1).  
5.2.2 Immunohistochemistry 
Following dissection, tissues were quickly fixed by immersion in freshly made PLP (4% 
formaldehyde (Electron Microscopy Sciences, PA 19440, USA), 1.8% lysine, 0.2% sodium-m-
periodate; McLean and Nakane 1974; Reuss et al. 2002; Schmidt et al. 2003; Wystub et al. 2003) for 
30min at room temperature. Alternatively, tissues was immersion fixed in absolute MeOH at -20 C 
for 15min. Fixed tissues were rinsed (3x10min) in 1% TritonX-100 in PBS, underwent final dissection 
and were incubated in blocking solution (0.2% IgG free & protease free bovine serum albumin 
(Jackson ImmunoResearch, via Stratech, UK); 0.3% TritonX-100, 0.1% sodium azide in PBS, pH 7.2) 
for a 1hr(min). On occasion blocking solution was supplemented with 0.3% donkey serum (DAKO) to 
help reduce non-specific binding of antibodies, particularly to the muscle connective tissue. TS 
muscles were incubated in polyclonal primary rabbit anti-neuroglobin (NGB: 1:100) or rabbit anti-
s100 (1:250: Dako) antibodies in blocking solution overnight at 4C. The polyclonal anti-NGB 
antibody was a generous gift from Stefan Reuss (Johannes Gutenberg University, Germany) and was 
raised against a conserved 55-70 amino acid sequence of the human and mouse NGB recombinant 
protein (H2N-CLSSPEFLDHIRKVML-CONH2). The specificity of the anti-NGB antibody has been 
previously confirmed (Reuss et al. 2002; Schmidt et al. 2003; Wystub et al. 2003). Following a 
rinse in blocking solution for 3x10min, preparations were incubated in Cyanine2 (Cy2)-conjugated 
donkey anti-rabbit IgG (1:500 in blocking solution: Jackson ImmunoResearch, via Stratech, UK) for 
1h at room temperature. Post-synaptic acetylcholine receptors were then labelled by incubation in 
TRITC-conjugated BTX for 30mins (5µg/ml in PBS: Invitrogen). After a minimum of 4x10min 
washes in PBS, muscles were mounted onto slides using 4% n-propylgallate in glycerol and stored in 




5.2.3 Image Capture 
 All preparations were examined on an upright Zeiss microscope equipped with epifluorescence FITC/ 
TRITC filter sets and fluorescent Leitz water-immersion objectives (x25 NA 0.6, x50 NA 0.8: see 






Immunoreactivity of NGB at the neuromuscular junctions (NMJs) of TS muscles fixed in PLP and 
MeOH is shown in Fig 5.1(A-C).  Despite selecting a very thin, planar muscle to enhance antibody 
penetration, changing the type of fixative and trying to reduce non-specific binding of antibodies with 
the addition of donkey serum (see methods), NGB immunoreactivity was, in general poor and of very 
low intensity. In regions of muscle where overlying connective tissue had been successfully removed, 
non-specific binding of antibodies and autofluorescence was low, NGB immunoreactivity could 
however be observed to localise at NMJs. In PLP fixed tissue (N=4, n=4), NGB immunoreactivity can 
be seen to almost directly match the characteristic „pretzel‟ morphology of the post-synaptic endplate 
(visualised with BTX). Careful comparison of BTX with NGB staining shows very small but discrete 
interlinking regions of NGB immunoreactivity that are not opposed by BTX (Fig 5.1A: arrowhead). 
This is a typical staining characteristic of an antigen in a presynaptic location, corresponding to 
interlinking synaptic boutons (Baxter et al. 2005). Further evidence of a presynaptic location is 
evidenced by what appears to be pre-terminal staining of axons and/or Schwann cells (Fig 5.1A 
(arrow). It is unclear however, if this presynaptic staining is due to the presence of NGB in motor 
nerve axons, and/or terminals, and/or Schwann cells. Fig 5.1D shows the typical morphology of 
Schwann cells (visualised by S100 immunoreactivity, a Schwann cell specific protein) at the NMJ of 
mouse TS muscle. Schwann cells are distinguishable from motor nerve axons and terminals (see main 
thesis for details of nerve terminal morphology and staining characteristics) by their cell bodies and by 
regular breaks in staining at the nodes of Ranvier. Similar staining characteristics can also be found at 
NMJs stained for NGB, with cell body-like structures (Fig 5.1B) and nodal-like breaks (Fig 5.1A). 
These nodal-like breaks would suggest that NGB is perhaps not located in motor nerve axons. Diffuse 
staining of NGB also appears around the endplate zone, suggestive of a postsynaptic location but not 
muscle fibres as a whole. Muscle fibres in general showed no fluorescence signal above what could be 
attributed to autofluorescence. In TS muscle fixed with MeOH (N=1, n=1: Fig5.1C), NGB 
immunoreactivity was much more confined and almost the complete reverse of the staining found in 
PLP fixed tissue with NGB immunoreactivity appearing to edge the NMJ boundary as defined by 
BTX staining. Again, it is unclear what location at the NMJ this staining may represent as without 
careful co-localisation studies with other known antigens, this could conceivably be presynaptic, 
postsynaptic or even perhaps staining of the basal lamina adjacent to the synaptic cleft. Why different 
fixatives should result in such vastly different NGB staining patterns is also unclear. Overall, these 
preliminary results suggest that NGB may be located at the NMJ and is most suggestive of being 
located in Schwann cells but, NGB could also be potentially located in motor nerve terminals and/or 
postsynaptic endplates/muscle fibres. Due to poor immunoreactivity, however these results are by no 





Fig 5.1 NGB immunoreactivity at the mouse NMJ. Double labelled mouse NMJs from 
TS muscles showing NGB (A-C) and S100 immunoreactivity (D: a Schwann cell specific 
protein) visualised with Cy2 secondary antibodies (GREEN). Postsynaptic endplates 
were labelled with TRITC conjugated BTX (RED) with tissues fixed in PLP shown in (A, 
B, & D) and tissues fixed in MeOH in (C). NGB can be observed to localise at the NMJ, 
with characteristic pretzel-like morphology that opposes BTX staining (most evident in 
B). NGB immunoreactivity can be seen to be interlinking with small discreet regions of 
NGB immunoreactivity not opposed by BTX that is suggestive of a presynaptic location 
(arrowhead in A). Presynaptic location is also indicated by the axonal-like projection in 
the arborisation of the NMJ (arrow in A). Low levels of diffuse staining can be seen to 
surround the endplate zone in (B). Compared with PLP fixed TS muscle (A&B), NGB 
immunoreactivity in TS muscle fixed in MeOH (C) is almost completely reversed. NGB is 
localised to the very edge of the NMJ, as defined by BTX staining.  It is unclear what 
location at the NMJ this staining may represent, as this could conceivably be 
presynaptic, postsynaptic or even perhaps staining of the basal lamina adjacent to the 
synaptic cleft. (D) shows the typical morphology of Schwann cells from the mouse TS 
muscle. Several Schwann cells can be seen to overlie and closely correspond to the 
characteristic ‘pretzel’ morphology of the postsynaptic endplate. This is very similar to 
presynaptic staining of -motor nerve terminals but Schwann cells can be distinguished 
from -motor nerve axons and terminals by the presence of their cell bodies (arrows) 
and by the regular breaks in staining at the nodes of Ranvier (arrowhead). When the 
S100 Schwann cell staining is compared to that of NGB, there are some similar 
features.  Numerous small swellings on the NMJ arborisation and incoming nerve look 
like the cell bodies of Schwann cell (arrows in B) and breaks in NGB immunoreactivity 
appear like nodes of Ranvier (arrow in A). Curiously in (D), approximately half of one 
endplate, with no apparent pathology, has no opposing S100 immunoreactivity 
(asterisk). This suggests that either the terminal Schwann cell is absent or is not S100 





Almost nothing is known about how -motor nerve terminals buffer against transient deficits in O2 
supply despite the fact that they may become hypoxic/ischaemic as a result of intermittent blood 
supply at rest, rapid rest-to-work transitions and impaired blood flow during muscle contraction 
(Shibata et al. 2005; Kernell 2006; Clanton 2007). Neuroglobin (NGB) is novel protein that has O2 
binding/release kinetics that is suggestive of a role in buffering against hypoxic insults (Dewilde et al. 
2001). NGB is known to be expressed in the cytoplasm of rodent CNS neurons where is was first 
identified (Burmester et al. 2000) and NGB mRNA and/or protein has also been reported to be 
expressed in the peripheral autonomic nervous system, liver, heart and in the cell bodies of -motor 
neurons in the spinal cord (Stefan Reuss, personal communication; Mammen et al. 2002; Reuss et al. 
2002; Wystub et al. 2003; Fordel et al. 2004; Hundahl et al. 2008). The data presented here is the first 
study that examines the expression of NGB at the mouse NMJ and while this study was inconclusive 
in regards to the expression of NGB in -motor nerve terminals, the results presented here provide 
some preliminary evidence of NGB expression at the NMJ.  
5.4.1 Is NGB expressed at the NMJ? 
In all immunohistochemical studies, and especially those where there is no prior knowledge of antigen 
location, it is essential that the specificity of the antibodies used are correctly determined to ensure 
that observed labelling patterns represent the true localisation of the antigen in question rather than 
being false-positive (or even false–negative) as a result of poor affinity, specificity or cross-reactivity 
of antibodies. In the preliminary study described here, control studies were not carried out however 
previous studies within the same laboratory, with the same muscle and same secondary antibodies 
have shown no immunoreactivity when primary antibodies are omitted (Vega-Riveroll et al. 2005) 
demonstrating that the secondary antibody does not bind unspecifically. There is also evidence to 
indicate the anti-NGB antibody is specific: The antibody was raised against a unique NGB amino acid 
sequence and detects NGB located in various regions in the mouse brain (e.g., cerebral cortex, 
cerebellum and purkinje cells) that was comparable to the localisation of NGB using mRNA in situ-
hybridisation (Reuss et al. 2002; Wystab et al. 2003) and similar to other staining patterns using anti-
NGB antibodies raised against different epitopes (e.g., Hundahl et al. 2008). Preabsorption of the 
primary anti-NGB antibody with its recombinant protein also blocked NGB staining in native mouse 
tissue samples. This, alongside western blotting where a single band was observed at the expected 
molecular weight (~17KDa) and ELISA
11
 analysis (Wystab et al. 2003; Schmidt et al. 2003; Laufs et 
al. 2004) collectively provide some evidence for the specificity of the primary antibody used here but 
it is by no means conclusive. This is a general difficulty in all studies that rely on specific antibody 
binding, particularly in native tissue samples, in confirming specificity (e.g., Lorincz and Nusser 
                                                          
11 ELISA: enzyme-linked immunosorbant assay 
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2008: Saper 2008). Antibodies can only recognise a limited number of amino acids on any given 
protein antigen and binding requires not only the correct sequence (which may or may not be linear) 
but also the correct 3D spatial configuration (Hayat 2002).  Finding unique sequences is therefore 
difficult and despite the fact that an antibody may be raised against what appears to be a unique amino 
acid sequence, it may also react with other proteins that also have unexpected epitopes due to their 
spatial configuration. This cross reactivity is most likely to occur in related family proteins/isoforms 
(Lorincz and Nusser 2008) but can occur in any protein including those proteins yet to be identified. 
This fundamental problem with immunohistochemistry has led to numerous debates and calls for best 
practice to help ensure specificity, although this may never be guaranteed. Several authors have 
suggested that to confirm specificity of antibody labelling, immunohistochemical studies should be 
carried out in genetic “knock-out” animals but this is not without its own caveats that includes the 
viability of knock-out animals and changes to other proteins that result in false-positive 
immunoreactivity as a result of unexpected effects of gene knock-outs (e.g., Anderson and Nedergaard 
2006; Lorincz and Nusser 2008: Saper 2008). Alternatively, a range of different antibodies can be 
used that are raised against different epitopes of the same antigen, and where the same staining 
patterns are found with different antibodies it can be assumed that antibody binding is indeed largely 
specific (as it is unlikely that different antibodies will all bind to produce the same staining pattern if 
they are not specific: Lorincz and Nusser 2008; Saper 2008). This method again however is also 
subject to its own caveats, as the cause(s) of different staining patterns can be difficult to interpret and 
may not necessarily mean antibodies bind unspecifically (see below). Many of the control procedures 
recommended for determining antibody specificity have already been carried out by others on the anti-
NGB antibody used in this study (see above) however, it is important that additional controls are also 
carried out and specifically use neuromuscular tissues in future studies. This should undoubtedly 
include omission of the primary anti-NGB antibodies to conform that the secondary antibody is not 
binding unspecifically and preabsorption of the primary antibody to its recombinant protein antigen 
(although the value of this as a control procedure is highly questionable if the antibody is monoclonal 
or has been affinity purified (Saper 2008) as was done with the antibody used here). Further analysis 
should also confirm that the anti-NGB does not cross-react with its related family members 
(haemoglobin, myoglobin and cytoglobin) because as far as I am aware, this has yet to be definitively 
and formally addressed (again, the true value of this as a control is questionable as such analysis will 
most probably rely on western blotting techniques (or similar) which uses unfixed and 
solubilised/linear (and probably recombinant) protein extracts and therefore there is no guarantee of 
comparable results on the cross-reactivity of an antibody when examining results from native, fixed 
tissues with that of western blot (or similar) analysis (Lorincz and Nusser 2008; Saper 2008)).  In 
addition to this, other antibodies raised against different epitopes of NGB should be used and staining 
patterns compared in positive control tissues and at the NMJ. In the future, it may also be possible to 
test anti-NGB antibodies in knock-out tissues should these animals be viable.  With the addition of 
these controls, it will help to determine if the NGB staining observed in the current study is specific at 
the mouse NMJ but until these studies are completed and despite the fact this antibody has been 
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previously published as specific, the observation of NGB immunoreactivity at the mouse NMJ 
remains a preliminary result.  
 
5.4.2 Where at the NMJ could NGB be expressed?  
If it is assumed that the NGB antibody binding is largely specific as shown in previous publications 
(Wystab et al. 2003; Schmidt et al. 2003; Laufs et al. 2004), the observed immunofluorescent staining 
pattern of NGB at the NMJ was suggestive of a presynaptic location, especially in Schwann cells. 
There was also some suggestion that NGB may also be located postsynaptically at the NMJ but not 
generally in the muscle fibre as a whole, which is consistent with real time PCR and in-situ 
hybridisation studies in rodent skeletal muscle (Reuss et al. 2002; Fordel et al. 2004). These 
preliminary findings however cannot rule the possibility that NGB may also be expressed in -motor 
nerve axons and terminals. In the mammalian brain, NGB only represents 0.01% (M range) of the 
total protein content (Burmester et al. 2000; Dewilde et al. 2001; although others have suggested a 
much higher concentration (Reuss et al. 2002)) and NGB has also been shown to be 
compartmentalised into cell bodies and dendrites, with very low expression in axons (Hundahl et al. 
2008)). It is possible that a generally low level of NGB expression will explain the poor 
immunoreactivity found here and if NGB is also compartmentalised, lower levels of NGB in -motor 
neuron axons may have rendered NGB immunoreactivity undetectable against background and 
possible Schwann cell fluorescence. The strongest evidence for the location of NGB at the NMJ 
however was for presynaptic Schwann cells due to the numerous cell body-like structures and breaks 
in immunoreactivity indicative of nodes of Ranvier.  This preliminary result is surprising as NGB is 
thought to be neuron specific due to  neuron-restrictive silencer element-like motifs in the human and 
mouse NGB gene that may actively repress expression in non-neuronal cells (Laufs et al .2004) and 
no detectable expression has been found in glial cells in the mouse CNS or in glial cell lines (Wystub 
et al. 2003; Laufs et al .2004)). In their mRNA in-situ hybridisation analysis, Reuss et al. (2002) 
however did identify some structures that were possibly a sub-population of specialised glial cells that 
may contain NGB is specific regions of the CNS. It may therefore be possible that NGB is expressed 
in a highly select group of glial cells and therefore raises the possibility that it may also be expressed 
in myelinating and terminal Schwann cells. From the preliminary results presented here, it may seem 
possible that NGB may be located in several compartments of the NMJ and therefore future studies 
should consider immunoprecipitation of diaminobenzidine (DAB) or similar techniques. This method 
involves significant amplification of immunoreactivity due to the increasing antibody binding ratio of 
biotinylated antibodies and of the peroxidise reaction which would help overcome the poor 
fluorescent immunoreactivity noted here (Hayat 2002).  DAB is also electron dense and with further 
tissue processing, would allow the localisation of NGB to be resolved to the sub-cellular level with 
electron microscopy. This technique was attempted numerous times in the current study however, a 
range of technical difficulties (no immunoreactivity could be achieved probably due to sodium azide 
contamination) meant that this line of investigation was unsuccessful and was abandoned.   
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The reasons underlying the changes in NGB immunoreactivity achieved with different fixatives is 
unknown. PLP fixative, that has been used in several of the studies examining NGB expression in 
rodents (Reuss et al. 2002; Schmidt et al. 2003; Wystub et al. 2003), contains formaldehyde with the 
addition of lysine and periodate, and can stabilise tissue carbohydrate as well as amino acids by 
chemical cross-linking (McLean and Nakane 1974; Hayat 2002). MeOH is a relatively mild 
precipitant fixative that causes coagulation of proteins in the absence of chemical cross-linking (Hayat 
2002). As already mentioned epitope recognition by an antibody is highly reliant on spatial 
configuration that can be easily altered by the process of fixation to bring about a change in antigen 
structure or physically prevent the antibody gaining access to the epitope that can be later reflected in 
observed staining patterns (e.g., Hayat 2002; Lorincz and Nusser 2008). Antibody-epitope recognition 
is also affected by a whole range of factors that not only includes type of fixative, but also duration, 
temperature, pH, detergents, blocking steps, ionic concentration and additional antigen/epitope 
retrieval steps of the entire immunohistochemical experimental process (Hayat 2002;Lorincz and 
Nusser 2008). Overall, this means that epitopes may become „masked‟ or „unmasked‟ by different 
immunohistological processing techniques, particularly if they are located in different cellular 
compartments and/or spatially linked to different proteins/structures (that may in turn respond 
differently to the experimental procedure to contribute to masking/unmasking of epitopes) to 
potentially produce very different staining patterns (reviewed, with numerous examples, by Hayat 
2002; Lorincz and Nusser 2008).  When different staining patterns are achieved is can be difficult to 
determine the false-positive (or –negative) results from the true localisation, or indeed if both staining 
patterns are proved correct, the reason underlying the differences but if carefully analysed, such 
results may provide important clues about different sub-cellular locations of an antigen (Lorincz and 
Nusser 2008). For example the differences in observed staining patterns in MeOH and PLP fixed 
tissues could have been caused by alternate epitope masking and unmasking due to the different 
fixatives having different effects on the antigen. Different NGB staining patterns could also be 
possibly attributed to NGB being located in different cellular compartments that may have had 
different pH or Ca
2+ 
concentrations for example and/or because NGB is located with different 
complexes (e.g., different accessory proteins). All of these possible factors in turn could have 
responded differently to the change in fixative (and to the immunohistochemical protocol as a whole) 
to cause varying degrees of epitope masking/unmasking and ultimately, led to different staining 
patterns. A further level of complexity is added when it is considered that the anti-NGB antibody used 
here is polyclonal.  Alternatively, one or both staining patterns observed with different fixatives could 
have been false positive due to non-specific binding or cross reactivity of the antibodies.  This 
highlights the need for further studies regarding the expression of NGB at the NMJ and that this needs 
to be done with careful consideration and methodical investigation of the various factors that can 
influence antibody-epitope binding (e.g., fixation, blocking steps and antigen retrieval techniques). 
This process would be helped by using antibodies raised against different epitopes of NGB, and with 
carful comparison and interpretation of staining patterns under various immunohistochemical 
 186 
experimental processes, to help determine if NGB is located at the NMJ. The potential caveats of 
immunohistochemical protocols also highlight the need to use a broad range of other investigative 
techniques (e.g., pharmacology, genetic and functional) to look at NGB expression at the NMJ. Only a 
combination of results from a range of techniques, as each has its own caveats, will be able to prove or 
disprove if NGB is located at the NMJ. The preliminary results presented do however provide a 
starting point for basing further study.     
 
5.4.3 If NGB is expressed at the NMJ, what is its role? 
As a member of the globin family, NGB has the capacity to bind, store and release O2 helping to 
maintain supplies of oxygen for oxidative phosphorylation of ATP. NGB has also been shown to be a 
reactive oxygen species scavenger (Fordel et al. 2006; Fordel et al. 2007b; Jin et al. 2008; Li et al. 
2008), to have some additional sodium dismutase activity as well as being able to act as an NADH 
oxidase, facilitating continuing ATP production in oxygen limiting conditions (Dewilde et al. 2001; 
Trandafir et al. 2007; Giuffre et al. 2008). There is still some controversy over the relative 
physiological importance and hierarchy of NGBs metabolic properties but NGB has been shown to 
convey protection during oxidative injury both in vivo and in vitro (Sun et al. 2001; Sun et al. 2003; 
Fordel et al. 2006; Fordel et al. 2007a; Fordel et al. 2007b; Li et al. 2007; Jin et al. 2008; Li et al. 
2008). NGB has also been shown to attenuate -amyloid pathology in culture, a major pathological 
hallmark of Alzheimer‟s disease (Li et al. 2007). The preliminary evidence that indicates the presence 
of NGB at the NMJ suggests a potentially important role in oxygen and metabolic homeostasis, and a 
defence mechanism against transient decreases in O2 levels. In particular, NGB may have a key role in 
O2/metabolic buffering in Schwann cells, based on the preliminary fluorescent immunohistochemical 
staining characteristics described here. Schwann cells play a vital role in the development, 
maintenance, plasticity and pathological responses of -motor nerve terminals by providing for 
example trophic support and cues (Balice-Gordon 1996; Son et al. 1996; Yin et al. 2004; De Winter et 
al. 2006). Little is known about their metabolic properties, their vulnerability to hypoxia/ischaemia-
reperfusion injuries or their potential involvement in the pathogenesis of similar injuries in -motor 
neurons (a situation that should be addressed in future studies) but NGB expression in Schwann cells 
perhaps suggests that they may have an improved ability to buffer against these types on insults. It is 
interesting to note that in invertebrates, neuronal myoglobin is highly expressed in glial cells with 
expression levels being particularly high in those of the mollusc living in hypoxic environments 
(Dewilde et al 1996; Reuss et al. 2002). This suggests a potentially important role for NGB in glial 
cells in helping to maintain neuronal O2/metabolic homeostasis.  Further investigations of the potential 
role of NGB at the NMJ are needed and perhaps further insights may be gained from using the 
hypoxia-reperfusion model system developed here (described in Chapters 2 and 3) and utilising tissue 
from the recently generated NGB over-expressing mouse (Khan et al. 2007). Our understanding of the 
role of NGB at the NMJ however can only be realistically achieved once the expression of NGB is 
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confirmed at the NMJ and the exact cellular location is determined, both of which are is still unclear 
from the results of present study. 
5.4.4 Summary 
In summary, NGB is a recently identified member of the oxygen-carrying family of globins and 
preliminary results suggest that it may be expressed at the mouse NMJ.  The preliminary fluorescent 
immunohistochemical staining provided evidence to suggest that NGB may be located in Schwann 
cells but there was also some evidence that it could also be expressed postsynaptically and possible 
expression is presynaptic nerve terminals cannot be ruled out. The preliminary results presented here 
suggest there may be a possible role for NGB in the O2 and metabolic buffering of NMJs against 
transient hypoxic/ischaemic insults. I do however highlight numerous difficulties in determining 
antibody specificity and interpreting immunohistochemical data in studies such as the pilot study 
described here. To help over come some of these difficulties I further suggest that to confirm or 
disprove the presented preliminary findings of NGB expression at the mouse NMJ, future work should 
use a range of antibodies raised against different NGB epitopes, where each antibody is proven to bind 
specifically and subjected to a range of different immunohistochemical staining protocols. Following 
on from studies confirming antibody specificity, the exact location of NGB (Schwann cell, 
postsynaptic endplate, motor nerve axon and/or terminal) can be further investigated, however NGB 
expression at the NMJ can only be realistically confirmed with a range of techniques including 
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6. General Discussion  
 
There is increasing evidence to support the notion that neurons can be considered compartmentalised 
with cell bodies, axons, and nerve terminals having many discreet structural, functional, and metabolic 
characteristics. Neurons also appear to be compartmentalised in terms of the vulnerability to 
pathological stimuli with nerve terminals in particular often being the principal site of functional and 
structural changes in many traumatic, toxic and neurodegenerative disease conditions (e.g. Raff et al. 
2002; Wishart et al. 2006; Conforti et al  2007a: see Table 1). The underlying reasons for this are 
unknown, but changes to and loss of nerve terminals undoubtedly cause aberrant functional changes 
due to loss of synaptic connectivity and trigger many of the punitive symptoms that characterise 
neuropathological conditions. One possible explanation for the vulnerability of nerve terminals is their 
high bioenergetic demands (Wong-Riley 1989; Attwell and Laughlin 2001; Miller and Sheetz 2004; 
Hollenbeck and Saxton 2005). The mitochondria contained within nerve terminals however are more 
susceptible to metabolic inhibition, have accumulated oxidative damage, reduced Ca
2+ 
buffering 
capacity and are more susceptible to rupture, that particularly affect the longest of neurons (e.g., -
motor neurons of the lower limbs: John 1996; Davey et al. 1998; Brown et al. 2006; Naga et al. 
2007).  This would clearly imply that nerve terminals would be highly vulnerable to pathological 
stimuli aimed directly at mitochondria and inhibition of aerobic respiration, such as 
hypoxia/ischaemia. In the CNS, the role of nerve terminals in mediating the devastating and often 
fatal consequences of ischaemic injuries (where the hypoxic element is the key pathological stimulus) 
are well known, but our understanding of similar injuries in the PNS are at best, poor. This is of 
particular clinical importance as up to 1 in 11,000 of the UK population suffer paralysis and long term 
neurological complications following ischaemia-reperfusion injuries caused by the application of 
surgical and non-surgical tourniquets (e.g., Bernard Roth 1931; Eckhoff 1931; McElvenny 1945; 
Rudge 1974; Saunders et al. 1979; Rorabeck 1980; McGraw and McEwen 1987; Kalla et al. 2003; 
Kam 2007; Murphy and O'Connor 2007).  To help develop preventative or therapeutic strategies to 
address this problem it is vital to determine the underlying causes and the principal pathological target 
of such stimuli. There have been several suggestions that the nerve terminals of -motor neurons 
maybe the principal site of injury following hypoxia/ischaemia but there has not yet been a conclusive 
study that has addressed this possibility.   
 
6.1 What are the key findings and long-term implications of the present study? 
By using a novel experimental model system, I have demonstrated the rapid and selective 
vulnerability of ex vivo mouse -motor nerve terminals to hypoxia-reperfusion injury. Following 2hr 
hypoxia-2hr reperfusion (2H-2R), I show significant loss of presynaptic neurofilament and synaptic 
vesicle protein (NF/SV2) immunoreactivity, disruption of the microtubule cytoskeleton and functional 
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loss of -motor nerve terminals and pre-terminal axons. That was collectively indicative of an 
ongoing process of -motor nerve terminal disassembly, while postsynaptic endplates and muscle 
fibres appeared unaffected by 2H-2R. The severity of these pathological changes was age and muscle 
type dependent: in 8-12wk old mice, ~83% of postsynaptic endplates appeared vacant (with no 
opposing presynaptic NF/SV2 immunoreactivity) in the predominantly fast-twitch lumbricals but in 
the predominantly slow-twitch TA and TS muscles, only 58% and 28% of endplates were vacant 
respectively. In juvenile mice (5-6wks) the response of TA and TS muscles was markedly increased 
with >97% of endplates appearing vacant while lumbrical muscles appeared largely unaffected by age. 
I also show that neuroprotective Wld
s
 mutation does not mitigate the pathology caused by 2H-2R. 
Overall, I have demonstrated that significant pathology at -motor nerve terminals occurs as a result 
of changing O2 levels where the hypoxic phase was carried out at levels below those reported for in 
vivo normoxia (0.5%- 4%: Gorczynski and Duling 1978; Klitzman et al. 1983; Honig and Gayeski 
1993; Shibata et al. 2001; Eu et al. 2003; Matsumoto et al. 2005) and similar to levels reported to 
occur during tourniquet induced ischaemia (0.25%: Gustafsson et al. 1999; Matsumoto et al. 2005). 
-motor nerve terminal pathology also occurred as a result of a clinically relevant stimulus of 2hr 
hypoxia, the same time frame that is generally agreed to be the upper limit for tourniquet application 
(McElvenny 1945; Kessler 1966; Rorabeck 1980; Pedowitz et al, 1992; Kalla et al, 2003; Younger et 
al, 2005; Malanjum and Fischer 2006; AORN 2007; Kam 2007). This study therefore contrasts with 
previous studies of ex vivo -motor nerve terminal responses to hypoxia that have only described 
reversible functional changes at highly variable (and possibly non-hypoxic) or undefined O2 levels 
(Krnjevic and Miledi 1959; Hubbard and Loyning 1966; Anwyl and Ling 1983; Nishimura 1986; 
Bazzy 1994; Zhu et al. 2006). It also contrasts with previous in vivo studies of ischaemia-reperfusion 
injuries where -motor nerve terminal pathology could not be conclusively distinguished from 
tourniquet induced ischaemia-reperfusion injury, tourniquet induced mechanical trauma or that of 
postsynaptic/muscle fibre damage (Makitie and Teravainen 1977a; Diwan and Milburn 1986; Tombol 
et al. 2002; Eastlack et al. 2004; David et al. 2007). Furthermore, these in vivo studies could not 
distinguish between the relative importance of hypoxia, hypoglycaemia, acidosis, gross ionic changes, 
gross inflammation and toxic metabolite build up that are all known to occur in response to ischaemia-
reperfusion injuries (see Chapter 1, sections 1. 6.1 and 1.7.2). Some of the neurological complications 
following the use of tourniquets may occur because they are incorrectly applied and/or over-pressured, 
triggering mechanical trauma to underlying nerves (Eckhoff 1931; McElvenny 1945; Fowler et al. 
1972; Ochoa et al. 1972; Rydevik and Nordborg 1980; Ohara et al. 1996; Kam et al. 2001; Kalla et al. 
2003).  From the results presented here however, functional and structural pathology at -motor nerve 
terminals distal to tourniquets and as a result of ischaemia-reperfusion injury may also significantly 
contribute to, or perhaps in some cases cause, the neurological complications following the 
application of tourniquets.  
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In further support of the finding that -motor nerve terminal pathology distal to tourniquets may be 
contributing to injury, is seems likely that the extent of pathology observed in the current study would 
underestimate the full extent of pathology over a similar same time frame in vivo. It has been 
previously noted that in general, ex vivo models of CNS hypoxia/ischaemia-reperfusion injuries are 
typically much slower to respond compared with in vivo model systems (Lipton 1999; Kovalenko et 
al. 2006). In the current study, experiments were carried out in the presence of glucose at room 
temperature but glucose is known to delay the onset of pathology by supporting anaerobic respiration 
(Allen et al. 2005) and hypothermia has also been shown to be a very effective neuroprotectant in 
ischaemia-reperfusion injuries in peripheral nerves (Kihara et al. 1996; Mitsui et al. 1999b; Mitsui et 
al. 1999c; Kawamura et al. 2005; Kawamura et al. 2006). It is also well accepted that the full extent 
of pathology following in vivo ischaemic injuries takes days to weeks to develop in the both the CNS 
(e.g., Nakano et al. 1990; Lipton 1999; Kovalenko et al. 2006).and in the periphery (Fowler et al. 
1972; Makitie and Teravainen 1977b; a; Zollman et al. 1991; Pedowitz et al. 1992; Nukada and 
McMorran 1994; Carden and Granger 2000; Tombol et al. 2002; Iida et al. 2003; Wang et al. 2008). 
Could the evidence of an on-going process of -motor nerve terminal disassembly described here 
have developed into gross structural loss of -motor nerve terminals: given a longer reperfusion 
period; at more physiologically relevant temperatures; or as a result of an ischaemic rather than an 
hypoxic stimulus? Could this be followed by retrograde degeneration and even loss of -motor 
neurons? Studies that have examined the effects of the direct disruption of synaptic vesicle release 
(Pastor et al. 1997; Berliocchi et al. 2005) and microtubules (Hsu and Lentz 1972; Wang et al. 2000; 
Wang et al. 2001), not unlike that described here (Chapter 2), have shown that these types of stimuli 
can not only cause -motor nerve terminal loss but also dying back neuropathies. Furthermore, a large 
range of other pathological stimuli that cause similar changes in nerve terminals are also known to 
cause gross -motor nerve loss and dying back neuropathies (see Chapter 1, section 1.6 and Table 1). 
The structural events described here are also known to occur during CNS hypoxia/ischaemia-
reperfusion injuries where swelling, vacuolisation, reduced synaptic vesicle density, loss of pre-
synaptic proteins critical for regulating synaptic vesicle turnover have been identified prior to other 
structural changes in axons or cell bodies (e.g., Williams and Grossman 1970; Rothman 1983; von 
Lubitz and Diemer 1983; Nishimura et al. 2000; Ishimaru et al. 2001; Bolay et al. 2002; Jourdain et 
al. 2002; Kovalenko et al. 2006). These selective structural and functional events at nerve terminals 
have been suggested to either signal back to the cell body to cause cell death or trigger retrograde cell 
death (Martone et al. 1999; Nishimura et al. 2000; Ishimaru et al. 2001; Bolay et al. 2002; Jourdain et 
al. 2002). From the results presented here, hypoxia-reperfusion injury certainly does appear to cause 
some retrograde pathology as NF/SV2 staining of pre-terminal axons was often absent but present in 
the larger intramuscular axon bundles to indicate a distal to proximal progression. It is however 
unclear at present if pre-terminal axon pathology was caused by retrograde spreading of -motor 
nerve terminal pathology or if axons were responding to 2H-2R per se. Considering that the average 
orthopaedic surgeon will apply ~200 tourniquets per annum (Middleton and Varian 1974) and that 
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>60% of patients will suffer long-term (>6months) neurological complications following the use of 
tourniquets (Saunders et al. 1979), the fate of -motor nerve terminals, axons and possibly even cell 
bodies in response to hypoxic/ischaemia-reperfusion injuries are important questions to answer in 
future studies as this will influence if, and how long it may take to recover from injuries of this type. 
-motor neurons have considerable regenerative abilities and are able to recover relatively rapidly 
even from complete denervation as long as the cell body, muscle fibres and Schwann cells remain 
viable. Over a period of weeks to months surviving proximal nerve stumps following axotomy are 
„guided‟ by Schwann cells to re-innervate skeletal muscle (Brown et al. 1976; Gordon and Stein 1982; 
Gordon et al. 1993; Son and Thompson 1995; Son et al. 1996; Costanzo et al. 1999; Costanzo et al. 
2000) but this process of de novo innervation can take many months to complete, linked to permanent 
changes in the dendritic tree (Sumner and Watson 1971; Brännström et al. 1992) and in some cases it 
can be very protracted and incomplete (Gordon and Stein 1982; Gordon et al. 1993; Fu and Gordon 
1995; Rafuse and Gordon 1998).  Recovery of skeletal muscle function can also be produced by a 
local mechanism of collateral re-innervation or „sprouting‟ by neighbouring  -motor nerve terminals 
and pre-terminal axons (specifically, at the nodes of Ranvier) that send projections into vacant 
postsynaptic endplates (Tam and Gordon 2003). Sprouting is a common injury response following, for 
example, partial denervation (Gordon et al. 1993; Frey et al. 2000) or application of Botulinum A 
toxin (Duchen and Strich 1968; Duchen 1970; Pastor et al. 1997; de Paiva et al. 1999; Meunier et al. 
2002) and can occur very rapidly with sprouts reported to grow at a rate of 1.4m per hr (Huang and 
Keynes 1983). The resulting increase in motor unit size can compensate for up to an 80% loss of -
motor neurons (Gordon et al. 1993) but significant and permanent collateral innervation may cause 
„stress‟ leading to an inability to maintain these excessively large motor units triggering delayed 
neuronal death (Kernell 2006).  Signs of ultrastructural recovery of -motor nerve terminals following 
tourniquet induced ischaemia-reperfusion injury have been described by Tombol et al. (2002) after 
1wk but recovery was not complete by the end of the 4wk experiment, with between 26% and 37% of 
nerve terminals still showing obvious signs of pathology. Others have described functional 
neuromuscular recovery typically beginning after 2wks but rarely complete, 90 days (Makitie and 
Teravainen 1977b) and 180 days (Fowler et al. 1972) after tourniquet induced ischaemia ,or 42days 
following arterial occlusion (Iida et al. 2003). In these studies it is unknown which mechanisms are 
responsible for the recovery processes (de novo or collateral innervation) but in YFP/mSOD1 mice, -
motor nerve terminals have been shown to project numerous sprouts 10days after tourniquet induced 
ischaemia-reperfusion injury (David et al. 2007) however it is unknown if the same mechanism would 







6.2 Does the vulnerability of -motor nerve terminals to hypoxia-reperfusion 
injury have a wider clinical significance? 
The main focus of this study has been the acute hypoxia/ischaemia-injuries caused by tourniquets but 
perhaps due to the lack of auto-regulated blood supply in the periphery (Smith et al. 1977; Low and 
Tuck 1984), the PNS may also be vulnerable to hypoxic/ischaemic injuries and related pathological 
event caused by other stimuli. 
 
Cardiovascular, pulmonary, haematological and metabolic disorders 
Numerous cardiovascular and pulmonary conditions that cause acute or chronic, systemic or localised 
hypoxia/ischaemia-reperfusion injuries are now increasingly recognised to trigger peripheral 
sensorimotor neuropathies that affect significant numbers of patients and have a range of clinical and 
sub-clinical symptoms (Teunissen et al. 2000). These conditions include; atherosclerotic peripheral 
vascular disease (Chopra and Hurwitz 1969; Nukada et al. 1996; McKenzie et al. 1999), acute 
peripheral arterial occlusion (i.e. embolisms: Thomas 1909; Lachance and Daube 1991; Nukada et al. 
1996), lung cancer (Trojaborg et al. 1969), serious lung infections (Caughey et al. 1958), chronic 
obstructive pulmonary disease (Malik et al. 1990; Nowak et al. 1990), vasculitis (Dyck et al. 1987; 
Fujimura et al. 1991; Burns et al. 2007b), acute respiratory failure (Gorson and Ropper 1993), 
polycythemia vera (a condition that results in insufficient numbers of red blood cells: Yiannikas et al. 
1983), cryoglobulinemia (a condition that results in precipitation of immunoglobulins at low 
temperatures) and related plasma protein disorders (Gemignani et al. 2005; Perez et al. 2008; 
Silberman and Lonial 2008). In many cases, the symptoms of the neuropathic sequelae are more 
punitive than the primary pathological condition, a situation that is seen in patients suffering 
peripheral neuropathies because of diabetis mellitus. Diabetes, a condition that affects the ability of 
insulin to exert control over blood glucose levels, is predicted to affect one in four people by 2025 
(Patlak 2002). In itself, diabetes is not a fatal condition as there are numerous therapeutic strategies to 
help manage blood glucose levels but the neuropathic sequelae of diabetes significantly contribute to 
its punitive consequences and mortality rate (Vinik et al. 2000; Patlak 2002; Dobretsov et al. 2007). 
Between 50% and 90% of diabetic patients suffer from complex and highly variable diabetic 
peripheral neuropathy, making it the most common form of neuropathy in developed countries (Vinik 
1999; Vinik et al. 2000; Dobretsov et al. 2007). The neuropathy has a distal to proximal progression 
(which can later affect the autonomic nervous system, e.g., nerve supply to the heart) and triggers 
positive and negative changes in sensory perception and motor control which often leads to chronic 
pain, insensitivity to trauma, permanent disability and amputation of limbs. Already described as a 
dying back neuropathy principally affecting the most distal extremities, morphological changes to 
neurons including demyelination, axonal atrophy, degeneration and overall loss (Dyck and Giannini 
1996; Vinik 1999; Dobretsov et al. 2007) but prior to these changes, degeneration and withdrawal of 
-motor nerve terminals has been observed (Fahim et al. 2000; Ramji et al. 2007). The underlying 
mechanisms of diabetic neuropathy are still not understood however there is considerable evidence to 
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suggest that metabolic changes and damaged mitochondria within neurons (that in particular, cause 
ROS formation), and hypoxia/ischaemia due to vascular changes play key roles in its development 
(Newrick et al. 1986; Malik et al. 1989; Tesfaye et al. 1993; Tesfaye et al. 1994; Dyck and Giannini 
1996; Vincent et al. 2004; Pop-Busui et al. 2006; Figueroa-Romero et al. 2008; Tannock and King 
2008). Based on the results presented here demonstrating the vulnerability of -motor terminals to 
hypoxia-reperfusion injury, similar pathological stimuli occurring in diabetes, haematological 
disorders, cardiovascular and pulmonary diseases may also be causing -motor nerve terminal 
pathology and be contributing or possibly causing the neuropathic sequelae associated with these 
conditions. It is interesting to note that while many of these neuropathic sequelae have a significant 
sensory component, the preliminary results present here suggested that the nerve terminals of the 
muscle spindles that are responsible for proprioception could be less affected by 2H-2R than -motor 
nerve terminals. This further highlights the need to build on the preliminary results presented here and 
further investigate if the nerve terminals of the muscle spindle are vulnerable/resistant to hypoxia-
reperfusion injury but also their vulnerability/resistance to other hypoxic/ischaemic injuries and to 
determine their role in related pathological conditions.  
 
Ageing 
Hypoxia may also underlie changes to -motor nerve terminals and the progressive loss of -motor 
neurons as part of the normal ageing process. In healthy humans there is progressive decrease in the 
partial pressure of arterial O2 (PaO2) corresponding to -0.245mmHg (~0.03%) per year, where at 10 
years PaO2 is 85mmHg (~11%), at 50 years PaO2 75mmHg (~9.8%) and by 90 years of age PaO2 is 
65mmHg (~8.5%: Crapo et al. 1999).  Increasing age is also associated with reduced nerve blood flow 
and decreases in bioenergetic compounds in peripheral nerves (Low et al. 1986; Kihara et al. 1991) 
while in skeletal muscle there is loss of capillaries (Degens et al. 1993), impairment of contraction-
induced vasodilatation (Carlson et al. 2008) and decreased blood flow (Tuma et al. 1985). Progressive 
age-related weakening of motor abilities typically begins in the lower extremities and at -motor 
nerve terminals, there is an increase in sprouting and synaptic guttering events that eventually leads to 
denervation and loss of -motor neurons (Wernig and Herrera 1986; Larsson and Ansved 1995; 
Verdu et al. 2000; Vandervoort 2002; Kernell 2006).  Again based on the evidence presented in the 
current study, it seems possible that systemic and localised decreases in O2 levels observed in the 




Several neurodegenerative diseases, already indentified as having nerve terminal loss as a principal 
event, also have direct links to pathological changes in aerobic respiration, mitochondria or „oxidative 
stress‟. ALS or Lou Gehrig's disease is the most common adult neurodegenerative disease affecting 
motor neurons with a lifetime risk of one in 2000, and is characterised by progressive loss of motor 
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neurons (Bruijn et al. 2004).  About 20% of familial cases are caused by mutations in SOD1, a vital 
ROS scavenging enzyme that has been shown to trigger impairment of oxidative phosphorylation, 
ATP depletion (Mattiazzi et al. 2002) and a wave of mitochondrial lysis (Higgins et al. 2003). These 
occur prior to the onset of clinical symptoms, which include early loss of -motor nerve terminals 
(Sasaki and Iwata 1996; 1999; Frey et al. 2000; Fischer et al. 2004; Schaefer et al. 2005; Zang da et 
al. 2005).  Hereditary Spastic paraplegia, affecting up to one in 10,000 people, is a heterogeneous 
condition that causes progressive weakness and spasticity in the lower limbs (Filla et al. 1992). In an 
autosomal dominant form, the disease is linked to mutations in Hsp60, a mitochondrial chaperon 
protein (Hansen et al. 2002). In an autosomal recessive form the condition has been linked to loss of 
the mitochondrial protein, paraplegin, that causes deficits in oxidative phosphorylation (Casari et al. 
1998) compromised complex 1 activity (see fig 1.1: Atorino et al. 2003), and has been shown to cause 
early morphological changes to synaptic mitochondria prior to degeneration (Ferreirinha et al. 2004).  
Charcot-Marie-Tooth disease sub-form 2A has been linked to defects in mitofusion 2 protein that is 
involved in mitochondrial fusion (Zuchner et al. 2004; Kijima et al. 2005; Chung et al. 2006).  The 
molecular/cellular events in these diseases are not unlike those caused by hypoxia/ischaemia-
reperfusion injury (e.g., mitochondrial impairment, ATP depletion and ROS formation) described here 
and therefore this study provides a direct link demonstrating that hypoxic/oxidative stress stimuli can 
cause rapid and selective -motor nerve pathology.  
 
Contraindications for the use of tourniquets 
From the discussion above it would not only suggest that -motor nerve terminal pathology caused by 
hypoxic stimuli may be involved in a range of clinical conditions, but also that patients suffering from 
these various neurodegenerative, cardiovascular, pulmonary, metabolic and haematological conditions 
may be at an increased risk of -motor nerve terminal pathology and neurological complications 
following tourniquet induced ischaemia-reperfusion injuries. This has been shown in the -motor 
nerve terminals of mice carrying mSOD1 that have been shown to be significantly more vulnerable 
compared to their wild-type counterparts (David et al. 2007). It has already been noted that children 
and young adults tend to be more resistant to tourniquet induced ischaemia-reperfusion injuries 
(Bruner 1951) and elderly are at increased risk because of pre-existing conditions (Kam 2005). 
Further to this, the elderly may be particularly vulnerable to long-term neurological complications due 
to tourniquet induced ischaemia-reperfusion injuries. This is not only because of systemic and 
localised reductions in O2 levels discussed above, but also because of a reduced ability of -motor 
neurons to produce collateral and de novo innervations (Verdu et al. 2000; Vandervoort 2002; Beal 






6.3 What could be learned from future studies? 
From the results presented in the current study and from the discussion above, increasing our 
understanding of the vulnerability of -motor nerve terminals to hypoxia-reperfusion injury and 
related pathological stimuli is of significant clinical importance. In combination with the ex vivo 
model system described here and in vivo models that utilise vascular occlusion to trigger ischaemia 
(thus avoiding potential complications of tourniquet induced mechanical trauma) will provide a 
powerful means for future studies to address the short and long term pathological consequences, 
including recovery processes, that occur following hypoxic/ischaemic-injuries.  The ex vivo model 
system provides the means to take a reductionist approach to studying hypoxia/ischaemia-reperfusion 
injuries where many of the individual variables linked with this highly complex pathological stimulus 
can be monitored and/or controlled. This will help with the identification of key pathological events, 
important time frames and tolerances for the onset of pathology and cellular/molecular mechanisms of 
pathogenesis.  These studies should be undertaken alongside longitudinal in vivo investigations that 
can examine how individual pathological factors co-evolve to cause ischaemia-reperfusion injuries.  
Full characterisation of hypoxia/ischemia-reperfusion injuries at -motor nerve terminals (and other 
nerve terminals of the PNS) will provide key information on how the long-term neurological 
complications develop following the use of tourniquet. This type of information can then be used to 
help establish preventative and therapeutic strategies against tourniquet-induced pathology and other 
neuropathies where similar pathological stimuli may be occurring. In addition, the model system 
developed here may also be used to help further our understanding of the mechanisms of -motor 
nerve terminal disassembly/loss and the factors that govern selective vulnerability/resistance between 
different groups of neurons that are increasingly common/recurring themes in the pathogenesis of 
many neurodegenerative conditions (see Chapter 3). The large size and accessibility of -motor nerve 
terminals (and the NMJ/skeletal muscle as a whole) means that a range of systematic structural, 
functional, pharmacological and genetic studies may be easily carried out in future investigations. 
Furthermore, the pathological events at -motor nerve terminals in response to hypoxia-reperfusion 
injury described here show some important similarities with those known to occur following CNS 
hypoxic/ischaemic injuries.  Continuing studies at -motor nerve terminals may also form an 
important paradigm of CNS hypoxic/ischaemic injuries and help in the identification of novel 
therapeutic targets in both the PNS and CNS.    
 
While this study has focused on the vulnerability of the PNS and in particular -motor nerve 
terminals, if looked at from a different and perhaps more classical point of view, -motor nerve 
terminals appear remarkably resistant to hypoxic/ischaemic injury. The lack of auto-regulated blood 
flow (Smith et al. 1977; Low and Tuck 1984), intermittent blood flow in resting muscle, rapid rest-to 
work transitions where skeletal muscle increases its demand for ATP >100times per unit of time 
(Kernell 2006), lateral forces occluding blood vessels during muscle contractions and reduced blood 
flow to the limbs in cold environments to maintain core temperatures (Smith et al. 1977; Low and 
 197 
Tuck 1984; Shibata et al. 2005; Kernell 2006; Clanton 2007), would suggest that -motor nerve 
terminals may be rendered hypoxic/ischaemic on a regular basis.  How do -motor nerve terminals 
continue to function under these conditions? A considerable amount of research has gone into 
examining skeletal muscle physiology at rest, in work and in various (potentially) hypoxic 
environments to understand the complex means of how skeletal muscle buffers against hypoxic 
insults. Similar studies in -motor neurons and their nerve terminals have yet to be carried out despite 
the equal requirement of both for the proficient command and control of skeletal muscle. From the 
limited studies that have been carried out and in comparison with the CNS, the PNS does appear to 
have a greater metabolic safety factor with ~10% of the oxygen requirement but similar ATP levels, 
and better anaerobic abilities (Stewart et al. 1965; Campa and Engel 1971; Low et al. 1985; Zollman 
et al. 1991; Mohler et al. 1999). Are these adaptations alone sufficient to buffer -motor neurons and 
their nerve terminals against transient hypoxic insults? When compared to the complex adaptations of 
skeletal muscle, it seems likely that we may have more to learn about how -motor neurons and their 
nerve terminals function under hypoxic conditions.  In the current study, I described preliminary work 
that made the first steps to address this issue by trying to determine if the novel oxygen storing 
protein, neuroglobin (NGB), was expressed in -motor nerve terminals (Chapter 5). While this needs 
to be the subject to further study and the results are currently only preliminary, the results suggested 
that NGB could be expressed at the mouse NMJ and if it is expressed, may indicate a role in buffering 
against hypoxia insults.  If NGB is expressed at the NMJ, what other factors at the NMJ as a whole 
help maintain ATP levels during hypoxic insults? Addressing this issue would not only improve our 
understanding of the physiology of -motor neurons, their nerve terminals and the NMJ in general, 
but may also provide targets to direct novel therapeutic strategies against hypoxia/ischaemic-
reperfusions injuries and other conditions with related pathological stimuli in the future.  
 
6.4 Summary 
Nerve terminals are known to be vulnerable to a range of toxic, traumatic and neurodegenerative 
disease stimuli, but it was unknown if the nerve terminals of -motor neurons were vulnerable to 
hypoxic injury. In response to my aim, I have demonstrated that -motor nerve terminals are highly 
and selectively vulnerable to hypoxia-reperfusion injury. This finding may not only have direct 
implications for the use of surgical and non-surgical tourniquets but also in a range of other disease 
processes where similar hypoxic/ischaemic stimuli maybe causing or contributing to the development 











Abbracchio, M.P., Burnstock, G., Verkhratsky, A. and Zimmermann, H. (2008). "Purinergic 
signalling in the nervous system: an overview." Trends Neurosci 
Abe, T., Limbrick, A.R. and Miledi, R. (1976). "Acute muscle denervation induced by beta-
bungarotoxin." Proc R Soc Lond B Biol Sci 194(1117): 545-53 
Abramov, A.Y., Scorziello, A. and Duchen, M.R. (2007). "Three Distinct Mechanisms Generate 
Oxygen Free Radicals in Neurons and Contribute to Cell Death during Anoxia and 
Reoxygenation." J. Neurosci. 27(5): 1129-1138 
Adalbert, R., Gillingwater, T.H., Haley, J.E., Bridge, K., Beirowski, B., Berek, L., Wagner, D., 
Grumme, D., Thomson, D., Celik, A., Addicks, K., Ribchester, R.R. and Coleman, M.P. 
(2005). "A rat model of slow Wallerian degeneration (WldS) with improved preservation of 
neuromuscular synapses." Eur J Neurosci 21(1): 271-7 
Adalbert, R., Nogradi, A., Szabo, A. and Coleman, M.P. (2006). "The slow Wallerian degeneration 
gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal 
axotomy." Eur J Neurosci 24(8): 2163-8 
Agbulut, O., Coirault, C., Niederlander, N., Huet, A., Vicart, P., Hagege, A., Puceat, M. and 
Menasche, P. (2006). "GFP expression in muscle cells impairs actin-myosin interactions: 
implications for cell therapy." Nat Meth 3(5): 331-331 
Agbulut, O., Huet, A., Niederlander, N., Puceat, M., Menasche, P. and Coirault, C. (2007). 
"Green Fluorescent Protein Impairs Actin-Myosin Interactions by Binding to the Actin-
binding Site of Myosin." J. Biol. Chem. 282(14): 10465-10471 
Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J.D., (1989) “The Cell: 
molecular biology of.” Second edition. Garland Publishing Inc 
Alkayed, N.J., Harukuni, I., Kimes, A.S., London, E.D., Traystman, R.J. and Hurn, P.D. (1998). 
"Gender-linked brain injury in experimental stroke." Stroke 29(1): 159-65; discussion 166 
Allen, N.J., Karadottir, R. and Attwell, D. (2005). "A preferential role for glycolysis in preventing 
the anoxic depolarization of rat hippocampal area CA1 pyramidal cells." J Neurosci 25(4): 
848-59 
Alnaes, E. and Rahamimoff, R. (1975). "On the role of mitochondria in transmitter release from 
motor nerve terminals." J Physiol 248(2): 285-306 
Ames, A. (2000). "CNS energy metabolism as related to function." Brain ResReviews 34(1-2): 42-68 
Ames, A., 3rd, Wright, R.L., Kowada, M., Thurston, J.M. and Majno, G. (1968). "Cerebral 
ischemia. II. The no-reflow phenomenon." Am J Pathol 52(2): 437-53 
Amir, I., Harris, J.B. and Zar, M.A. (1997). "The effect of palytoxin on neuromuscular junctions in 
the anococcygeus muscle of the rat." J Neurocytol 26(6): 367-76 
Anderson, C.M. and Nedergaard, M. (2006). "Emerging challenges of assigning P2X7 receptor 
function and immunoreactivity in neurons." Trends Neurosci 29(5): 257-62 
Ankarcrona, M., Dypbukt, J.M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S.A. and 
Nicotera, P. (1995). "Glutamate-induced neuronal death: A succession of necrosis or 
apoptosis depending on mitochondrial function." Neuron 15(4): 961-973 
Anwyl, R. and Ling, L.W. (1983). "Modification by temperature and external calcium of the increase 
in spontaneous transmitter release induced by a metabolic inhibitor at the neuromuscular 
junction." Brain Res270(2): 355-357 
Aokage, T., Ohsawa, I. and Ohta, S. (2004). "Green fluorescent protein causes mitochondria to 
aggregate in the presence of the Bcl-2 family proteins." Biochem Biophys Res Comm 314(3): 
711-716 
AORN (2007). "Recommended Practice for the Use of the Pneumatic Tourniquet in the perioperative 
Practice Setting." AORN Standard, Recommended Practice and Guidelines 2007 available 
from www.tourniquets.org 
Apel, P.J., Alton, T., Northam, C., Ma, J., Callahan, M., Sonntag, W.E. and Li, Z. (2009). "How 
age impairs the response of the neuromuscular junction to nerve transection and repair: An 
experimental study in rats." J Orthop Res 27(3): 385-93 
Araki, T., Sasaki, Y. and Milbrandt, J. (2004). "Increased nuclear NAD biosynthesis and SIRT1 
activation prevent axonal degeneration." Science 305(5686): 1010-3 





 transport in canine brain." Stroke 12(6): 726-30 
Atorino, L., Silvestri, L., Koppen, M., Cassina, L., Ballabio, A., Marconi, R., Langer, T. and 
Casari, G. (2003). "Loss of m-AAA protease in mitochondria causes complex I deficiency 
 200 
and increased sensitivity to oxidative stress in hereditary spastic paraplegia." J Cell Biol 
163(4): 777-87 
Attwell, D. and Laughlin, S.B. (2001). "An energy budget for signalling in the grey matter of the 
brain." J Cereb Blood Flow Metab 21(10): 1133-45 
Awerbuck, D., Luong, V., Plyley, M.J. and McKee, N.H. (1994). "Skeletal muscle form and 
function after 4 hr ischemia-hypothermia." J Surg Res 57(4): 480-6 
Baens, M., Noels, H., Broeckx, V., Hagens, S., Fevery, S., Billiau, A.D., Vankelecom, H. and 
Marynen, P. (2006). "The dark side of EGFP: defective polyubiquitination." PLoS ONE 1: 
e54 
Bagdatoglu, O.T., Polat, G., Bagdatoglu, C. and Atik, U. (2006). "Roles of nitric oxide, 
malondialdehyde, and fibronectin in an experimental peripheral nerve ischemia-reperfusion 
model." Microsurgery 26(3): 207-11 
Bagdatoglu, O.T., Polat, G., Bagdatoglu, C. and Atik, U. (2008). "Effects of Peripheral Nerve 
Ischemia-Reperfusion Model on Serum Cytokine Levels." Turk Neurosurg 18(2): 149-156 
Bak, L.K., Schousboe, A., Sonnewald, U. and Waagepetersen, H.S. (2006). "Glucose is necessary 
to maintain neurotransmitter homeostasis during synaptic activity in cultured glutamatergic 
neurons." J Cereb Blood Flow Metab 26(10): 1285-97 
Balice-Gordon, R.J. and Lichtman, J.W. (1990). "In vivo visualization of the growth of pre- and 
postsynaptic elements of neuromuscular junctions in the mouse." J. Neurosci. 10(3): 894-908 
Balice-Gordon, R.J. and Lichtman, J.W. (1994). "Long-term synapse loss induced by focal 
blockade of postsynaptic receptors." Nature 372(6506): 519-524 
Balice-Gordon, R.J. (1996). "Dynamic roles at the neuromuscular junction. Schwann cells." Curr 
Biol 6(9): 1054-6 
Barclay, C.J. (2005). "Modelling diffusive O(2) supply to isolated preparations of mammalian 
skeletal and cardiac muscle." J Muscle Res Cell Motil 26(4-5): 225-35 
Barker, D. and Ip, M.C. (1960). "The primary and secondary endings of the mammalian muscle 
spindle." J Physiol 153: 8-10P 
Barker, D. and Ip, M.C. (1966). "Sprouting and Degeneration of Mammalian Motor Axons in 
Normal and De-afferentated Skeletal Muscle." Proc Roy Soc Lond B Biol Sci 163(993): 538-
554 
Barker, D., Stacey, M.J. and Adal, M.N. (1970). "Fusimotor Innervation in the Cat." Phil Trans Roy 
Soc Lond B Biol Sci 258(825): 315-346 
Barker, D. (1974). The Morphology of Muscle Receptors. Muscle Receptors: Handbook of Sensory 
Physiology III/2. C. C. Hunt, Spinger-Verlag New York: 2-174 
Baxter, R.L., Vega-Riveroll, L.J., Deuchars, J. and Parson, S.H. (2005). "A2A adenosine receptors 
are located on presynaptic motor nerve terminals in the mouse." Synapse 57(4): 229-34 
Bazzy, A.R. (1994). "Effect of hypoxia on neuromuscular transmission in the developing diaphragm." 
J Appl Physiol 76(2): 708-713 
Beal, M.F. (2000). "Energetics in the pathogenesis of neurodegenerative diseases." Trends Neurosci 
23(7): 298-304 
Beal, M.F. (2005). "Mitochondria take centre stage in aging and neurodegeneration." Ann Neurol 
58(4): 495-505 
Beirowski, B., Adalbert, R., Wagner, D., Grumme, D.S., Addicks, K., Ribchester, R.R. and 
Coleman, M.P. (2005). "The progressive nature of Wallerian degeneration in wild-type and 
slow Wallerian degeneration (WldS) nerves." BMC Neurosci 6(1): 6 
Beirowski, B., Babetto, E., Coleman, M.P. and Martin, K.R. (2008). "The Wld(S) gene delays 
axonal but not somatic degeneration in a rat glaucoma model." Eur J Neurosci 
Beirowski, B., Babetto, E., Gilley, J., Mazzola, F., Conforti, L., Janeckova, L., Magni, G., 
Ribchester, R.R. and Coleman, M.P. (2009). "Non-Nuclear WldS Determines Its 
Neuroprotective Efficacy for Axons and Synapses In Vivo." J. Neurosci. 29(3): 653-668 
Benveniste, H., Drejer, J., Schousboe, A. and Diemer, N.H. (1984). "Elevation of the Extracellular 
Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral 
Ischemia Monitored by Intracerebral Microdialysis." J Neurochem43(5): 1369-1374 
Berliocchi, L., Fava, E., Leist, M., Horvat, V., Dinsdale, D., Read, D. and Nicotera, P. (2005). 
"Botulinum neurotoxin C initiates two different programs for neurite degeneration and 
neuronal apoptosis." J. Cell Biol. 168(4): 607-618 
Bernard Roth, P. (1931). "Tourniquet paralysis." Lancet 218(5636): 554-554 
 201 
Bernstein, M. and Lichtman, J.W. (1999). "Axonal atrophy: The retraction reaction." Curr Opin 
Neurobiol 9(3): 364-370 
Bettini, N.L., Moores, T.S., Baxter, B., Deuchars, J. and Parson, S.H. (2007). "Dynamic 
remodelling of synapses can occur in the absence of the parent cell body." BMC Neurosci 8: 
79 
Betz, W.J., Ribchester, R.R. and Ridge, R.M. (1990). "Competitive mechanisms underlying 
synapse elimination in the lumbrical muscle of the rat." J Neurobiol 21(1): 1-17 
Betz, W.J., Mao, F. and Bewick, G.S. (1992). "Activity-dependent fluorescent staining and 
destaining of living vertebrate motor nerve terminals." J. Neurosci. 12(2): 363-375 
Bewick, G.S., Reid, B., Jawaid, S., Hatcher, T. and Shanley, L. (2004). "Postnatal emergence of 
mature release properties in terminals of rat fast- and slow-twitch muscles." Eur J Neurosci 
19(11): 2967-76 
Bickler, P.E. and Donohoe, P.H. (2002). "Adaptive responses of vertebrate neurons to hypoxia." J 
Exp Biol 205(Pt 23): 3579-86 
Billuart, P., Winter, C.G., Maresh, A., Zhao, X. and Luo, L. (2001). "Regulating Axon Branch 
Stability: The Role of p190 RhoGAP in Repressing a Retraction Signalling Pathway." Cell 
107(2): 195-207 
Birks, R., Katz, B. and Miledi, R. (1960). "Physiological and structural changes at the amphibian 
myoneural junction, in the course of nerve degeneration." J Physiol 150: 145-68 
Bishop, D.L., Misgeld, T., Walsh, M.K., Gan, W.B. and Lichtman, J.W. (2004). "Axon branch 
removal at developing synapses by axosomes shedding." Neuron 44(4): 651-61 
Bixby, J.L. (1981). "Ultrastructural observations on synapse elimination in neonatal rabbit skeletal 
muscle." J Neurocytol 10(1): 81-100 
Blokhuis, G.G. and Veldstra, H. (1970). "Heterogeneity of mitochondria in rat brain." FEBS Lett 
11(3): 197-199 
Bolay, H., Gursoy-Ozdemir, Y., Sara, Y., Onur, R., Can, A. and Dalkara, T. (2002). "Persistent 
Defect in Transmitter Release and Synapsin Phosphorylation in Cerebral Cortex After 
Transient Moderate Ischemic Injury." Stroke 33(5): 1369-1375 
Boyd, I.A. (1962). "The Structure and Innervation of the Nuclear Bag Muscle Fibre System and the 
Nuclear Chain Muscle Fibre System in Mammalian Muscle Spindles." Phil Trans Roy Soc 
Lond B Biol Sci 245(720): 81-136 
Boyd, I.A. and Gladden, M.H. (1985). The Muscle Spindle, Macmillan/Stockton Press 
Bramlett, H.M. (2005). "Sex differences and the effect of hormonal therapy on ischemic brain 
injury." Pathophysiology 12(1): 17-27 
Brännström, T., Havton, L. and Kellerth, J.-O. (1992). "Restorative effects of reinnervation on the 
size and dendritic arborization patterns of axotomized cat spinal alpha-motoneurons."  J 
Compar Neurol 318(4): 452-461 
Bray, J.J., Hawken, M.J., Hubbard, J.I., Pockett, S. and Wilson, L. (1976). "The membrane 
potential of rat diaphragm muscle fibres and the effect of denervation." J Physiol 255(3): 
651-67 
Brendza, R.P., O'Brien, C., Simmons, K., Daniel W. McKeel, D.W., Bales, K.R., Paul, S.M., 
Olney, J.W., Sanes, J.R. and Holtzman, D.M. (2003). "PDAPP; YFP double transgenic 
mice: A tool to study amyloid- associated changes in axonal, dendritic, and synaptic 
structures."  J Compar Neurolo 456(4): 375-383 
Bridge, K.E., Berg, N., Adalbert, R., Babetto, E., Dias, T., Spillantini, M.-G., Ribchester, R.R. 
and Coleman, M.P. (2009). "Late onset distal axonal swelling in YFP-H transgenic mice." 
Neurobiology Aging 30(2): 309-21 
Brouns, R., and De Deyn, P.P. (2009). “The complexity of neurobiological processes in acute 
ischemic stroke.” Clinical Neurology and Neurosurgery 111(6): 483-495 
Brown, M.C., Jansen, J.K. and Van Essen, D. (1976). "Polyneuronal innervation of skeletal muscle 
in new-born rats and its elimination during maturation." J Physiol 261(2): 387-422 
Brown, M.R., Sullivan, P.G. and Geddes, J.W. (2006). "Synaptic mitochondria are more susceptible 
to Ca
2+
overload than nonsynaptic mitochondria." J Biol Chem 281(17): 11658-68 
Bruijn, L.I., Miller, T.M. and Cleveland, D.W. (2004). "Unravelling the mechanisms involved in 
motor neuron degeneration in ALS." Annu Rev Neurosci 27: 723-49 
Bruner, J.M. (1951). "Safety factors in the use of the pneumatic tourniquet for haemostasis in surgery 
of the hand." J Bone Joint Surg Am 33(A:1): 221-4 
 202 
Bu, B., Li, J., Davies, P. and Vincent, I. (2002). "Deregulation of cdk5, Hyperphosphorylation, and 
Cytoskeletal Pathology in the Niemann-Pick Type C Murine Model." J. Neurosci. 22(15): 
6515-6525 
Bukharaeva, E.A., Salakhutdinov, R.I., Vyskocil, F. and Nikolsky, E.E. (2005). "Spontaneous 
quantal and non-quantal release of acetylcholine at mouse endplate during onset of hypoxia." 
Physiol Res 54(2): 251-5 
Bunge, M.B. (1986). "The axonal cytoskeleton: its role in generating and maintaining cell form." 
Trends Neurosci 9: 477-482 
Buono, M.J. and Kolkhorst, F.W. (2001). "Submitting Illuminations for Review:Estimating ATP 
resynthesis during a marathon run: a method to introduce metabolism." Advan. Physiol. Edu. 
25(2): 70-71 
Burghes, A.H. and Beattie, C.E. (2009). "Spinal muscular atrophy: why do low levels of survival 
motor neuron protein make motor neurons sick?" Nat Rev Neurosci 
Burmester, T., Weich, B., Reinhardt, S. and Hankeln, T. (2000). "A vertebrate globin expressed in 
the brain." Nature 407(6803): 520-3 
Burne, J.F., Staple, J.K. and Raff, M.C. (1996). "Glial cells are increased proportionally in 
transgenic optic nerves with increased numbers of axons." J Neurosci 16(6): 2064-73 
Burns, A.S., Jawaid, S., Zhong, H., Yoshihara, H., Bhagat, S., Murray, M., Roy, R.R., Tessler, 
A. and Son, Y.J. (2007a). "Paralysis elicited by spinal cord injury evokes selective 
disassembly of neuromuscular synapses with and without terminal sprouting in ankle flexors 
of the adult rat." J Comp Neurol 500(1): 116-33 
Burns, T.M., Schaublin, G.A. and Dyck, P.J.B. (2007b). "Vasculitic Neuropathies." Neurologic 
Clinics 25(1): 89-113 
Burnstock, G. (2006). "Pathophysiology and therapeutic potential of purinergic signalling." 
Pharmacol Rev 58(1): 58-86 
Cadet, J.L., Jayanthi, S. and Deng, X. (2003). "Speed kills: cellular and molecular bases of 
methamphetamine-induced nerve terminal degeneration and neuronal apoptosis." FASEB J. 
17(13): 1775-1788 
Campa, J.F. and Engel, W.K. (1971). "Histochemical and Functional Correlations in Anterior Horn 
Neurons of the Cat Spinal Cord." Science 171(3967): 198-199 
Cardasis, C.A. and Padykula, H.A. (1981). "Ultrastructural evidence indicating reorganization at the 
neuromuscular junction in the normal rat soleus muscle." Anat Rec 200(1): 41-59 
Carden, D.L. and Granger, D.N. (2000). "Pathophysiology of ischaemia-reperfusion injury." J 
Pathol 190(3): 255-66 
Carlson, R.E., Kirby, B.S., Voyles, W.F. and Dinenno, F.A. (2008). "Evidence for impaired 
skeletal muscle contraction-induced rapid vasodilation in aging humans." Am J Physiol Heart 
Circ Physiol 294(4): H1963-70 
Caroni, P. (1997a). "Overexpression of growth-associated proteins in the neurons of adult transgenic 
mice." J Neurosci Meth 71(1): 3-9 
Caroni, P. (1997b). "Intrinsic neuronal determinants that promote axonal sprouting and elongation." 
Bioessays 19(9): 767-75 
Casari, G., De Fusco, M., Ciarmatori, S., Zeviani, M., Mora, M., Fernandez, P., De Michele, G., 
Filla, A., Cocozza, S., Marconi, R., Durr, A., Fontaine, B. and Ballabio, A. (1998). 
"Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-
encoded mitochondrial metalloprotease." Cell 93(6): 973-83 
Casey, E.B. and Le Quesne, P.M. (1972). "Electrophysiological evidence for a distal lesion in 
alcoholic neuropathy." J Neurol Neurosurg Psychiatry 35(5): 624-30 
Caughey, J.E., Wilson, R.F. and Borrie, J. (1958). "Peripheral Neuropathy (Peripheral Neuritis) 
with Bronchiectasis." Thorax 13(1): 59-63 
Cavaliere, F., Amadio, S., Sancesario, G., Bernardi, G. and Volonte, C. (2004). "Synaptic P2X7 
and oxygen/glucose deprivation in organotypic hippocampal cultures." J Cereb Blood Flow 
Metab 24(4): 392-8 
Cerretelli, P. and Samaja, M. (2003). "Acid-base balance at exercise in normoxia and in chronic 
hypoxia. Revisiting the "lactate paradox"." Eur J Appl Physiol 90(5-6): 431-48 
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W. and Prasher, D.C. (1994). "Green fluorescent 
protein as a marker for gene expression." Science 263(5148): 802-5 
Chalmers, G.R. and Edgerton, V.R. (1989). "Single motoneuron succinate dehydrogenase activity." 
J. Histochem. Cytochem. 37(7): 1107-1114 
 203 
Chalmers, G.R., Roy, R.R. and Edgerton, V.R. (1992). "Adaptability of the oxidative capacity of 
motoneurons." Brain Res 570: 1-10 
Chan, P.H. and Fishman, R.A. (1980). "Transient formation of superoxide radicals in 
polyunsaturated fatty acid-induced brain swelling." J Neurochem 35(4): 1004-7 
Chan, P.H. (1996). "Role of Oxidants in Ischemic Brain Damage." Stroke 27(6): 1124-1129 
Chan, R.K., Austen, W.G., Jr., Ibrahim, S., Ding, G.Y., Verna, N., Hechtman, H.B. and Moore, 
F.D., Jr. (2004). "Reperfusion injury to skeletal muscle affects primarily type II muscle 
fibers." J Surg Res 122(1): 54-60 
Chang, C.C. (1999). "Looking back on the discovery of α-bungarotoxin." J Biomed Sci 6(6): 368-375 
Chaudhry, V. and Cornblath, D.R. (1992). "Wallerian degeneration in human nerves: Serial 
electrophysiological studies." Muscle  Nerve 15(6): 687-693 
Chervu, A., Moore, W.S., Homsher, E. and Quinones-Baldrich, W.J. (1989). "Differential 
recovery of skeletal muscle and peripheral nerve function after ischemia and reperfusion." J 
Surg Res 47(1): 12-9 
Chessell, I.P., Simon, J., Hibell, A.D., Michel, A.D., Barnard, E.A. and Humphrey, P.P.A. 
(1998). "Cloning and functional characterisation of the mouse P2X7 receptor." FEBS Letters 
439(1-2): 26-30 
Choi, D.W. (1988). "Calcium-mediated neurotoxicity: relationship to specific channel types and role 
in ischemic damage." Trends Neurosci 11(10): 465-469 
Chopra, J.S. and Hurwitz, L.J. (1969). "A comparative study of peripheral nerve conduction in 
diabetes and non-diabetic chronic occlusive peripheral vascular disease." Brain 92(1): 83-96 
Chung, K.W., Kim, S.B., Park, K.D., Choi, K.G., Lee, J.H., Eun, H.W., Suh, J.S., Hwang, J.H., 
Kim, W.K., Seo, B.C., Kim, S.H., Son, I.H., Kim, S.M., Sunwoo, I.N. and Choi, B.O. 
(2006). "Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 
2 (MFN2) mutations." Brain 129(Pt 8): 2103-18 
Chvostek, F. (1892). "Ein Fall von isch. Lamhmung in Folge von embolie der Art. fem., ." 
Jahfbucher f. Psychiatrie(x): 255.Thomas, 1909 
Cifuentes-Diaz, C., Nicole, S., Velasco, M.E., Borra-Cebrian, C., Panozzo, C., Frugier, T., Millet, 
G., Roblot, N., Joshi, V. and Melki, J. (2002). "Neurofilament accumulation at the motor 
endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model." Hum Mol 
Genet 11(12): 1439-47 
Cipollone, L.T. (1898). "Nuove ricerche sul fuso neuromuscolare." Ann. Med. Navale Coloniale 4: 
464-514.From: Matthews, P. B. (1964). "Muscle Spindles and Their Motor Control." Physiol 
Rev 44: 219-88 
Clanton, T.L. (2007). "Hypoxia-induced reactive oxygen species formation in skeletal muscle." J 
Appl Physiol 102(6): 2379-2388 
Clark, A.W., Mauro, A., Longenecker, H.E. and Hurlbut, W.P. (1970). "Effects of Black Widow 
Spider Venom on the Frog Neuromuscular Junction: Effects on the Fine Structure of the Frog 
Neuromuscular Junction." Nature 225(5234): 703-705 
Clark, A.W., Hurlbut, W.P. and Mauro, A. (1972). "Changes in the fine structure of the 
neuromuscular junction of the frog caused by black widow spider venom." J Cell Biol 52(1): 
1-14 
Clark, L.C., Jr., Wolf, R., Granger, D. and Taylor, Z. (1953). "Continuous recording of blood 
oxygen tensions by polarography." J Appl Physiol 6(3): 189-93 
Clinton, J., Forsyth, C., Royston, M.C. and Roberts, G.W. (1993). "Synaptic degeneration is the 
primary neuropathological feature in prion disease: a preliminary study." Neuroreport 4(1): 
65-8 
Close, R.I. (1972). "Dynamic properties of mammalian skeletal muscles." Physiol Rev 52(1): 129-97 
Coleman, M. (2005). "Axon degeneration mechanisms: commonality amid diversity." Nat Rev 
Neurosci 6(11): 889-98 
Coleman, M.P., Conforti, L., Buckmaster, E.A., Tarlton, A., Ewing, R.M., Brown, M.C., Lyon, 
M.F. and Perry, V.H. (1998). "An 85-kb tandem triplication in the slow Wallerian 
degeneration (Wlds) mouse." Proc Natl Acad Sci U S A 95(17): 9985-9990 
Coleman, M.P. and Ribchester, R.R. (2004). "Programmed axon death, synaptic dysfunction and 
the ubiquitin proteasome system." Curr Drug Targets CNS Neurol Disord 3(3): 227-38 
Coleman, P., Federoff, H. and Kurlan, R. (2004). "A focus on the synapse for neuroprotection in 
Alzheimer disease and other dementias." Neurology 63(7): 1155-62 
 204 
Colman, H., Nabekura, J. and Lichtman, J.W. (1997). "Alterations in synaptic strength preceding 
axon withdrawal." Science 275(5298): 356-61 
Colomar, A. and Amedee, T. (2001). "ATP stimulation of P2X(7) receptors activates three different 
ionic conductances on cultured mouse Schwann cells." Eur J Neurosci 14(6): 927-36 
Conforti, L., Tarlton, A., Mack, T.G., Mi, W., Buckmaster, E.A., Wagner, D., Perry, V.H. and 
Coleman, M.P. (2000). "A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in 
the slow Wallerian degeneration (WldS) mouse." Proc Natl Acad Sci U S A 97(21): 11377-82 
Conforti, L., Adalbert, R. and Coleman, M.P. (2007a). "Neuronal death: where does the end 
begin?" Trends Neurosci 30(4): 159-166 
Conforti, L., Fang, G., Beirowski, B., Wang, M.S., Sorci, L., Asress, S., Adalbert, R., Silva, A., 
Bridge, K., Huang, X.P., Magni, G., Glass, J.D. and Coleman, M.P. (2007b). "NAD(
+
) 
and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian 
degeneration." Cell Death Differ 14(1): 116-27 
Costa, C., Zhao, L., Shen, Y., Su, X., Hao, L., Colgan, S.P., Stahl, G.L., Zhou, T. and Wang, Y.  
(2006). "Role of complement component C5 in cerebral ischemia/reperfusion injury." Brain 
Res 1100(1): 142-51 
Costanzo, E.M., Barry, J.A. and Ribchester, R.R. (1999). "Co-regulation of synaptic efficacy at 
stable polyneuronally innervated neuromuscular junctions in reinnervated rat muscle." J 
Physiol 521 Pt 2: 365-74 
Costanzo, E.M., Barry, J.A. and Ribchester, R.R. (2000). "Competition at silent synapses in 
reinnervated skeletal muscle." Nat Neurosci 3(7): 694-700 
Crapo, R.O., Jensen, R.L., Hegewald, M. and Tashkin, D.P. (1999). "Arterial blood gas reference 
values for sea level and an altitude of 1,400 meters." Am J Respir Crit Care Med 160(5 Pt 1): 
1525-31 
Cubitt, A.B., Heim, R., Adams, S.R., Boyd, A.E., Gross, L.A. and Tsien, R.Y. (1995). 
"Understanding, improving and using green fluorescent proteins." Trends Biochemi Sci 
20(11): 448-455 
Cunningham, C., Deacon, R., Wells, H., Boche, D., Waters, S., Diniz, C.P., Scott, H., Rawlins, 
J.N. and Perry, V.H. (2003). "Synaptic changes characterize early behavioural signs in the 
ME7 model of murine prion disease." Eur J Neurosci 17(10): 2147-55 
Cupp, C.J. and Uemura, E. (1980). "Age-related changes in prefrontal cortex of Macaca mulatta: 
Quantitative analysis of dendritic branching patterns." Exp Neurol 69(1): 143-163 
D'Amelio, F. and Daunton, N.G. (1992). "Effects of spaceflight in the adductor longus muscle of 
rats flown in the Soviet Biosatellite COSMOS 2044. A study employing neural cell adhesion 
molecule (N-CAM) immunocytochemistry and conventional morphological techniques (light 
and electron microscopy)." J Neuropathol Exp Neurol 51(4): 415-31 
Dagani, F., Gorini, A., Polgatti, M., Villa, R.F. and Benzi, G. (1983). "Rat cortex synaptic and 
nonsynaptic mitochondria: enzymatic characterization and pharmacological effects of 
naftidrofuryl." J Neurosci Res 10(2): 135-40 
Dagani, F., Marzatico, F. and Curti, D. (1988). "Oxidative metabolism of nonsynaptic mitochondria 
isolated from rat brain hippocampus: a comparative regional study." J Neurochem 50(4): 
1233-6 
Davey, G.P., Peuchen, S. and Clark, J.B. (1998). "Energy Thresholds in Brain Mitochondria: 
Potential Involvement in Neurodegeneration." J. Biol. Chem. 273(21): 12753-12757 
David, G., Nguyen, K. and Barrett, E.F. (2007). "Early vulnerability to ischemia/reperfusion injury 
in motor terminals innervating fast muscles of SOD1-G93A mice." Exp Neurol 204(1): 411-
20 
Davies, C.A., Mann, D.M., Sumpter, P.Q. and Yates, P.O. (1987). "A quantitative morphometric 
analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients 
with Alzheimer's disease." J Neurol Sci 78(2): 151-64 
de Paiva, A., Meunier, F.d.r.A., MolgÃ³, J., Aoki, K.R. and Dolly, J.O. (1999). "Functional repair 
of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic 
activity between nerve sprouts and their parent terminals." Proc. Nat. Acad. Sci. U.S.A. 
96(6): 3200-3205 
De Robertis, E. and Danielli, G.H.B.a.J.F. (1959). Submicroscopic Morphology of the Synapse. 
International Review of Cytology, Academic Press. Volume 8: 61-96 
De Winter, F., Vo, T., Stam, F.J., Wisman, L.A., Bar, P.R., Niclou, S.P., van Muiswinkel, F.L. 
and Verhaagen, J. (2006). "The expression of the chemorepellent Semaphorin 3A is 
 205 
selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that 
display limited anatomical plasticity and enhanced vulnerability in motor neuron disease." 
Mol Cell Neurosci 32(1-2): 102-17 
Deckwerth, T.L. and Johnson, E.M., Jr. (1994). "Neurites can remain viable after destruction of the 
neuronal soma by programmed cell death (apoptosis)." Dev Biol 165(1): 63-72 
Degens, H., Turek, Z., Hoofd, L., van't Hof, M.A. and Binkhorst, R.A. (1993). "Capillarisation 
and fibre types in hypertrophied m. plantaris in rats of various ages." Respir Physiol 94(2): 
217-26 
Dent, E.W. and Gertler, F.B. (2003). "Cytoskeletal dynamics and transport in growth cone motility 
and axon guidance." Neuron 40(2): 209-27 
Desaki, J. and Uehara, Y. (1981). "The overall morphology of neuromuscular junctions as revealed 
by scanning electron microscopy." J Neurocytol 10(1): 101-10 
DeSantis, M. and Norman, W.P. (1979). "An ultrastructural study of nerve terminal degeneration in 
muscle spindles of the tenuissimus muscle of the cat." J Neurocytol 8(1): 67-80 
Deuchars, S.A., Atkinson, L., Brooke, R.E., Musa, H., Milligan, C.J., Batten, T.F., Buckley, N.J., 
Parson, S.H. and Deuchars, J. (2001). "Neuronal P2X7 receptors are targeted to 
presynaptic terminals in the central and peripheral nervous systems." J Neurosci 21(18): 
7143-52 
Devgan, V., Rao, M.R.S. and Seshagiri, P.B. (2004). "Impact of embryonic expression of enhanced 
green fluorescent protein on early mouse development." Biochem Biophysl Res Com 313(4): 
1030-1036 
Dewar, D., Yam, P. and McCulloch, J. (1999). "Drug development for stroke: importance of 
protecting cerebral white matter." Eur J Pharmaco 375(1-3): 41-50 
Dewilde, S., Blaxter, M., Van Hauwaert, M.L., Vanfleteren, J., Esmans, E.L., Marden, M., 
Griffon, N., Moens, L., (1996). “Globin and globin gene structure of the nerve myoglobin of 
Aphrodite aculeata” J Biol Chem 271; 19865-19870 
Dewilde, S., Kiger, L., Burmester, T., Hankeln, T., Baudin-Creuza, V., Aerts, T., Marden, M.C., 
Caubergs, R. and Moens, L. (2001). "Biochemical characterization and ligand binding 
properties of neuroglobin, a novel member of the globin family." J Biol Chem 276(42): 
38949-55 
Dillon, C. and Goda, Y. (2005). "The actin cytoskeleton: integrating form and function at the 
synapse." Annu Rev Neurosci 28: 25-55 
DiProspero, N.A., Chen, E.Y., Charles, V., Plomann, M., Kordower, J.H. and Tagle, D.A. 
(2004). "Early changes in Huntington's disease patient brains involve alterations in 
cytoskeletal and synaptic elements." J Neurocytol 33(5): 517-33 
Diwan, F.H. and Milburn, A. (1986). "The effects of temporary ischaemia on rat muscle spindles." J 
Embryol Exp Morphol 92: 223-54 
Dixon, R.W. and Harris, J.B. (1999). "Nerve terminal damage by beta-bungarotoxin: its clinical 
significance." Am J Pathol 154(2): 447-55 
Dobretsov, M., Romanovsky, D. and Stimers, J.R. (2007). "Early diabetic neuropathy: triggers and 
mechanisms." World J Gastroenterol 13(2): 175-91 
Donselaar, Y., Kernell, D. and Eerbeek, O. (1986). "Soma size and oxidative enzyme activity in 
normal and chronically stimulated motoneurones of the Cat's spinal cord." Brain Res385(1): 
22-29 
Dow, P., Shinn, S. and Ovalle, W. (1980). "Ultrastructural study of a blood-muscle spindle barrier 
after systemic administration of horseradish peroxidase." Am J Anat 157(4): 375-388 
Doyle, K.P., Simon, R.P. and Stenzel-Poore, M.P. (2008). "Mechanisms of ischemic brain damage." 
Neuropharmacol 55(3): 310-318 
Du, F., Zhu, X.-H., Zhang, Y., Friedman, M., Zhang, N., UÄŸurbil, K.m. and Chen, W. (2008). 
"Tightly coupled brain activity and cerebral ATP metabolic rate." Proc Natl Acad Sci U S A 
105(17): 6409-6414 
Duchen, L.W. and Strich, S.J. (1968). "The effects of botulinum toxin on the pattern of innervation 
of skeletal muscle in the mouse." Q J Exp Physiol Cogn Med Sci 53(1): 84-89 
Duchen, L.W. (1970). "Changes in motor innervation and cholinesterase localization induced by 
botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles." 
J Neurol Neurosurg Psychiatry 33(1): 40-54 
Duchen, L.W., Gomez, S. and Queiroz, L.S. (1981). "The neuromuscular junction of the mouse 
after black widow spider venom." J Physiol 316: 279-91 
 206 
Dyck, P.J., Benstead, T.J., Conn, D.L., Stevens, J.C., Windebank, A.J. and Low, P.A. (1987). 
"Nonsystemic vasculitic neuropathy." Brain 110 ( Pt 4): 843-53 
Dyck, P.J. and Giannini, C. (1996). "Pathologic alterations in the diabetic neuropathies of humans: a 
review." J Neuropathol Exp Neurol 55(12): 1181-93 
Dytham, C. (2003). Choosing and Using Statistics: A Biologist's Guide (2nd Ed): Chapter 7, 
Blackwell Publishing 
Eastlack, R.K., Groppo, E.R., Hargens, A.R. and Pedowitz, R.A. (2004). "Ischemic-
preconditioning does not prevent neuromuscular dysfunction after ischemia-reperfusion 
injury." J Orthop Res 22(4): 918-23 
Eckhoff, N. (1931). "Tourniquet paralysis: A plea for the extended use of the pneumatic tourniquet." 
Lancet 5633: 343-345 
Edgar, J.M. (2004). "Oligodendroglial modulation of fast axonal transport in a mouse model of 
hereditary spastic paraplegia." J. Cell Biol. 166: 121-131 
Eguchi, Y., Shimizu, S. and Tsujimoto, Y. (1997). "Intracellular ATP Levels Determine Cell Death 
Fate by Apoptosis or Necrosis." Cancer Res 57(10): 1835-1840 
Elleder, M., Jirasek, A., Smid, F., Ledvinova, J. and Besley, G.T. (1985). "Niemann-Pick disease 
type C. Study on the nature of the cerebral storage process." Acta Neuropathol 66(4): 325-36 
Erb, D.E. and Povlishock, J.T. (1991). "Neuroplasticity following traumatic brain injury: a study of 
GABAergic terminal loss and recovery in the cat dorsal lateral vestibular nucleus." Exp 
Brain Res 83(2): 253-67 
Erecinska, M. and Silver, I.A. (1989). "ATP and brain function." J Cereb Blood Flow Metab 9(1): 2-
19 
Eu, J.P., Hare, J.M., Hess, D.T., Skaf, M., Sun, J., Cardenas-Navina, I., Sun, Q.A., Dewhirst, M., 
Meissner, G. and Stamler, J.S. (2003). "Concerted regulation of skeletal muscle 
contractility by oxygen tension and endogenous nitric oxide." Proc Natl Acad Sci U S A 
100(25): 15229-34 
Ey, B., Kobsar, I., Blazyca, H., Kroner, A. and Martini, R. (2007). "Visualization of degenerating 
axons in a dysmyelinating mouse mutant with axonal loss." Mol Cell Neurosci 35(1): 153-60 
Fahim, M.A. and Robbins, N. (1982). "Ultrastructural studies of young and old mouse 
neuromuscular junctions." J Neurocytol 11(4): 641-56 
Fahim, M.A., Holley, J.A. and Robbins, N. (1984). "Topographic comparison of neuromuscular 
junctions in mouse slow and fast twitch muscles." Neurosci 13(1): 227-35 
Fahim, M.A., Hasan, M.Y. and Alshuaib, W.B. (2000). "Early morphological remodelling of 
neuromuscular junction in a murine model of diabetes." J Appl Physiol 89(6): 2235-2240 
Fang, C., Bernardes-Silva, M., Coleman, M.P. and Perry, V.H. (2005). "The cellular distribution 
of the Wld s chimeric protein and its constituent proteins in the CNS." Neurosci 135(4): 
1107-18 
Feldman, R.P. and Goodrich, J.T. (1999). "The Edwin Smith Surgical Papyrus." Child's Nervous 
System 15(6-7): 281-284 
Feng, G., Mellor, R.H., Bernstein, M., Keller-Peck, C., Nguyen, Q.T., Wallace, M., Nerbonne, 
J.M., Lichtman, J.W. and Sanes, J.R. (2000). "Imaging neuronal subsets in transgenic 
mice expressing multiple spectral variants of GFP." Neuron 28(1): 41-51 
Ferguson, B., Matyszak, M.K., Esiri, M.M. and Perry, V.H. (1997). "Axonal damage in acute 
multiple sclerosis lesions." Brain 120(3): 393-399 
Ferrari, D., Los, M., Bauer, M.K., Vandenabeele, P., Wesselborg, S. and Schulze-Osthoff, K. 
(1999). "P2Z purinoreceptor ligation induces activation of caspases with distinct roles in 
apoptotic and necrotic alterations of cell death." FEBS Lett 447(1): 71-5 
Ferreirinha, F., Quattrini, A., Pirozzi, M., Valsecchi, V., Dina, G., Broccoli, V., Auricchio, A., 
Piemonte, F., Tozzi, G., Gaeta, L., Casari, G., Ballabio, A. and Rugarli, E.I. (2004). 
"Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria 
and impairment of axonal transport." J Clin Invest 113(2): 231-42 
Ferri, A., Sanes, J.R., Coleman, M.P., Cunningham, J.M. and Kato, A.C. (2003). "Inhibiting axon 
degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model 
of motoneuron disease." Curr Biol 13(8): 669-73 
Figueroa-Romero, C., Sadidi, M. and Feldman, E.L. (2008). "Mechanisms of disease: the oxidative 
stress theory of diabetic neuropathy." Rev Endocr Metab Disord 9(4): 301-14 
 207 
Filla, A., De Michele, G., Marconi, R., Bucci, L., Carillo, C., Castellano, A.E., Iorio, L., 
Kniahynicki, C., Rossi, F. and Campanella, G. (1992). "Prevalence of hereditary ataxias 
and spastic paraplegias in Molise, a region of Italy." J Neurol 239(6): 351-3 
Finn, J.T., Weil, M., Archer, F., Siman, R., Srinivasan, A. and Raff, M.C. (2000). "Evidence that 
Wallerian degeneration and localized axon degeneration induced by local neurotrophin 
deprivation do not involve caspases." J Neurosci 20(4): 1333-41 
Fischer, L.R., Culver, D.G., Tennant, P., Davis, A.A., Wang, M., Castellano-Sanchez, A., Khan, 
J., Polak, M.A. and Glass, J.D. (2004). "Amyotrophic lateral sclerosis is a distal 
axonopathy: evidence in mice and man." Exp Neurol 185(2): 232-40 
Fischer, L.R., Culver, D.G., Davis, A.A., Tennant, P., Wang, M., Coleman, M., Asress, S., 
Adalbert, R., Alexander, G.M. and Glass, J.D. (2005). "The WldS gene modestly prolongs 
survival in the SOD1G93A fALS mouse." Neurobiol Dis 19(1-2): 293-300 
Fish, J.S., McKee, N.H., Pynn, B.R., Kuzon, W.M. and Plyley, M.J. (1989). "Isometric contractile 
function recovery following tourniquet ischemia." J Surg Res 47(4): 365-370 
Fordel, E., Geuens, E., Dewilde, S., Rottiers, P., Carmeliet, P., Grooten, J. and Moens, L. (2004). 
"Cytoglobin expression is upregulated in all tissues upon hypoxia: an in vitro and in vivo 
study by quantitative real-time PCR." Biochem Biophys Res Commun 319(2): 342-8 
Fordel, E., Thijs, L., Martinet, W., Lenjou, M., Laufs, T., Van Bockstaele, D., Moens, L. and 
Dewilde, S. (2006). "Neuroglobin and cytoglobin overexpression protects human SH-SY5Y 
neuroblastoma cells against oxidative stress-induced cell death." Neurosci Lett 410(2): 146-
51 
Fordel, E., Thijs, L., Martinet, W., Schrijvers, D., Moens, L. and Dewilde, S. (2007a). "Anoxia or 
oxygen and glucose deprivation in SH-SY5Y cells: a step closer to the unraveling of 
neuroglobin and cytoglobin functions." Gene 398(1-2): 114-22 
Fordel, E., Thijs, L., Moens, L. and Dewilde, S. (2007b). "Neuroglobin and cytoglobin expression 
in mice. Evidence for a correlation with reactive oxygen species scavenging." Febs J 274(5): 
1312-7 
Fowler, T.J., Danta, G. and Gilliatt, R.W. (1972). "Recovery of nerve conduction after a pneumatic 
tourniquet: observations on the hind-limb of the baboon." J Neurol Neurosurg Psychiatry 
35(5): 638-47 
Frey, D., Schneider, C., Xu, L., Borg, J., Spooren, W. and Caroni, P. (2000). "Early and selective 
loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron 
diseases." J Neurosci 20(7): 2534-42 
Froyland, E., Skjaeret, C., Wright, M.S., Dalen, M.L., Cvancarova, M., Kasi, C. and Rootwelt, 
T. (2008). "Inflammatory receptors and pathways in human NT2-N neurons during hypoxia 
and reoxygenation. Impact of acidosis." Brain Res 1217: 37-49 
Fu, S.Y. and Gordon, T. (1995). "Contributing factors to poor functional recovery after delayed 
nerve repair: prolonged axotomy." J Neurosci 15(5 Pt 2): 3876-85 
Fujikawa, D.G. (2000). "Confusion between neuronal apoptosis and activation of programmed cell 
death mechanisms in acute necrotic insults." Trends Neurosci 23(9): 410-411 
Fujimura, H., Lacroix, C. and Said, G. (1991). "Vulnerability of nerve fibers to ischaemia: a 
quantitative light and electron microscope study." Brain 114(4): 1929-1942 
Fujiwara, N., Abe, T., Endoh, H., Warashina, A. and Shimoji, K. (1992). "Changes in intracellular 
pH of mouse hippocampal slices responding to hypoxia and/or glucose depletion." Brain 
Res572(1-2): 335-339 
Fukuyama, N., Takizawa, S., Ishida, H., Hoshiai, K., Shinohara, Y. and Nakazawa, H. (1998). 
"Peroxynitrite Formation in Focal Cerebral Ischemia-Reperfusion in Rats Occurs 
Predominantly in the Peri-Infarct Region." J Cereb Blood Flow Metab 18(2): 123-129 
Fullerton, P.M. and Barnes, J.M. (1966). "Peripheral neuropathy in rats produced by acrylamide." 
Br J Ind Med 23(3): 210-21 
Fullerton, P.M. (1969). "Electrophysiological and histological observations on peripheral nerves in 
acrylamide poisoning in man." J Neurol Neurosurg Psychiatry 32(3): 186-92 
Galbraith, J.A. and Gallant, P.E. (2000). "Axonal transport of tubulin and actin." J Neurocytol 
29(11-12): 889-911 
Gall, G.A.E. and Kyle, W.H. (1968). "Growth of the laboratory mouse." Theoretical and Applied 
Genetics 38: 304-308 
 208 
Galvin, J.E., Uryu, K., Lee, V.M. and Trojanowski, J.Q. (1999). "Axon pathology in Parkinson's 
disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-
synuclein." Proc Natl Acad Sci U S A 96(23): 13450-5 
Gardiner, M., Nilsson, B., Rehncrona, S. and Siesjö, B.K. (1981). "Free Fatty Acids in the Rat 
Brain in Moderate and Severe Hypoxia." J Neurochem36(4): 1500-1505 
Gemignani, F., Brindani, F., Alfieri, S., Giuberti, T., Allegri, I., Ferrari, C. and Marbini, A. 
(2005). "Clinical spectrum of cryoglobulinaemic neuropathy." J Neurol Neurosurg 
Psychiatry 76(10): 1410-4 
George, E.B., Glass, J.D. and Griffin, J.W. (1995). "Axotomy-induced axonal degeneration is 
mediated by calcium influx through ion-specific channels." J. Neurosci. 15(10): 6445-6452 
Gerard, R.W. (1930). "The Response of nerve to oxygen lack." Am J Physiol 92: 498-541 
Gillingwater, T.H. and Ribchester, R.R. (2001). "Compartmental neurodegeneration and synaptic 
plasticity in the Wld(s) mutant mouse." J Physiol 534(Pt 3): 627-39 
Gillingwater, T.H., Thomson, D., Mack, T.G.A., Soffin, E.M., Mattison, R.J., Coleman, M.P. 
and Ribchester, R.R. (2002). "Age-dependent synapse withdrawal at axotomised 
neuromuscular junctions in Wlds mutant and Ube4b/Nmnat transgenic mice." J Physiol 
(Lond) 543(3): 739-755 
Gillingwater, T.H., Ingham, C.A., Coleman, M.P. and Ribchester, R.R. (2003). "Ultrastructural 
correlates of synapse withdrawal at axotomized neuromuscular junctions in mutant and 
transgenic mice expressing the Wld gene." J Anat 203(3): 265-76 
Gillingwater, T.H. and Ribchester, R.R. (2003). "The relationship of neuromuscular synapse 
elimination to synaptic degeneration and pathology: insights from WldS and other mutant 
mice." J Neurocytol 32(5-8): 863-81 
Gillingwater, T.H., Haley, J.E., Ribchester, R.R. and Horsburgh, K. (2004). "Neuroprotection 
after transient global cerebral ischemia in Wld(s) mutant mice." J Cereb Blood Flow Metab 
24(1): 62-6 
Gillingwater, T.H., Ingham, C.A., Parry, K.E., Wright, A.K., Haley, J.E., Wishart, T.M., 
Arbuthnott, G.W. and Ribchester, R.R. (2006a). "Delayed synaptic degeneration in the 
CNS of Wlds mice after cortical lesion." Brain 129(Pt 6): 1546-56 
Gillingwater, T.H., Wishart, T.M., Chen, P.E., Haley, J.E., Robertson, K., MacDonald, S.H.F., 
Middleton, S., Wawrowski, K., Shipston, M.J., Melmed, S., Wyllie, D.J.A., Skehel, P.A., 
Coleman, M.P. and Ribchester, R.R. (2006b). "The neuroprotective WldS gene regulates 
expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human 
cells." Hum. Mol. Genet. 15(4): 625-635 
Giuffre, A., Moschetti, T., Vallone, B. and Brunori, M. (2008). "Neuroglobin: enzymatic reduction 
and oxygen affinity." Biochem Biophys Res Commun 367(4): 893-8 
Glass, J.D. and Griffin, J.W. (1991). "Neurofilament redistribution in transected nerves: evidence 
for bidirectional transport of neurofilaments." J Neurosci 11(10): 3146-54 
Glass, J.D., Schryer, B.L. and Griffin, J.W. (1994). "Calcium-mediated degeneration of the axonal 
cytoskeleton in the Ola mouse." J Neurochem 62(6): 2472-5 
Glazer, E.J., Baker, T. and Riker, W.F., Jr. (1978). "The neuropathology of DFP at cat soleus 
neuromuscular junction." J Neurocytol 7(6): 741-58 
Goodfellow, J.A., Bowes, T., Sheikh, K., Odaka, M., Halstead, S.K., Humphreys, P.D., Wagner, 
E.R., Yuki, N., Furukawa, K., Furukawa, K., Plomp, J.J. and Willison, H.J. (2005). 
"Overexpression of GD1a Ganglioside Sensitizes Motor Nerve Terminals to Anti-GD1a 
Antibody-Mediated Injury in a Model of Acute Motor Axonal Neuropathy." J. Neurosci. 
25(7): 1620-1628 
Gorczynski, R.J. and Duling, B.R. (1978). "Role of oxygen in arteriolar functional vasodilation in 
hamster striated muscle." Am J Physiol 235(5): H505-15 
Gordon, T. and Stein, R.B. (1982). "Time course and extent of recovery in reinnervated motor units 
of cat triceps surae muscles." J Physiol 323: 307-23 
Gordon, T., Yang, J.F., Ayer, K., Stein, R.B. and Tyreman, N. (1993). "Recovery potential of 
muscle after partial denervation: a comparison between rats and humans." Brain Res Bull 
30(3-4): 477-82 
Gorson, K.C. and Ropper, A.H. (1993). "Acute respiratory failure neuropathy: a variant of critical 
illness polyneuropathy." Crit Care Med 21(2): 267-71 
 209 
Goto, H., Yang, B., Petersen, D., Pepper, K.A., Alfaro, P.A., Kohn, D.B. and Reynolds, C.P. 
(2003). "Transduction of green fluorescent protein increased oxidative stress and enhanced 
sensitivity to cytotoxic drugs in neuroblastoma cell lines." Mol Cancer Ther 2(9): 911-917 
Graveland, G.A., Williams, R.S. and DiFiglia, M. (1985). "Evidence for degenerative and 
regenerative changes in neostriatal spiny neurons in Huntington's disease." Science 
227(4688): 770-3 
Greenbaum, L., Rothmann, C., Lavie, R. and Malik, Z. (2000). "Green fluorescent protein 
photobleaching: a model for protein damage by endogenous and exogenous singlet oxygen." 
Biol Chem 381(12): 1251-8 
Grutzendler, J., Kasthuri, N. and Gan, W.-B. (2002). "Long-term dendritic spine stability in the 
adult cortex." Nature 420(6917): 812-816 
Gustafsson, U., Gidlof, A., Povlsen, B. and Sirsjo, A. (1999). "Skeletal muscle tissue oxygen 
pressure distribution during early reperfusion after prolonged ischaemia." Eur J Vasc 
Endovasc Surg 17(1): 41-6 
Hafezparast, M., Klocke, R., Ruhrberg, C., Marquardt, A., Ahmad-Annuar, A., Bowen, S., 
Lalli, G., Witherden, A.S., Hummerich, H., Nicholson, S., Morgan, P.J., Oozageer, R., 
Priestley, J.V., Averill, S., King, V.R., Ball, S., Peters, J., Toda, T., Yamamoto, A., 
Hiraoka, Y., Augustin, M., Korthaus, D., Wattler, S., Wabnitz, P., Dickneite, C., 
Lampel, S., Boehme, F., Peraus, G., Popp, A., Rudelius, M., Schlegel, J., Fuchs, H., de 
Angelis, M.H., Schiavo, G., Shima, D.T., Russ, A.P., Stumm, G., Martin, J.E. and 
Fisher, E.M.C. (2003). "Mutations in Dynein Link Motor Neuron Degeneration to Defects 
in Retrograde Transport." Science 300(5620): 808-812 
Haigh, J.R., Noremberg, K. and Parsons, S.M. (1994). "Acetylcholine active transport by rat brain 
synaptic vesicles." Neuroreport 5(7): 773-6 
Haljamae, H. and Enger, E. (1975). "Human skeletal muscle energy metabolism during and after 
complete tourniquet ischemia." Ann Surg 182(1): 9-14 
Hall, Z.W. and Sanes, J.R. (1993). "Synaptic structure and development: The neuromuscular 
junction." Cell 72(Sup 1): 99-121 
Halliwell, B. (2006). "Oxidative stress and neurodegeneration: where are we now?" J Neurochem 
97(6): 1634-1658 
Hames, B.D., and Hooper, N.M., (2000) “Biochemistry: Instant Notes”. Second Edition BIOS 
Scientific Publishers Lim 
Hand, S.C. and Menze, M.A. (2008). "Mitochondria in energy-limited states: mechanisms that blunt 
the signaling of cell death." J Exp Biol 211(12): 1829-1840 
Hansen, J.J., Durr, A., Cournu-Rebeix, I., Georgopoulos, C., Ang, D., Nielsen, M.N., Davoine, 
C.S., Brice, A., Fontaine, B., Gregersen, N. and Bross, P. (2002). "Hereditary spastic 
paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial 
chaperonin Hsp60." Am J Hum Genet 70(5): 1328-32 
Hasbani, D.M. and O'Malley, K.L. (2006). "Wld(S) mice are protected against the Parkinsonian 
mimetic MPTP." Exp Neurol 202(1): 93-9 
Hashizume, K., Kanda, K. and Burke, R.E. (1988). "Medial gastrocnemius motor nucleus in the rat: 
Age-related changes in the number and size of motoneurons." J Comp Neurol 269(3): 425-
430 
Hatzipantelis, K.P., Natsis, K. and Albani, M. (2001). "Effect of acute limb ischaemia on 
neuromuscular function in rats." Eur J Surg 167(11): 831-8 
Hayat, A.A. (2002). Microscopy, immunohistochemistry and antigen retrieval methods: for light and 
electron microscopy, Kluwer Academic/ Plenum Publishers 
He, K., Nukada, H., McMorran, P.D. and Murphy, M.P. (1999). "Protein carbonyl formation and 
tyrosine nitration as markers of oxidative damage during ischaemia-reperfusion injury to rat 
sciatic nerve." Neurosci 94(3): 909-16 
Heim, R., Prasher, D.C. and Tsien, R.Y. (1994). "Wavelength mutations and posttranslational 
autoxidation of green fluorescent protein." Proc Natl Acad Sci U S A 91(26): 12501-4 
Hennig, R. and Lomo, T. (1985). "Firing patterns of motor units in normal rats." Nature 314(6007): 
164-6 
Herrera, A.A. and Zeng, Y. (2003). "Activity-dependent switch from synapse formation to synapse 
elimination during development of neuromuscular junctions." J Neurocytol 32(5-8): 817-33 
Herrera, A.J., de Pablos, R.M., Carreno-Muller, E., Villaran, R.F., Venero, J.L., Tomas-
Camardiel, M., Cano, J. and Machado, A. (2008). "The intrastriatal injection of thrombin 
 210 
in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through 
synaptic elimination." J Neurochem 105(3): 750-62 
Higgins, C.M., Jung, C. and Xu, Z. (2003). "ALS-associated mutant SOD1G93A causes 
mitochondrial vacuolation by expansion of the intermembrane space and by involvement of 
SOD1 aggregation and peroxisomes." BMC Neurosci 4: 16 
Hodes, R. (1949). "Selective destruction of large motoneurons by poliomyelitis virus; conduction 
velocity of motor nerve fibers of chronic poliomyelitis patients." J Neurophysiol 12(4): 257-
66 
Hodes, R., Peacock, S.M., Jr. and Bodian, D. (1949). "Selective destruction of large motoneurons 
by poliomyelitis virus; size of motoneurons in the spinal cord of rhesus monkeys." J 
Neuropathol Exp Neurol 8(4): 400-10 
Hodges, P.W. (1999). "Is there a role for transversus abdominis in lumbo-pelvic stability?" Man Ther 
4(2): 74-86 
Hollenbeck, P.J. and Saxton, W.M. (2005). "The axonal transport of mitochondria." J Cell Sci 
118(23): 5411-5419 
Honig, C.R. and Gayeski, T.E. (1993). "Resistance to O2 diffusion in anemic red muscle: roles of 
flux density and cell PO2." Am J Physiol 265(3 Pt 2): H868-75 
Hoopfer, E.D., McLaughlin, T., Watts, R.J., Schuldiner, O., O'Leary, D.D. and Luo, L. (2006). 
"Wlds protection distinguishes axon degeneration following injury from naturally occurring 
developmental pruning." Neuron 50(6): 883-95 
Hosaka, M. and Sudhof, T.C. (1998). "Synapsins I and II are ATP-binding proteins with differential 
Ca2
+
 regulation." J Biol Chem 273(3): 1425-9 
Howell, G.R., Libby, R.T., Jakobs, T.C., Smith, R.S., Phalan, F.C., Barter, J.W., Barbay, J.M., 
Marchant, J.K., Mahesh, N., Porciatti, V., Whitmore, A.V., Masland, R.H. and John, 
S.W. (2007). "Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J 
glaucoma." J Cell Biol 179(7): 1523-37 
Hsu, L. and Lentz, T.L. (1972). "Effect of colchicine on the fine structure of the neuromuscular 
junction." Cell Tissue Res 135(4): 439-448 
Huang, C.L.H. and Keynes, R.J. (1983). "Terminal sprouting of mouse motor nerves when the post-
synaptic membrane degenerates." Brain Res274(2): 225-229 
Huang, W.Y., Aramburu, J., Douglas, P.S. and Izumo, S. (2000). "Transgenic expression of green 
fluorescence protein can cause dilated cardiomyopathy." Nat Med 6(5): 482-3: ABSTRACT 
Hubbard, J.I. and Loyning, Y. (1966). "The effects of hypoxia on neuromuscular transmission in a 
mammalian preparation." J Physiol 185(1): 205-23 
Hudson, C.S., Deshpande, S.S. and Albuquerque, E.X. (1984). "Consequences of axonal transport 
blockade by batrachotoxin on mammalian neuromuscular junction. III. An ultrastructural 
study." Brain Res 296(2): 319-32 
Hundahl, C.A., Allen, G.C., Nyengaard, J.R., Dewilde, S., Carter, B.D., Kelsen, J. and Hay-
Schmidt, A. (2008). "Neuroglobin in the Rat Brain: Localization." Neuroendocrinology 
Idstrom, J.P., Soussi, B., Elander, A. and Bylund-Fellenius, A.C. (1990). "Purine metabolism after 
in vivo ischemia and reperfusion in rat skeletal muscle." Am J Physiol Heart Circ Physiol 
258(6): H1668-1673 
Iida, H., Schmelzer, J.D., Schmeichel, A.M., Wang, Y. and Low, P.A. (2003). "Peripheral nerve 
ischemia: reperfusion injury and fibber regeneration." Exp Neurol 184(2): 997-1002 
Ikegami, K. and Koike, T. (2003). "Non-apoptotic neurite degeneration in apoptotic neuronal death: 
pivotal role of mitochondrial function in neurites." Neurosci 122(3): 617-626 
Inouye, S. and Tsuji, F.I. (1994a). "Evidence for redox forms of the Aequorea green fluorescent 
protein." FEBS Letters 351(2): 211-214 
Inouye, S. and Tsuji, F.I. (1994b). "Aequorea green fluorescent protein. Expression of the gene and 
fluorescence characteristics of the recombinant protein." FEBS Lett 341(2-3): 277-80 
Iscoe, S. (1998). "Control of abdominal muscles." Progr Neurobiol56(4): 433-506 
Ishihara, A., Naitoh, H., Araki, H. and Nishihira, Y. (1988). "Soma size and oxidative enzyme 
activity of motoneurones supplying the fast twitch and slow twitch muscles in the rat." Brain 
Res 446(1): 195-8 
Ishihara, A., Roy, R.R. and Edgerton, V.R. (1995). "Succinate dehydrogenase activity and soma 
size of motoneurons innervating different portions of the rat tibialis anterior." Neurosci 
68(3): 813-22 
 211 
Ishimaru, H., Casamenti, F., Ueda, K., Maruyama, Y. and Pepeu, G. (2001). "Changes in 
presynaptic proteins, SNAP-25 and synaptophysin, in the hippocampal CA1 area in ischemic 
gerbils." Brain Res 903(1-2): 94-101 





exchanger (NCX) in neurons following ischaemia." J Clin Neurosci 14(6): 507-514 
Jin, K., Mao, X.O., Xie, L., Khan, A.A. and Greenberg, D.A. (2008). "Neuroglobin protects against 
nitric oxide toxicity." Neurosci Lett 430(2): 135-7 
John, B.C. (1996). "Threshold Effects and Control of Oxidative Phosphorylation in Nonsynaptic Rat 
Brain Mitochondria." J Neurochem 66(4): 1617-1624 
Johnson, I.P. and Duberley, R.M. (1998). "Motoneuron survival and expression of neuropeptides 
and neurotrophic factor receptors following axotomy in adult and ageing rats." Neurosci 
84(1): 141-50 
Jourdain, P., Nikonenko, I., Alberi, S. and Muller, D. (2002). "Remodeling of Hippocampal 
Synaptic Networks by a Brief Anoxia-Hypoglycemia." J. Neurosci. 22(8): 3108-3116 
Jung, Y.J., Park, S.J., Park, J.S. and Lee, K.E. (2004). "Glucose/oxygen deprivation induces the 
alteration of synapsin I and phosphosynapsin." Brain Res 996(1): 47-54 
Kalla, T.P., Younger, A., McEwen, J.A. and Inkpen, K. (2003). "Survey of tourniquet use in 
podiatric surgery." J Foot Ankle Surg 42(2): 68-76 
Kam, P.C.A., Kavanaugh, R. and Yoong, F.F.Y. (2001). "The arterial tourniquet: 
pathophysiological consequences and anaesthetic implications." Anaesthesia 56(6): 534-545 
Kam, P.C.A. (2007). "Uses and precautions of tourniquets." The Foundation Years 3(5): 228-229 
Kam, P.C.A. (2005). "Uses and precautions of tourniquets." Surgery (Oxford) 23(2): 76-77 
Kandel, E.R., and Schwarts, J.H., (1985) “Principals of Neural Science.” Second Edition, Elsevier 
Kaneko, S., Wang, J., Kaneko, M., Yiu, G., Hurrell, J.M., Chitnis, T., Khoury, S.J. and He, Z. 
(2006). "Protecting Axonal Degeneration by Increasing Nicotinamide Adenine Dinucleotide 
Levels in Experimental Autoimmune Encephalomyelitis Models." J. Neurosci. 26(38): 9794-
9804 
Kariya, S., Mauricio, R., Dai, Y. and Monani, U.R. (2009). "The neuroprotective factor Wld(s) fails 
to mitigate distal axonal and neuromuscular junction (NMJ) defects in mouse models of 
spinal muscular atrophy." Neurosci Lett 449(3): 246-51 
Kashihara, Y., Kuno, M. and Miyata, Y. (1987). "Cell death of axotomized motoneurones in 
neonatal rats, and its prevention by peripheral reinnervation." J Physiol 386: 135-48 
Kass, I.S. and Lipton, P. (1982). "Mechanisms involved in irreversible anoxic damage to the in vitro 
rat hippocampal slice." J Physiol 332(1): 459-472 
Katz, B. (1966). “Nerve, Muscle, and Synapse.” McGraw-Hill, New York. from Zheng, L., Godfrey, 
A., Waller, J.H., Godfrey, T.G., Chen, K., and Sun, Y., (2000) “Effects of High-
Potassium-Induced Depolarization on Amino Acid Chemistry of the Dorsal Cochlear 
Nucleus in Rat Brain Slices” Neurochem Res 25(6): 823–835 
Kawabuchi, M., Cintra, W.M., Deshpande, S.S. and Albuquerque, E.X. (1991). "Morphological 
and electrophysiological study of distal motor nerve fiber degeneration and sprouting after 
irreversible cholinesterase inhibition." Synapse 8(3): 218-28 
Kawamura, N., Schmelzer, J.D., Wang, Y., Schmeichel, A.M. and Low, P.A. (2005). "The 
therapeutic window of hypothermic neuroprotection in experimental ischemic neuropathy: 
protection in ischemic phase and potential deterioration in later reperfusion phase." Exp 
Neurol 195(2): 305-12 
Kawamura, N., Schmeichel, A.M., Wang, Y., Schmelzer, J.D. and Low, P.A. (2006). "Multiple 
effects of hypothermia on inflammatory response following ischemia-reperfusion injury in 
experimental ischemic neuropathy." Exp Neurol 202(2): 487-96 
Kawamura, Y.M.D., Dyck, P.J.M.D., Shimono, M.M.D., Okazaki, H.M.D., Tateishi, J.M.D. and 
Doi, H.M.D. (1981). "Morphometric Comparison of the Vulnerability of Peripheral Motor 
and Sensory Neurons in Amyotrophic Lateral Sclerosis. [Article]." J Neuropath Exp Neurol 
40(6): 667-675 
Keller-Peck, C.R., Walsh, M.K., Gan, W.B., Feng, G., Sanes, J.R. and Lichtman, J.W. (2001). 
"Asynchronous synapse elimination in neonatal motor units: studies using GFP transgenic 
mice." Neuron 31(3): 381-94 
Kemplay, S. (1984). "Effects of dithiobiuret intoxication on motor end plates in sternocostalis and 
hind limb muscles of female rats." Acta Neuropathol 65(1): 77-84 
Kernell, D. (2006). The Motoneuron and its Muscle Fibres, Oxford University Press 
 212 
Kerschensteiner, M., Schwab, M.E., Lichtman, J.W. and Misgeld, T. (2005). "In vivo imaging of 
axonal degeneration and regeneration in the injured spinal cord." Nature Med. 11: 572-577 
Kerschensteiner, M., Reuter, M.S., Lichtman, J.W. and Misgeld, T. (2008). "Ex vivo imaging of 
motor axon dynamics in murine triangularis sterni explants." Nat Protoc 3(10): 1645-53 
Kessler, F.B. (1966). "The brachial tourniquet and local analgesia in surgery of the upper limb." J 
Trauma 6(1): 43-7 
Khan, A.A., Sun, Y., Jin, K., Mao, X.O., Chen, S., Ellerby, L.M. and Greenberg, D.A. (2007). "A 
neuroglobin-overexpressing transgenic mouse." Gene 398(1-2): 172-6 
Kiebish, M.A., Han, X., Cheng, H., Lunceford, A., Clarke, C.F., Moon, H., Chuang, J.H. and 
Seyfried, T.N. (2008). "Lipidomic analysis and electron transport chain activities in 
C57BL/6J mouse brain mitochondria." J Neurochem 106(1): 299-312 
Kihara, M., Nickander, K.K. and Low, P.A. (1991). "The effect of aging on endoneurial blood 
flow, hyperemic response and oxygen-free radicals in rat sciatic nerve." Brain Res 562: 1-5 
Kihara, M., Schmelzer, J.D., Kihara, Y., Smithson, I.L. and Low, P.A. (1996). "Efficacy of limb 
cooling on the salvage of peripheral nerve from ischemic fiber degeneration." Muscle Nerve 
19(2): 203-9 
Kijima, K., Numakura, C., Izumino, H., Umetsu, K., Nezu, A., Shiiki, T., Ogawa, M., Ishizaki, 
Y., Kitamura, T., Shozawa, Y. and Hayasaka, K. (2005). "Mitochondrial GTPase 
mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A." Hum Genet 116(1-2): 
23-7 
Kim, H.J., Martemyanov, K.A. and Thayer, S.A. (2008). "Human Immunodeficiency Virus Protein 
Tat Induces Synapse Loss via a Reversible Process That Is Distinct from Cell Death." J. 
Neurosci. 28(48): 12604-12613 
Kim, M., Jiang, L.H., Wilson, H.L., North, R.A. and Surprenant, A. (2001). "Proteomic and 
functional evidence for a P2X7 receptor signalling complex." Embo J 20(22): 6347-58 
Kitamoto, T., Shin, R.W., Doh-ura, K., Tomokane, N., Miyazono, M., Muramoto, T. and 
Tateishi, J. (1992). "Abnormal isoform of prion proteins accumulates in the synaptic 
structures of the central nervous system in patients with Creutzfeldt-Jakob disease." Am J 
Pathol 140(6): 1285-94 
Klein, R.L., Dayton, R.D., Leidenheimer, N.J., Jansen, K., Golde, T.E. and Zweig, R.M. (2006). 
"Efficient Neuronal Gene Transfer with AAV8 Leads to Neurotoxic Levels of Tau or Green 
Fluorescent Proteins." Mol Ther 13(3): 517-527: Abstract 
Klitzman, B., Popel, A.S. and Duling, B.R. (1983). "Oxygen transport in resting and contracting 
hamster cremaster muscles: Experimental and theoretical microvascular studies." Microvasc 
Res 25(1): 108-131 
Komara, J.S., Nayini, N.R., Bialick, H.A., Indrieri, R.J., Evans, A.T., Garritano, A.M., Hoehner, 
T.J., Jacobs, W.A., Huang, R.R., Krause, G.S. and et al. (1986). "Brain iron delocalization 
and lipid peroxidation following cardiac arrest." Ann Emerg Med 15(4): 384-9 
Kovalenko, T., Osadchenko, I., Nikonenko, A., Lushnikova, I., Voronin, K., Nikonenko, I., 
Muller, D. and Skibo, G. (2006). "Ischemia-induced modifications in hippocampal CA1 
stratum radiatum excitatory synapses." Hippocampus 16(10): 814-25 
Krestel, H.E., Mihaljevic, A.L.A., Hoffman, D.A. and Schneider, A. (2004). "Neuronal co-
expression of EGFP and -galactosidase in mice causes neuropathology and premature 
death." Neurobiol Disease 17(2): 310-318 
Krnjevic, K. and Miledi, R. (1959). "Presynaptic failure of neuromuscular propagation in rats." J 
Physiol 149: 1-22 
Kuffler, Nicholls and Martin (1984). From Neuron to Brain (2
nd
 Edition), Sinauer Associates, USA 
Lachance, D. and Daube, J. (1991). "Acute peripheral arterial occlusion: Electrophysiological study 
of 32 cases." Muscle Nerve 14(7): 633-639 
Lai, J.C.M., Walsh, J.M., Dennis, S.C. and Clark, J.B. (1977). "Synaptic and non-synaptic 
mitochondria from rat brain: isolation and characterization." J Neurochem 28(3): 625-631 
Laird, F.M., Farah, M.H., Ackerley, S., Hoke, A., Maragakis, N., Rothstein, J.D., Griffin, J., 
Price, D.L., Martin, L.J. and Wong, P.C. (2008). "Motor neuron disease occurring in a 
mutant dynactin mouse model is characterized by defects in vesicular trafficking." J Neurosci 
28(9): 1997-2005 
Lamhonwah, A.M. and Tein, I. (1999). "GFP-Human high-affinity carnitine transporter OCTN2 
protein: subcellular localization and functional restoration of carnitine uptake in mutant cell 
lines with the carnitine transporter defect." Biochem Biophys Res Commun 264(3): 909-14 
 213 
LaMonte, B.H., Wallace, K.E., Holloway, B.A., Shelly, S.S., Ascano, J., Tokito, M., Van Winkle, 
T., Howland, D.S. and Holzbaur, E.L.F. (2002). "Disruption of Dynein/Dynactin Inhibits 
Axonal Transport in Motor Neurons Causing Late-Onset Progressive Degeneration." Neuron 
34(5): 715-727 
Lamprecht, R., Farb, C.R. and LeDoux, J.E. (2002). "Fear memory formation involves p190 
RhoGAP and ROCK proteins through a GRB2-mediated complex." Neuron 36(4): 727-38 
Larsson, L. and Ansved, T. (1995). "Effects of ageing on the motor unit." Progr Neurobiol45(5): 
397-415 
Laser, H., Conforti, L., Morreale, G., Mack, T.G.M., Heyer, M., Haley, J.E., Wishart, T.M., 
Beirowski, B., Walker, S.A., Haase, G., Celik, A., Adalbert, R., Wagner, D., Grumme, 
D., Ribchester, R.R., Plomann, M. and Coleman, M.P. (2006). "The Slow Wallerian 
Degeneration Protein, WldS, Binds Directly to VCP/p97 and Partially Redistributes It within 
the Nucleus." Mol. Biol. Cell 17(3): 1075-1084 
Laskowski, M.B. and Sanes, J.R. (1987). "Topographic mapping of motor pools onto skeletal 
muscles." J Neurosci 7(1): 252-60 
Laufs, T.L., Wystub, S., Reuss, S., Burmester, T., Saaler-Reinhardt, S. and Hankeln, T. (2004). 
"Neuron-specific expression of neuroglobin in mammals." Neurosci Lett 362(2): 83-6 
Le Feuvre, R., Brough, D. and Rothwell, N. (2002). "Extracellular ATP and P2X7 receptors in 
neurodegeneration." Eur J Pharmacol 447(2-3): 261-9 
Le Feuvre, R.A., Brough, D., Touzani, O. and Rothwell, N.J. (2003). "Role of P2X7 receptors in 
ischemic and excitotoxic brain injury in vivo." J Cereb Blood Flow Metab 23(3): 381-4 
Leist, M., Single, B., Castoldi, A.F., Kuhnle, S. and Nicotera, P. (1997). "Intracellular Adenosine 
Triphosphate (ATP) Concentration: A Switch in the Decision Between Apoptosis and 
Necrosis." J. Exp. Med. 185(8): 1481-1486 
Leonardo, R.A. (1943). History of Surgery, New York: Forben Press. from Kessler, F.B., (1966) The 
briachial tourniquet and local analgesia in surgery of the upper limb, J Trauma, 6(1):43-7 
Leong, S.F., Lai, J.C., Lim, L. and Clark, J.B. (1984). "The activities of some energy-metabolising 
enzymes in nonsynaptic (free) and synaptic mitochondria derived from selected brain 
regions." J Neurochem 42(5): 1306-12 
Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., 
Gwinn-Hardy, K., Murphy, M.P., Baker, M., Yu, X., Duff, K., Hardy, J., Corral, A., 
Lin, W., Yen, S.-H., Dickson, D.W., Davies, P. and Hutton, M. (2000). "Neurofibrillary 
tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) 
tau protein." Nat Genet 25(4): 402-405 
Li, R.C., Pouranfar, F., Lee, S.K., Morris, M.W., Wang, Y. and Gozal, D. (2007). "Neuroglobin 
protects PC12 cells against beta-amyloid-induced cell injury." Neurobiol Aging 
Li, R.C., Morris, M.W., Lee, S.K., Pouranfar, F., Wang, Y. and Gozal, D. (2008). "Neuroglobin 
protects PC12 cells against oxidative stress." Brain Res 1190: 159-66 
Liberski, P.P. and Budka, H. (1999). "Neuroaxonal pathology in Creutzfeldt-Jakob disease." Acta 
Neuropathol 97(4): 329-34 
Lichtman, J.W., Magrassi, L. and Purves, D. (1987). "Visualization of neuromuscular junctions 
over periods of several months in living mice." J Neurosci 7(4): 1215-22 
Lichtman, J.W. and Fraser, S.E. (2001). "The neuronal naturalist: watching neurons in their native 
habitat." Nat Neurosci 4 Suppl: 1215-20 
Lichtman, J.W. and Sanes, J.R. (2003). "Watching the neuromuscular junction." J Neurocytol 32(5-
8): 767-75 
Liddel, E.G.T. (1952). "Charles Scott Sherrington 1857-1952." Obituary notices of fellows of the 
Royal Society 8(21): 241-270 
Lipton, P. (1999). "Ischemic Cell Death in Brain Neurons." Physiol. Rev. 79(4): 1431-1568 
Liu, H.-S., Jan, M.-S., Chou, C.-K., Chen, P.-H. and Ke, N.-J. (1999). "Is Green Fluorescent 
Protein Toxic to the Living Cells?" Biochem Biophys Res Comm 260(3): 712-717 
Lobner, D. and Lipton, P. (1993). "Intracellular calcium levels and calcium fluxes in the CA1 region 
of the rat hippocampal slice during in vitro ischemia: relationship to electrophysiological cell 
damage." J. Neurosci. 13(11): 4861-4871 
Lodish, H., Berk, A., Kaiser, C.A., Krieger, M., Scott, M.P., Bretscher, A., Pleogh, H., and 
Matsudaira, P. (2008) “Molecular Cell Biology”. Sixth edition, W.H. Freeman & Company 
Longstaff, A. (2000). “Neuroscience: Instant Notes” BIOS Scientific Publishers 
 214 
LoPachin, R.M., Ross, J.F. and Lehning, E.J. (2002). "Nerve terminals as the primary site of 
acrylamide action: a hypothesis." Neurotox 23(1): 43-59 
LoPachin, R.M., Balaban, C.D. and Ross, J.F. (2003). "Acrylamide axonopathy revisited." Toxico 
App Pharmaco 188(3): 135-153 
Lorinze, A. and Nusser, Z. (2008) “Specificity of Immunoreactions: The Importance of Testing 
Specificity in Each Method” J Neurosci 28(37): 9083-9086 
Low, L.K. and Cheng, H.J. (2005). "A little nip and tuck: axon refinement during development and 
axonal injury." Curr Opin Neurobiol 15(5): 549-56 
Low, P.A. and Tuck, R.R. (1984). "Effects of changes of blood pressure, respiratory acidosis and 
hypoxia on blood flow in the sciatic nerve of the rat." J Physiol 347: 513-24 
Low, P.A., Tuck, R.R., Dyck, P.J., Schmelzer, J.D. and Yao, J.K. (1984). "Prevention of some 
electrophysiological and biochemical abnormalities with oxygen supplementation in 
experimental diabetic neuropathy." Proc Natl Acad Sci U S A 81(21): 6894-8 
Low, P.A., Ward, K., Schmelzer, J.D. and Brimijoin, S. (1985). "Ischemic conduction failure and 
energy metabolism in experimental diabetic neuropathy." Am J Physiol Endocrinol Metab 
248(4): E457-462 
Low, P.A., Schmelzer, J.D. and Ward, K.K. (1986). "The effect of age on energy metabolism and 
resistance to ischaemic conduction failure in rat peripheral nerve." J Physiol 374: 263-271 
Lu, J. and Lichtman, J.W. (2007). "Imaging the neuromuscular junction over the past centuries ?" 
Sheng Li Xue Bao 59(6): 683-96 
Luduena, R.F., Anderson, W.H., Prasad, V., Jordan, M.A., Ferrigni, K.C., Roach, M.C., 
Horowitz, P.M., Murphy, D.B. and Fellous, A. (1986). "Interactions of vinblastine and 
maytansine with tubulin." Ann N Y Acad Sci 466: 718-32 
Lunn, E.R., Perry, V.H., Brown, M.C., Rosen, H. and Gordon, S. (1989). "Absence of Wallerian 
degeneration does not hinder regeneration in peripheral nerve." Eur J Neurosci 1(1): 27-33 
Luo, L. and O'Leary, D.D. (2005). "Axon retraction and degeneration in development and disease." 
Annu Rev Neurosci 28: 127-56 
Lyon, M.F., Ogunkolade, B.W., Brown, M.C., Atherton, D.J. and Perry, V.H. (1993). "A gene 
affecting Wallerian nerve degeneration maps distally on mouse chromosome 4." Proc Natl 
Acad Sci U S A 90(20): 9717-20 
MacDonald, B.K., Cockerell, O.C., Sander, J.W. and Shorvon, S.D. (2000). "The incidence and 
lifetime prevalence of neurological disorders in a prospective community-based study in the 
UK." Brain 123 ( Pt 4): 665-76 
Mack, T.G., Reiner, M., Beirowski, B., Mi, W., Emanuelli, M., Wagner, D., Thomson, D., 
Gillingwater, T., Court, F., Conforti, L., Fernando, F.S., Tarlton, A., Andressen, C., 
Addicks, K., Magni, G., Ribchester, R.R., Perry, V.H. and Coleman, M.P. (2001). 
"Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat 
chimeric gene." Nat Neurosci 4(12): 1199-206 
Mak, G.W.-Y., Wong, C.-H. and Tsui, S.K.-W. (2007). "Green fluorescent protein induces the 
secretion of inflammatory cytokine interleukin-6 in muscle cells." Anal Biochem 362(2): 
296-298 
Makitie, J. and Teravainen, H. (1977a). "Ultrastructure of striated muscle of the rat after temporary 
ischemia." Acta Neuropathol 37(3): 237-45 
Makitie, J. and Teravainen, H. (1977b). "Peripheral nerve injury and recovery after temporary 
ischemia." Acta Neuropathol 37(1): 55-63 
Malanjum, L.S. and Fischer, B. (2006). "Procedures under tourniquet." Anaesth Inten Care Med  
7(3): 81-83 
Malik, R.A., Newrick, P.G., Sharma, A.K., Jennings, A., Ah-See, A.K., Mayhew, T.M., 
Jakubowski, J., Boulton, A.J. and Ward, J.D. (1989). "Microangiopathy in human diabetic 
neuropathy: relationship between capillary abnormalities and the severity of neuropathy." 
Diabetologia 32(2): 92-102 
Malik, R.A., Masson, E.A., Sharma, A.K., Lye, R.H., Ah-See, A.K., Compton, A.M., Tomlinson, 
D.R., Hanley, S.P. and Boulton, A.J. (1990). "Hypoxic neuropathy: relevance to human 
diabetic neuropathy." Diabetologia 33(5): 311-8 
Malthankar-Phatak, G.H., Patel, A.B., Xia, Y., Hong, S., Chowdhury, G.M., Behar, K.L., Orina, 
I.A. and Lai, J.C. (2008). "Effects of continuous hypoxia on energy metabolism in cultured 
cerebro-cortical neurons." Brain Res 
 215 
Mammen, P.P., Shelton, J.M., Goetsch, S.C., Williams, S.C., Richardson, J.A., Garry, M.G. and 
Garry, D.J. (2002). "Neuroglobin, a novel member of the globin family, is expressed in 
focal regions of the brain." J Histochem Cytochem 50(12): 1591-8 
Mars, M. and Gregory, M.A. (1991). "A histometric analysis of skeletal myofibers following 90 min 
of tourniquet ischemia and reperfusion." J Surg Res 50(2): 191-195 
Martone, M.E., Jones, Y.Z., Young, S.J., Ellisman, M.H., Zivin, J.A. and Hu, B.-R. (1999). 
"Modification of Postsynaptic Densities after Transient Cerebral Ischemia: A Quantitative 
and Three-Dimensional Ultrastructural Study." J. Neurosci. 19(6): 1988-1997 
Maruhashi, J. and Wright, E.B. (1967). "Effect of oxygen lack on the single isolated mammalian 
(rat) nerve fiber." J Neurophysiol 30(3): 434-52 
Matsumoto, A., Matsumoto, S., Sowers, A.L., Koscielniak, J.W., Trigg, N.J., Kuppusamy, P., 
Mitchell, J.B., Subramanian, S., Krishna, M.C. and Matsumoto, K.-I. (2005). "Absolute 
oxygen tension (pO2) in murine fatty and muscle tissue as determined by EPR." Mag Reson 
Med 54(6): 1530-1535 
Matthews, P.B. (1964). "Muscle Spindles and Their Motor Control." Physiol Rev 44: 219-88 
Mattiazzi, M., D'Aurelio, M., Gajewski, C.D., Martushova, K., Kiaei, M., Beal, M.F. and 
Manfredi, G. (2002). "Mutated human SOD1 causes dysfunction of oxidative 
phosphorylation in mitochondria of transgenic mice." J Biol Chem 277(33): 29626-33 
Mattson, M.P., Gleichmann, M. and Cheng, A. (2008). "Mitochondria in Neuroplasticity and 
Neurological Disorders."  Neuron 60(5): 748-766 
Matute, C., Torre, I., Perez-Cerda, F., Perez-Samartin, A., Alberdi, E., Etxebarria, E., Arranz, 
A.M., Ravid, R., Rodriguez-Antiguedad, A., Sanchez-Gomez, M. and Domercq, M. 
(2007). "P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and 
Ameliorates Experimental Autoimmune Encephalomyelitis." J. Neurosci. 27(35): 9525-9533 
McCann, C.M., Nguyen, Q.T., Santo Neto, H. and Lichtman, J.W. (2007). "Rapid synapse 
elimination after postsynaptic protein synthesis inhibition in vivo." J Neurosci 27(22): 6064-
7 
McElvenny, R.T. (1945). "The tourniquet : Its clinical application." Amer J Surg 69(1): 94-106 
McEwen, J.A. (1981). "Complications of and improvements in pneumatic tourniquets used in 
surgery." Med Instrum 15(4): 253-7 
McGraw, R.W. and McEwen, J.A. (1987). Unsatisfactory Results in Hand Surgery: The tourniquet. 
The Hand and Upper Limb. R. M. McFarlane, Churchill Livingstone. 3: 5-13 
McKenzie, D., Nukada, H., van Rij, A.M. and McMorran, P.D. (1999). "Endoneurial 
microvascular abnormalities of sural nerve in non-diabetic chronic atherosclerotic occlusive 
disease." J Neuro Sci 162(1): 84-88 
McLean, I.W. and Nakane, P.K. (1974). "Periodate-lysine-paraformaldehyde fixative. A new 
fixation for immunoelectron microscopy." J Histochem Cytochem 22(12): 1077-83 
Mehta, S.L., Manhas, N., and Raghubir, R. (2007) “Molecular targets in cerebral ischemia for 
developing novel therapeutics.” Brain Res Rev 54(1): 34-66 
Meunier, F.A., Schiavo, G. and Molgo, J. (2002). "Botulinum neurotoxins: from paralysis to 
recovery of functional neuromuscular transmission." J Physiol Paris 96(1-2): 105-13 
Mi, W., Beirowski, B., Gillingwater, T.H., Adalbert, R., Wagner, D., Grumme, D., Osaka, H., 
Conforti, L., Arnhold, S., Addicks, K., Wada, K., Ribchester, R.R. and Coleman, M.P. 
(2005). "The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in 
gracile axonal dystrophy mice." Brain 128(Pt 2): 405-16 
Middleton, K.W.D. and Varian, J.P. (1974). "Tourniquet Paralysis1." ANZ J Surg 44(2): 124-128 
Miledi, R. and Slater, C.R. (1968). "Electrophysiology and Electron-Microscopy of Rat 
Neuromuscular Junctions After Nerve Degeneration." Proc Roy Soc Lond B Biol Sci 
169(1016): 289-306 
Miledi, R. and Slater, C.R. (1970). "On the degeneration of rat neuromuscular junctions after nerve 
section." J Physiol 207(2): 507-28 
Miller, K.E. and Sheetz, M.P. (2004). "Axonal mitochondrial transport and potential are correlated." 
J Cell Sci 117(13): 2791-2804 
Milnerwood, A.J., Cummings, D.M., Dallerac, G.M., Brown, J.Y., Vatsavayai, S.C., Hirst, M.C., 
Rezaie, P. and Murphy, K.P.S.J. (2006). "Early Development of Aberrant Synaptic 
Plasticity in a Mouse Model of Huntington's Disease." Hum. Mol. Genet.: ddl092 
Misgeld, T. and Kerschensteiner, M. (2006). "In vivo imaging of the diseased nervous system." Nat 
Rev Neurosci 7(6): 449-63 
 216 
Mitsui, Y., Okamoto, K., Martin, D.P., Schmelzer, J.D. and Low, P.A. (1999a). "The expression of 
proinflammatory cytokine mRNA in the sciatic-tibial nerve of ischemia-reperfusion injury." 
Brain Res 844(1-2): 192-5 
Mitsui, Y., Schmelzer, J.D., Zollman, P.J., Kihara, M. and Low, P.A. (1999b). "Hypothermic 
neuroprotection of peripheral nerve of rats from ischaemia-reperfusion injury." Brain 122 ( 
Pt 1): 161-9 
Mitsui, Y., Schmelzer, J.D., Zollman, P.J., Mitsui, M., Kihara, M. and Low, P.A. (1999c). 
"Hypothermic neuroprotection of peripheral nerve of rats from ischemia-reperfusion injury: 
intraischemic vs. reperfusion hypothermia." Brain Res 827(1-2): 63-9 
Miura, H., Oda, K., Endo, C., Yamazaki, K., Shibasaki, H. and Kikuchi, T. (1993). "Progressive 
degeneration of motor nerve terminals in GAD mutant mouse with hereditary sensory 
axonopathy." Neuropathol Appl Neurobiol 19(1): 41-51 
Moens, L. and Dewilde, S. (2000). "Globins in the brain." Nature 407(6803): 461-2 
Moens, U., Mathiesen, I., Ghelue, M.V. and Rekvig, O.P. (2002). "Green fluorescent protein 
modified to bind DNA initiates production of anti-DNA antibodies when expressed in vivo." 
Mol Immunol 38(7): 505-514 
Mohamed, A.F. (1989). "Rapid neuromuscular remodeling following limb immobilization." Anat Rec 
224(1): 102-109 
Mohamed, A.F. (1995). "Chronic corticosterone treatment-induced ultrastructural changes at rat 
neuromuscular junction." The Anatomical Record 242(3): 424-431 
Mohler, L.R., Pedowitz, R.A., Lopez, M.A. and Gershuni, D.H. (1999). "Effects of tourniquet 
compression on neuromuscular function." Clin Orthop Relat Res(359): 213-20 
Moldaver, J. (1954). "Tourniquet paralysis syndrome." AMA Arch Surg 68(2): 136-44 
Moores, T.S., Hasdemir, B., Vega-Riveroll, L., Deuchars, J. and Parson, S.H. (2005). "Properties 
of presynaptic P2X7-like receptors at the neuromuscular junction." Brain Res 1034(1-2): 40-
50 
Muller, K.A., Ryals, J.M., Feldman, E.L. and Wright, D.E. (2008). "Abnormal Muscle Spindle 
Innervation and Large-Fiber Neuropathy in Diabetic Mice." Diabetes 57(6): 1693-1701 
Munoz-Martinez, E.J., Cueva, J. and Joseph-Nathan, P. (1983). "Denervation caused by tullidora 
(Karwinskia humboldtiana)." Neuropathol Appl Neurobiol 9(2): 121-34 ABSTRACT 
Murphy, S. and O'Connor, C. (2007). "Modern pneumatic tourniquets in orthopaedic nursing 
practice." J Orthop Nurs 11(3-4): 224-228 
Murray, L.M., Comley, L.H., Thomson, D., Parkinson, N., Talbot, K. and Gillingwater, T.H. 
(2008a). "Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic 
pathology at the neuromuscular junction in mouse models of spinal muscular atrophy." Hum 
Mol Genet 17(7): 949-62 
Murray, L.M., Thomson, D., Conklin, A., Wishart, T.M. and Gillingwater, T.H. (2008b). "Loss 
of translation elongation factor (eEF1A2) expression in vivo differentiates between Wallerian 
degeneration and dying-back neuronal pathology." J Anat 213(6): 633-45 
Nachmansohn, D. and Machado, A.L. (1943). "The formation of acetylcholine. A new enzyme: 
"Choline acetylase"." J Neurophysiol 6(5): 397-403 
Naga, K.K., Sullivan, P.G. and Geddes, J.W. (2007). "High cyclophilin D content of synaptic 
mitochondria results in increased vulnerability to permeability transition." J Neurosci 27(28): 
7469-75 
Nagamatsu, M., Schmelzer, J.D., Zollman, P.J., Smithson, I.L., Nickander, K.K. and Low, P.A. 
(1996). "Ischemic reperfusion causes lipid peroxidation and fiber degeneration." Muscle 
Nerve 19(1): 37-47 
Nagao, S., Kitaoka, T., Fujita, K., Kuyama, H. and Ohkawa, M. (1996). "Effect of tris-
(hydroxymethyl)-aminomethane on experimental focal cerebral ischemia." Exp Brain Res 
111(1): 51-6 
Nakano, H., Masuda, K., Sasaki, S. and Katsuta, S. (1997). "Oxidative enzyme activity and soma 
size in motoneurons innervating the rat slow-twitch and fast-twitch muscles after chronic 
activity." Brain Res Bull 43(2): 149-54 
Nakano, S., Kogure, K. and Fujikura, H. (1990). "Ischemia-induced slowly progressive neuronal 
damage in the rat brain." Neurosci 38(1): 115-24 
Newbery, H.J., Gillingwater, T., Dharmasaroja, P., Peters, J., Wharton, S.B., Thomson, D., 
Ribchester, R.R. and Abbott, C.M. (2005). "Progressive loss of motor neuron function in 
 217 
wasted mice: effects of a spontaneous null mutation in the gene for the eEFI A2 translation 
factor." J Neuropathol Exp Neurol 64(4): 295-303 
Newrick, P.G., Wilson, A.J., Jakubowski, J., Boulton, A.J. and Ward, J.D. (1986). "Sural nerve 
oxygen tension in diabetes." Br Med J (Clin Res Ed) 293(6554): 1053-4 
Nicholls, D.G. and Budd, S.L. (2000). "Mitochondria and Neuronal Survival." Physiol. Rev. 80(1): 
315-360 
Nicotera, P., Leist, M., Fava, E., Berliocchi, L. and Volbracht, C. (2000). "Energy requirement for 
caspase activation and neuronal cell death." Brain Pathol 10(2): 276-82 
Niell, C.M. and Smith, S.J. (2004). "Live optical imaging of nervous system development." Annu 
Rev Physiol 66: 771-98 
Niewiadomska, M., Kulczycki, J., Wochnik-Dyjas, D., Szpak, G.M., Rakowicz, M., Lojkowska, 
W., Niedzielska, K., Inglot, E., Wieclawska, M., Glazowski, C. and Tarnowska-
Dziduszko, E. (2002). "Impairment of the peripheral nervous system in Creutzfeldt-Jakob 
disease." Arch Neurol 59(9): 1430-6 
Nishimura, H., Matsuyama, T., Obata, K., Nakajima, Y., Kitano, H., Sugita, M. and Okamoto, 
M. (2000). "Changes in Mint1, a Novel Synaptic Protein, After Transient Global Ischemia in 
Mouse Hippocampus." J Cereb Blood Flow Metab 20(10): 1437-1445 
Nishimura, M. (1986). "Factors influencing an increase in spontaneous transmitter release by hypoxia 
at the mouse neuromuscular junction." J Physiol 372: 303-13 
Nitz, A.J., Dobner, J.J. and Matulionis, D.H. (1986). "Pneumatic tourniquet application and nerve 
integrity: Motor function and electrophysiology." Exp Neurol 94(2): 264-279 
Nogawa, S., Zhang, F., Ross, M.E. and Iadecola, C. (1997). "Cyclo-Oxygenase-2 Gene Expression 
in Neurons Contributes to Ischemic Brain Damage." J. Neurosci. 17(8): 2746-2755 
North, R.A. and Surprenant, A. (2000). "Pharmacology of Cloned P2X Receptors." Ann Rev Pharm 
Toxicol40(1): 563-580 
North, R.A. (2002). "Molecular Physiology of P2X Receptors." Physiol. Rev. 82(4): 1013-1067 
Northington, F.J., Zelaya, M.E., O'Riordan, D.P., Blomgren, K., Flock, D.L., Hagberg, H., 
Ferriero, D.M. and Martin, L.J. (2007). "Failure to complete apoptosis following neonatal 
hypoxia-ischemia manifests as "continuum" phenotype of cell death and occurs with multiple 
manifestations of mitochondrial dysfunction in rodent forebrain." Neurosci 149(4): 822-33 
Nowak, D., Bruch, M., Arnaud, F., Fabel, H., Kiessling, D., Nolte, D., Overlack, A., Rolke, M., 
Ulmer, W.T., Worth, H. and et al. (1990). "Peripheral neuropathies in patients with chronic 
obstructive pulmonary disease: a multicenter prevalence study." Lung 168(1): 43-51 
Nukada, H. and McMorran, P.D. (1994). "Perivascular demyelination and intramyelinic oedema in 
reperfusion nerve injury." J Anat 185 ( Pt 2): 259-66 
Nukada, H., van Rij, A.M., Packer, S.G.K. and McMorran, P.D. (1996). "Pathology of acute and 
chronic ischaemic neuropathy in atherosclerotic peripheral vascular disease." Brain 119(5): 
1449-1450 
O'Hanlon, G.M., Plomp, J.J., Chakrabarti, M., Morrison, I., Wagner, E.R., Goodyear, C.S., 
Yin, X., Trapp, B.D., Conner, J., Molenaar, P.C., Stewart, S., Rowan, E.G. and 
Willison, H.J. (2001). "Anti-GQ1b ganglioside antibodies mediate complement-dependent 
destruction of the motor nerve terminal." Brain 124(Pt 5): 893-906 
O'Hanlon, G.M., Humphreys, P.D., Goldman, R.S., Halstead, S.K., Bullens, R.W., Plomp, J.J., 
Ushkaryov, Y. and Willison, H.J. (2003). "Calpain inhibitors protect against axonal 
degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury." 
Brain 126(Pt 11): 2497-509 
Obara, M., Szeliga, M. and Albrecht, J. (2008). "Regulation of pH in the mammalian central 
nervous system under normal and pathological conditions: Facts and hypotheses." 
Neurochem Int 52(6): 905-919 
Ochoa, J., Fowler, T.J. and Gilliatt, R.W. (1972). "Anatomical changes in peripheral nerves 
compressed by a pneumatic tourniquet." J Anat 113(Pt 3): 433-55 
Ogata, T. and Mori, M. (1964). "Histochemical study of oxidative enzymes in vertebrate muscle." J. 
Histochem. Cytochem. 12(3): 171-182 
Ogata, T. and Yamasaki, Y. (1985). "Scanning electron-microscopic studies on the three-
dimensional structure of mitochondria in the mammalian red, white and intermediate muscle 
fibers." Cell Tissue Res 241(2): 251-6 
 218 
Ohara, W.M., Pedowitz, R.A., Oyama, B.K. and Gershuni, D.H. (1996). "Comparison of 
functional deficits in the rabbit tibialis anterior following tourniquet ischemia and tourniquet 
compression." J Orthop Res 14(4): 626-32 
Okamoto, M., Longenecker, H.E., Jr., Riker, W.F., Jr. and Song, S.K. (1971). "Destruction of 
mammalian motor nerve terminals by black widow spider venom." Science 172(984): 733-6 
Oldfors, A. (1981). "Nerve fibre degeneration of the central and peripheral nervous systems in severe 
protein deprivation in rats." Acta Neuropathol 54(2): 121-7 
Oldfors, A. and Persson, M. (1982). "Peripheral nerve fibre degeneration in protein-deprived young 
rats. An ultrastructural study." Acta Neuropathol 57(1): 1-6 
Olney, J.W. (1969). "Brain lesions, obesity, and other disturbances in mice treated with monosodium 
glutamate." Science 164(880): 719-21 
Omatsu-Kanbe, M., Shibata, M., Yamamoto, T., Isono, T. and Matsuura, H. (2004). "Actin 
filaments play a permissive role in the inhibition of store-operated Ca
2+
 entry by extracellular 
ATP in rat brown adipocytes." Biochem J 381(Pt 2): 389-96 
Ordy, J.M., Wengenack, T.M., Bialobok, P., Coleman, P.D., Rodier, P., Baggs, R.B., Dunlap, 
W.P. and Kates, B. (1993). "Selective Vulnerability and Early Progression of Hippocampal 
CA1 Pyramidal Cell Degeneration and GFAP-Positive Astrocyte Reactivity in the Rat Four-
Vessel Occlusion Model of Transient Global Ischemia." Exp Neurol 119(1): 128-139 
Pahud, G., Salem, N., van de Goor, J., Medilanski, J., Pellegrinelli, N. and Eder-Colli, L. (1998). 
"Study of subcellular localization of membrane-bound choline acetyltransferase in 
Drosophila central nervous system and its association with membranes." Eur J Neurosci 
10(5): 1644-53 
Palade, G.E. and Palay, S.L. (1954). "Electron microscope observations of the interneuronal and 
neuromuscular synapse." Anat Rec 118(2): 335-336 
Parson, S.H., Mackintosh, C.L. and Ribchester, R.R. (1997). "Elimination of motor nerve 
terminals in neonatal mice expressing a gene for slow wallerian degeneration (C57Bl/Wlds)." 
Eur J Neurosci 9(8): 1586-92 
Parson, S.H., Ribchester, R.R., Davie, N., Gandhi, N.P., Malik, R.Q., Gillingwater, T.H. and 
Thomson, D. (2004). "Axotomy-dependent and -independent synapse elimination in organ 
cultures of Wld(s) mutant mouse skeletal muscle." J Neurosci Res 76(1): 64-75 
Partanen, S., Haapanen, A., Kielar, C., Pontikis, C., Alexander, N., Inkinen, T., Saftig, P., 
Gillingwater, T.H., Cooper, J.D. and Tyynela, J. (2008). "Synaptic changes in the 
thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal 
ceroid-lipofuscinosis." J Neuropathol Exp Neurol 67(1): 16-29 
Pastor, A.M., Moreno-Lopez, B., De La Cruz, R.R. and Delgado-Garcia, J.M. (1997). "Effects of 
botulinum neurotoxin type A on abducens motoneurons in the cat: ultrastructural and 
synaptic alterations." Neurosci 81(2): 457-78 
Patlak, M. (2002). "New weapons to combat an ancient disease: treating diabetes." Faseb J 16(14): 
1853 
Patterson, S. and Klenerman, L. (1979). "The effect of pneumatic tourniquets on the ultrastructure 
of skeletal muscle." J Bone Joint Surg Br 61-B(2): 178-183 
Pedowitz, R.A., Fridén, J. and Thornell, L.-E. (1992). "Skeletal muscle injury induced by a 
pneumatic tourniquet: An enzyme- and immunohistochemical study in rabbits." J Surg Res 
52(3): 243-250 
Perez, D., de la Torre, R.G., Carrio, I., Pinto, J. and Moris, G. (2008). "Cryoglobulinaemic 
neuropathy: a further cause of bilateral sciatic neuropathy." Int Arch Med 1(1): 18 
Perry, V.H., Brown, M.C., Lunn, E.R., Tree, P. and Gordon, S. (1990). "Evidence that very slow 
Wallerian degeneration in C57BL/Ola mice is an intrinsic property of the peripheral nerve." 
Eur J  Neurosci. 2: 802-808 
Peters, A., Sethares, C. and Moss, M.B. (1998). "The effects of aging on layer 1 in area 46 of 
prefrontal cortex in the rhesus monkey." Cereb Cortex 8(8): 671-84 
Petzold, A. (2005). "Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration 
and loss." J Neuro Sci 233(1-2): 183-198 
Pfeiffer, Z.A., Aga, M., Prabhu, U., Watters, J.J., Hall, D.J. and Bertics, P.J. (2004). "The 
nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 
264.7 macrophages via p38 MAP kinase and Rho." J Leukoc Biol 75(6): 1173-82 
Piantadosi, C.A. and Zhang, J. (1996). "Mitochondrial Generation of Reactive Oxygen Species 
After Brain Ischemia in the Rat." Stroke 27(2): 327-332 
 219 
Pierzga, J.M. and Segal, S.S. (1994). "Spatial relationships between neuromuscular junctions and 
microvessels in hamster cremaster muscle." Microvasc Res 48(1): 50-67 
Polla, B., D'Antona, G., Bottinelli, R. and Reggiani, C. (2004). "Respiratory muscle fibres: 
specialisation and plasticity." Thorax 59(9): 808-17 
Pop-Busui, R., Sima, A. and Stevens, M. (2006). "Diabetic neuropathy and oxidative stress." 
Diabetes Metab Res Rev 22(4): 257-73 
Portera-Cailliau, C., Price, D.L. and Martin, L.J. (1997). "Excitotoxic neuronal death in the 
immature brain is an apoptosis-necrosis morphological continuum." The Journal of 
Comparative Neurology 378(1): 10-87 
Prasarnpun, S., Walsh, J. and Harris, J.B. (2004). "Beta-bungarotoxin-induced depletion of 
synaptic vesicles at the mammalian neuromuscular junction." Neuropharmacology 47(2): 
304-14 
Prasarnpun, S., Walsh, J., Awad, S.S. and Harris, J.B. (2005). "Envenoming bites by kraits: the 
biological basis of treatment-resistant neuromuscular paralysis." Brain 128(Pt 12): 2987-96 
Prineas, J. (1969a). "The pathogenesis of dying-back polyneuropathies. II. An ultrastructural study of 
experimental acrylamide intoxication in the cat." J Neuropathol Exp Neurol 28(4): 598-621 
Prineas, J. (1969b). "The pathogenesis of dying-back polyneuropathies. I. An ultrastructural study of 
experimental tri-ortho-cresyl phosphate intoxication in the cat." J Neuropathol Exp Neurol 
28(4): 571-97 
Pubill, D., Dayanithi, G., Siatka, C., Andres, M., Dufour, M.N., Guillon, G. and Mendre, C. 
(2001). "ATP induces intracellular calcium increases and actin cytoskeleton disaggregation 
via P2x receptors." Cell Calcium 29(5): 299-309 
Pun, S., Sigrist, M., Santos, A.F., Ruegg, M.A., Sanes, J.R., Jessell, T.M., Arber, S. and Caroni, 
P. (2002). "An intrinsic distinction in neuromuscular junction assembly and maintenance in 
different skeletal muscles." Neuron 34(3): 357-70 
Pun, S., Santos, A.F., Saxena, S., Xu, L. and Caroni, P. (2006). "Selective vulnerability and 
pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF." Nat 
Neurosci 9(3): 408-19 
Qi, W.N., Yan, Z.Q., Whang, P.G., Zhou, Q., Chen, L.E., Seaber, A.V., Stamler, J.S. and 
Urbaniak, J.R. (2001). "Gene and protein expressions of nitric oxide synthases in ischemia-
reperfused peripheral nerve of the rat." Am J Physiol Cell Physiol 281(3): C849-56 
Queiroz, L.S. and Duchen, L.W. (1982). "Effects of Latrodectus Spider Venoms on Sensory and 
Motor Nerve Terminals of Muscle Spindles." Proc Roy Soc Lond B Biol Sci 216(1202): 103-
110 
Raff, M.C., Whitmore, A.V. and Finn, J.T. (2002). "Axonal self-destruction and 
neurodegeneration." Science 296(5569): 868-71 
Raffaelli, N., Sorci, L., Amici, A., Emanuelli, M., Mazzola, F. and Magni, G. (2002). 
"Identification of a novel human nicotinamide mononucleotide adenylyltransferase." 
Biochem Biophys Res Commun 297(4): 835-40 
Rafuse, V.F. and Gordon, T. (1998). "Incomplete rematching of nerve and muscle properties in 
motor units after extensive nerve injuries in cat hind limb muscle." J Physiol 509 ( Pt 3): 
909-26 
Ramji, N., Toth, C., Kennedy, J. and Zochodne, D.W. (2007). "Does diabetes mellitus target motor 
neurons?" Neurobiology of Disease 26(2): 301-311 
Ranvier, L., Ed. (1874). De quelques faits relatifs a l'histologie et à la physiologie des muscles striés. 
Archives de Physiologie Normale et Pathologique. From: Kernell, D (2006) The 
motorneuron and its muscle fibres; monographs of the physiological society 50. Oxford 
University Press 
Reid, B., Slater, C.R. and Bewick, G.S. (1999). "Synaptic Vesicle Dynamics in Rat Fast and Slow 
Motor Nerve Terminals." J. Neurosci. 19(7): 2511-2521 
Reuss, S., Saaler-Reinhardt, S., Weich, B., Wystub, S., Reuss, M.H., Burmester, T. and Hankeln, 
T. (2002). "Expression analysis of neuroglobin mRNA in rodent tissues." Neurosci 115(3): 
645-56 
Ribchester, R.R., Tsao, J.W., Barry, J.A., Asgari-Jirhandeh, N., Perry, V.H. and Brown, M.C. 
(1995). "Persistence of Neuromuscular Junctions after Axotomy in Mice with Slow 
Wallerian Degeneration (C57BL/Wlds)." Eur J Neurosci  7(7): 1641-1650 
Ribchester, R.R., Thomson, D., Wood, N.I., Hinks, T., Gillingwater, T.H., Wishart, T.M., Court, 
F.A. and Morton, A.J. (2004). "Progressive abnormalities in skeletal muscle and 
 220 
neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation." 
Eur J Neurosci 20(11): 3092-114 
Rich, M. and Lichtman, J.W. (1989). "Motor nerve terminal loss from degenerating muscle fibers." 
Neuron 3(6): 677-88 
Rich, M.M., Colman, H. and Lichtman, J.W. (1994). "In vivo imaging shows loss of synaptic sites 
from neuromuscular junctions in a model of myasthenia gravis." Neurology 44(11): 2138-45 
Ridge, J.W. (1972). "Hypoxia and the energy charge of the cerebral adenylate pool." J Biochem 
127(2): 351-5 
Rigoni, M., Paoli, M., Milanesi, E., Caccin, P., Rasola, A., Bernardi, P. and Montecucco, C. 
(2008). "Snake Phospholipase A2 Neurotoxins Enter Neurons, Bind Specifically to 
Mitochondria, and Open Their Transition Pores." J. Biol. Chem. 283(49): 34013-34020 
Riley, D.A. (1981). "Ultrastructural evidence for axon retraction during the spontaneous elimination 
of polyneuronal innervation of the rat soleus muscle." J Neurocytol 10(3): 425-40 
Riley, D.A., Ilyina-Kakueva, E.I., Ellis, S., Bain, J.L., Slocum, G.R. and Sedlak, F.R. (1990). 
"Skeletal muscle fiber, nerve, and blood vessel breakdown in space-flown rats." Faseb J 
4(1): 84-91 
Rizzoli, S.O., Richards, D.A. and Betz, W.J. (2003). "Monitoring synaptic vesicle recycling in frog 
motor nerve terminals with FM dyes." J Neurocytol 32(5-8): 539-49 
Roberts, M., Vincent, A., Newsom-Davis, J. and Willison, H. (1994). "Serum factor in Miller-
Fisher variant of Guillain-Barré syndrome and neurotransmitter release."  Lancet 343(8895): 
454-455 
Rogozhin, A.A., Pang, K.K., Bukharaeva, E., Young, C. and Slater, C.R. (2008). "Recovery of 
mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin 
A." J Physiol 586(13): 3163-82 
Rolfe, D.F. and Brown, G.C. (1997). "Cellular energy utilization and molecular origin of standard 
metabolic rate in mammals." Physiol Rev 77(3): 731-58 
Rorabeck, C.H. (1980). "Tourniquet-induced nerve ischemia: an experimental investigation." J 
Trauma 20(4): 280-6 
Rosenthal, J.L. and Taraskevich, P.S. (1977). "Reduction of multiaxonal innervation at the 
neuromuscular junction of the rat during development." J Physiol 270(2): 299-310 
Rothman, S. (1984). "Synaptic release of excitatory amino acid neurotransmitter mediates anoxic 
neuronal death." J Neurosci 4(7): 1884-91 
Rothman, S.M. (1983). "Synaptic Activity Mediates Death of Hypoxic Neurons." Science 220(4596): 
536-537 
Roy, R.R., Matsumoto, A., Zhong, H., Ishihara, A. and Edgerton, V.R. (2007). "Rat alpha- and 
gamma-motoneuron soma size and succinate dehydrogenase activity are independent of 
neuromuscular activity level." Muscle Nerve 36(2): 234-41 
Rudge, P. (1974). "Tourniquet paralysis with prolonged conduction block: An electro-physiological 
study." J Bone Joint Surg Br 56-B(4): 716-720 
Ruffini, A. (1898). "On the Minute Anatomy of the Neuromuscular Spindles of the Cat, and on their 
Physiological Significance." J Physiol 23(3): 190-208 3 
Rydevik, B. and Nordborg, C. (1980). "Changes in nerve function and nerve fibre structure induced 
by acute, graded compression." J Neurol Neurosurg Psychiatry 43(12): 1070-1082 
Sagot, Y., Dubois-Dauphin, M., Tan, S.A., de Bilbao, F., Aebischer, P., Martinou, J.C. and Kato, 
A.C. (1995). "Bcl-2 overexpression prevents motoneuron cell body loss but not axonal 
degeneration in a mouse model of a neurodegenerative disease." J Neurosci 15(11): 7727-33 
Sahenk, Z. and Mendell, J.R. (1979). "Ultrastructural study of zinc pyridinethione-induced 
peripheral neuropathy." J Neuropathol Exp Neurol 38(5): 532-50 
Sahenk, Z. (1990). "Distal terminal axonopathy produced by 2,4-dithiobiuret: effects of long-term 
intoxication in rats." Acta Neuropathol 81(2): 141-7 
Sajadi, A., Schneider, B.L. and Aebischer, P. (2004). "Wld
S
-mediated protection of dopaminergic 
fibers in an animal model of Parkinson disease." Curr. Biol. 14: 326-330 
Samdani, A.F., Dawson, T.M. and Dawson, V.L. (1997). "Nitric Oxide Synthase in Models of Focal 
Ischemia." Stroke 28(6): 1283-1288 
Samsam, M., Mi, W., Wessig, C., Zielasek, J., Toyka, K.V., Coleman, M.P. and Martini, R. 
(2003). "The Wlds mutation delays robust loss of motor and sensory axons in a genetic 
model for myelin-related axonopathy." J Neurosci 23(7): 2833-9 
 221 
Sanes, J.R. and Lichtman, J.W. (1999). "Development of the vertebrate neuromuscular junction." 
Ann Rev Neurosci 22(1): 389-442 
Santos, A.F. and Caroni, P. (2003). "Assembly, plasticity and selective vulnerability to disease of 
mouse neuromuscular junctions." J Neurocytol 32(5-8): 849-62 
Saper, C.B. (2008). “A Guide to the Perplexed on the Specificity of Antibodies” J Histochem 
Cytochem 57(1): 1–5 
Sasaki, S. and Iwata, M. (1996). "Synaptic loss in anterior horn neurons in lower motor neuron 
disease." Acta Neuropathol (Berl) 91(4): 416-21 
Sasaki, S. and Iwata, M. (1999). "Ultrastructural change of synapses of Betz cells in patients with 
amyotrophic lateral sclerosis." Neurosci Lett 268(1): 29-32 
Sasaki, Y., Araki, T. and Milbrandt, J. (2006). "Stimulation of Nicotinamide Adenine Dinucleotide 
Biosynthetic Pathways Delays Axonal Degeneration after Axotomy." J. Neurosci. 26(33): 
8484-8491 
Sasaki, Y., Vohra, B.P., Baloh, R.H. and Milbrandt, J. (2009a). "Transgenic mice expressing the 
Nmnat1 protein manifest robust delay in axonal degeneration in vivo." J Neurosci 29(20): 
6526-34 
Sasaki, Y., Vohra, B.P.S., Lund, F.E. and Milbrandt, J. (2009b). "Nicotinamide Mononucleotide 
Adenylyl Transferase-Mediated Axonal Protection Requires Enzymatic Activity But Not 
Increased Levels of Neuronal Nicotinamide Adenine Dinucleotide." J. Neurosci. 29(17): 
5525-5535 
Saunders, K.C., Louis, D.L., Weingarden, S.I. and Waylonis, G.W. (1979). "Effect of tourniquet 
time on postoperative quadriceps function." Clin Orthop Relat Res(143): 194-9 
Saxena, S. and Caroni, P. (2007). "Mechanisms of axon degeneration: from development to 
disease." Prog Neurobiol 83(3): 174-91 
Schaefer, A.M., Sanes, J.R. and Lichtman, J.W. (2005). "A compensatory subpopulation of motor 
neurons in a mouse model of amyotrophic lateral sclerosis." J Comp Neurol 490(3): 209-19 
Schlaepfer, W.W. and Hasler, M.B. (1979). "Characterization of the calcium-induced disruption of 
neurofilaments in rat peripheral nerve." Brain Res168(2): 299-309 
Schmalbruch, H., al-Amood, W.S. and Lewis, D.M. (1991a). "Morphology of long-term denervated 
rat soleus muscle and the effect of chronic electrical stimulation." J Physiol 441: 233-41 
Schmalbruch, H., Jensen, H.J., Bjaerg, M., Kamieniecka, Z. and Kurland, L. (1991b). "A new 
mouse mutant with progressive motor neuropathy." J Neuropathol Exp Neurol 50(3): 192-
204 
Schmidt, M., Giessl, A., Laufs, T., Hankeln, T., Wolfrum, U. and Burmester, T. (2003). "How 
does the eye breathe? Evidence for neuroglobin-mediated oxygen supply in the mammalian 
retina." J Biol Chem 278(3): 1932-5 
Schwarz, J., Planck, J., Briegel, J. and Straube, A. (1997). "Single-fiber electromyography, nerve 
conduction studies, and conventional electromyography in patients with critical-illness 
polyneuropathy: Evidence for a lesion of terminal motor axons." Muscle Nerve 20(6): 696-
701 
Scully, R.E., Shannon, J.M. and Dickersin, G.R. (1961). "Factors Involved in Recovery from 
Experimental Skeletal Muscle Ischemia Produced in Dogs: I. Histologic and Histochemical 
Pattern of Ischemic Muscle." Am J Pathol 39(6): 721-737 
Shaner, N.C., Steinbach, P.A. and Tsien, R.Y. (2005). "A guide to choosing fluorescent proteins." 
Nat Methods 2(12): 905-9 
Shepherd, G.M. (1991). Foundations of the neuron doctrine: History of Neuroscience (No 6), Oxford 
University Press 
Sherrington, C.S. (1893). "Further Experimental Note on the Correlation of Action of Antagonistic 
Muscles." Br Med J 1(1693): 1218 
Shibata, M., Ichioka, S., Ando, J. and Kamiya, A. (2001). "Microvascular and interstitial PO(2) 
measurements in rat skeletal muscle by phosphorescence quenching." J Appl Physiol 91(1): 
321-7 
Shibata, M., Ichioka, S., Ando, J., Togawa, T. and Kamiya, A. (2005). "Nonlinear Regulation of 
Capillary Perfusion in Relation to Ambient pO2 Changes in Skeletal Muscle." Eur J Appl 
Physiol 94(3): 352-355 
Shimomura, O., Johnson, F.H. and Saiga, Y. (1962). "Extraction, Purification and Properties of 
Aequorin, a Bioluminescent Protein from the Luminous Hydromedusan, Aequorea." J Cell 
Comp Physiol 59(3): 223-239 
 222 
Siesjo, B.K. (1988). "Historical overview. Calcium, ischemia, and death of brain cells." Ann N Y Acad 
Sci 522: 638-61 
Silberman, J. and Lonial, S. (2008). "Review of peripheral neuropathy in plasma cell disorders." 
Hematol Oncol 26(2): 55-65 
Silinsky, E.M. (1975). "On the association between transmitter secretion and the release of adenine 
nucleotides from mammalian motor nerve terminals." J Physiol 247(1): 145-62 
Silver, I.A. (1977). "Ion fluxes in hypoxic tissues." Microvasc Res 13(3): 409-20 
Simonin, Y., Perrin, F.E. and Kato, A.C. (2007). "Axonal involvement in the Wlds neuroprotective 
effect: analysis of pure motoneurons in a mouse model protected from motor neuron disease 
at a pre-symptomatic age." J Neurochem101(2): 530-542 
Smith, C.P. and Carroll, P.T. (1980). "A comparison of solubilized and membrane bound forms of 
choline-O-acetyltransferase (EC 2.3.1.6) in mouse brain nerve endings." Brain Res 185(2): 
363-71 
Smith, D.O. (1991). "Sources of adenosine released during neuromuscular transmission in the rat." J 
Physiol 432: 343-54 
Smith, D.R., Kobrine, A.I. and Rizzoli, H.V. (1977). "Absence of autoregulation in peripheral nerve 
blood flow." J Neurol Sci 33(3): 347-52 
Son, Y.J. and Thompson, W.J. (1995). "Schwann cell processes guide regeneration of peripheral 
axons." Neuron 14(1): 125-32 
Son, Y.J., Trachtenberg, J.T. and Thompson, W.J. (1996). "Schwann cells induce and guide 
sprouting and reinnervation of neuromuscular junctions." Trends Neurosci 19(7): 280-5 
Sonsalla, P.K., Manzino, L., Sinton, C.M., Liang, C.L., German, D.C. and Zeevalk, G.D. (1997). 
"Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia 
nigra." Brain Res773(1-2): 223-226 
Southam, E., Thomas, P.K., King, R.H.M., Goss-Sampson, M.A. and Muller, D.P.R. (1991). 
"Experimental Vitamin E deficiency in rats: Morphological and functional evidence of 
abnormal axonal transport secondary to free radical damage." Brain 114(2): 915-936 
Spaans, F., Vredeveld, J.W., Morre, H.H., Jacobs, B.C. and De Baets, M.H. (2003). "Dysfunction 
at the motor end-plate and axon membrane in Guillain-Barre syndrome: a single-fiber EMG 
study." Muscle Nerve 27(4): 426-34 
Stadler, H. and Tsukita, S. (1984). "Synaptic vesicles contain an ATP-dependent proton pump and 
show 'knob-like' protrusions on their surface." Embo J 3(13): 3333-7 
Stenger, R.J., Spiro, D., Scully, R.E. and Shannon, J.M. (1962). "Ultrastructural and physiologic 
alterations in ischemic skeletal muscle." Am J Pathol 40: 1-20 
Sterz, R., Pagala, M. and Peper, K. (1983). "Postjunctional characteristics of the endplates in 
mammalian fast and slow muscles." Pflugers Arch 398(1): 48-54 
Stewart, M.A., Passonneau, J.V. and Lowry, O.H. (1965). "Substrate changes in peripheral nerve 
during ischaemia and Wallerian degeneration." J Neurochem 12(8): 719-27 
Sudhof, T.C. (2004). "The Synaptic Vesicle Cycle." Ann Rev Neurosci 27(1): 509-547 
Sumner, B.E. and Watson, W.E. (1971). "Retraction and expansion of the dendritic tree of motor 
neurones of adult rats induced in vivo." Nature 233(5317): 273-5 
Sun, Y., Jin, K., Mao, X.O., Zhu, Y. and Greenberg, D.A. (2001). "Neuroglobin is up-regulated by 
and protects neurons from hypoxic-ischemic injury." Proc Natl Acad Sci U S A 98(26): 
15306-11 
Sun, Y., Jin, K., Peel, A., Mao, X.O., Xie, L. and Greenberg, D.A. (2003). "Neuroglobin protects 
the brain from experimental stroke in vivo." Proc Natl Acad Sci U S A 100(6): 3497-500 
Sun, Y., Jin, K., Mao, X.O., Xie, L., Peel, A., Childs, J.T., Logvinova, A., Wang, X. and 
Greenberg, D.A. (2005). "Effect of aging on neuroglobin expression in rodent brain." 
Neurobiol Aging 26(2): 275-8 
Surprenant, A., Rassendren, F., Kawashima, E., North, R.A. and Buell, G. (1996). "The Cytolytic 
P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7)." Science 
272(5262): 735-738 
Suzuki, M., McHugh, J., Tork, C., Shelley, B., Klein, S.M., Aebischer, P. and Svendsen, C.N. 
(2007). "GDNF secreting human neural progenitor cells protect dying motor neurons, but not 
their projection to muscle, in a rat model of familial ALS." PLoS ONE 2(1): e689 
Swash, M. and Fox, K.P. (1972). "The effect of age on human skeletal muscle studies of the 
morphology and innervation of muscle spindles." J Neurol Sci 16(4): 417-432 
 223 
Szabo, M., Salpeter, E.E., Randall, W. and Salpeter, M.M. (2003). "Transients in acetylcholine 
receptor site density and degradation during reinnervation of mouse sternomastoid muscle." J 
Neurochem 84(1): 180-188 
Takagi, A., Oda, K., Kikuchi, T. and Kajihara, H. (1996). "Fine structural changes of muscle 
spindles in the gracile axonal dystrophy mutant mouse." Virchows Arch 428(4-5): 289-96 
Tam, S.L. and Gordon, T. (2003). "Mechanisms controlling axonal sprouting at the neuromuscular 
junction." J Neurocytol 32(5-8): 961-74 
Tanaka, Y., Hasegawa, A. and Ando, S. (1996). "Impaired synaptic functions with aging as 
characterized by decreased calcium influx and acetylcholine release." J Neurosci Res 43(1): 
63-76 
Tannock, L.R. and King, V.L. (2008). "Proteoglycan mediated lipoprotein retention: a mechanism of 
diabetic atherosclerosis." Rev Endocr Metab Disord 9(4): 289-300 
Taylor, M.D., Holdeman, A.S., Weltmer, S.G., Ryals, J.M. and Wright, D.E. (2005). "Modulation 
of muscle spindle innervation by neurotrophin-3 following nerve injury." Exp Neurol 191(1): 
211-22 
Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A. and 
Katzman, R. (1991). "Physical basis of cognitive alterations in Alzheimer's disease: synapse 
loss is the major correlate of cognitive impairment." Ann Neurol 30(4): 572-80 
Tesfaye, S., Harris, N., Jakubowski, J.J., Mody, C., Wilson, R.M., Rennie, I.G. and Ward, J.D. 
(1993). "Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a 
novel technique of nerve photography and fluorescein angiography." Diabetologia 36(12): 
1266-74 
Tesfaye, S., Malik, R. and Ward, J.D. (1994). "Vascular factors in diabetic neuropathy." 
Diabetologia 37(9): 847-54 
Teunissen, L.L., Notermans, N.C. and Wokke, J.H. (2000). "Relationship between ischemia and 
neuropathy." Eur Neurol 44(1): 1-7 
Thomas, J.J. (1909). "Nerve Involvement in the Ischaemic Paralysis and Contracture of Volkmann." 
Ann Surg 49(3): 330-70 
Thompson, J.E. (1996). "The Evolution of Surgery for the Treatment and Prevention of Stroke: The 
Willis Lecture." Stroke 27(8): 1427-1434 
Tiraihi, T. and Rezaie, M.J. (2004). "Synaptic lesions and synaptophysin distribution change in 
spinal motoneurons at early stages following sciatic nerve transection in neonatal rats." Brain 
Res Dev Brain Res 148(1): 97-103 
Tombol, T., Pataki, G., Nemeth, A. and Hamar, J. (2002). "Ultrastructural changes of the 
neuromuscular junction in reperfusion injury." Cells Tissues Organs 170(2-3): 139-50 
Tower, S.S. (1932). "Atrophy and degeneration in the muscle spindle." Brain 55(1): 77-90 
Trachtenberg, J.T. and Thompson, W.J. (1997). "Nerve Terminal Withdrawal from Rat 
Neuromuscular Junctions Induced by Neuregulin and Schwann Cells." J. Neurosci. 17(16): 
6243-6255 
Trachtenberg, J.T., Chen, B.E., Knott, G.W., Feng, G., Sanes, J.R., Welker, E. and Svoboda, K. 
(2002). "Long-term in vivo imaging of experience-dependent synaptic plasticity in adult 
cortex." Nature 420(6917): 788-794 
Trandafir, F., Hoogewijs, D., Altieri, F., Rivetti di Val Cervo, P., Ramser, K., Van Doorslaer, S., 
Vanfleteren, J.R., Moens, L. and Dewilde, S. (2007). "Neuroglobin and cytoglobin as 
potential enzyme or substrate." Gene 398(1-2): 103-13 
Trojaborg, W., Frantzen, E. and Andersen, I. (1969). "Peripheral neuropathy and myopathy 
associated with carcinoma of the lung." Brain 92(1): 71-82 
Tsai, J., Grutzendler, J., Duff, K. and Gan, W.-B. (2004). "Fibrillar amyloid deposition leads to 
local synaptic abnormalities and breakage of neuronal branches." Nat Neurosci 7(11): 1181-
1183 
Tsao, J.W., Brown, M.C., Carden, M.J., McLean, W.G. and Perry, V.H. (1994). "Loss of the 
Compound Action Potential: an Electrophysiological, Biochemical and Morphological Study 
of Early Events in Axonal Degeneration in the C57BL/Ola Mouse." Eur J Neurosci  6(4): 
516-524 
Tsao, J.W., George, E.B. and Griffin, J.W. (1999). "Temperature Modulation Reveals Three 
Distinct Stages of Wallerian Degeneration." J. Neurosci. 19(12): 4718-4726 
Tsien, R.Y. (1998). "The Green Fluorescent Protein." Ann Rev Biochem67(1): 509-544 
 224 
Tu, P.H., Raju, P., Robinson, K.A., Gurney, M.E., Trojanowski, J.Q. and Lee, V.M. (1996). 
"Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal 
cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions." Proc. Nat. 
Acad. Sci. U.S.A. 93(7): 3155-3160 
Tuma, R.F., Irion, G.L., Vasthare, U.S. and Heinel, L.A. (1985). "Age-related changes in regional 
blood flow in the rat." Am J Physiol 249(3 Pt 2): H485-91 
Ushkaryov, Y.A., Volynski, K.E. and Ashton, A.C. (2004). "The multiple actions of black widow 
spider toxins and their selective use in neurosecretion studies." Toxicon 43(5): 527-542 
van der Putten, H., Wiederhold, K.H., Probst, A., Barbieri, S., Mistl, C., Danner, S., 
Kauffmann, S., Hofele, K., Spooren, W.P., Ruegg, M.A., Lin, S., Caroni, P., Sommer, 
B., Tolnay, M. and Bilbe, G. (2000). "Neuropathology in mice expressing human alpha-
synuclein." J Neurosci 20(16): 6021-9 
van Deursen, R.W.M. and Simoneau, G.G. (1999). "Foot and ankle sensory neuropathy, 
proprioception, and postural stability." J Orthop Sports Phys Ther 29(12): 718-726 
Vande Velde, C., Garcia, M.L., Yin, X., Trapp, B.D. and Cleveland, D.W. (2004). "The 
neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron 
disease." Neuromolecular Med 5(3): 193-203 
Vandervoort, A.A. (2002). "Aging of the human neuromuscular system." Muscle Nerve 25(1): 17-25 
Vega-Riveroll, L.J., Wylie, S.R., Loughna, P.T., Parson, S.H. and Chantler, P.D. (2005). 
"Nonmuscle myosins IIA and IIB are present in adult motor nerve terminals." Neuroreport 
16(11): 1143-6 
Verdu, E., Ceballos, D., Vilches, J.J. and Navarro, X. (2000). "Influence of aging on peripheral 
nerve function and regeneration." J Peripher Nerv Syst 5(4): 191-208 
Vial, J.D. (1958). "The early changes in the axoplasm during wallerian degeneration." J Biophys 
Biochem Cytol 4(5): 551-5 
Vincent, A.M., Russell, J.W., Low, P. and Feldman, E.L. (2004). "Oxidative stress in the 
pathogenesis of diabetic neuropathy." Endocr Rev 25(4): 612-28 
Vinik, A.I. (1999). "Diabetic neuropathy: pathogenesis and therapy." Am J Med 107(2B): 17S-26S 
Vinik, A.I., Park, T.S., Stansberry, K.B. and Pittenger, G.L. (2000). "Diabetic neuropathies." 
Diabetologia 43(8): 957-73 
Volknandt, W. and Zimmermann, H. (1986). "Acetylcholine, ATP, and proteoglycan are common 
to synaptic vesicles isolated from the electric organs of electric eel and electric catfish as well 
as from rat diaphragm." J Neurochem 47(5): 1449-62 
von Lubitz, D.K. and Diemer, N.H. (1983). "Cerebral ischemia in the rat: ultrastructural and 
morphometric analysis of synapses in stratum radiatum of the hippocampal CA-1 region." 
Acta Neuropathol 61(1): 52-60 
Waldeyer, H.W.G. (1891). ""Uber einige neuere Forschungen im Gebiete der Anatomie des 
Centralnervensystems"." Deutsche medicinische Wochenschrift 17(Dec 10): 1352-1356.Full 
translation from: Shepherd, G.M. (1991) "Foundations of the neuron doctrine: History of 
Neuoscience, No 6." pg 181-193, Oxford University Press.  
Waller, A. (1850). "Experiments on the section of glossopharyngeal and hypoglossal nerves of the 
frog and observations of the alternatives produced thereby in the structure of their primitive 
fibres." Phil. Trans. R. Soc. Lond. B 140: 423-429 
Waller, A. (1852). "Examen des alterations qui ont lieu dans les filets d'origine du nerf 
pneumogastrique et des nerfs rachidiens, par suite de la section de ces nerfs au-dessus de 
leurs ganglions." C. r. hebd. Acad. Sci (Paris) 34: 842-847.From: Shepherd, G (1991) 
Foundations of the Neuron Doctrine: History of Neuroscience (No 6), Oxford University 
Press 
Walsh, M.K. and Lichtman, J.W. (2003). "In vivo time-lapse imaging of synaptic takeover 
associated with naturally occurring synapse elimination." Neuron 37(1): 67-73 
Walsh, M.K. and Quigley, H.A. (2008). "In vivo time-lapse fluorescence imaging of individual 
retinal ganglion cells in mice." J Neurosci Methods 169(1): 214-21 
Wang, J., Zhai, Q., Chen, Y., Lin, E., Gu, W., McBurney, M.W. and He, Z. (2005). "A local 
mechanism mediates NAD-dependent protection of axon degeneration." J Cell Biol 170(3): 
349-55 
Wang, M., Wu, Y., Culver, D.G. and Glass, J.D. (2001). "The gene for slow Wallerian degeneration 
(Wld(s)) is also protective against vincristine neuropathy." Neurobiol Dis 8(1): 155-61 
 225 
Wang, M.S., Wu, Y., Culver, D.G. and Glass, J.D. (2000). "Pathogenesis of axonal degeneration: 
parallels between Wallerian degeneration and vincristine neuropathy." J Neuropathol Exp 
Neurol 59(7): 599-606 
Wang, Y., Kawamura, N., Schmelzer, J.D., Schmeichel, A.M. and Low, P.A. (2008). "Decreased 
peripheral nerve damage after ischemia-reperfusion injury in mice lacking TNF-alpha." J 
Neuro Sci 267(1-2): 107-111 
Watanabe, M., Tsukiyama, T. and Hatakeyama, S. (2007). "Protection of vincristine-induced 
neuropathy by WldS expression and the independence of the activity of Nmnat1." Neurosci 
Lett 411(3): 228-32 
Watson, D.F. and Griffin, J.W. (1987). "Vacor neuropathy: ultrastructural and axonal transport 
studies." J Neuropathol Exp Neurol 46(1): 96-108 
Wernig, A., Carmody, J.J., Anzil, A.P., Hansert, E., Marciniak, M. and Zucker, H. (1984). 
"Persistence of nerve sprouting with features of synapse remodelling in soleus muscles of 
adult mice." Neuroscience 11(1): 241-53 
Wernig, A. and Herrera, A.A. (1986). "Sprouting and remodelling at the nerve-muscle junction." 
Progr Neurobiol27(3): 251-291 
White, B.C., Sullivan, J.M., DeGracia, D.J., O'Neil, B.J., Neumar, R.W., Grossman, L.I., Rafols, 
J.A. and Krause, G.S. (2000). "Brain ischemia and reperfusion: molecular mechanisms of 
neuronal injury." J Neurol Sci 179(S 1-2): 1-33 
Whitmore, A.V., Lindsten, T., Raff, M.C. and Thompson, C.B. (2003). "The proapoptotic proteins 
Bax and Bak are not involved in Wallerian degeneration." Cell Death Differ 10(2): 260-1 
Wigston, D.J. (1989). "Remodeling of neuromuscular junctions in adult mouse soleus." J. Neurosci. 
9(2): 639-647 
Wigston, D.J. (1990). "Repeated in vivo visualization of neuromuscular junctions in adult mouse 
lateral gastrocnemius." J. Neurosci. 10(6): 1753-1761 
Williams, V. and Grossman, R.G. (1970). "Ultrastructure of cortical synapses after failure of 
presynaptic activity in ischemia." Anat Rec 166(2): 131-41 
Winlow, W. and Usherwood, P.N. (1975). "Ultrastructural studies of normal and degenerating 
mouse neuromuscular junctions." J Neurocytol 4(4): 377-94 
Winlow, W. and Usherwood, P.N. (1976). "Electrophysiological studies of normal and degenerating 
mouse neuromuscular junctions." Brain Res 110(3): 447-61 
Wishart, T.M., Parson, S.H. and Gillingwater, T.H. (2006). "Synaptic vulnerability in 
neurodegenerative disease." J Neuropathol Exp Neurol 65(8): 733-9 
Wishart, T.M., Paterson, J.M., Short, D.M., Meredith, S., Robertson, K.A., Sutherland, C., 
Cousin, M.A., Dutia, M.B. and Gillingwater, T.H. (2007). "Differential proteomics 
analysis of synaptic proteins identifies potential cellular targets and protein mediators of 
synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene." Mol 
Cell Proteomics 6(8): 1318-30 
Wishart, T.M., Pemberton, H.N., James, S.R., McCabe, C.J. and Gillingwater, T.H. (2008). 
"Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow 
Wallerian degeneration; Wlds)." Genome Biol 9(6): R101 
Woitaske, M.D. and McCarter, R.J. (1998). "Effects of fiber type on ischemia-reperfusion injury in 
mouse skeletal muscle." Plast Reconstr Surg 102(6): 2052-63 
Wong-Riley, M.T. (1989). "Cytochrome oxidase: an endogenous metabolic marker for neuronal 
activity." Trends Neurosci 12(3): 94-101 
Wood, S.J. and Slater, C.R. (1995). "Action potential generation in rat slow- and fast-twitch 
muscles." J Physiol 486 ( Pt 2): 401-10 
Wood, S.J. and Slater, C.R. (1997). "The contribution of postsynaptic folds to the safety factor for 
neuromuscular transmission in rat fast- and slow-twitch muscles." J Physiol 500 ( Pt 1): 165-
76 
Wood, S.J. and Slater, C.R. (2001). "Safety factor at the neuromuscular junction." Prog Neurobiol 
64(4): 393-429 
Wuerker, R.B. and Kirkpatrick, J.B. (1972). "Neuronal microtubules, neurofilaments, and 
microfilaments." Int Rev Cytol 33: 45-75 
Wylie, S.R. and Chantler, P.D. (2003). "Myosin IIA drives neurite retraction." Mol Biol Cell 14(11): 
4654-66 
 226 
Wystub, S., Laufs, T., Schmidt, M., Burmester, T., Maas, U., Saaler-Reinhardt, S., Hankeln, T. 
and Reuss, S. (2003). "Localization of neuroglobin protein in the mouse brain." Neurosci 
Lett 346(1-2): 114-6 
Xu, T. and Bajjalieh, S.M. (2001). "SV2 modulates the size of the readily releasable pool of 
secretory vesicles." Nat Cell Biol 3(8): 691-8 
Yahata, N., Yuasa, S. and Araki, T. (2009). "Nicotinamide mononucleotide adenylyltransferase 
expression in mitochondrial matrix delays Wallerian degeneration." J Neurosci 29(19): 6276-
84 
Yakovlev, A.G. and Faden, A.I. (2004). "Mechanisms of Neuronal Cell Death: Implications for 
Development of Neuroprotective Strategies." NeuroRX 1(1): 5-16 
Yao, J. and Bajjalieh, S.M. (2008). "Synaptic vesicle protein 2 (SV2) binds adenine nucleotides." J 
Biol Chem 
Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I.P., Naylor, A., Bountra, C., Banati, R.R. 
and Anand, P. (2006). "COX-2, CB2 and P2X7-immunoreactivities are increased in 
activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis 
spinal cord." BMC Neurol 6: 12 
Yiannikas, C., McLeod, J.G. and Walsh, J.C. (1983). "Peripheral neuropathy associated with 
polycythemia vera." Neurology 33(2): 139-43.From Teunissen, L.L., Notermans, N.C. and 
Wokke, J.H. (2000). "Relationship between ischemia and neuropathy." Eur Neurol 44(1): 1-7 
 
Yin, X., Kidd, G.J., Pioro, E.P., McDonough, J., Dutta, R., Feltri, M.L., Wrabetz, L., Messing, 
A., Wyatt, R.M., Balice-Gordon, R.J. and Trapp, B.D. (2004). "Dysmyelinated lower 
motor neurons retract and regenerate dysfunctional synaptic terminals." J Neurosci 24(15): 
3890-8 
Yoshikawa, H., Tarui, S. and Hashimoto, P.H. (1985). "Diminished retrograde transport causes 
axonal dystrophy in the nucleus gracilis. Electron- and light-microscopic study." Acta 
Neuropathol 68(2): 93-100 
Younger, A.S., Kalla, T.P., McEwen, J.A. and Inkpen, K. (2005). "Survey of tourniquet use in 
orthopaedic foot and ankle surgery." Foot Ankle Int 26(3): 208-17 
Zang da, W., Lopes, E.C. and Cheema, S.S. (2005). "Loss of synaptophysin-positive boutons on 
lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H 
transgenic mouse model of ALS." J Neurosci Res 79(5): 694-9 
Zeevalk, G.D., Manzino, L., Hoppe, J. and Sonsalla, P. (1997). "In vivo vulnerability of dopamine 
neurons to inhibition of energy metabolism." Eur J Pharmacol 320(2-3): 111-9 
Zefirov, A. L.,  Abdrakhmanov, M. M., and Grigor’ev, P. N. (2006) “Effects of High-Potassium 
Solutions and Caffeine on Synaptic Vesicle Exoendocytosis Processes in the Frog 
Neuromuscular Junction” Neurosci Behav Physio, 36( 7):781-788 
Zhai, Q., Wang, J., Kim, A., Liu, Q., Watts, R., Hoopfer, E., Mitchison, T., Luo, L. and He, Z. 
(2003). "Involvement of the ubiquitin-proteasome system in the early stages of wallerian 
degeneration." Neuron 39(2): 217-25 
Zhang, J.P. (1995). "Free Fatty Acids, Neutral Glycerides, and Phosphoglycerides in Transient Focal 
Cerebral Ischemia." J Neurochem 64(4): 1688-1695 
Zhang, S., Boyd, J., Delaney, K. and Murphy, T.H. (2005). "Rapid reversible changes in dendritic 
spine structure in vivo gated by the degree of ischemia." J Neurosci 25(22): 5333-8 
Zhang, Y. and Lipton, P. (1999). "Cytosolic Ca
2+
 Changes during In Vitro Ischemia in Rat 




 Release from 
Mitochondria." J. Neurosci. 19(9): 3307-3315 
Zhu, X., Heunks, L.M., Ennen, L., Machiels, H.A., Van Der Heijden, H.F. and Dekhuijzen, P.N. 
(2006). "Nitric oxide modulates neuromuscular transmission during hypoxia in rat 
diaphragm." Muscle Nerve 33(1): 104-12 
Zollman, P.J., Awad, O., Schmelzer, J.D. and Low, P.A. (1991). "Effect of ischemia and 
reperfusion in vivo on energy metabolism of rat sciatic-tibial and caudal nerves." Exp Neurol 
114(3): 315-20 
Zubay, G. (1998). Biochemistry: Fourth Edition, WCB/McGraw-Hill 
Zuchner, S., Mersiyanova, I.V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E.L., 
Zappia, M., Nelis, E., Patitucci, A., Senderek, J., Parman, Y., Evgrafov, O., Jonghe, 
P.D., Takahashi, Y., Tsuji, S., Pericak-Vance, M.A., Quattrone, A., Battaloglu, E., 
Polyakov, A.V., Timmerman, V., Schroder, J.M. and Vance, J.M. (2004). "Mutations in 
 227 
the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A." Nat 














In the following appendix is the tabulated data for Chapters 2 and 3which includes raw data, % data 
and summary statistics. Tables 1-3 show -motor nerve terminal response, Tables 4 show 
observations of muscle spindle innervation.  
 
 Table 1: -motor nerve terminals response from 8-12wk old C57Bl/6 mice 
a) Lumbrical control data 
b) Lumbrical 2H-2R data 
c) TA control data 
d) TA 2H-2R data 
e) TS control data 
f) TS 2H-2R data 
 
Table 2: -motor nerve terminals response from 5-6wk old C57Bl/6 mice 
a) Lumbrical control data 
b) Lumbrical 2H-2R data 
c) TA control data 
d) TA 2H-2R data 
e) TS control data 
f) TS 2H-2R data 
 
 
Table 3: -motor nerve terminals response from 5-6wk old „ Wld
s
‟ mice 
a) Lumbrical control data 
b) Lumbrical 2H-2R data 
c) TA control data 
d) TA 2H-2R data 
e) TS control data 
f) TS 2H-2R data 
 
Table 4: Observations of IA nerve terminal and -NMJ from lumbrical muscles 
a) 8-12wk old C57Bl/6 control data 
b) 8-12wk old C57Bl/6 2H-2R data 
c) 5-6wk old C57Bl/6 control data 
d) 5-6wk old C57Bl/6 2H-2R data 
e) 5-6wk old  Wlds control data 
f) 5-6wk old Wlds 2H-2R data 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































IA/II ending -NMJ IA/II ending -NMJ
1 1 yes yes
2 2 yes yes
3 3 no yes
4 4 no yes
1 yes yes 1 yes yes
2 no yes 2 yes no
3 no yes 3 yes yes
4 no yes 4 no no
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 yes yes 3 yes yes
4 no yes 4 no yes
1 yes yes 1 yes yes
2 no yes 2 yes yes
3 yes yes 3 yes yes
4 no yes 4 no yes
1 yes yes 1 no no
2 no yes 2 yes yes
3 yes yes 3 yes yes
4 no yes 4 no yes
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 yes yes 3 no no
4 yes yes 4 yes yes
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 yes yes 3 no yes
4 yes yes 4 no yes
6 7
24 28
IA/II ending -NMJ IA/II ending -NMJ
16 24 18 24












Table 4(a) Observed presence of muscle 
spindle innervations in control lumbrical 
muscle from 8-12wks C57Bl/6 mice 
excluded
Table 4(b) Observed presence of muscle 
spindle innervations in 2H-2R lumbrical 
muscle from 8-12wks C57Bl/6 mice 
NOTES: The total number of muscles observed with at least 1 morphologically normal IA/II nerve terminal 


























1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 yes yes 3 yes yes
4 yes yes 4 no yes
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 yes yes 3 yes yes
4 yes yes 4 no no
1 yes yes 1 no yes
2 yes yes 2 no yes
3 yes yes 3 yes yes
4 yes yes 4 no yes
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 yes yes 3 no yes
4 yes yes 4 no no
4 4
16 16
IA/II ending -NMJ IA/II ending -NMJ
16 16 9 14
100 100 56.25 87.5% Total 'yes' % Total 'yes'
NOTES: The total number of muscles observed with at least 1 morphologically normal IA/II nerve 
terminal endings and/or g-NMJ in the 'Total yes' rows. '% mean yes' values calculated by ('total 
yes'/'muscle (n)')x100).
Statistics Statistics
Total 'yes' Total 'yes'
animals (N ) animals (N )






Table 4(c) Observed presence of muscle 
spindle innervations in control lumbrical 
muscle from 5-6wks C57Bl/6 mice 
Table 4(d) Observed presence of 
muscle spindle innervations in 2H-2R 








IA/II ending -NMJ IA/II ending -NMJ
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 yes yes 3 yes yes
4 yes no 4 yes no
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 no yes 3 no yes
4 no no 4 no yes
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 yes yes 3 yes yes
4 no yes 4 no yes
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 yes yes 3 yes yes
4 yes yes 4 no yes
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 no yes 3 yes yes
4 no no 4 yes yes
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 yes yes 3 no yes
4 no yes 4 no no
1 yes yes 1 yes yes
2 yes yes 2 yes yes
3 yes yes 3 yes yes
4 yes yes 4 yes yes
7 7
28 28
IA/II ending -NMJ IA/II ending -NMJ
22 25 22 26
78.6 89.3 78.6 92.9% Total 'yes' % Total 'yes'
NOTES: The total number of muscles observed with at least 1 morphologically normal IA/II nerve terminal 
endings and/or g-NMJ in the 'Total yes' rows. '% mean yes' values calculated by ('total yes'/'muscle 
(n)')x100).
Statistics Statistics
Total 'yes' Total 'yes'
animals (N ) animals (N )









Table 4(e) Observed presence of muscle 
spindle innervations in control lumbrical 
muscle from 5-6wks Wlds mice 
Table 4(f) Observed presence of muscle spindle 
innervations in 2H-2R lumbrical muscle from 5-
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Full copies of the following papers can be found as PDF files on attached DVD. 
 
Baxter B, Gillingwater TH, Parson SH (2008) “Rapid loss of motor nerve terminals following 
hypoxia-reperfusion injury occurs via mechanisms distinct from classic Wallerian 
degeneration.” Journal of Anatomy 212(6):827-835 
 
Motor nerve terminals are known to be vulnerable to a wide range of pathological stimuli. To 
further characterize this vulnerability, we have developed a novel model system to examine 
the response of mouse motor nerve terminals in ex vivo nerve/muscle preparations to 2 h 
hypoxia followed by 2 h reperfusion. This insult induced a rapid loss of neurofilament and 
synaptic vesicle protein immunoreactivity at pre-synaptic motor nerve terminals but did not 
appear to affect post-synaptic endplates or muscle fibres. The severity of nerve terminal loss 
was dependent on the age of the mouse and muscle type: in 8-12-week-old mice the 
predominantly fast-twitch lumbrical muscles showed an 82.5% loss, whereas the 
predominantly slow-twitch muscles transversus abdominis and triangularis sterni showed a 
57.8% and 27.2% loss, respectively. This was contrasted with a > 97% loss in the 
predominantly slow-twitch muscles from 5-6-week-old mice. We have also demonstrated 
that nerve terminal loss occurs by a mechanism distinct from Wallerian degeneration, as the 
slow Wallerian degeneration (Wld(s)) gene did not modify the extent of nerve terminal 
pathology. Together, these data show that our new model of hypoxia-reperfusion injury is 
robust and repeatable, that it induces rapid, quantitative changes in motor nerve terminals and 
that it can be used to further examine the mechanisms regulating nerve terminal vulnerability 
in response to hypoxia-reperfusion injury. 
 
Bettini NL, Moores TS, Baxter B, Deuchars J, Parson SH (2007) “Dynamic remodelling of 
synapses can occur in the absence of the parent cell body.” BMC Neurosci Sep 26; 8:79 
 
BACKGROUND: Retraction of nerve terminals is a characteristic feature of development, 
injury and insult and may herald many neurodegenerative diseases. Although morphological 
events have been well characterized, we know relatively little about the nature of the 
underlying cellular machinery. Evidence suggests a strong local component in determining 
which neuronal branches and synapses are lost, but a greater understanding of this basic 
neurological process is required. Here we test the hypothesis that nerve terminals are semi-
autonomous and able to rapidly respond to local stimuli in the absence of communication 
with their parent cell body. RESULTS: We used an isolated preparation consisting of distal 
peripheral nerve stumps, associated nerve terminals and post-synaptic muscle fibres, 
maintained in-vitro for up to 3 hrs. In this system synapses are intact but the presynaptic 
nerve terminal is disconnected from its cell soma. In control preparations synapses were 
stable for extended periods and did not undergo Wallerian degeneration. In contrast, addition 
of purines triggers rapid changes at synapses. Using fluorescence and electron microscopy 
we observe ultrastructural and gross morphological events consistent with nerve terminal 
retraction. We find no evidence of Wallerian or Wallerian-like degeneration in these 
preparations. Pharmacological experiments implicate pre-synaptic P2X7 receptor subunits as 
key mediators of these events. CONCLUSION: The data presented suggest; first that isolated 
nerve terminals are able to regulate connectivity independent of signals from the cell body, 
second that synapses exist in a dynamic state, poised to shift from stability to loss by 
activating intrinsic mechanisms and molecules, and third that local purines acting at 
purinergic receptors can trigger these events. A role for ATP receptors in this is not 
surprising since they are frequently activated during cellular injury, when adenosine tri-
phosphate is released from damaged cells. Local control demands that the elements necessary 
to drive retraction are constitutively present. We hypothesize that pre-existing scaffolds of 
 241 
molecular motors and cytoskeletal proteins could provide the dynamism required to drive 
such structural changes in nerve terminals in the absence of the cell body. 
 
Baxter RL, Deuchars J, Parson SH (2005) “A2A Adenosine Receptors are Located on Presynaptic 
Motor Nerve Terminals in the Mouse”. Synapse 57:229-234 
 
Extracellular adenosine is present at the mammalian neuromuscular junction (NMJ) by virtue 
of its release from activated nerve terminals and muscle fibres, and as a metabolite of 
adenosine tri-phosphate, which is coreleased with acetylcholine. Two activities for adenosine 
have been described: an inhibitory effect presumed to be modulated by the A1 receptor 
subtype, and a facilitatory effect mediated by the A2A receptor subtype. To date, only 
pharmacological evidence is available for these actions. We have used an antibody against 
the A2A receptor subtype, and demonstrated that A2A receptors are present on presynaptic 
motor nerve terminals at NMJs but not on associated glial or muscle cells, in the mouse. 
These results therefore provide additional evidence that there are multiple adenosine 
receptors present at the NMJ, and that stimulation of quantal and nonquantal release of 




B. Baxter, M.J. Parsons, T. H. Gillingwater & S. H. Parson (2009) “Hypoxia induces rapid and 
selective injury to  -motor nerve terminals.” Journal of Anatomy.(awaiting publication) PX 
Intra-uterine environment and Placentation , University of Nottingham 2-4 July 2008, 
Anatomical Society of Great Britain & Ireland 
A growing body of evidence shows that presynaptic nerve terminals throughout the nervous 
system are vulnerable to a range of traumatic, toxic and disease-related neurodegenerative 
stimuli. Using a novel ex vivo model, we have recently shown that -motor nerve terminals 
in several mouse muscles are highly susceptible to hypoxia-reperfusion injury. 2hr hypoxia 
(<0.25% O2) followed by 2hr reperfusion in lumbrical muscles triggered loss of 
neurofilament 168kDa (NF) and synaptic vesicle 2 (SV2) protein immunoreactivity in 82.5% 
(n=28) of presynaptic -motor nerve terminals. This insult did not appear to affect post-
synaptic endplates or muscle fibres.  We also established that this loss of -motor nerve 
terminal morphology occurs by a mechanism distinct from Wallerian degeneration, as the 
slow Wallerian degeneration (Wld
s
) gene did not protect nerve terminals from these 
pathological changes. We now show that 1A muscle spindle afferents and -motor terminals 
appear to be more resistant to hypoxia-reperfusion injury compared with -motor nerve 
terminals. Furthermore, we now demonstrate that significant loss of -motor nerve terminals 
in mouse lumbrical muscles occurs in response to hypoxia alone, without reperfusion. A time 
series analysis shows that loss of NF/ SV2 immunoreactivity in -motor nerve terminals first 
appears after a 1.5hr hypoxia insult and significant loss appears after 2hr, 23% (n=20) and 
44.1% (n=20) loss respectively. Collectively, this data suggests that -motor nerve terminals 
are highly and selectively vulnerable to hypoxic injury and that pathology is rapidly induced 
within 1.5hr of hypoxia alone. These findings may have clinical implications for the use of 
surgical tourniquets and in the etiology of many neurodegenerative diseases where 




Baxter, B.; Gillingwater, T. H.; Parson, S. H (2008). “Vulnerability of motor nerve terminals to 
hypoxia.” Journal of Anatomy. 212(1):81. P2 Advances in Stem Cell Biology,  University of 
Durham  3-5 July 2007 Anatomical Society of Great Britain & Ireland 
Damage to neurons caused by ischemia and/or ischaemia-reperfusion injuries are now 
thought to contribute to the neurological defects seen as a consequence of surgery, cardio-
pulmonary failure and stroke. There is growing evidence to indicate that that compared with 
the axon and cell body, the nerve terminal/synaptic compartment of neurons is especially 
vulnerable to functional and morphological changes in response to pathological stimuli. To 
investigate if nerve terminals are vulnerable to ischaemic-reperfusion injury we have 
developed at ex-vivo model utilizing the mouse neuromuscular junction. Preliminary work 
has been based on the hypoxic element of ischaemia as this is largely believed to be the most 
damaging. This work suggests that 2 hours of hypoxia can selectively trigger rapid disruption 
and apparent loss of motor nerve terminal morphology. The heterogeneity of the 
morphological responses to hypoxia indicates that a) several mechanism of loss may be 
active and b) these mechanisms may, at least in part, be controlled locally.  It is likely that 
these morphological changes would have an adverse affect on synaptic function and 
connectivity. This therefore, may contribute to some of the punitive symptoms following 





Baxter, R.; Parson, S. H (2007) “Does hypoxia prime mouse motor nerve terminal loss?” Journal of 
Anatomy. 210(5):626-627.P14 Neuroanatomy: Centenary of Cajal,  University of Madrid, 13-
15th September 2005, Joint Meeting of the Anatomical Society of Great Britain and Ireland 
and the Spanish Anatomical Society 
Changes to or loss of synaptic connectivity as a result of neuronal death causes either 
aberrant or complete loss of function of post-synaptic targets. It is this loss of synaptic 
connectivity that causes the punitive symptoms seen in neuropathological disorders. 
Recently, changes to and loss of nerve terminals has been shown to occur before cell body 
death and prior to the manifestation of clinical symptoms in a number of neuropathies, e.g., 
Alzheimer's disease. Understanding the mechanisms and triggers of nerve terminal loss are 
therefore of key importance. Using the neuromuscular junction as a model synapse, mouse 
skeletal muscle explants with long distal nerve stumps were maintained for >3hous. We have 
shown that nerve terminals appear to be quickly lost in response to adenosine triphosphate 
(ATP) and hypoxia. In wild type mice, this appears as a significant reduction to 
neurofilament and synaptic vesicle immunoreactivity, indicative of gross morphological 
change in >3 hours. Real time monitoring of nerve terminals using transgenic Thy-
1/16(YFP)/C57Bl mice that express yellow fluorescent protein in all their neurons reveal that 
degenerative changes can occur over minute timescales. This work suggests that nerve 
terminals may be very quickly lost during ischemia where increases in extracellular ATP are 
coupled with reduced oxygen availability. Using YFP transgenic mice we will investigate 
previous unpublished findings that 3'-O-(4-benzoyl)benzoyl adenosine triphosphate (BzATP) 
causes adult motor nerve terminal withdrawal. Future work will include investigations into 
the morphological and cellular events induced by ischaemic insult, and in particular, the 
involvement of the cytoskeletal as a possible mediator of nerve terminal stability, 
degeneration and withdrawal. 
 
